DOI,paper_doi,paper_title,count_atlas,Publication_PMID,Publication_link_x,count_lnpdb,Index,LNP_ID,Experiment_ID,Formulation_ID,IL_name,IL_SMILES,IL_protonated_SMILES,IL_head_name,IL_head_SMILES,IL_linker_name,IL_linker_SMILES,IL_tail1_name,IL_tail1_SMILES,IL_tail2_name,IL_tail2_SMILES,IL_tail3_name,IL_tail3_SMILES,IL_tail4_name,IL_tail4_SMILES,IL_molratio,IL_to_nucleicacid_massratio,IL_to_nucleicacid_chargeratio,HL_name,HL_SMILES,HL_molratio,CHL_name,CHL_SMILES,CHL_molratio,PEG_name,PEG_SMILES,PEG_molratio,fifthcomponent_name,fifthcomponent_SMILES,fifthcomponent_molratio,Aqueous_buffer,Dialysis_buffer,Mixing_method,Model,Model_type,Model_target,Route_of_administration,Cargo,Cargo_type,Dose_ug_nucleicacid,Experiment_method,Experiment_batching,Experiment_value,Publication_link_y,Heavy.Atoms,Rings,Aromatic.Rings,Rotatable.Bonds,van.der.Waals.Molecular.Volume,Topological.Polar.Surface.Area,Hydrogen.Bond.Donors,Hydrogen.Bond.Acceptors,LogP,Molar.Refractivity,Fraction.sp3.Carbons,sp3.Carbons,Nitrogen.Count,Molecular.Weight,has_ester,has_carbonate,has_disulfide
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3881,LNP_0003881,LM_2019,LM_2019_F1,A12Iso52DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OCC)N1CCCN(C)C,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OCC)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,4.472089488,https://www.nature.com/articles/s41587-019-0247-3,50,1,0,36,699.664179,45.14,0,5,13.0275,220.425,0.866666667,1,3,700.194,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3882,LNP_0003882,LM_2019,LM_2019_F2,A2Iso52DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OCC)N1CCCN1CCCC1,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OCC)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,4.463215259,https://www.nature.com/articles/s41587-019-0247-3,52,2,0,36,725.679829,45.14,0,5,13.5617,227.545,0.872340426,1,3,726.232,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3883,LNP_0003883,LM_2019,LM_2019_F3,A3Iso52DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CCCNCC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,3.878274157,https://www.nature.com/articles/s41587-019-0247-3,53,0,0,41,745.7060438,70.67,2,5,12.801,231.6854,0.872340426,0,3,746.263,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3884,LNP_0003884,LM_2019,LM_2019_F4,A5Iso52DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OCC)N1CCN(C)C,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OCC)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,2.565824307,https://www.nature.com/articles/s41587-019-0247-3,49,1,0,35,685.6485289,45.14,0,5,12.6374,215.808,0.863636364,1,3,686.167,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3885,LNP_0003885,LM_2019,LM_2019_F5,A1Iso52DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OCC)N1CCN(CC)CC,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OCC)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,3.15785114,https://www.nature.com/articles/s41587-019-0247-3,51,1,0,37,713.679829,45.14,0,5,13.4176,225.042,0.869565217,1,3,714.221,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3886,LNP_0003886,LM_2019,LM_2019_F6,A4Iso52DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,3.188261707,https://www.nature.com/articles/s41587-019-0247-3,51,0,0,38,717.6747436,61.88,1,5,11.9729,222.4617,0.866666667,0,3,718.209,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3887,LNP_0003887,LM_2019,LM_2019_F7,A6Iso52DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.444794102,https://www.nature.com/articles/s41587-019-0247-3,52,0,0,39,731.6903937,61.88,1,5,12.363,227.0787,0.869565217,0,3,732.236,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3888,LNP_0003888,LM_2019,LM_2019_F8,A8Iso52DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N1CCN(C)CC1,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.384572443,https://www.nature.com/articles/s41587-019-0247-3,51,1,0,35,715.6590936,61.88,1,5,11.7269,220.3477,0.866666667,0,3,716.193,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3889,LNP_0003889,LM_2019,LM_2019_F9,A7Iso52DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.999820445,https://www.nature.com/articles/s41587-019-0247-3,52,0,0,39,731.6903937,61.88,1,5,12.363,227.0787,0.869565217,0,3,732.236,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3890,LNP_0003890,LM_2019,LM_2019_F10,A11Iso52DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.738483578,https://www.nature.com/articles/s41587-019-0247-3,50,0,0,38,704.6431092,78.87,2,5,11.7937,215.6105,0.863636364,0,2,705.166,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3891,LNP_0003891,LM_2019,LM_2019_F11,A9Iso52DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCN(CC)CC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.479232867,https://www.nature.com/articles/s41587-019-0247-3,53,0,0,40,745.7060438,61.88,1,5,12.7531,231.6957,0.872340426,0,3,746.263,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3892,LNP_0003892,LM_2019,LM_2019_F12,A10Iso52DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)[N+](C)(CCO)[H],A10,CNCCO,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.191489397,https://www.nature.com/articles/s41587-019-0247-3,49,0,0,37,690.6274591,78.87,2,5,11.4036,210.9935,0.860465116,0,2,691.139,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3893,LNP_0003893,LM_2019,LM_2019_F13,A3Iso62DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CCCNCC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,3.711520803,https://www.nature.com/articles/s41587-019-0247-3,55,0,0,40,773.7373439,70.67,2,5,13.5796,240.8974,0.87755102,0,3,774.317,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3894,LNP_0003894,LM_2019,LM_2019_F14,A2Iso62DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCCN1CCCC1,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,3.635545379,https://www.nature.com/articles/s41587-019-0247-3,54,2,0,35,753.7111292,45.14,0,5,14.3403,236.757,0.87755102,1,3,754.286,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3895,LNP_0003895,LM_2019,LM_2019_F15,A12Iso62DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCCN(C)C,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,3.546299668,https://www.nature.com/articles/s41587-019-0247-3,52,1,0,35,727.6954791,45.14,0,5,13.8061,229.637,0.872340426,1,3,728.248,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3896,LNP_0003896,LM_2019,LM_2019_F16,A5Iso62DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCN(C)C,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.726660714,https://www.nature.com/articles/s41587-019-0247-3,51,1,0,34,713.679829,45.14,0,5,13.416,225.02,0.869565217,1,3,714.221,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3897,LNP_0003897,LM_2019,LM_2019_F17,A1Iso62DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCN(CC)CC,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,3.844042837,https://www.nature.com/articles/s41587-019-0247-3,53,1,0,36,741.7111292,45.14,0,5,14.1962,234.254,0.875,1,3,742.275,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3898,LNP_0003898,LM_2019,LM_2019_F18,A2Iso92DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCCN1CCCC1)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NCS(=O)(=O)c1ccc(C)cc1,A2,C1CCN(C1)CCCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,2.001818663,https://www.nature.com/articles/s41587-019-0247-3,58,2,1,39,825.6781148,78.51,2,5,13.73172,251.3032,0.784313725,0,3,826.374,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3899,LNP_0003899,LM_2019,LM_2019_F19,A1Iso92DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCN(CC)CC)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NCS(=O)(=O)c1ccc(C)cc1,A1,CCN(CC)CCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,3.737306236,https://www.nature.com/articles/s41587-019-0247-3,57,1,1,40,813.6781148,78.51,2,5,13.58762,248.8002,0.78,0,3,814.363,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3900,LNP_0003900,LM_2019,LM_2019_F20,A5Iso92DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCN(C)C)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCC[N+](C)(C)[H])C(=O)NCS(=O)(=O)c1ccc(C)cc1,A5,CN(C)CCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,3.820367389,https://www.nature.com/articles/s41587-019-0247-3,55,1,1,38,785.6468146,78.51,2,5,12.80742,239.5662,0.770833333,0,3,786.309,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3901,LNP_0003901,LM_2019,LM_2019_F21,A12Iso92DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCCN(C)C)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCC[N+](C)(C)[H])C(=O)NCS(=O)(=O)c1ccc(C)cc1,A12,CN(C)CCCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.456197424,https://www.nature.com/articles/s41587-019-0247-3,56,1,1,39,799.6624647,78.51,2,5,13.19752,244.1832,0.775510204,0,3,800.336,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3902,LNP_0003902,LM_2019,LM_2019_F22,A9Iso92DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCN(CC)CC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.345332765,https://www.nature.com/articles/s41587-019-0247-3,58,1,1,40,827.6937648,69.72,1,5,13.92982,253.4275,0.784313725,0,3,828.39,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3903,LNP_0003903,LM_2019,LM_2019_F23,A8Iso92DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N1CCN(C)CC1,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.088669003,https://www.nature.com/articles/s41587-019-0247-3,56,2,1,35,797.6468146,69.72,1,5,12.90362,242.0795,0.775510204,0,3,798.32,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3904,LNP_0003904,LM_2019,LM_2019_F24,A3Iso92DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CCCNCC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,2.180686648,https://www.nature.com/articles/s41587-019-0247-3,58,1,1,41,827.6937648,78.51,2,5,13.97772,253.4172,0.784313725,0,3,828.39,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3905,LNP_0003905,LM_2019,LM_2019_F25,A6Iso92DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.637111397,https://www.nature.com/articles/s41587-019-0247-3,57,1,1,39,813.6781148,69.72,1,5,13.53972,248.8105,0.78,0,3,814.363,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3906,LNP_0003906,LM_2019,LM_2019_F26,A7Iso92DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.068285818,https://www.nature.com/articles/s41587-019-0247-3,57,1,1,39,813.6781148,69.72,1,5,13.53972,248.8105,0.78,0,3,814.363,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3907,LNP_0003907,LM_2019,LM_2019_F27,A4Iso92DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,2.107374246,https://www.nature.com/articles/s41587-019-0247-3,56,1,1,38,799.6624647,69.72,1,5,13.14962,244.1935,0.775510204,0,3,800.336,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3908,LNP_0003908,LM_2019,LM_2019_F28,A11Iso62DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)[N+](CC)(CCO)[H],A11,CCNCCO,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.498663101,https://www.nature.com/articles/s41587-019-0247-3,52,0,0,37,732.6744093,78.87,2,5,12.5723,224.8225,0.869565217,0,2,733.22,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3909,LNP_0003909,LM_2019,LM_2019_F29,A9Iso62DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCN(CC)CC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.581922521,https://www.nature.com/articles/s41587-019-0247-3,55,0,0,39,773.7373439,61.88,1,5,13.5317,240.9077,0.87755102,0,3,774.317,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3910,LNP_0003910,LM_2019,LM_2019_F30,A11Iso92DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)[N+](CC)(CCO)[H],A11,CCNCCO,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.583119163,https://www.nature.com/articles/s41587-019-0247-3,55,1,1,38,786.6308302,86.71,2,5,12.97042,237.3423,0.770833333,0,2,787.293,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3911,LNP_0003911,LM_2019,LM_2019_F31,A6Iso62DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.374199832,https://www.nature.com/articles/s41587-019-0247-3,54,0,0,38,759.7216938,61.88,1,5,13.1416,236.2907,0.875,0,3,760.29,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3912,LNP_0003912,LM_2019,LM_2019_F32,A4Iso62DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,3.596488941,https://www.nature.com/articles/s41587-019-0247-3,53,0,0,37,745.7060438,61.88,1,5,12.7515,231.6737,0.872340426,0,3,746.263,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3913,LNP_0003913,LM_2019,LM_2019_F33,A7Iso62DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.541999553,https://www.nature.com/articles/s41587-019-0247-3,54,0,0,38,759.7216938,61.88,1,5,13.1416,236.2907,0.875,0,3,760.29,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3914,LNP_0003914,LM_2019,LM_2019_F34,A8Iso62DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N1CCN(C)CC1,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.226941316,https://www.nature.com/articles/s41587-019-0247-3,53,1,0,34,743.6903937,61.88,1,5,12.5055,229.5597,0.872340426,0,3,744.247,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3915,LNP_0003915,LM_2019,LM_2019_F35,A10Iso92DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)[N+](C)(CCO)[H],A10,CNCCO,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.466904932,https://www.nature.com/articles/s41587-019-0247-3,54,1,1,37,772.6151802,86.71,2,5,12.58032,232.7253,0.765957447,0,2,773.266,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3916,LNP_0003916,LM_2019,LM_2019_F36,A10Iso62DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)[N+](C)(CCO)[H],A10,CNCCO,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.27878529,https://www.nature.com/articles/s41587-019-0247-3,51,0,0,36,718.6587592,78.87,2,5,12.1822,220.2055,0.866666667,0,2,719.193,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3917,LNP_0003917,LM_2019,LM_2019_F37,A1Iso12DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCN(CC)CC)C(=O)NC(C)(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NC(C)(C)C,A1,CCN(CC)CCN,Iso1,CC(C)(C)[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.177608588,https://www.nature.com/articles/s41587-019-0247-3,50,0,0,37,701.7162145,44.37,2,3,13.6463,225.3214,0.891304348,0,3,702.254,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3918,LNP_0003918,LM_2019,LM_2019_F38,A1Iso22DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCN(CC)CC)C(=O)NCCCC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NCCCC,A1,CCN(CC)CCN,Iso2,CCCC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.488716131,https://www.nature.com/articles/s41587-019-0247-3,50,0,0,40,701.7162145,44.37,2,3,13.6479,225.3434,0.891304348,0,3,702.254,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3919,LNP_0003919,LM_2019,LM_2019_F39,A1Iso32DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCN(CC)CC)C(=O)NCCCCC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NCCCCC,A1,CCN(CC)CCN,Iso3,CCCCC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.379821543,https://www.nature.com/articles/s41587-019-0247-3,51,0,0,41,715.7318646,44.37,2,3,14.038,229.9604,0.893617021,0,3,716.281,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3920,LNP_0003920,LM_2019,LM_2019_F40,A1Iso42DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OC)N1CCN(CC)CC,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OC)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso4,[C-]#[N+]CC(=O)OC,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.749568192,https://www.nature.com/articles/s41587-019-0247-3,50,1,0,36,699.664179,45.14,0,5,13.0275,220.425,0.866666667,1,3,700.194,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3921,LNP_0003921,LM_2019,LM_2019_F41,A1Iso72DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCN(CC)CC,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.480471016,https://www.nature.com/articles/s41587-019-0247-3,54,1,0,36,755.7267792,45.14,0,5,14.5863,238.871,0.87755102,1,3,756.302,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3922,LNP_0003922,LM_2019,LM_2019_F42,A1Iso82DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(CC(=O)OCC)N1CCN(CC)CC,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(CC(=O)OCC)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso8,CCOC(=O)CC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.177443084,https://www.nature.com/articles/s41587-019-0247-3,52,1,0,38,727.6954791,45.14,0,5,13.8077,229.659,0.872340426,1,3,728.248,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3923,LNP_0003923,LM_2019,LM_2019_F43,A1Iso102DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCN(CC)CC)C(=O)NC1CCCCC1,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NC1CCCCC1,A1,CCN(CC)CCN,Iso10,[C-]#[N+]C1CCCCC1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.775166623,https://www.nature.com/articles/s41587-019-0247-3,52,1,0,38,727.7318646,44.37,2,3,14.1805,232.4414,0.895833333,0,3,728.292,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3924,LNP_0003924,LM_2019,LM_2019_F44,A1Iso1C11,CCCCCCCCCCC(CCCCCCCCCC)(NCCN(CC)CC)C(=O)NC(C)(C)C,CCCCCCCCCCC(CCCCCCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NC(C)(C)C,A1,CCN(CC)CCN,Iso1,CC(C)(C)[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.474084304,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,25,509.5284138,44.37,2,3,8.6329,160.8714,0.96875,0,3,509.908,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3925,LNP_0003925,LM_2019,LM_2019_F45,A1Iso2C11,CCCCCCCCCCC(CCCCCCCCCC)(NCCN(CC)CC)C(=O)NCCCC,CCCCCCCCCCC(CCCCCCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NCCCC,A1,CCN(CC)CCN,Iso2,CCCC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.336896756,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,28,509.5284138,44.37,2,3,8.6345,160.8934,0.96875,0,3,509.908,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3926,LNP_0003926,LM_2019,LM_2019_F46,A1Iso3C11,CCCCCCCCCCC(CCCCCCCCCC)(NCCN(CC)CC)C(=O)NCCCCC,CCCCCCCCCCC(CCCCCCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NCCCCC,A1,CCN(CC)CCN,Iso3,CCCCC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.015041733,https://www.nature.com/articles/s41587-019-0247-3,37,0,0,29,523.5440638,44.37,2,3,9.0246,165.5104,0.96969697,0,3,523.935,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3927,LNP_0003927,LM_2019,LM_2019_F47,A1Iso4C11,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C(=O)OC)N1CCN(CC)CC,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C(=O)OC)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso4,[C-]#[N+]CC(=O)OC,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.389787299,https://www.nature.com/articles/s41587-019-0247-3,36,1,0,24,507.4763782,45.14,0,5,8.0141,155.975,0.935483871,1,3,507.848,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3928,LNP_0003928,LM_2019,LM_2019_F48,A1Iso5C11,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C(=O)OCC)N1CCN(CC)CC,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C(=O)OCC)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso5,CCOC(=O)C[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.856763869,https://www.nature.com/articles/s41587-019-0247-3,37,1,0,25,521.4920283,45.14,0,5,8.4042,160.592,0.9375,1,3,521.875,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3929,LNP_0003929,LM_2019,LM_2019_F49,A1Iso6C11,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCN(CC)CC,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,3.323535609,https://www.nature.com/articles/s41587-019-0247-3,39,1,0,24,549.5233284,45.14,0,5,9.1828,169.804,0.941176471,1,3,549.929,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3930,LNP_0003930,LM_2019,LM_2019_F50,A1Iso7C11,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCN(CC)CC,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.93426936,https://www.nature.com/articles/s41587-019-0247-3,40,1,0,24,563.5389784,45.14,0,5,9.5729,174.421,0.942857143,1,3,563.956,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3931,LNP_0003931,LM_2019,LM_2019_F51,A1Iso8C11,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(CC(=O)OCC)N1CCN(CC)CC,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(CC(=O)OCC)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso8,CCOC(=O)CC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.650820343,https://www.nature.com/articles/s41587-019-0247-3,38,1,0,26,535.5076783,45.14,0,5,8.7943,165.209,0.939393939,1,3,535.902,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3932,LNP_0003932,LM_2019,LM_2019_F52,A1Iso9C11,CCCCCCCCCCC(CCCCCCCCCC)(NCCN(CC)CC)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCCCCCC(CCCCCCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NCS(=O)(=O)c1ccc(C)cc1,A1,CCN(CC)CCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,3.159151031,https://www.nature.com/articles/s41587-019-0247-3,43,1,1,28,621.490314,78.51,2,5,8.57422,184.3502,0.805555556,0,3,622.017,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3933,LNP_0003933,LM_2019,LM_2019_F53,A1Iso10C11,CCCCCCCCCCC(CCCCCCCCCC)(NCCN(CC)CC)C(=O)NC1CCCCC1,CCCCCCCCCCC(CCCCCCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NC1CCCCC1,A1,CCN(CC)CCN,Iso10,[C-]#[N+]C1CCCCC1,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.348322866,https://www.nature.com/articles/s41587-019-0247-3,38,1,0,26,535.5440638,44.37,2,3,9.1671,167.9914,0.970588235,0,3,535.946,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3934,LNP_0003934,LM_2019,LM_2019_F54,A1Iso1C10,CCCCCCCCCC(CCCCCCCCC)(NCCN(CC)CC)C(=O)NC(C)(C)C,CCCCCCCCCC(CCCCCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NC(C)(C)C,A1,CCN(CC)CCN,Iso1,CC(C)(C)[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.250602574,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,23,481.4971136,44.37,2,3,7.8527,151.6374,0.966666667,0,3,481.854,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3935,LNP_0003935,LM_2019,LM_2019_F55,A1Iso2C10,CCCCCCCCCC(CCCCCCCCC)(NCCN(CC)CC)C(=O)NCCCC,CCCCCCCCCC(CCCCCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NCCCC,A1,CCN(CC)CCN,Iso2,CCCC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.300524633,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,26,481.4971136,44.37,2,3,7.8543,151.6594,0.966666667,0,3,481.854,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3936,LNP_0003936,LM_2019,LM_2019_F56,A1Iso3C10,CCCCCCCCCC(CCCCCCCCC)(NCCN(CC)CC)C(=O)NCCCCC,CCCCCCCCCC(CCCCCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NCCCCC,A1,CCN(CC)CCN,Iso3,CCCCC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.32722321,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,27,495.5127637,44.37,2,3,8.2444,156.2764,0.967741935,0,3,495.881,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3937,LNP_0003937,LM_2019,LM_2019_F57,A1Iso4C10,CCCCCCCCCC1(CCCCCCCCC)C=NC(C(=O)OC)N1CCN(CC)CC,CCCCCCCCCC1(CCCCCCCCC)C=NC(C(=O)OC)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso4,[C-]#[N+]CC(=O)OC,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.80329897,https://www.nature.com/articles/s41587-019-0247-3,34,1,0,22,479.4450781,45.14,0,5,7.2339,146.741,0.931034483,1,3,479.794,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3938,LNP_0003938,LM_2019,LM_2019_F58,A1Iso5C10,CCCCCCCCCC1(CCCCCCCCC)C=NC(C(=O)OCC)N1CCN(CC)CC,CCCCCCCCCC1(CCCCCCCCC)C=NC(C(=O)OCC)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso5,CCOC(=O)C[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.429955949,https://www.nature.com/articles/s41587-019-0247-3,35,1,0,23,493.4607281,45.14,0,5,7.624,151.358,0.933333333,1,3,493.821,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3939,LNP_0003939,LM_2019,LM_2019_F59,A1Iso6C10,CCCCCCCCCC1(CCCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCN(CC)CC,CCCCCCCCCC1(CCCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.355911315,https://www.nature.com/articles/s41587-019-0247-3,37,1,0,22,521.4920283,45.14,0,5,8.4026,160.57,0.9375,1,3,521.875,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3940,LNP_0003940,LM_2019,LM_2019_F60,A1Iso7C10,CCCCCCCCCC1(CCCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCN(CC)CC,CCCCCCCCCC1(CCCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.742906755,https://www.nature.com/articles/s41587-019-0247-3,38,1,0,22,535.5076783,45.14,0,5,8.7927,165.187,0.939393939,1,3,535.902,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3941,LNP_0003941,LM_2019,LM_2019_F61,A1Iso8C10,CCCCCCCCCC1(CCCCCCCCC)C=NC(CC(=O)OCC)N1CCN(CC)CC,CCCCCCCCCC1(CCCCCCCCC)C=NC(CC(=O)OCC)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso8,CCOC(=O)CC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.647189246,https://www.nature.com/articles/s41587-019-0247-3,36,1,0,24,507.4763782,45.14,0,5,8.0141,155.975,0.935483871,1,3,507.848,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3942,LNP_0003942,LM_2019,LM_2019_F62,A1Iso9C10,CCCCCCCCCC(CCCCCCCCC)(NCCN(CC)CC)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCCCCC(CCCCCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NCS(=O)(=O)c1ccc(C)cc1,A1,CCN(CC)CCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.306168408,https://www.nature.com/articles/s41587-019-0247-3,41,1,1,26,593.4590139,78.51,2,5,7.79402,175.1162,0.794117647,0,3,593.963,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3943,LNP_0003943,LM_2019,LM_2019_F63,A1Iso10C10,CCCCCCCCCC(CCCCCCCCC)(NCCN(CC)CC)C(=O)NC1CCCCC1,CCCCCCCCCC(CCCCCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NC1CCCCC1,A1,CCN(CC)CCN,Iso10,[C-]#[N+]C1CCCCC1,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.091537082,https://www.nature.com/articles/s41587-019-0247-3,36,1,0,24,507.5127637,44.37,2,3,8.3869,158.7574,0.96875,0,3,507.892,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3944,LNP_0003944,LM_2019,LM_2019_F64,A1Iso1C9,CCCCCCCCC(CCCCCCCC)(NCCN(CC)CC)C(=O)NC(C)(C)C,CCCCCCCCC(CCCCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NC(C)(C)C,A1,CCN(CC)CCN,Iso1,CC(C)(C)[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.978701031,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,21,453.4658135,44.37,2,3,7.0725,142.4034,0.964285714,0,3,453.8,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3945,LNP_0003945,LM_2019,LM_2019_F65,A1Iso2C9,CCCCCCCCC(CCCCCCCC)(NCCN(CC)CC)C(=O)NCCCC,CCCCCCCCC(CCCCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NCCCC,A1,CCN(CC)CCN,Iso2,CCCC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.326804479,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,24,453.4658135,44.37,2,3,7.0741,142.4254,0.964285714,0,3,453.8,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3946,LNP_0003946,LM_2019,LM_2019_F66,A1Iso3C9,CCCCCCCCC(CCCCCCCC)(NCCN(CC)CC)C(=O)NCCCCC,CCCCCCCCC(CCCCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NCCCCC,A1,CCN(CC)CCN,Iso3,CCCCC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.409947695,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,25,467.4814636,44.37,2,3,7.4642,147.0424,0.965517241,0,3,467.827,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3947,LNP_0003947,LM_2019,LM_2019_F67,A1Iso4C9,CCCCCCCCC1(CCCCCCCC)C=NC(C(=O)OC)N1CCN(CC)CC,CCCCCCCCC1(CCCCCCCC)C=NC(C(=O)OC)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso4,[C-]#[N+]CC(=O)OC,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.0274427,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,20,451.4137779,45.14,0,5,6.4537,137.507,0.925925926,1,3,451.74,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3948,LNP_0003948,LM_2019,LM_2019_F68,A1Iso5C9,CCCCCCCCC1(CCCCCCCC)C=NC(C(=O)OCC)N1CCN(CC)CC,CCCCCCCCC1(CCCCCCCC)C=NC(C(=O)OCC)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso5,CCOC(=O)C[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.619136637,https://www.nature.com/articles/s41587-019-0247-3,33,1,0,21,465.429428,45.14,0,5,6.8438,142.124,0.928571429,1,3,465.767,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3949,LNP_0003949,LM_2019,LM_2019_F69,A1Iso6C9,CCCCCCCCC1(CCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCN(CC)CC,CCCCCCCCC1(CCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.409193479,https://www.nature.com/articles/s41587-019-0247-3,35,1,0,20,493.4607281,45.14,0,5,7.6224,151.336,0.933333333,1,3,493.821,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3950,LNP_0003950,LM_2019,LM_2019_F70,A1Iso7C9,CCCCCCCCC1(CCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCN(CC)CC,CCCCCCCCC1(CCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.711599526,https://www.nature.com/articles/s41587-019-0247-3,36,1,0,20,507.4763782,45.14,0,5,8.0125,155.953,0.935483871,1,3,507.848,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3951,LNP_0003951,LM_2019,LM_2019_F71,A1Iso8C9,CCCCCCCCC1(CCCCCCCC)C=NC(CC(=O)OCC)N1CCN(CC)CC,CCCCCCCCC1(CCCCCCCC)C=NC(CC(=O)OCC)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso8,CCOC(=O)CC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.826712884,https://www.nature.com/articles/s41587-019-0247-3,34,1,0,22,479.4450781,45.14,0,5,7.2339,146.741,0.931034483,1,3,479.794,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3952,LNP_0003952,LM_2019,LM_2019_F72,A1Iso9C9,CCCCCCCCC(CCCCCCCC)(NCCN(CC)CC)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCCCC(CCCCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NCS(=O)(=O)c1ccc(C)cc1,A1,CCN(CC)CCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,2.316975098,https://www.nature.com/articles/s41587-019-0247-3,39,1,1,24,565.4277137,78.51,2,5,7.01382,165.8822,0.78125,0,3,565.909,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3953,LNP_0003953,LM_2019,LM_2019_F73,A1Iso10C9,CCCCCCCCC(CCCCCCCC)(NCCN(CC)CC)C(=O)NC1CCCCC1,CCCCCCCCC(CCCCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NC1CCCCC1,A1,CCN(CC)CCN,Iso10,[C-]#[N+]C1CCCCC1,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.865535517,https://www.nature.com/articles/s41587-019-0247-3,34,1,0,22,479.4814636,44.37,2,3,7.6067,149.5234,0.966666667,0,3,479.838,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3954,LNP_0003954,LM_2019,LM_2019_F74,A1Iso1C8,CCCCCCCC(CCCCCCC)(NCCN(CC)CC)C(=O)NC(C)(C)C,CCCCCCCC(CCCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NC(C)(C)C,A1,CCN(CC)CCN,Iso1,CC(C)(C)[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.054297987,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,19,425.4345134,44.37,2,3,6.2923,133.1694,0.961538462,0,3,425.746,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3955,LNP_0003955,LM_2019,LM_2019_F75,A1Iso2C8,CCCCCCCC(CCCCCCC)(NCCN(CC)CC)C(=O)NCCCC,CCCCCCCC(CCCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NCCCC,A1,CCN(CC)CCN,Iso2,CCCC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.862216034,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,22,425.4345134,44.37,2,3,6.2939,133.1914,0.961538462,0,3,425.746,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3956,LNP_0003956,LM_2019,LM_2019_F76,A1Iso3C8,CCCCCCCC(CCCCCCC)(NCCN(CC)CC)C(=O)NCCCCC,CCCCCCCC(CCCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NCCCCC,A1,CCN(CC)CCN,Iso3,CCCCC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.607723398,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,23,439.4501634,44.37,2,3,6.684,137.8084,0.962962963,0,3,439.773,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3957,LNP_0003957,LM_2019,LM_2019_F77,A1Iso4C8,CCCCCCCC1(CCCCCCC)C=NC(C(=O)OC)N1CCN(CC)CC,CCCCCCCC1(CCCCCCC)C=NC(C(=O)OC)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso4,[C-]#[N+]CC(=O)OC,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.011674016,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,18,423.3824778,45.14,0,5,5.6735,128.273,0.92,1,3,423.686,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3958,LNP_0003958,LM_2019,LM_2019_F78,A1Iso5C8,CCCCCCCC1(CCCCCCC)C=NC(C(=O)OCC)N1CCN(CC)CC,CCCCCCCC1(CCCCCCC)C=NC(C(=O)OCC)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso5,CCOC(=O)C[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.877806405,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,19,437.3981279,45.14,0,5,6.0636,132.89,0.923076923,1,3,437.713,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3959,LNP_0003959,LM_2019,LM_2019_F79,A1Iso6C8,CCCCCCCC1(CCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCN(CC)CC,CCCCCCCC1(CCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.505408359,https://www.nature.com/articles/s41587-019-0247-3,33,1,0,18,465.429428,45.14,0,5,6.8422,142.102,0.928571429,1,3,465.767,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3960,LNP_0003960,LM_2019,LM_2019_F80,A1Iso7C8,CCCCCCCC1(CCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCN(CC)CC,CCCCCCCC1(CCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.662476421,https://www.nature.com/articles/s41587-019-0247-3,34,1,0,18,479.4450781,45.14,0,5,7.2323,146.719,0.931034483,1,3,479.794,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3961,LNP_0003961,LM_2019,LM_2019_F81,A1Iso8C8,CCCCCCCC1(CCCCCCC)C=NC(CC(=O)OCC)N1CCN(CC)CC,CCCCCCCC1(CCCCCCC)C=NC(CC(=O)OCC)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso8,CCOC(=O)CC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.274330458,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,20,451.4137779,45.14,0,5,6.4537,137.507,0.925925926,1,3,451.74,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3962,LNP_0003962,LM_2019,LM_2019_F82,A1Iso9C8,CCCCCCCC(CCCCCCC)(NCCN(CC)CC)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCCC(CCCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NCS(=O)(=O)c1ccc(C)cc1,A1,CCN(CC)CCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.445092538,https://www.nature.com/articles/s41587-019-0247-3,37,1,1,22,537.3964136,78.51,2,5,6.23362,156.6482,0.766666667,0,3,537.855,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3963,LNP_0003963,LM_2019,LM_2019_F83,A1Iso10C8,CCCCCCCC(CCCCCCC)(NCCN(CC)CC)C(=O)NC1CCCCC1,CCCCCCCC(CCCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NC1CCCCC1,A1,CCN(CC)CCN,Iso10,[C-]#[N+]C1CCCCC1,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.203882261,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,20,451.4501634,44.37,2,3,6.8265,140.2894,0.964285714,0,3,451.784,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3964,LNP_0003964,LM_2019,LM_2019_F84,A1Iso1C7,CCCCCCC(CCCCCC)(NCCN(CC)CC)C(=O)NC(C)(C)C,CCCCCCC(CCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NC(C)(C)C,A1,CCN(CC)CCN,Iso1,CC(C)(C)[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.103573651,https://www.nature.com/articles/s41587-019-0247-3,28,0,0,17,397.4032133,44.37,2,3,5.5121,123.9354,0.958333333,0,3,397.692,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3965,LNP_0003965,LM_2019,LM_2019_F85,A1Iso2C7,CCCCCCC(CCCCCC)(NCCN(CC)CC)C(=O)NCCCC,CCCCCCC(CCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NCCCC,A1,CCN(CC)CCN,Iso2,CCCC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.281441554,https://www.nature.com/articles/s41587-019-0247-3,28,0,0,20,397.4032133,44.37,2,3,5.5137,123.9574,0.958333333,0,3,397.692,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3966,LNP_0003966,LM_2019,LM_2019_F86,A1Iso3C7,CCCCCCC(CCCCCC)(NCCN(CC)CC)C(=O)NCCCCC,CCCCCCC(CCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NCCCCC,A1,CCN(CC)CCN,Iso3,CCCCC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.332592323,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,21,411.4188633,44.37,2,3,5.9038,128.5744,0.96,0,3,411.719,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3967,LNP_0003967,LM_2019,LM_2019_F87,A1Iso4C7,CCCCCCC1(CCCCCC)C=NC(C(=O)OC)N1CCN(CC)CC,CCCCCCC1(CCCCCC)C=NC(C(=O)OC)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso4,[C-]#[N+]CC(=O)OC,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.486819549,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,16,395.3511777,45.14,0,5,4.8933,119.039,0.913043478,1,3,395.632,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3968,LNP_0003968,LM_2019,LM_2019_F88,A1Iso5C7,CCCCCCC1(CCCCCC)C=NC(C(=O)OCC)N1CCN(CC)CC,CCCCCCC1(CCCCCC)C=NC(C(=O)OCC)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso5,CCOC(=O)C[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.693538513,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,17,409.3668277,45.14,0,5,5.2834,123.656,0.916666667,1,3,409.659,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3969,LNP_0003969,LM_2019,LM_2019_F89,A1Iso6C7,CCCCCCC1(CCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCN(CC)CC,CCCCCCC1(CCCCCC)C=NC(C(=O)OC(C)(C)C)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.400341463,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,16,437.3981279,45.14,0,5,6.062,132.868,0.923076923,1,3,437.713,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3970,LNP_0003970,LM_2019,LM_2019_F90,A1Iso7C7,CCCCCCC1(CCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCN(CC)CC,CCCCCCC1(CCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.93426936,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,16,451.4137779,45.14,0,5,6.4521,137.485,0.925925926,1,3,451.74,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3971,LNP_0003971,LM_2019,LM_2019_F91,A1Iso8C7,CCCCCCC1(CCCCCC)C=NC(CC(=O)OCC)N1CCN(CC)CC,CCCCCCC1(CCCCCC)C=NC(CC(=O)OCC)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso8,CCOC(=O)CC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.344650143,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,18,423.3824778,45.14,0,5,5.6735,128.273,0.92,1,3,423.686,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3972,LNP_0003972,LM_2019,LM_2019_F92,A1Iso9C7,CCCCCCC(CCCCCC)(NCCN(CC)CC)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCC(CCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NCS(=O)(=O)c1ccc(C)cc1,A1,CCN(CC)CCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.002697876,https://www.nature.com/articles/s41587-019-0247-3,35,1,1,20,509.3651135,78.51,2,5,5.45342,147.4142,0.75,0,3,509.801,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3973,LNP_0003973,LM_2019,LM_2019_F93,A1Iso10C7,CCCCCCC(CCCCCC)(NCCN(CC)CC)C(=O)NC1CCCCC1,CCCCCCC(CCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NC1CCCCC1,A1,CCN(CC)CCN,Iso10,[C-]#[N+]C1CCCCC1,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.839377282,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,18,423.4188633,44.37,2,3,6.0463,131.0554,0.961538462,0,3,423.73,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3974,LNP_0003974,LM_2019,LM_2019_F94,A1Iso1CC7,CCN(CC)CCNC1(C(=O)NC(C)(C)C)CCCCCCCCCCCCCC1,CC[N+](CC)(CCNC1(C(=O)NC(C)(C)C)CCCCCCCCCCCCCC1)[H],A1,CCN(CC)CCN,Iso1,CC(C)(C)[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.050534513,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,7,423.4188633,44.37,2,3,6.0463,131.0554,0.961538462,0,3,423.73,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3975,LNP_0003975,LM_2019,LM_2019_F95,A1Iso2CC7,CCCCNC(=O)C1(NCCN(CC)CC)CCCCCCCCCCCCCC1,CCCCNC(=O)C1(NCC[N+](CC)(CC)[H])CCCCCCCCCCCCCC1,A1,CCN(CC)CCN,Iso2,CCCC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.312093408,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,10,423.4188633,44.37,2,3,6.0479,131.0774,0.961538462,0,3,423.73,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3976,LNP_0003976,LM_2019,LM_2019_F96,A1Iso3CC7,CCCCCNC(=O)C1(NCCN(CC)CC)CCCCCCCCCCCCCC1,CCCCCNC(=O)C1(NCC[N+](CC)(CC)[H])CCCCCCCCCCCCCC1,A1,CCN(CC)CCN,Iso3,CCCCC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.387124484,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,11,437.4345134,44.37,2,3,6.438,135.6944,0.962962963,0,3,437.757,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3977,LNP_0003977,LM_2019,LM_2019_F97,A1Iso4CC7,CCN(CC)CCN1C(C(=O)OC)N=CC12CCCCCCCCCCCCCC2,CC[N+](CC)(CCN1C(C(=O)OC)N=CC12CCCCCCCCCCCCCC2)[H],A1,CCN(CC)CCN,Iso4,[C-]#[N+]CC(=O)OC,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.712483038,https://www.nature.com/articles/s41587-019-0247-3,30,2,0,6,421.3668277,45.14,0,5,5.4275,126.159,0.92,1,3,421.67,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3978,LNP_0003978,LM_2019,LM_2019_F98,A1Iso5CC7,CCOC(=O)C1N=CC2(CCCCCCCCCCCCCC2)N1CCN(CC)CC,CCOC(=O)C1N=CC2(CCCCCCCCCCCCCC2)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso5,CCOC(=O)C[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.167355044,https://www.nature.com/articles/s41587-019-0247-3,31,2,0,7,435.3824778,45.14,0,5,5.8176,130.776,0.923076923,1,3,435.697,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3979,LNP_0003979,LM_2019,LM_2019_F99,A1Iso6CC7,CCN(CC)CCN1C(C(=O)OC(C)(C)C)N=CC12CCCCCCCCCCCCCC2,CC[N+](CC)(CCN1C(C(=O)OC(C)(C)C)N=CC12CCCCCCCCCCCCCC2)[H],A1,CCN(CC)CCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.731289507,https://www.nature.com/articles/s41587-019-0247-3,33,2,0,6,463.4137779,45.14,0,5,6.5962,139.988,0.928571429,1,3,463.751,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3980,LNP_0003980,LM_2019,LM_2019_F100,A1Iso7CC7,CCN(CC)CCN1C2(C=NC1(C)C(=O)OC(C)(C)C)CCCCCCCCCCCCCC2,CC[N+](CC)(CCN1C2(C=NC1(C)C(=O)OC(C)(C)C)CCCCCCCCCCCCCC2)[H],A1,CCN(CC)CCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.176822153,https://www.nature.com/articles/s41587-019-0247-3,34,2,0,6,477.429428,45.14,0,5,6.9863,144.605,0.931034483,1,3,477.778,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3981,LNP_0003981,LM_2019,LM_2019_F101,A1Iso8CC7,CCOC(=O)CC1N=CC2(CCCCCCCCCCCCCC2)N1CCN(CC)CC,CCOC(=O)CC1N=CC2(CCCCCCCCCCCCCC2)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso8,CCOC(=O)CC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.67511562,https://www.nature.com/articles/s41587-019-0247-3,32,2,0,8,449.3981279,45.14,0,5,6.2077,135.393,0.925925926,1,3,449.724,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3982,LNP_0003982,LM_2019,LM_2019_F102,A1Iso9CC7,CCN(CC)CCNC1(C(=O)NCS(=O)(=O)c2ccc(C)cc2)CCCCCCCCCCCCCC1,CC[N+](CC)(CCNC1(C(=O)NCS(=O)(=O)c2ccc(C)cc2)CCCCCCCCCCCCCC1)[H],A1,CCN(CC)CCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.803142312,https://www.nature.com/articles/s41587-019-0247-3,37,2,1,10,535.3807636,78.51,2,5,5.98762,154.5342,0.766666667,0,3,535.839,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3983,LNP_0003983,LM_2019,LM_2019_F103,A1Iso10CC7,CCN(CC)CCNC1(C(=O)NC2CCCCC2)CCCCCCCCCCCCCC1,CC[N+](CC)(CCNC1(C(=O)NC2CCCCC2)CCCCCCCCCCCCCC1)[H],A1,CCN(CC)CCN,Iso10,[C-]#[N+]C1CCCCC1,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.126315635,https://www.nature.com/articles/s41587-019-0247-3,32,2,0,8,449.4345134,44.37,2,3,6.5805,138.1754,0.964285714,0,3,449.768,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3984,LNP_0003984,LM_2019,LM_2019_F104,A1Iso1CC6,CCN(CC)CCNC1(C(=O)NC(C)(C)C)CCCCCCCCCCC1,CC[N+](CC)(CCNC1(C(=O)NC(C)(C)C)CCCCCCCCCCC1)[H],A1,CCN(CC)CCN,Iso1,CC(C)(C)[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.014302889,https://www.nature.com/articles/s41587-019-0247-3,27,1,0,7,381.3719131,44.37,2,3,4.876,117.2044,0.956521739,0,3,381.649,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3985,LNP_0003985,LM_2019,LM_2019_F105,A1Iso2CC6,CCCCNC(=O)C1(NCCN(CC)CC)CCCCCCCCCCC1,CCCCNC(=O)C1(NCC[N+](CC)(CC)[H])CCCCCCCCCCC1,A1,CCN(CC)CCN,Iso2,CCCC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.798002521,https://www.nature.com/articles/s41587-019-0247-3,27,1,0,10,381.3719131,44.37,2,3,4.8776,117.2264,0.956521739,0,3,381.649,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3986,LNP_0003986,LM_2019,LM_2019_F106,A1Iso3CC6,CCCCCNC(=O)C1(NCCN(CC)CC)CCCCCCCCCCC1,CCCCCNC(=O)C1(NCC[N+](CC)(CC)[H])CCCCCCCCCCC1,A1,CCN(CC)CCN,Iso3,CCCCC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.636212968,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,11,395.3875632,44.37,2,3,5.2677,121.8434,0.958333333,0,3,395.676,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3987,LNP_0003987,LM_2019,LM_2019_F107,A1Iso4CC6,CCN(CC)CCN1C(C(=O)OC)N=CC12CCCCCCCCCCC2,CC[N+](CC)(CCN1C(C(=O)OC)N=CC12CCCCCCCCCCC2)[H],A1,CCN(CC)CCN,Iso4,[C-]#[N+]CC(=O)OC,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.336029502,https://www.nature.com/articles/s41587-019-0247-3,27,2,0,6,379.3198776,45.14,0,5,4.2572,112.308,0.909090909,1,3,379.589,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3988,LNP_0003988,LM_2019,LM_2019_F108,A1Iso5CC6,CCOC(=O)C1N=CC2(CCCCCCCCCCC2)N1CCN(CC)CC,CCOC(=O)C1N=CC2(CCCCCCCCCCC2)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso5,CCOC(=O)C[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.540521688,https://www.nature.com/articles/s41587-019-0247-3,28,2,0,7,393.3355276,45.14,0,5,4.6473,116.925,0.913043478,1,3,393.616,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3989,LNP_0003989,LM_2019,LM_2019_F109,A1Iso6CC6,CCN(CC)CCN1C(C(=O)OC(C)(C)C)N=CC12CCCCCCCCCCC2,CC[N+](CC)(CCN1C(C(=O)OC(C)(C)C)N=CC12CCCCCCCCCCC2)[H],A1,CCN(CC)CCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.584189388,https://www.nature.com/articles/s41587-019-0247-3,30,2,0,6,421.3668277,45.14,0,5,5.4259,126.137,0.92,1,3,421.67,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3990,LNP_0003990,LM_2019,LM_2019_F110,A1Iso7CC6,CCN(CC)CCN1C2(C=NC1(C)C(=O)OC(C)(C)C)CCCCCCCCCCC2,CC[N+](CC)(CCN1C2(C=NC1(C)C(=O)OC(C)(C)C)CCCCCCCCCCC2)[H],A1,CCN(CC)CCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.141484998,https://www.nature.com/articles/s41587-019-0247-3,31,2,0,6,435.3824778,45.14,0,5,5.816,130.754,0.923076923,1,3,435.697,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3991,LNP_0003991,LM_2019,LM_2019_F111,A1Iso8CC6,CCOC(=O)CC1N=CC2(CCCCCCCCCCC2)N1CCN(CC)CC,CCOC(=O)CC1N=CC2(CCCCCCCCCCC2)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso8,CCOC(=O)CC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.414706718,https://www.nature.com/articles/s41587-019-0247-3,29,2,0,8,407.3511777,45.14,0,5,5.0374,121.542,0.916666667,1,3,407.643,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3992,LNP_0003992,LM_2019,LM_2019_F112,A1Iso9CC6,CCN(CC)CCNC1(C(=O)NCS(=O)(=O)c2ccc(C)cc2)CCCCCCCCCCC1,CC[N+](CC)(CCNC1(C(=O)NCS(=O)(=O)c2ccc(C)cc2)CCCCCCCCCCC1)[H],A1,CCN(CC)CCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.157246598,https://www.nature.com/articles/s41587-019-0247-3,34,2,1,10,493.3338134,78.51,2,5,4.81732,140.6832,0.740740741,0,3,493.758,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3993,LNP_0003993,LM_2019,LM_2019_F113,A1Iso10CC6,CCN(CC)CCNC1(C(=O)NC2CCCCC2)CCCCCCCCCCC1,CC[N+](CC)(CCNC1(C(=O)NC2CCCCC2)CCCCCCCCCCC1)[H],A1,CCN(CC)CCN,Iso10,[C-]#[N+]C1CCCCC1,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.817503415,https://www.nature.com/articles/s41587-019-0247-3,29,2,0,8,407.3875632,44.37,2,3,5.4102,124.3244,0.96,0,3,407.687,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3994,LNP_0003994,LM_2019,LM_2019_F114,A1Iso1C6,CCCCCC(CCCCC)(NCCN(CC)CC)C(=O)NC(C)(C)C,CCCCCC(CCCCC)(NCC[N+](CC)(CC)[H])C(=O)NC(C)(C)C,A1,CCN(CC)CCN,Iso1,CC(C)(C)[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.305564973,https://www.nature.com/articles/s41587-019-0247-3,26,0,0,15,369.3719131,44.37,2,3,4.7319,114.7014,0.954545455,0,3,369.638,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3995,LNP_0003995,LM_2019,LM_2019_F115,A1Iso2C6,CCCCCC(CCCCC)(NCCN(CC)CC)C(=O)NCCCC,CCCCCC(CCCCC)(NCC[N+](CC)(CC)[H])C(=O)NCCCC,A1,CCN(CC)CCN,Iso2,CCCC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.354028833,https://www.nature.com/articles/s41587-019-0247-3,26,0,0,18,369.3719131,44.37,2,3,4.7335,114.7234,0.954545455,0,3,369.638,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3996,LNP_0003996,LM_2019,LM_2019_F116,A1Iso3C6,CCCCCNC(=O)C(CCCCC)(CCCCC)NCCN(CC)CC,CCCCCNC(=O)C(CCCCC)(CCCCC)NCC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso3,CCCCC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.31045235,https://www.nature.com/articles/s41587-019-0247-3,27,0,0,19,383.3875632,44.37,2,3,5.1236,119.3404,0.956521739,0,3,383.665,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3997,LNP_0003997,LM_2019,LM_2019_F117,A1Iso4C6,CCCCCC1(CCCCC)C=NC(C(=O)OC)N1CCN(CC)CC,CCCCCC1(CCCCC)C=NC(C(=O)OC)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso4,[C-]#[N+]CC(=O)OC,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.558542709,https://www.nature.com/articles/s41587-019-0247-3,26,1,0,14,367.3198776,45.14,0,5,4.1131,109.805,0.904761905,1,3,367.578,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3998,LNP_0003998,LM_2019,LM_2019_F118,A1Iso5C6,CCCCCC1(CCCCC)C=NC(C(=O)OCC)N1CCN(CC)CC,CCCCCC1(CCCCC)C=NC(C(=O)OCC)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso5,CCOC(=O)C[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.924077082,https://www.nature.com/articles/s41587-019-0247-3,27,1,0,15,381.3355276,45.14,0,5,4.5032,114.422,0.909090909,1,3,381.605,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,3999,LNP_0003999,LM_2019,LM_2019_F119,A1Iso6C6,CCCCCC1(CCCCC)C=NC(C(=O)OC(C)(C)C)N1CCN(CC)CC,CCCCCC1(CCCCC)C=NC(C(=O)OC(C)(C)C)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.048791436,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,14,409.3668277,45.14,0,5,5.2818,123.634,0.916666667,1,3,409.659,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4000,LNP_0004000,LM_2019,LM_2019_F120,A1Iso7C6,CCCCCC1(CCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCN(CC)CC,CCCCCC1(CCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.109480064,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,14,423.3824778,45.14,0,5,5.6719,128.251,0.92,1,3,423.686,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4001,LNP_0004001,LM_2019,LM_2019_F121,A1Iso8C6,CCCCCC1(CCCCC)C=NC(CC(=O)OCC)N1CCN(CC)CC,CCCCCC1(CCCCC)C=NC(CC(=O)OCC)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso8,CCOC(=O)CC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.387124484,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,16,395.3511777,45.14,0,5,4.8933,119.039,0.913043478,1,3,395.632,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4002,LNP_0004002,LM_2019,LM_2019_F122,A1Iso9C6,CCCCCC(CCCCC)(NCCN(CC)CC)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCC(CCCCC)(NCC[N+](CC)(CC)[H])C(=O)NCS(=O)(=O)c1ccc(C)cc1,A1,CCN(CC)CCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.805556452,https://www.nature.com/articles/s41587-019-0247-3,33,1,1,18,481.3338134,78.51,2,5,4.67322,138.1802,0.730769231,0,3,481.747,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4003,LNP_0004003,LM_2019,LM_2019_F123,A1Iso10C6,CCCCCC(CCCCC)(NCCN(CC)CC)C(=O)NC1CCCCC1,CCCCCC(CCCCC)(NCC[N+](CC)(CC)[H])C(=O)NC1CCCCC1,A1,CCN(CC)CCN,Iso10,[C-]#[N+]C1CCCCC1,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.322322239,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,16,395.3875632,44.37,2,3,5.2661,121.8214,0.958333333,0,3,395.676,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4004,LNP_0004004,LM_2019,LM_2019_F124,A2Iso12DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCCN1CCCC1)C(=O)NC(C)(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NC(C)(C)C,A2,C1CCN(C1)CCCN,Iso1,CC(C)(C)[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,2.903139486,https://www.nature.com/articles/s41587-019-0247-3,51,1,0,36,713.7162145,44.37,2,3,13.7904,227.8244,0.893617021,0,3,714.265,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4005,LNP_0004005,LM_2019,LM_2019_F125,A2Iso22DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCCN1CCCC1)C(=O)NCCCC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NCCCC,A2,C1CCN(C1)CCCN,Iso2,CCCC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.843706996,https://www.nature.com/articles/s41587-019-0247-3,51,1,0,39,713.7162145,44.37,2,3,13.792,227.8464,0.893617021,0,3,714.265,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4006,LNP_0004006,LM_2019,LM_2019_F126,A2Iso32DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCCN1CCCC1)C(=O)NCCCCC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NCCCCC,A2,C1CCN(C1)CCCN,Iso3,CCCCC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.537315608,https://www.nature.com/articles/s41587-019-0247-3,52,1,0,40,727.7318646,44.37,2,3,14.1821,232.4634,0.895833333,0,3,728.292,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4007,LNP_0004007,LM_2019,LM_2019_F127,A2Iso42DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OC)N1CCCN1CCCC1,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OC)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso4,[C-]#[N+]CC(=O)OC,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,3.552371007,https://www.nature.com/articles/s41587-019-0247-3,51,2,0,35,711.664179,45.14,0,5,13.1716,222.928,0.869565217,1,3,712.205,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4008,LNP_0004008,LM_2019,LM_2019_F128,A2Iso72DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCCN1CCCC1,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,2.621275799,https://www.nature.com/articles/s41587-019-0247-3,55,2,0,35,767.7267792,45.14,0,5,14.7304,241.374,0.88,1,3,768.313,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4009,LNP_0004009,LM_2019,LM_2019_F129,A2Iso82DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(CC(=O)OCC)N1CCCN1CCCC1,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(CC(=O)OCC)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso8,CCOC(=O)CC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.410494115,https://www.nature.com/articles/s41587-019-0247-3,53,2,0,37,739.6954791,45.14,0,5,13.9518,232.162,0.875,1,3,740.259,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4010,LNP_0004010,LM_2019,LM_2019_F130,A2Iso102DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCCN1CCCC1)C(=O)NC1CCCCC1,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NC1CCCCC1,A2,C1CCN(C1)CCCN,Iso10,[C-]#[N+]C1CCCCC1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.377170285,https://www.nature.com/articles/s41587-019-0247-3,53,2,0,37,739.7318646,44.37,2,3,14.3246,234.9444,0.897959184,0,3,740.303,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4011,LNP_0004011,LM_2019,LM_2019_F131,A2Iso1C11,CCCCCCCCCCC(CCCCCCCCCC)(NCCCN1CCCC1)C(=O)NC(C)(C)C,CCCCCCCCCCC(CCCCCCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NC(C)(C)C,A2,C1CCN(C1)CCCN,Iso1,CC(C)(C)[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.34247535,https://www.nature.com/articles/s41587-019-0247-3,37,1,0,24,521.5284138,44.37,2,3,8.777,163.3744,0.96969697,0,3,521.919,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4012,LNP_0004012,LM_2019,LM_2019_F132,A2Iso2C11,CCCCCCCCCCC(CCCCCCCCCC)(NCCCN1CCCC1)C(=O)NCCCC,CCCCCCCCCCC(CCCCCCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NCCCC,A2,C1CCN(C1)CCCN,Iso2,CCCC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.514657843,https://www.nature.com/articles/s41587-019-0247-3,37,1,0,27,521.5284138,44.37,2,3,8.7786,163.3964,0.96969697,0,3,521.919,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4013,LNP_0004013,LM_2019,LM_2019_F133,A2Iso3C11,CCCCCCCCCCC(CCCCCCCCCC)(NCCCN1CCCC1)C(=O)NCCCCC,CCCCCCCCCCC(CCCCCCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NCCCCC,A2,C1CCN(C1)CCCN,Iso3,CCCCC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.960922359,https://www.nature.com/articles/s41587-019-0247-3,38,1,0,28,535.5440638,44.37,2,3,9.1687,168.0134,0.970588235,0,3,535.946,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4014,LNP_0004014,LM_2019,LM_2019_F134,A2Iso4C11,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C(=O)OC)N1CCCN1CCCC1,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C(=O)OC)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso4,[C-]#[N+]CC(=O)OC,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,2.121265631,https://www.nature.com/articles/s41587-019-0247-3,37,2,0,23,519.4763782,45.14,0,5,8.1582,158.478,0.9375,1,3,519.859,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4015,LNP_0004015,LM_2019,LM_2019_F135,A2Iso5C11,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C(=O)OCC)N1CCCN1CCCC1,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C(=O)OCC)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso5,CCOC(=O)C[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,2.092888747,https://www.nature.com/articles/s41587-019-0247-3,38,2,0,24,533.4920283,45.14,0,5,8.5483,163.095,0.939393939,1,3,533.886,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4016,LNP_0004016,LM_2019,LM_2019_F136,A2Iso6C11,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCCN1CCCC1,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,2.268611049,https://www.nature.com/articles/s41587-019-0247-3,40,2,0,23,561.5233284,45.14,0,5,9.3269,172.307,0.942857143,1,3,561.94,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4017,LNP_0004017,LM_2019,LM_2019_F137,A2Iso7C11,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCCN1CCCC1,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.155846111,https://www.nature.com/articles/s41587-019-0247-3,41,2,0,23,575.5389784,45.14,0,5,9.717,176.924,0.944444444,1,3,575.967,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4018,LNP_0004018,LM_2019,LM_2019_F138,A2Iso8C11,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(CC(=O)OCC)N1CCCN1CCCC1,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(CC(=O)OCC)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso8,CCOC(=O)CC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.243441195,https://www.nature.com/articles/s41587-019-0247-3,39,2,0,25,547.5076783,45.14,0,5,8.9384,167.712,0.941176471,1,3,547.913,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4019,LNP_0004019,LM_2019,LM_2019_F139,A2Iso9C11,CCCCCCCCCCC(CCCCCCCCCC)(NCCCN1CCCC1)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCCCCCC(CCCCCCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NCS(=O)(=O)c1ccc(C)cc1,A2,C1CCN(C1)CCCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.058100067,https://www.nature.com/articles/s41587-019-0247-3,44,2,1,27,633.490314,78.51,2,5,8.71832,186.8532,0.810810811,0,3,634.028,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4020,LNP_0004020,LM_2019,LM_2019_F140,A2Iso10C11,CCCCCCCCCCC(CCCCCCCCCC)(NCCCN1CCCC1)C(=O)NC1CCCCC1,CCCCCCCCCCC(CCCCCCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NC1CCCCC1,A2,C1CCN(C1)CCCN,Iso10,[C-]#[N+]C1CCCCC1,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.186805141,https://www.nature.com/articles/s41587-019-0247-3,39,2,0,25,547.5440638,44.37,2,3,9.3112,170.4944,0.971428571,0,3,547.957,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4021,LNP_0004021,LM_2019,LM_2019_F141,A2Iso1C10,CCCCCCCCCC(CCCCCCCCC)(NCCCN1CCCC1)C(=O)NC(C)(C)C,CCCCCCCCCC(CCCCCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NC(C)(C)C,A2,C1CCN(C1)CCCN,Iso1,CC(C)(C)[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.624730562,https://www.nature.com/articles/s41587-019-0247-3,35,1,0,22,493.4971136,44.37,2,3,7.9968,154.1404,0.967741935,0,3,493.865,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4022,LNP_0004022,LM_2019,LM_2019_F142,A2Iso2C10,CCCCCCCCCC(CCCCCCCCC)(NCCCN1CCCC1)C(=O)NCCCC,CCCCCCCCCC(CCCCCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NCCCC,A2,C1CCN(C1)CCCN,Iso2,CCCC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.079338703,https://www.nature.com/articles/s41587-019-0247-3,35,1,0,25,493.4971136,44.37,2,3,7.9984,154.1624,0.967741935,0,3,493.865,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4023,LNP_0004023,LM_2019,LM_2019_F143,A2Iso3C10,CCCCCCCCCC(CCCCCCCCC)(NCCCN1CCCC1)C(=O)NCCCCC,CCCCCCCCCC(CCCCCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NCCCCC,A2,C1CCN(C1)CCCN,Iso3,CCCCC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.379795246,https://www.nature.com/articles/s41587-019-0247-3,36,1,0,26,507.5127637,44.37,2,3,8.3885,158.7794,0.96875,0,3,507.892,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4024,LNP_0004024,LM_2019,LM_2019_F144,A2Iso4C10,CCCCCCCCCC1(CCCCCCCCC)C=NC(C(=O)OC)N1CCCN1CCCC1,CCCCCCCCCC1(CCCCCCCCC)C=NC(C(=O)OC)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso4,[C-]#[N+]CC(=O)OC,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,2.043058964,https://www.nature.com/articles/s41587-019-0247-3,35,2,0,21,491.4450781,45.14,0,5,7.378,149.244,0.933333333,1,3,491.805,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4025,LNP_0004025,LM_2019,LM_2019_F145,A2Iso5C10,CCCCCCCCCC1(CCCCCCCCC)C=NC(C(=O)OCC)N1CCCN1CCCC1,CCCCCCCCCC1(CCCCCCCCC)C=NC(C(=O)OCC)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso5,CCOC(=O)C[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.733870673,https://www.nature.com/articles/s41587-019-0247-3,36,2,0,22,505.4607281,45.14,0,5,7.7681,153.861,0.935483871,1,3,505.832,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4026,LNP_0004026,LM_2019,LM_2019_F146,A2Iso6C10,CCCCCCCCCC1(CCCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCCN1CCCC1,CCCCCCCCCC1(CCCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.492054398,https://www.nature.com/articles/s41587-019-0247-3,38,2,0,21,533.4920283,45.14,0,5,8.5467,163.073,0.939393939,1,3,533.886,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4027,LNP_0004027,LM_2019,LM_2019_F147,A2Iso7C10,CCCCCCCCCC1(CCCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCCN1CCCC1,CCCCCCCCCC1(CCCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.012092184,https://www.nature.com/articles/s41587-019-0247-3,39,2,0,21,547.5076783,45.14,0,5,8.9368,167.69,0.941176471,1,3,547.913,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4028,LNP_0004028,LM_2019,LM_2019_F148,A2Iso8C10,CCCCCCCCCC1(CCCCCCCCC)C=NC(CC(=O)OCC)N1CCCN1CCCC1,CCCCCCCCCC1(CCCCCCCCC)C=NC(CC(=O)OCC)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso8,CCOC(=O)CC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.270008453,https://www.nature.com/articles/s41587-019-0247-3,37,2,0,23,519.4763782,45.14,0,5,8.1582,158.478,0.9375,1,3,519.859,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4029,LNP_0004029,LM_2019,LM_2019_F149,A2Iso9C10,CCCCCCCCCC(CCCCCCCCC)(NCCCN1CCCC1)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCCCCC(CCCCCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NCS(=O)(=O)c1ccc(C)cc1,A2,C1CCN(C1)CCCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.709473682,https://www.nature.com/articles/s41587-019-0247-3,42,2,1,25,605.4590139,78.51,2,5,7.93812,177.6192,0.8,0,3,605.974,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4030,LNP_0004030,LM_2019,LM_2019_F150,A2Iso10C10,CCCCCCCCCC(CCCCCCCCC)(NCCCN1CCCC1)C(=O)NC1CCCCC1,CCCCCCCCCC(CCCCCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NC1CCCCC1,A2,C1CCN(C1)CCCN,Iso10,[C-]#[N+]C1CCCCC1,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.591757488,https://www.nature.com/articles/s41587-019-0247-3,37,2,0,23,519.5127637,44.37,2,3,8.531,161.2604,0.96969697,0,3,519.903,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4031,LNP_0004031,LM_2019,LM_2019_F151,A2Iso1C9,CCCCCCCCC(CCCCCCCC)(NCCCN1CCCC1)C(=O)NC(C)(C)C,CCCCCCCCC(CCCCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NC(C)(C)C,A2,C1CCN(C1)CCCN,Iso1,CC(C)(C)[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.459114659,https://www.nature.com/articles/s41587-019-0247-3,33,1,0,20,465.4658135,44.37,2,3,7.2166,144.9064,0.965517241,0,3,465.811,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4032,LNP_0004032,LM_2019,LM_2019_F152,A2Iso2C9,CCCCCCCCC(CCCCCCCC)(NCCCN1CCCC1)C(=O)NCCCC,CCCCCCCCC(CCCCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NCCCC,A2,C1CCN(C1)CCCN,Iso2,CCCC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.936760197,https://www.nature.com/articles/s41587-019-0247-3,33,1,0,23,465.4658135,44.37,2,3,7.2182,144.9284,0.965517241,0,3,465.811,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4033,LNP_0004033,LM_2019,LM_2019_F153,A2Iso3C9,CCCCCCCCC(CCCCCCCC)(NCCCN1CCCC1)C(=O)NCCCCC,CCCCCCCCC(CCCCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NCCCCC,A2,C1CCN(C1)CCCN,Iso3,CCCCC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.111186702,https://www.nature.com/articles/s41587-019-0247-3,34,1,0,24,479.4814636,44.37,2,3,7.6083,149.5454,0.966666667,0,3,479.838,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4034,LNP_0004034,LM_2019,LM_2019_F154,A2Iso4C9,CCCCCCCCC1(CCCCCCCC)C=NC(C(=O)OC)N1CCCN1CCCC1,CCCCCCCCC1(CCCCCCCC)C=NC(C(=O)OC)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso4,[C-]#[N+]CC(=O)OC,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.393117883,https://www.nature.com/articles/s41587-019-0247-3,33,2,0,19,463.4137779,45.14,0,5,6.5978,140.01,0.928571429,1,3,463.751,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4035,LNP_0004035,LM_2019,LM_2019_F155,A2Iso5C9,CCCCCCCCC1(CCCCCCCC)C=NC(C(=O)OCC)N1CCCN1CCCC1,CCCCCCCCC1(CCCCCCCC)C=NC(C(=O)OCC)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso5,CCOC(=O)C[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.85919991,https://www.nature.com/articles/s41587-019-0247-3,34,2,0,20,477.429428,45.14,0,5,6.9879,144.627,0.931034483,1,3,477.778,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4036,LNP_0004036,LM_2019,LM_2019_F156,A2Iso6C9,CCCCCCCCC1(CCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCCN1CCCC1,CCCCCCCCC1(CCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.464552618,https://www.nature.com/articles/s41587-019-0247-3,36,2,0,19,505.4607281,45.14,0,5,7.7665,153.839,0.935483871,1,3,505.832,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4037,LNP_0004037,LM_2019,LM_2019_F157,A2Iso7C9,CCCCCCCCC1(CCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCCN1CCCC1,CCCCCCCCC1(CCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.359128333,https://www.nature.com/articles/s41587-019-0247-3,37,2,0,19,519.4763782,45.14,0,5,8.1566,158.456,0.9375,1,3,519.859,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4038,LNP_0004038,LM_2019,LM_2019_F158,A2Iso8C9,CCCCCCCCC1(CCCCCCCC)C=NC(CC(=O)OCC)N1CCCN1CCCC1,CCCCCCCCC1(CCCCCCCC)C=NC(CC(=O)OCC)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso8,CCOC(=O)CC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.494114315,https://www.nature.com/articles/s41587-019-0247-3,35,2,0,21,491.4450781,45.14,0,5,7.378,149.244,0.933333333,1,3,491.805,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4039,LNP_0004039,LM_2019,LM_2019_F159,A2Iso9C9,CCCCCCCCC(CCCCCCCC)(NCCCN1CCCC1)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCCCC(CCCCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NCS(=O)(=O)c1ccc(C)cc1,A2,C1CCN(C1)CCCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.021481358,https://www.nature.com/articles/s41587-019-0247-3,40,2,1,23,577.4277137,78.51,2,5,7.15792,168.3852,0.787878788,0,3,577.92,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4040,LNP_0004040,LM_2019,LM_2019_F160,A2Iso10C9,CCCCCCCCC(CCCCCCCC)(NCCCN1CCCC1)C(=O)NC1CCCCC1,CCCCCCCCC(CCCCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NC1CCCCC1,A2,C1CCN(C1)CCCN,Iso10,[C-]#[N+]C1CCCCC1,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.309681821,https://www.nature.com/articles/s41587-019-0247-3,35,2,0,21,491.4814636,44.37,2,3,7.7508,152.0264,0.967741935,0,3,491.849,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4041,LNP_0004041,LM_2019,LM_2019_F161,A2Iso1C8,CCCCCCCC(CCCCCCC)(NCCCN1CCCC1)C(=O)NC(C)(C)C,CCCCCCCC(CCCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NC(C)(C)C,A2,C1CCN(C1)CCCN,Iso1,CC(C)(C)[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.53167942,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,18,437.4345134,44.37,2,3,6.4364,135.6724,0.962962963,0,3,437.757,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4042,LNP_0004042,LM_2019,LM_2019_F162,A2Iso2C8,CCCCCCCC(CCCCCCC)(NCCCN1CCCC1)C(=O)NCCCC,CCCCCCCC(CCCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NCCCC,A2,C1CCN(C1)CCCN,Iso2,CCCC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.446593871,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,21,437.4345134,44.37,2,3,6.438,135.6944,0.962962963,0,3,437.757,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4043,LNP_0004043,LM_2019,LM_2019_F163,A2Iso3C8,CCCCCCCC(CCCCCCC)(NCCCN1CCCC1)C(=O)NCCCCC,CCCCCCCC(CCCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NCCCCC,A2,C1CCN(C1)CCCN,Iso3,CCCCC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.127690795,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,22,451.4501634,44.37,2,3,6.8281,140.3114,0.964285714,0,3,451.784,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4044,LNP_0004044,LM_2019,LM_2019_F164,A2Iso4C8,CCCCCCCC1(CCCCCCC)C=NC(C(=O)OC)N1CCCN1CCCC1,CCCCCCCC1(CCCCCCC)C=NC(C(=O)OC)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso4,[C-]#[N+]CC(=O)OC,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.863760779,https://www.nature.com/articles/s41587-019-0247-3,31,2,0,17,435.3824778,45.14,0,5,5.8176,130.776,0.923076923,1,3,435.697,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4045,LNP_0004045,LM_2019,LM_2019_F165,A2Iso5C8,CCCCCCCC1(CCCCCCC)C=NC(C(=O)OCC)N1CCCN1CCCC1,CCCCCCCC1(CCCCCCC)C=NC(C(=O)OCC)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso5,CCOC(=O)C[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.869037194,https://www.nature.com/articles/s41587-019-0247-3,32,2,0,18,449.3981279,45.14,0,5,6.2077,135.393,0.925925926,1,3,449.724,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4046,LNP_0004046,LM_2019,LM_2019_F166,A2Iso6C8,CCCCCCCC1(CCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCCN1CCCC1,CCCCCCCC1(CCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.367062234,https://www.nature.com/articles/s41587-019-0247-3,34,2,0,17,477.429428,45.14,0,5,6.9863,144.605,0.931034483,1,3,477.778,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4047,LNP_0004047,LM_2019,LM_2019_F167,A2Iso7C8,CCCCCCCC1(CCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCCN1CCCC1,CCCCCCCC1(CCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.687588201,https://www.nature.com/articles/s41587-019-0247-3,35,2,0,17,491.4450781,45.14,0,5,7.3764,149.222,0.933333333,1,3,491.805,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4048,LNP_0004048,LM_2019,LM_2019_F168,A2Iso8C8,CCCCCCCC1(CCCCCCC)C=NC(CC(=O)OCC)N1CCCN1CCCC1,CCCCCCCC1(CCCCCCC)C=NC(CC(=O)OCC)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso8,CCOC(=O)CC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.415008087,https://www.nature.com/articles/s41587-019-0247-3,33,2,0,19,463.4137779,45.14,0,5,6.5978,140.01,0.928571429,1,3,463.751,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4049,LNP_0004049,LM_2019,LM_2019_F169,A2Iso9C8,CCCCCCCC(CCCCCCC)(NCCCN1CCCC1)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCCC(CCCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NCS(=O)(=O)c1ccc(C)cc1,A2,C1CCN(C1)CCCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.331391352,https://www.nature.com/articles/s41587-019-0247-3,38,2,1,21,549.3964136,78.51,2,5,6.37772,159.1512,0.774193548,0,3,549.866,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4050,LNP_0004050,LM_2019,LM_2019_F170,A2Iso10C8,CCCCCCCC(CCCCCCC)(NCCCN1CCCC1)C(=O)NC1CCCCC1,CCCCCCCC(CCCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NC1CCCCC1,A2,C1CCN(C1)CCCN,Iso10,[C-]#[N+]C1CCCCC1,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.863848542,https://www.nature.com/articles/s41587-019-0247-3,33,2,0,19,463.4501634,44.37,2,3,6.9706,142.7924,0.965517241,0,3,463.795,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4051,LNP_0004051,LM_2019,LM_2019_F171,A2Iso1C7,CCCCCCC(CCCCCC)(NCCCN1CCCC1)C(=O)NC(C)(C)C,CCCCCCC(CCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NC(C)(C)C,A2,C1CCN(C1)CCCN,Iso1,CC(C)(C)[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.227332885,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,16,409.4032133,44.37,2,3,5.6562,126.4384,0.96,0,3,409.703,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4052,LNP_0004052,LM_2019,LM_2019_F172,A2Iso2C7,CCCCCCC(CCCCCC)(NCCCN1CCCC1)C(=O)NCCCC,CCCCCCC(CCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NCCCC,A2,C1CCN(C1)CCCN,Iso2,CCCC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.196588892,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,19,409.4032133,44.37,2,3,5.6578,126.4604,0.96,0,3,409.703,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4053,LNP_0004053,LM_2019,LM_2019_F173,A2Iso3C7,CCCCCCC(CCCCCC)(NCCCN1CCCC1)C(=O)NCCCCC,CCCCCCC(CCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NCCCCC,A2,C1CCN(C1)CCCN,Iso3,CCCCC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.187449781,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,20,423.4188633,44.37,2,3,6.0479,131.0774,0.961538462,0,3,423.73,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4054,LNP_0004054,LM_2019,LM_2019_F174,A2Iso4C7,CCCCCCC1(CCCCCC)C=NC(C(=O)OC)N1CCCN1CCCC1,CCCCCCC1(CCCCCC)C=NC(C(=O)OC)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso4,[C-]#[N+]CC(=O)OC,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.911521005,https://www.nature.com/articles/s41587-019-0247-3,29,2,0,15,407.3511777,45.14,0,5,5.0374,121.542,0.916666667,1,3,407.643,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4055,LNP_0004055,LM_2019,LM_2019_F175,A2Iso5C7,CCCCCCC1(CCCCCC)C=NC(C(=O)OCC)N1CCCN1CCCC1,CCCCCCC1(CCCCCC)C=NC(C(=O)OCC)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso5,CCOC(=O)C[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.574647693,https://www.nature.com/articles/s41587-019-0247-3,30,2,0,16,421.3668277,45.14,0,5,5.4275,126.159,0.92,1,3,421.67,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4056,LNP_0004056,LM_2019,LM_2019_F176,A2Iso6C7,CCCCCCC1(CCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCCN1CCCC1,CCCCCCC1(CCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,2.268611049,https://www.nature.com/articles/s41587-019-0247-3,32,2,0,15,449.3981279,45.14,0,5,6.2061,135.371,0.925925926,1,3,449.724,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4057,LNP_0004057,LM_2019,LM_2019_F177,A2Iso7C7,CCCCCCC1(CCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCCN1CCCC1,CCCCCCC1(CCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.155846111,https://www.nature.com/articles/s41587-019-0247-3,33,2,0,15,463.4137779,45.14,0,5,6.5962,139.988,0.928571429,1,3,463.751,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4058,LNP_0004058,LM_2019,LM_2019_F178,A2Iso8C7,CCCCCCC1(CCCCCC)C=NC(CC(=O)OCC)N1CCCN1CCCC1,CCCCCCC1(CCCCCC)C=NC(CC(=O)OCC)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso8,CCOC(=O)CC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.066495306,https://www.nature.com/articles/s41587-019-0247-3,31,2,0,17,435.3824778,45.14,0,5,5.8176,130.776,0.923076923,1,3,435.697,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4059,LNP_0004059,LM_2019,LM_2019_F179,A2Iso9C7,CCCCCCC(CCCCCC)(NCCCN1CCCC1)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCC(CCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NCS(=O)(=O)c1ccc(C)cc1,A2,C1CCN(C1)CCCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.18404995,https://www.nature.com/articles/s41587-019-0247-3,36,2,1,19,521.3651135,78.51,2,5,5.59752,149.9172,0.75862069,0,3,521.812,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4060,LNP_0004060,LM_2019,LM_2019_F180,A2Iso10C7,CCCCCCC(CCCCCC)(NCCCN1CCCC1)C(=O)NC1CCCCC1,CCCCCCC(CCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NC1CCCCC1,A2,C1CCN(C1)CCCN,Iso10,[C-]#[N+]C1CCCCC1,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.469754256,https://www.nature.com/articles/s41587-019-0247-3,31,2,0,17,435.4188633,44.37,2,3,6.1904,133.5584,0.962962963,0,3,435.741,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4061,LNP_0004061,LM_2019,LM_2019_F181,A2Iso1CC7,CC(C)(C)NC(=O)C1(NCCCN2CCCC2)CCCCCCCCCCCCCC1,CC(C)(C)NC(=O)C1(NCCC[N+]2([H])CCCC2)CCCCCCCCCCCCCC1,A2,C1CCN(C1)CCCN,Iso1,CC(C)(C)[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.366203226,https://www.nature.com/articles/s41587-019-0247-3,31,2,0,6,435.4188633,44.37,2,3,6.1904,133.5584,0.962962963,0,3,435.741,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4062,LNP_0004062,LM_2019,LM_2019_F182,A2Iso2CC7,CCCCNC(=O)C1(NCCCN2CCCC2)CCCCCCCCCCCCCC1,CCCCNC(=O)C1(NCCC[N+]2([H])CCCC2)CCCCCCCCCCCCCC1,A2,C1CCN(C1)CCCN,Iso2,CCCC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.325766455,https://www.nature.com/articles/s41587-019-0247-3,31,2,0,9,435.4188633,44.37,2,3,6.192,133.5804,0.962962963,0,3,435.741,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4063,LNP_0004063,LM_2019,LM_2019_F183,A2Iso3CC7,CCCCCNC(=O)C1(NCCCN2CCCC2)CCCCCCCCCCCCCC1,CCCCCNC(=O)C1(NCCC[N+]2([H])CCCC2)CCCCCCCCCCCCCC1,A2,C1CCN(C1)CCCN,Iso3,CCCCC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.779394104,https://www.nature.com/articles/s41587-019-0247-3,32,2,0,10,449.4345134,44.37,2,3,6.5821,138.1974,0.964285714,0,3,449.768,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4064,LNP_0004064,LM_2019,LM_2019_F184,A2Iso4CC7,COC(=O)C1N=CC2(CCCCCCCCCCCCCC2)N1CCCN1CCCC1,COC(=O)C1N=CC2(CCCCCCCCCCCCCC2)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso4,[C-]#[N+]CC(=O)OC,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.00346331,https://www.nature.com/articles/s41587-019-0247-3,31,3,0,5,433.3668277,45.14,0,5,5.5716,128.662,0.923076923,1,3,433.681,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4065,LNP_0004065,LM_2019,LM_2019_F185,A2Iso5CC7,CCOC(=O)C1N=CC2(CCCCCCCCCCCCCC2)N1CCCN1CCCC1,CCOC(=O)C1N=CC2(CCCCCCCCCCCCCC2)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso5,CCOC(=O)C[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.90471736,https://www.nature.com/articles/s41587-019-0247-3,32,3,0,6,447.3824778,45.14,0,5,5.9617,133.279,0.925925926,1,3,447.708,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4066,LNP_0004066,LM_2019,LM_2019_F186,A2Iso6CC7,CC(C)(C)OC(=O)C1N=CC2(CCCCCCCCCCCCCC2)N1CCCN1CCCC1,CC(C)(C)OC(=O)C1N=CC2(CCCCCCCCCCCCCC2)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.955031564,https://www.nature.com/articles/s41587-019-0247-3,34,3,0,5,475.4137779,45.14,0,5,6.7403,142.491,0.931034483,1,3,475.762,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4067,LNP_0004067,LM_2019,LM_2019_F187,A2Iso7CC7,CC(C)(C)OC(=O)C1(C)N=CC2(CCCCCCCCCCCCCC2)N1CCCN1CCCC1,CC(C)(C)OC(=O)C1(C)N=CC2(CCCCCCCCCCCCCC2)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.269433476,https://www.nature.com/articles/s41587-019-0247-3,35,3,0,5,489.429428,45.14,0,5,7.1304,147.108,0.933333333,1,3,489.789,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4068,LNP_0004068,LM_2019,LM_2019_F188,A2Iso8CC7,CCOC(=O)CC1N=CC2(CCCCCCCCCCCCCC2)N1CCCN1CCCC1,CCOC(=O)CC1N=CC2(CCCCCCCCCCCCCC2)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso8,CCOC(=O)CC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.170183443,https://www.nature.com/articles/s41587-019-0247-3,33,3,0,7,461.3981279,45.14,0,5,6.3518,137.896,0.928571429,1,3,461.735,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4069,LNP_0004069,LM_2019,LM_2019_F189,A2Iso9CC7,Cc1ccc(S(=O)(=O)CNC(=O)C2(NCCCN3CCCC3)CCCCCCCCCCCCCC2)cc1,Cc1ccc(S(=O)(=O)CNC(=O)C2(NCCC[N+]3([H])CCCC3)CCCCCCCCCCCCCC2)cc1,A2,C1CCN(C1)CCCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.724367367,https://www.nature.com/articles/s41587-019-0247-3,38,3,1,9,547.3807636,78.51,2,5,6.13172,157.0372,0.774193548,0,3,547.85,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4070,LNP_0004070,LM_2019,LM_2019_F190,A2Iso10CC7,O=C(NC1CCCCC1)C1(NCCCN2CCCC2)CCCCCCCCCCCCCC1,O=C(NC1CCCCC1)C1(NCCC[N+]2([H])CCCC2)CCCCCCCCCCCCCC1,A2,C1CCN(C1)CCCN,Iso10,[C-]#[N+]C1CCCCC1,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.102518251,https://www.nature.com/articles/s41587-019-0247-3,33,3,0,7,461.4345134,44.37,2,3,6.7246,140.6784,0.965517241,0,3,461.779,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4071,LNP_0004071,LM_2019,LM_2019_F191,A2Iso1CC6,CC(C)(C)NC(=O)C1(NCCCN2CCCC2)CCCCCCCCCCC1,CC(C)(C)NC(=O)C1(NCCC[N+]2([H])CCCC2)CCCCCCCCCCC1,A2,C1CCN(C1)CCCN,Iso1,CC(C)(C)[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.561655425,https://www.nature.com/articles/s41587-019-0247-3,28,2,0,6,393.3719131,44.37,2,3,5.0201,119.7074,0.958333333,0,3,393.66,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4072,LNP_0004072,LM_2019,LM_2019_F192,A2Iso2CC6,CCCCNC(=O)C1(NCCCN2CCCC2)CCCCCCCCCCC1,CCCCNC(=O)C1(NCCC[N+]2([H])CCCC2)CCCCCCCCCCC1,A2,C1CCN(C1)CCCN,Iso2,CCCC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.935871453,https://www.nature.com/articles/s41587-019-0247-3,28,2,0,9,393.3719131,44.37,2,3,5.0217,119.7294,0.958333333,0,3,393.66,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4073,LNP_0004073,LM_2019,LM_2019_F193,A2Iso3CC6,CCCCCNC(=O)C1(NCCCN2CCCC2)CCCCCCCCCCC1,CCCCCNC(=O)C1(NCCC[N+]2([H])CCCC2)CCCCCCCCCCC1,A2,C1CCN(C1)CCCN,Iso3,CCCCC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.041725277,https://www.nature.com/articles/s41587-019-0247-3,29,2,0,10,407.3875632,44.37,2,3,5.4118,124.3464,0.96,0,3,407.687,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4074,LNP_0004074,LM_2019,LM_2019_F194,A2Iso4CC6,COC(=O)C1N=CC2(CCCCCCCCCCC2)N1CCCN1CCCC1,COC(=O)C1N=CC2(CCCCCCCCCCC2)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso4,[C-]#[N+]CC(=O)OC,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.283074405,https://www.nature.com/articles/s41587-019-0247-3,28,3,0,5,391.3198776,45.14,0,5,4.4013,114.811,0.913043478,1,3,391.6,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4075,LNP_0004075,LM_2019,LM_2019_F195,A2Iso5CC6,CCOC(=O)C1N=CC2(CCCCCCCCCCC2)N1CCCN1CCCC1,CCOC(=O)C1N=CC2(CCCCCCCCCCC2)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso5,CCOC(=O)C[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.054805356,https://www.nature.com/articles/s41587-019-0247-3,29,3,0,6,405.3355276,45.14,0,5,4.7914,119.428,0.916666667,1,3,405.627,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4076,LNP_0004076,LM_2019,LM_2019_F196,A2Iso6CC6,CC(C)(C)OC(=O)C1N=CC2(CCCCCCCCCCC2)N1CCCN1CCCC1,CC(C)(C)OC(=O)C1N=CC2(CCCCCCCCCCC2)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.510959412,https://www.nature.com/articles/s41587-019-0247-3,31,3,0,5,433.3668277,45.14,0,5,5.57,128.64,0.923076923,1,3,433.681,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4077,LNP_0004077,LM_2019,LM_2019_F197,A2Iso7CC6,CC(C)(C)OC(=O)C1(C)N=CC2(CCCCCCCCCCC2)N1CCCN1CCCC1,CC(C)(C)OC(=O)C1(C)N=CC2(CCCCCCCCCCC2)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.233681648,https://www.nature.com/articles/s41587-019-0247-3,32,3,0,5,447.3824778,45.14,0,5,5.9601,133.257,0.925925926,1,3,447.708,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4078,LNP_0004078,LM_2019,LM_2019_F198,A2Iso8CC6,CCOC(=O)CC1N=CC2(CCCCCCCCCCC2)N1CCCN1CCCC1,CCOC(=O)CC1N=CC2(CCCCCCCCCCC2)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso8,CCOC(=O)CC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.914444284,https://www.nature.com/articles/s41587-019-0247-3,30,3,0,7,419.3511777,45.14,0,5,5.1815,124.045,0.92,1,3,419.654,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4079,LNP_0004079,LM_2019,LM_2019_F199,A2Iso9CC6,Cc1ccc(S(=O)(=O)CNC(=O)C2(NCCCN3CCCC3)CCCCCCCCCCC2)cc1,Cc1ccc(S(=O)(=O)CNC(=O)C2(NCCC[N+]3([H])CCCC3)CCCCCCCCCCC2)cc1,A2,C1CCN(C1)CCCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.88839575,https://www.nature.com/articles/s41587-019-0247-3,35,3,1,9,505.3338134,78.51,2,5,4.96142,143.1862,0.75,0,3,505.769,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4080,LNP_0004080,LM_2019,LM_2019_F200,A2Iso10CC6,O=C(NC1CCCCC1)C1(NCCCN2CCCC2)CCCCCCCCCCC1,O=C(NC1CCCCC1)C1(NCCC[N+]2([H])CCCC2)CCCCCCCCCCC1,A2,C1CCN(C1)CCCN,Iso10,[C-]#[N+]C1CCCCC1,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.680317071,https://www.nature.com/articles/s41587-019-0247-3,30,3,0,7,419.3875632,44.37,2,3,5.5543,126.8274,0.961538462,0,3,419.698,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4081,LNP_0004081,LM_2019,LM_2019_F201,A2Iso1C6,CCCCCC(CCCCC)(NCCCN1CCCC1)C(=O)NC(C)(C)C,CCCCCC(CCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NC(C)(C)C,A2,C1CCN(C1)CCCN,Iso1,CC(C)(C)[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.310858636,https://www.nature.com/articles/s41587-019-0247-3,27,1,0,14,381.3719131,44.37,2,3,4.876,117.2044,0.956521739,0,3,381.649,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4082,LNP_0004082,LM_2019,LM_2019_F202,A2Iso2C6,CCCCCC(CCCCC)(NCCCN1CCCC1)C(=O)NCCCC,CCCCCC(CCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NCCCC,A2,C1CCN(C1)CCCN,Iso2,CCCC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.338320396,https://www.nature.com/articles/s41587-019-0247-3,27,1,0,17,381.3719131,44.37,2,3,4.8776,117.2264,0.956521739,0,3,381.649,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4083,LNP_0004083,LM_2019,LM_2019_F203,A2Iso3C6,CCCCCNC(=O)C(CCCCC)(CCCCC)NCCCN1CCCC1,CCCCCNC(=O)C(CCCCC)(CCCCC)NCCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso3,CCCCC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.050064818,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,18,395.3875632,44.37,2,3,5.2677,121.8434,0.958333333,0,3,395.676,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4084,LNP_0004084,LM_2019,LM_2019_F204,A2Iso4C6,CCCCCC1(CCCCC)C=NC(C(=O)OC)N1CCCN1CCCC1,CCCCCC1(CCCCC)C=NC(C(=O)OC)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso4,[C-]#[N+]CC(=O)OC,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.99359228,https://www.nature.com/articles/s41587-019-0247-3,27,2,0,13,379.3198776,45.14,0,5,4.2572,112.308,0.909090909,1,3,379.589,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4085,LNP_0004085,LM_2019,LM_2019_F205,A2Iso5C6,CCCCCC1(CCCCC)C=NC(C(=O)OCC)N1CCCN1CCCC1,CCCCCC1(CCCCC)C=NC(C(=O)OCC)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso5,CCOC(=O)C[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.72406397,https://www.nature.com/articles/s41587-019-0247-3,28,2,0,14,393.3355276,45.14,0,5,4.6473,116.925,0.913043478,1,3,393.616,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4086,LNP_0004086,LM_2019,LM_2019_F206,A2Iso6C6,CCCCCC1(CCCCC)C=NC(C(=O)OC(C)(C)C)N1CCCN1CCCC1,CCCCCC1(CCCCC)C=NC(C(=O)OC(C)(C)C)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.351545841,https://www.nature.com/articles/s41587-019-0247-3,30,2,0,13,421.3668277,45.14,0,5,5.4259,126.137,0.92,1,3,421.67,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4087,LNP_0004087,LM_2019,LM_2019_F207,A2Iso7C6,CCCCCC1(CCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCCN1CCCC1,CCCCCC1(CCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.105938009,https://www.nature.com/articles/s41587-019-0247-3,31,2,0,13,435.3824778,45.14,0,5,5.816,130.754,0.923076923,1,3,435.697,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4088,LNP_0004088,LM_2019,LM_2019_F208,A2Iso8C6,CCCCCC1(CCCCC)C=NC(CC(=O)OCC)N1CCCN1CCCC1,CCCCCC1(CCCCC)C=NC(CC(=O)OCC)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso8,CCOC(=O)CC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.779394104,https://www.nature.com/articles/s41587-019-0247-3,29,2,0,15,407.3511777,45.14,0,5,5.0374,121.542,0.916666667,1,3,407.643,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4089,LNP_0004089,LM_2019,LM_2019_F209,A2Iso9C6,CCCCCC(CCCCC)(NCCCN1CCCC1)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCC(CCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NCS(=O)(=O)c1ccc(C)cc1,A2,C1CCN(C1)CCCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.293950294,https://www.nature.com/articles/s41587-019-0247-3,34,2,1,17,493.3338134,78.51,2,5,4.81732,140.6832,0.740740741,0,3,493.758,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4090,LNP_0004090,LM_2019,LM_2019_F210,A2Iso10C6,CCCCCC(CCCCC)(NCCCN1CCCC1)C(=O)NC1CCCCC1,CCCCCC(CCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NC1CCCCC1,A2,C1CCN(C1)CCCN,Iso10,[C-]#[N+]C1CCCCC1,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.147498873,https://www.nature.com/articles/s41587-019-0247-3,29,2,0,15,407.3875632,44.37,2,3,5.4102,124.3244,0.96,0,3,407.687,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4091,LNP_0004091,LM_2019,LM_2019_F211,A3Iso12DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)(C)C)N(CC)CCCNCC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)(C)C)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso1,CC(C)(C)[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,2.358653671,https://www.nature.com/articles/s41587-019-0247-3,51,0,0,38,715.7318646,44.37,2,3,14.0364,229.9384,0.893617021,0,3,716.281,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4092,LNP_0004092,LM_2019,LM_2019_F212,A3Iso22DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCC)N(CC)CCCNCC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso2,CCCC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.021674271,https://www.nature.com/articles/s41587-019-0247-3,51,0,0,41,715.7318646,44.37,2,3,14.038,229.9604,0.893617021,0,3,716.281,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4093,LNP_0004093,LM_2019,LM_2019_F213,A3Iso32DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCCC)N(CC)CCCNCC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso3,CCCCC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.309447475,https://www.nature.com/articles/s41587-019-0247-3,52,0,0,42,729.7475147,44.37,2,3,14.4281,234.5774,0.895833333,0,3,730.308,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4094,LNP_0004094,LM_2019,LM_2019_F214,A3Iso42DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC)N(CC)CCCNCC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso4,[C-]#[N+]CC(=O)OC,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,3.036562101,https://www.nature.com/articles/s41587-019-0247-3,52,0,0,40,731.6903937,70.67,2,5,12.4109,227.0684,0.869565217,0,3,732.236,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4095,LNP_0004095,LM_2019,LM_2019_F215,A3Iso72DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CCCNCC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.579286948,https://www.nature.com/articles/s41587-019-0247-3,56,0,0,40,787.752994,70.67,2,5,13.9681,245.4924,0.88,1,3,788.344,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4096,LNP_0004096,LM_2019,LM_2019_F216,A3Iso82DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCC(=O)OCC)N(CC)CCCNCC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCC(=O)OCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso8,CCOC(=O)CC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.134343412,https://www.nature.com/articles/s41587-019-0247-3,54,0,0,42,759.7216938,70.67,2,5,13.1911,236.3024,0.875,0,3,760.29,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4097,LNP_0004097,LM_2019,LM_2019_F217,A3Iso102DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC1CCCCC1)N(CC)CCCNCC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC1CCCCC1)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso10,[C-]#[N+]C1CCCCC1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.495309478,https://www.nature.com/articles/s41587-019-0247-3,53,1,0,39,741.7475147,44.37,2,3,14.5706,237.0584,0.897959184,0,3,742.319,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4098,LNP_0004098,LM_2019,LM_2019_F218,A3Iso1C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)(C)C)N(CC)CCCNCC,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)(C)C)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso1,CC(C)(C)[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.242912957,https://www.nature.com/articles/s41587-019-0247-3,37,0,0,26,523.5440638,44.37,2,3,9.023,165.4884,0.96969697,0,3,523.935,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4099,LNP_0004099,LM_2019,LM_2019_F219,A3Iso2C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCC)N(CC)CCCNCC,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso2,CCCC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.941609577,https://www.nature.com/articles/s41587-019-0247-3,37,0,0,29,523.5440638,44.37,2,3,9.0246,165.5104,0.96969697,0,3,523.935,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4100,LNP_0004100,LM_2019,LM_2019_F220,A3Iso3C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCCC)N(CC)CCCNCC,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso3,CCCCC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.194799527,https://www.nature.com/articles/s41587-019-0247-3,38,0,0,30,537.5597139,44.37,2,3,9.4147,170.1274,0.970588235,0,3,537.962,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4101,LNP_0004101,LM_2019,LM_2019_F221,A3Iso4C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC)N(CC)CCCNCC,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso4,[C-]#[N+]CC(=O)OC,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.909141877,https://www.nature.com/articles/s41587-019-0247-3,38,0,0,28,539.5025929,70.67,2,5,7.3975,162.6184,0.9375,0,3,539.89,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4102,LNP_0004102,LM_2019,LM_2019_F222,A3Iso5C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CCCNCC,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso5,CCOC(=O)C[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,2.088171035,https://www.nature.com/articles/s41587-019-0247-3,39,0,0,29,553.518243,70.67,2,5,7.7876,167.2354,0.939393939,0,3,553.917,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4103,LNP_0004103,LM_2019,LM_2019_F223,A3Iso6C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CCCNCC,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.330258419,https://www.nature.com/articles/s41587-019-0247-3,41,0,0,28,581.5495431,70.67,2,5,8.5662,176.4474,0.942857143,0,3,581.971,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4104,LNP_0004104,LM_2019,LM_2019_F224,A3Iso7C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CCCNCC,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,2.293248401,https://www.nature.com/articles/s41587-019-0247-3,42,0,0,28,595.5651932,70.67,2,5,8.9547,181.0424,0.944444444,1,3,595.998,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4105,LNP_0004105,LM_2019,LM_2019_F225,A3Iso8C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCC(=O)OCC)N(CC)CCCNCC,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCC(=O)OCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso8,CCOC(=O)CC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.598871885,https://www.nature.com/articles/s41587-019-0247-3,40,0,0,30,567.5338931,70.67,2,5,8.1777,171.8524,0.941176471,0,3,567.944,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4106,LNP_0004106,LM_2019,LM_2019_F226,A3Iso9C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CCCNCC,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.551349341,https://www.nature.com/articles/s41587-019-0247-3,44,1,1,29,635.5059641,78.51,2,5,8.96432,188.9672,0.810810811,0,3,636.044,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4107,LNP_0004107,LM_2019,LM_2019_F227,A3Iso10C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC1CCCCC1)N(CC)CCCNCC,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC1CCCCC1)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso10,[C-]#[N+]C1CCCCC1,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.140579654,https://www.nature.com/articles/s41587-019-0247-3,39,1,0,27,549.5597139,44.37,2,3,9.5572,172.6084,0.971428571,0,3,549.973,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4108,LNP_0004108,LM_2019,LM_2019_F228,A3Iso1C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)(C)C)N(CC)CCCNCC,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)(C)C)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso1,CC(C)(C)[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.696869992,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,24,495.5127637,44.37,2,3,8.2428,156.2544,0.967741935,0,3,495.881,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4109,LNP_0004109,LM_2019,LM_2019_F229,A3Iso2C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCC)N(CC)CCCNCC,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso2,CCCC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.751470119,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,27,495.5127637,44.37,2,3,8.2444,156.2764,0.967741935,0,3,495.881,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4110,LNP_0004110,LM_2019,LM_2019_F230,A3Iso3C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCCC)N(CC)CCCNCC,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso3,CCCCC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.859024246,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,28,509.5284138,44.37,2,3,8.6345,160.8934,0.96875,0,3,509.908,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4111,LNP_0004111,LM_2019,LM_2019_F231,A3Iso4C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC)N(CC)CCCNCC,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso4,[C-]#[N+]CC(=O)OC,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.92738432,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,26,511.4712928,70.67,2,5,6.6173,153.3844,0.933333333,0,3,511.836,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4112,LNP_0004112,LM_2019,LM_2019_F232,A3Iso5C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CCCNCC,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso5,CCOC(=O)C[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.54383802,https://www.nature.com/articles/s41587-019-0247-3,37,0,0,27,525.4869429,70.67,2,5,7.0074,158.0014,0.935483871,0,3,525.863,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4113,LNP_0004113,LM_2019,LM_2019_F233,A3Iso6C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CCCNCC,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.135215911,https://www.nature.com/articles/s41587-019-0247-3,39,0,0,26,553.518243,70.67,2,5,7.786,167.2134,0.939393939,0,3,553.917,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4114,LNP_0004114,LM_2019,LM_2019_F234,A3Iso7C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CCCNCC,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.894303297,https://www.nature.com/articles/s41587-019-0247-3,40,0,0,26,567.5338931,70.67,2,5,8.1745,171.8084,0.941176471,1,3,567.944,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4115,LNP_0004115,LM_2019,LM_2019_F235,A3Iso8C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCC(=O)OCC)N(CC)CCCNCC,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCC(=O)OCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso8,CCOC(=O)CC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.064544296,https://www.nature.com/articles/s41587-019-0247-3,38,0,0,28,539.5025929,70.67,2,5,7.3975,162.6184,0.9375,0,3,539.89,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4116,LNP_0004116,LM_2019,LM_2019_F236,A3Iso9C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CCCNCC,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.202559054,https://www.nature.com/articles/s41587-019-0247-3,42,1,1,27,607.4746639,78.51,2,5,8.18412,179.7332,0.8,0,3,607.99,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4117,LNP_0004117,LM_2019,LM_2019_F237,A3Iso10C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC1CCCCC1)N(CC)CCCNCC,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC1CCCCC1)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso10,[C-]#[N+]C1CCCCC1,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.580998954,https://www.nature.com/articles/s41587-019-0247-3,37,1,0,25,521.5284138,44.37,2,3,8.777,163.3744,0.96969697,0,3,521.919,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4118,LNP_0004118,LM_2019,LM_2019_F238,A3Iso1C9,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)(C)C)N(CC)CCCNCC,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)(C)C)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso1,CC(C)(C)[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.459702704,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,22,467.4814636,44.37,2,3,7.4626,147.0204,0.965517241,0,3,467.827,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4119,LNP_0004119,LM_2019,LM_2019_F239,A3Iso2C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCC)N(CC)CCCNCC,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso2,CCCC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.174754366,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,25,467.4814636,44.37,2,3,7.4642,147.0424,0.965517241,0,3,467.827,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4120,LNP_0004120,LM_2019,LM_2019_F240,A3Iso3C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCCC)N(CC)CCCNCC,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso3,CCCCC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.57039779,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,26,481.4971136,44.37,2,3,7.8543,151.6594,0.966666667,0,3,481.854,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4121,LNP_0004121,LM_2019,LM_2019_F241,A3Iso4C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC)N(CC)CCCNCC,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso4,[C-]#[N+]CC(=O)OC,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.373840919,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,24,483.4399927,70.67,2,5,5.8371,144.1504,0.928571429,0,3,483.782,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4122,LNP_0004122,LM_2019,LM_2019_F242,A3Iso5C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CCCNCC,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso5,CCOC(=O)C[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.029909168,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,25,497.4556427,70.67,2,5,6.2272,148.7674,0.931034483,0,3,497.809,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4123,LNP_0004123,LM_2019,LM_2019_F243,A3Iso6C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CCCNCC,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.6429538,https://www.nature.com/articles/s41587-019-0247-3,37,0,0,24,525.4869429,70.67,2,5,7.0058,157.9794,0.935483871,0,3,525.863,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4124,LNP_0004124,LM_2019,LM_2019_F244,A3Iso7C9,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CCCNCC,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.045766652,https://www.nature.com/articles/s41587-019-0247-3,38,0,0,24,539.5025929,70.67,2,5,7.3943,162.5744,0.9375,1,3,539.89,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4125,LNP_0004125,LM_2019,LM_2019_F245,A3Iso8C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCCC(=O)OCC)N(CC)CCCNCC,CCCCCCCCC(CCCCCCCC)(C(=O)NCCC(=O)OCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso8,CCOC(=O)CC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.444991217,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,26,511.4712928,70.67,2,5,6.6173,153.3844,0.933333333,0,3,511.836,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4126,LNP_0004126,LM_2019,LM_2019_F246,A3Iso9C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CCCNCC,CCCCCCCCC(CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.216511557,https://www.nature.com/articles/s41587-019-0247-3,40,1,1,25,579.4433638,78.51,2,5,7.40392,170.4992,0.787878788,0,3,579.936,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4127,LNP_0004127,LM_2019,LM_2019_F247,A3Iso10C9,CCCCCCCCC(CCCCCCCC)(C(=O)NC1CCCCC1)N(CC)CCCNCC,CCCCCCCCC(CCCCCCCC)(C(=O)NC1CCCCC1)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso10,[C-]#[N+]C1CCCCC1,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.960805391,https://www.nature.com/articles/s41587-019-0247-3,35,1,0,23,493.4971136,44.37,2,3,7.9968,154.1404,0.967741935,0,3,493.865,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4128,LNP_0004128,LM_2019,LM_2019_F248,A3Iso1C8,CCCCCCCC(CCCCCCC)(C(=O)NC(C)(C)C)N(CC)CCCNCC,CCCCCCCC(CCCCCCC)(C(=O)NC(C)(C)C)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso1,CC(C)(C)[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.304648899,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,20,439.4501634,44.37,2,3,6.6824,137.7864,0.962962963,0,3,439.773,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4129,LNP_0004129,LM_2019,LM_2019_F249,A3Iso2C8,CCCCCCCC(CCCCCCC)(C(=O)NCCCC)N(CC)CCCNCC,CCCCCCCC(CCCCCCC)(C(=O)NCCCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso2,CCCC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.496897867,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,23,439.4501634,44.37,2,3,6.684,137.8084,0.962962963,0,3,439.773,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4130,LNP_0004130,LM_2019,LM_2019_F250,A3Iso3C8,CCCCCCCC(CCCCCCC)(C(=O)NCCCCC)N(CC)CCCNCC,CCCCCCCC(CCCCCCC)(C(=O)NCCCCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso3,CCCCC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.141442023,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,24,453.4658135,44.37,2,3,7.0741,142.4254,0.964285714,0,3,453.8,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4131,LNP_0004131,LM_2019,LM_2019_F251,A3Iso4C8,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC)N(CC)CCCNCC,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso4,[C-]#[N+]CC(=O)OC,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.220857456,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,22,455.4086926,70.67,2,5,5.0569,134.9164,0.923076923,0,3,455.728,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4132,LNP_0004132,LM_2019,LM_2019_F252,A3Iso5C8,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CCCNCC,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso5,CCOC(=O)C[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.120806297,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,23,469.4243426,70.67,2,5,5.447,139.5334,0.925925926,0,3,469.755,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4133,LNP_0004133,LM_2019,LM_2019_F253,A3Iso6C8,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CCCNCC,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.982109009,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,22,497.4556427,70.67,2,5,6.2256,148.7454,0.931034483,0,3,497.809,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4134,LNP_0004134,LM_2019,LM_2019_F254,A3Iso7C8,CCCCCCCC(CCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CCCNCC,CCCCCCCC(CCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.862029672,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,22,511.4712928,70.67,2,5,6.6141,153.3404,0.933333333,1,3,511.836,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4135,LNP_0004135,LM_2019,LM_2019_F255,A3Iso8C8,CCCCCCCC(CCCCCCC)(C(=O)NCCC(=O)OCC)N(CC)CCCNCC,CCCCCCCC(CCCCCCC)(C(=O)NCCC(=O)OCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso8,CCOC(=O)CC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.482900842,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,24,483.4399927,70.67,2,5,5.8371,144.1504,0.928571429,0,3,483.782,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4136,LNP_0004136,LM_2019,LM_2019_F256,A3Iso9C8,CCCCCCCC(CCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CCCNCC,CCCCCCCC(CCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.447014377,https://www.nature.com/articles/s41587-019-0247-3,38,1,1,23,551.4120637,78.51,2,5,6.62372,161.2652,0.774193548,0,3,551.882,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4137,LNP_0004137,LM_2019,LM_2019_F257,A3Iso10C8,CCCCCCCC(CCCCCCC)(C(=O)NC1CCCCC1)N(CC)CCCNCC,CCCCCCCC(CCCCCCC)(C(=O)NC1CCCCC1)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso10,[C-]#[N+]C1CCCCC1,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.916042616,https://www.nature.com/articles/s41587-019-0247-3,33,1,0,21,465.4658135,44.37,2,3,7.2166,144.9064,0.965517241,0,3,465.811,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4138,LNP_0004138,LM_2019,LM_2019_F258,A3Iso1C7,CCCCCCC(CCCCCC)(C(=O)NC(C)(C)C)N(CC)CCCNCC,CCCCCCC(CCCCCC)(C(=O)NC(C)(C)C)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso1,CC(C)(C)[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.009120754,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,18,411.4188633,44.37,2,3,5.9022,128.5524,0.96,0,3,411.719,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4139,LNP_0004139,LM_2019,LM_2019_F259,A3Iso2C7,CCCCCCC(CCCCCC)(C(=O)NCCCC)N(CC)CCCNCC,CCCCCCC(CCCCCC)(C(=O)NCCCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso2,CCCC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.934763626,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,21,411.4188633,44.37,2,3,5.9038,128.5744,0.96,0,3,411.719,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4140,LNP_0004140,LM_2019,LM_2019_F260,A3Iso3C7,CCCCCCC(CCCCCC)(C(=O)NCCCCC)N(CC)CCCNCC,CCCCCCC(CCCCCC)(C(=O)NCCCCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso3,CCCCC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.971397794,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,22,425.4345134,44.37,2,3,6.2939,133.1914,0.961538462,0,3,425.746,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4141,LNP_0004141,LM_2019,LM_2019_F261,A3Iso4C7,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC)N(CC)CCCNCC,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso4,[C-]#[N+]CC(=O)OC,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.200704374,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,20,427.3773924,70.67,2,5,4.2767,125.6824,0.916666667,0,3,427.674,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4142,LNP_0004142,LM_2019,LM_2019_F262,A3Iso5C7,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OCC)N(CC)CCCNCC,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso5,CCOC(=O)C[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.170002635,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,21,441.3930425,70.67,2,5,4.6668,130.2994,0.92,0,3,441.701,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4143,LNP_0004143,LM_2019,LM_2019_F263,A3Iso6C7,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CCCNCC,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC(C)(C)C)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.147908643,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,20,469.4243426,70.67,2,5,5.4454,139.5114,0.925925926,0,3,469.755,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4144,LNP_0004144,LM_2019,LM_2019_F264,A3Iso7C7,CCCCCCC(CCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CCCNCC,CCCCCCC(CCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.034896737,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,20,483.4399927,70.67,2,5,5.8339,144.1064,0.928571429,1,3,483.782,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4145,LNP_0004145,LM_2019,LM_2019_F265,A3Iso8C7,CCCCCCC(CCCCCC)(C(=O)NCCC(=O)OCC)N(CC)CCCNCC,CCCCCCC(CCCCCC)(C(=O)NCCC(=O)OCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso8,CCOC(=O)CC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.641478262,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,22,455.4086926,70.67,2,5,5.0569,134.9164,0.923076923,0,3,455.728,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4146,LNP_0004146,LM_2019,LM_2019_F266,A3Iso9C7,CCCCCCC(CCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CCCNCC,CCCCCCC(CCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.330258419,https://www.nature.com/articles/s41587-019-0247-3,36,1,1,21,523.3807636,78.51,2,5,5.84352,152.0312,0.75862069,0,3,523.828,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4147,LNP_0004147,LM_2019,LM_2019_F267,A3Iso10C7,CCCCCCC(CCCCCC)(C(=O)NC1CCCCC1)N(CC)CCCNCC,CCCCCCC(CCCCCC)(C(=O)NC1CCCCC1)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso10,[C-]#[N+]C1CCCCC1,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.43488277,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,19,437.4345134,44.37,2,3,6.4364,135.6724,0.962962963,0,3,437.757,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4148,LNP_0004148,LM_2019,LM_2019_F268,A3Iso1CC7,CCNCCCN(CC)C1(C(=O)NC(C)(C)C)CCCCCCCCCCCCCC1,CCNCCC[N+](CC)(C1(C(=O)NC(C)(C)C)CCCCCCCCCCCCCC1)[H],A3,CCNCCCNCC,Iso1,CC(C)(C)[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.135175907,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,8,437.4345134,44.37,2,3,6.4364,135.6724,0.962962963,0,3,437.757,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4149,LNP_0004149,LM_2019,LM_2019_F269,A3Iso2CC7,CCCCNC(=O)C1(N(CC)CCCNCC)CCCCCCCCCCCCCC1,CCCCNC(=O)C1([N+](CC)(CCCNCC)[H])CCCCCCCCCCCCCC1,A3,CCNCCCNCC,Iso2,CCCC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.718222018,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,11,437.4345134,44.37,2,3,6.438,135.6944,0.962962963,0,3,437.757,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4150,LNP_0004150,LM_2019,LM_2019_F270,A3Iso3CC7,CCCCCNC(=O)C1(N(CC)CCCNCC)CCCCCCCCCCCCCC1,CCCCCNC(=O)C1([N+](CC)(CCCNCC)[H])CCCCCCCCCCCCCC1,A3,CCNCCCNCC,Iso3,CCCCC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.117493951,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,12,451.4501634,44.37,2,3,6.8281,140.3114,0.964285714,0,3,451.784,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4151,LNP_0004151,LM_2019,LM_2019_F271,A3Iso4CC7,CCNCCCN(CC)C1(C(=O)NCC(=O)OC)CCCCCCCCCCCCCC1,CCNCCC[N+](CC)(C1(C(=O)NCC(=O)OC)CCCCCCCCCCCCCC1)[H],A3,CCNCCCNCC,Iso4,[C-]#[N+]CC(=O)OC,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.906584774,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,10,453.3930425,70.67,2,5,4.8109,132.8024,0.923076923,0,3,453.712,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4152,LNP_0004152,LM_2019,LM_2019_F272,A3Iso5CC7,CCNCCCN(CC)C1(C(=O)NCC(=O)OCC)CCCCCCCCCCCCCC1,CCNCCC[N+](CC)(C1(C(=O)NCC(=O)OCC)CCCCCCCCCCCCCC1)[H],A3,CCNCCCNCC,Iso5,CCOC(=O)C[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.021517273,https://www.nature.com/articles/s41587-019-0247-3,33,1,0,11,467.4086926,70.67,2,5,5.201,137.4194,0.925925926,0,3,467.739,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4153,LNP_0004153,LM_2019,LM_2019_F273,A3Iso6CC7,CCNCCCN(CC)C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCCCCC1,CCNCCC[N+](CC)(C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCCCCC1)[H],A3,CCNCCCNCC,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.488302608,https://www.nature.com/articles/s41587-019-0247-3,35,1,0,10,495.4399927,70.67,2,5,5.9796,146.6314,0.931034483,0,3,495.793,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4154,LNP_0004154,LM_2019,LM_2019_F274,A3Iso7CC7,CCNCCCN(CC)C1(C(=O)NC(C)C(=O)OC(C)(C)C)CCCCCCCCCCCCCC1,CCNCCC[N+](CC)(C1(C(=O)NC(C)C(=O)OC(C)(C)C)CCCCCCCCCCCCCC1)[H],A3,CCNCCCNCC,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.299059793,https://www.nature.com/articles/s41587-019-0247-3,36,1,0,10,509.4556427,70.67,2,5,6.3681,151.2264,0.933333333,1,3,509.82,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4155,LNP_0004155,LM_2019,LM_2019_F275,A3Iso8CC7,CCNCCCN(CC)C1(C(=O)NCCC(=O)OCC)CCCCCCCCCCCCCC1,CCNCCC[N+](CC)(C1(C(=O)NCCC(=O)OCC)CCCCCCCCCCCCCC1)[H],A3,CCNCCCNCC,Iso8,CCOC(=O)CC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.426801187,https://www.nature.com/articles/s41587-019-0247-3,34,1,0,12,481.4243426,70.67,2,5,5.5911,142.0364,0.928571429,0,3,481.766,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4156,LNP_0004156,LM_2019,LM_2019_F276,A3Iso9CC7,CCNCCCN(CC)C1(C(=O)NCS(=O)(=O)c2ccc(C)cc2)CCCCCCCCCCCCCC1,CCNCCC[N+](CC)(C1(C(=O)NCS(=O)(=O)c2ccc(C)cc2)CCCCCCCCCCCCCC1)[H],A3,CCNCCCNCC,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.151626167,https://www.nature.com/articles/s41587-019-0247-3,38,2,1,11,549.3964136,78.51,2,5,6.37772,159.1512,0.774193548,0,3,549.866,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4157,LNP_0004157,LM_2019,LM_2019_F277,A3Iso10CC7,CCNCCCN(CC)C1(C(=O)NC2CCCCC2)CCCCCCCCCCCCCC1,CCNCCC[N+](CC)(C1(C(=O)NC2CCCCC2)CCCCCCCCCCCCCC1)[H],A3,CCNCCCNCC,Iso10,[C-]#[N+]C1CCCCC1,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.498995714,https://www.nature.com/articles/s41587-019-0247-3,33,2,0,9,463.4501634,44.37,2,3,6.9706,142.7924,0.965517241,0,3,463.795,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4158,LNP_0004158,LM_2019,LM_2019_F278,A3Iso1CC6,CCNCCCN(CC)C1(C(=O)NC(C)(C)C)CCCCCCCCCCC1,CCNCCC[N+](CC)(C1(C(=O)NC(C)(C)C)CCCCCCCCCCC1)[H],A3,CCNCCCNCC,Iso1,CC(C)(C)[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.505880605,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,8,395.3875632,44.37,2,3,5.2661,121.8214,0.958333333,0,3,395.676,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4159,LNP_0004159,LM_2019,LM_2019_F279,A3Iso2CC6,CCCCNC(=O)C1(N(CC)CCCNCC)CCCCCCCCCCC1,CCCCNC(=O)C1([N+](CC)(CCCNCC)[H])CCCCCCCCCCC1,A3,CCNCCCNCC,Iso2,CCCC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.353556365,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,11,395.3875632,44.37,2,3,5.2677,121.8434,0.958333333,0,3,395.676,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4160,LNP_0004160,LM_2019,LM_2019_F280,A3Iso3CC6,CCCCCNC(=O)C1(N(CC)CCCNCC)CCCCCCCCCCC1,CCCCCNC(=O)C1([N+](CC)(CCCNCC)[H])CCCCCCCCCCC1,A3,CCNCCCNCC,Iso3,CCCCC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.028096266,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,12,409.4032133,44.37,2,3,5.6578,126.4604,0.96,0,3,409.703,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4161,LNP_0004161,LM_2019,LM_2019_F281,A3Iso4CC6,CCNCCCN(CC)C1(C(=O)NCC(=O)OC)CCCCCCCCCCC1,CCNCCC[N+](CC)(C1(C(=O)NCC(=O)OC)CCCCCCCCCCC1)[H],A3,CCNCCCNCC,Iso4,[C-]#[N+]CC(=O)OC,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.456804771,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,10,411.3460923,70.67,2,5,3.6406,118.9514,0.913043478,0,3,411.631,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4162,LNP_0004162,LM_2019,LM_2019_F282,A3Iso5CC6,CCNCCCN(CC)C1(C(=O)NCC(=O)OCC)CCCCCCCCCCC1,CCNCCC[N+](CC)(C1(C(=O)NCC(=O)OCC)CCCCCCCCCCC1)[H],A3,CCNCCCNCC,Iso5,CCOC(=O)C[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.327269986,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,11,425.3617424,70.67,2,5,4.0307,123.5684,0.916666667,0,3,425.658,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4163,LNP_0004163,LM_2019,LM_2019_F283,A3Iso6CC6,CCNCCCN(CC)C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCC1,CCNCCC[N+](CC)(C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCC1)[H],A3,CCNCCCNCC,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.424070088,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,10,453.3930425,70.67,2,5,4.8093,132.7804,0.923076923,0,3,453.712,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4164,LNP_0004164,LM_2019,LM_2019_F284,A3Iso7CC6,CCNCCCN(CC)C1(C(=O)NC(C)C(=O)OC(C)(C)C)CCCCCCCCCCC1,CCNCCC[N+](CC)(C1(C(=O)NC(C)C(=O)OC(C)(C)C)CCCCCCCCCCC1)[H],A3,CCNCCCNCC,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.255897013,https://www.nature.com/articles/s41587-019-0247-3,33,1,0,10,467.4086926,70.67,2,5,5.1978,137.3754,0.925925926,1,3,467.739,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4165,LNP_0004165,LM_2019,LM_2019_F285,A3Iso8CC6,CCNCCCN(CC)C1(C(=O)NCCC(=O)OCC)CCCCCCCCCCC1,CCNCCC[N+](CC)(C1(C(=O)NCCC(=O)OCC)CCCCCCCCCCC1)[H],A3,CCNCCCNCC,Iso8,CCOC(=O)CC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.547001455,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,12,439.3773924,70.67,2,5,4.4208,128.1854,0.92,0,3,439.685,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4166,LNP_0004166,LM_2019,LM_2019_F286,A3Iso9CC6,CCNCCCN(CC)C1(C(=O)NCS(=O)(=O)c2ccc(C)cc2)CCCCCCCCCCC1,CCNCCC[N+](CC)(C1(C(=O)NCS(=O)(=O)c2ccc(C)cc2)CCCCCCCCCCC1)[H],A3,CCNCCCNCC,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-2.325658245,https://www.nature.com/articles/s41587-019-0247-3,35,2,1,11,507.3494634,78.51,2,5,5.20742,145.3002,0.75,0,3,507.785,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4167,LNP_0004167,LM_2019,LM_2019_F287,A3Iso10CC6,CCNCCCN(CC)C1(C(=O)NC2CCCCC2)CCCCCCCCCCC1,CCNCCC[N+](CC)(C1(C(=O)NC2CCCCC2)CCCCCCCCCCC1)[H],A3,CCNCCCNCC,Iso10,[C-]#[N+]C1CCCCC1,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.156963792,https://www.nature.com/articles/s41587-019-0247-3,30,2,0,9,421.4032133,44.37,2,3,5.8003,128.9414,0.961538462,0,3,421.714,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4168,LNP_0004168,LM_2019,LM_2019_F288,A3Iso1C6,CCCCCC(CCCCC)(C(=O)NC(C)(C)C)N(CC)CCCNCC,CCCCCC(CCCCC)(C(=O)NC(C)(C)C)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso1,CC(C)(C)[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.266269649,https://www.nature.com/articles/s41587-019-0247-3,27,0,0,16,383.3875632,44.37,2,3,5.122,119.3184,0.956521739,0,3,383.665,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4169,LNP_0004169,LM_2019,LM_2019_F289,A3Iso2C6,CCCCCC(CCCCC)(C(=O)NCCCC)N(CC)CCCNCC,CCCCCC(CCCCC)(C(=O)NCCCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso2,CCCC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.350424386,https://www.nature.com/articles/s41587-019-0247-3,27,0,0,19,383.3875632,44.37,2,3,5.1236,119.3404,0.956521739,0,3,383.665,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4170,LNP_0004170,LM_2019,LM_2019_F290,A3Iso3C6,CCCCCNC(=O)C(CCCCC)(CCCCC)N(CC)CCCNCC,CCCCCNC(=O)C(CCCCC)(CCCCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso3,CCCCC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.04000918,https://www.nature.com/articles/s41587-019-0247-3,28,0,0,20,397.4032133,44.37,2,3,5.5137,123.9574,0.958333333,0,3,397.692,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4171,LNP_0004171,LM_2019,LM_2019_F291,A3Iso4C6,CCCCCC(CCCCC)(C(=O)NCC(=O)OC)N(CC)CCCNCC,CCCCCC(CCCCC)(C(=O)NCC(=O)OC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso4,[C-]#[N+]CC(=O)OC,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.976203619,https://www.nature.com/articles/s41587-019-0247-3,28,0,0,18,399.3460923,70.67,2,5,3.4965,116.4484,0.909090909,0,3,399.62,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4172,LNP_0004172,LM_2019,LM_2019_F292,A3Iso5C6,CCCCCC(CCCCC)(C(=O)NCC(=O)OCC)N(CC)CCCNCC,CCCCCC(CCCCC)(C(=O)NCC(=O)OCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso5,CCOC(=O)C[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.216161246,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,19,413.3617424,70.67,2,5,3.8866,121.0654,0.913043478,0,3,413.647,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4173,LNP_0004173,LM_2019,LM_2019_F293,A3Iso6C6,CCCCCC(CCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CCCNCC,CCCCCC(CCCCC)(C(=O)NCC(=O)OC(C)(C)C)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.276861674,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,18,441.3930425,70.67,2,5,4.6652,130.2774,0.92,0,3,441.701,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4174,LNP_0004174,LM_2019,LM_2019_F294,A3Iso7C6,CCCCCC(CCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CCCNCC,CCCCCC(CCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.068040655,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,18,455.4086926,70.67,2,5,5.0537,134.8724,0.923076923,1,3,455.728,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4175,LNP_0004175,LM_2019,LM_2019_F295,A3Iso8C6,CCCCCC(CCCCC)(C(=O)NCCC(=O)OCC)N(CC)CCCNCC,CCCCCC(CCCCC)(C(=O)NCCC(=O)OCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso8,CCOC(=O)CC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.117493951,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,20,427.3773924,70.67,2,5,4.2767,125.6824,0.916666667,0,3,427.674,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4176,LNP_0004176,LM_2019,LM_2019_F296,A3Iso9C6,CCCCCC(CCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CCCNCC,CCCCCC(CCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.086813839,https://www.nature.com/articles/s41587-019-0247-3,34,1,1,19,495.3494634,78.51,2,5,5.06332,142.7972,0.740740741,0,3,495.774,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4177,LNP_0004177,LM_2019,LM_2019_F297,A3Iso10C6,CCCCCC(CCCCC)(C(=O)NC1CCCCC1)N(CC)CCCNCC,CCCCCC(CCCCC)(C(=O)NC1CCCCC1)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso10,[C-]#[N+]C1CCCCC1,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.37785936,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,17,409.4032133,44.37,2,3,5.6562,126.4384,0.96,0,3,409.703,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4178,LNP_0004178,LM_2019,LM_2019_F298,A4Iso12DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)(C)C)N(C)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)(C)C)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.696305324,https://www.nature.com/articles/s41587-019-0247-3,49,0,0,35,687.7005645,35.58,1,3,13.2083,220.7147,0.888888889,0,3,688.227,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4179,LNP_0004179,LM_2019,LM_2019_F299,A4Iso22DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCC)N(C)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso2,CCCC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.100581214,https://www.nature.com/articles/s41587-019-0247-3,49,0,0,38,687.7005645,35.58,1,3,13.2099,220.7367,0.888888889,0,3,688.227,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4180,LNP_0004180,LM_2019,LM_2019_F300,A4Iso32DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCCC)N(C)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso3,CCCCC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.903467772,https://www.nature.com/articles/s41587-019-0247-3,50,0,0,39,701.7162145,35.58,1,3,13.6,225.3537,0.891304348,0,3,702.254,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4181,LNP_0004181,LM_2019,LM_2019_F301,A4Iso42DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC)N(C)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.059956445,https://www.nature.com/articles/s41587-019-0247-3,50,0,0,37,703.6590936,61.88,1,5,11.5828,217.8447,0.863636364,0,3,704.182,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4182,LNP_0004182,LM_2019,LM_2019_F302,A4Iso72DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.075298593,https://www.nature.com/articles/s41587-019-0247-3,54,0,0,37,759.7216938,61.88,1,5,13.14,236.2687,0.875,1,3,760.29,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4183,LNP_0004183,LM_2019,LM_2019_F303,A4Iso82DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.043668197,https://www.nature.com/articles/s41587-019-0247-3,52,0,0,39,731.6903937,61.88,1,5,12.363,227.0787,0.869565217,0,3,732.236,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4184,LNP_0004184,LM_2019,LM_2019_F304,A4Iso102DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC1CCCCC1)N(C)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC1CCCCC1)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.127184052,https://www.nature.com/articles/s41587-019-0247-3,51,1,0,36,713.7162145,35.58,1,3,13.7425,227.8347,0.893617021,0,3,714.265,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4185,LNP_0004185,LM_2019,LM_2019_F305,A4Iso1C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)(C)C)N(C)CCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)(C)C)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.686104904,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,23,495.5127637,35.58,1,3,8.1949,156.2647,0.967741935,0,3,495.881,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4186,LNP_0004186,LM_2019,LM_2019_F306,A4Iso2C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCC)N(C)CCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso2,CCCC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.492733072,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,26,495.5127637,35.58,1,3,8.1965,156.2867,0.967741935,0,3,495.881,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4187,LNP_0004187,LM_2019,LM_2019_F307,A4Iso3C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCCC)N(C)CCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso3,CCCCC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.178058942,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,27,509.5284138,35.58,1,3,8.5866,160.9037,0.96875,0,3,509.908,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4188,LNP_0004188,LM_2019,LM_2019_F308,A4Iso4C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC)N(C)CCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.752655736,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,25,511.4712928,61.88,1,5,6.5694,153.3947,0.933333333,0,3,511.836,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4189,LNP_0004189,LM_2019,LM_2019_F309,A4Iso5C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.03484213,https://www.nature.com/articles/s41587-019-0247-3,37,0,0,26,525.4869429,61.88,1,5,6.9595,158.0117,0.935483871,0,3,525.863,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4190,LNP_0004190,LM_2019,LM_2019_F310,A4Iso6C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.071447856,https://www.nature.com/articles/s41587-019-0247-3,39,0,0,25,553.518243,61.88,1,5,7.7381,167.2237,0.939393939,0,3,553.917,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4191,LNP_0004191,LM_2019,LM_2019_F311,A4Iso7C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.212824393,https://www.nature.com/articles/s41587-019-0247-3,40,0,0,25,567.5338931,61.88,1,5,8.1266,171.8187,0.941176471,1,3,567.944,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4192,LNP_0004192,LM_2019,LM_2019_F312,A4Iso8C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.317351081,https://www.nature.com/articles/s41587-019-0247-3,38,0,0,27,539.5025929,61.88,1,5,7.3496,162.6287,0.9375,0,3,539.89,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4193,LNP_0004193,LM_2019,LM_2019_F313,A4Iso9C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.352317007,https://www.nature.com/articles/s41587-019-0247-3,42,1,1,26,607.4746639,69.72,1,5,8.13622,179.7435,0.8,0,3,607.99,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4194,LNP_0004194,LM_2019,LM_2019_F314,A4Iso10C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC1CCCCC1)N(C)CCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC1CCCCC1)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.020634433,https://www.nature.com/articles/s41587-019-0247-3,37,1,0,24,521.5284138,35.58,1,3,8.7291,163.3847,0.96969697,0,3,521.919,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4195,LNP_0004195,LM_2019,LM_2019_F315,A4Iso1C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)(C)C)N(C)CCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)(C)C)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.406618298,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,21,467.4814636,35.58,1,3,7.4147,147.0307,0.965517241,0,3,467.827,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4196,LNP_0004196,LM_2019,LM_2019_F316,A4Iso2C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCC)N(C)CCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso2,CCCC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.688260166,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,24,467.4814636,35.58,1,3,7.4163,147.0527,0.965517241,0,3,467.827,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4197,LNP_0004197,LM_2019,LM_2019_F317,A4Iso3C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCCC)N(C)CCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso3,CCCCC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.116188156,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,25,481.4971136,35.58,1,3,7.8064,151.6697,0.966666667,0,3,481.854,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4198,LNP_0004198,LM_2019,LM_2019_F318,A4Iso4C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC)N(C)CCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.22666807,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,23,483.4399927,61.88,1,5,5.7892,144.1607,0.928571429,0,3,483.782,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4199,LNP_0004199,LM_2019,LM_2019_F319,A4Iso5C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.450632624,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,24,497.4556427,61.88,1,5,6.1793,148.7777,0.931034483,0,3,497.809,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4200,LNP_0004200,LM_2019,LM_2019_F320,A4Iso6C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.170291132,https://www.nature.com/articles/s41587-019-0247-3,37,0,0,23,525.4869429,61.88,1,5,6.9579,157.9897,0.935483871,0,3,525.863,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4201,LNP_0004201,LM_2019,LM_2019_F321,A4Iso7C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.302604519,https://www.nature.com/articles/s41587-019-0247-3,38,0,0,23,539.5025929,61.88,1,5,7.3464,162.5847,0.9375,1,3,539.89,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4202,LNP_0004202,LM_2019,LM_2019_F322,A4Iso8C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.712574581,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,25,511.4712928,61.88,1,5,6.5694,153.3947,0.933333333,0,3,511.836,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4203,LNP_0004203,LM_2019,LM_2019_F323,A4Iso9C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.783374016,https://www.nature.com/articles/s41587-019-0247-3,40,1,1,24,579.4433638,69.72,1,5,7.35602,170.5095,0.787878788,0,3,579.936,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4204,LNP_0004204,LM_2019,LM_2019_F324,A4Iso10C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC1CCCCC1)N(C)CCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC1CCCCC1)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.932872955,https://www.nature.com/articles/s41587-019-0247-3,35,1,0,22,493.4971136,35.58,1,3,7.9489,154.1507,0.967741935,0,3,493.865,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4205,LNP_0004205,LM_2019,LM_2019_F325,A4Iso1C9,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)(C)C)N(C)CCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)(C)C)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.539994241,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,19,439.4501634,35.58,1,3,6.6345,137.7967,0.962962963,0,3,439.773,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4206,LNP_0004206,LM_2019,LM_2019_F326,A4Iso2C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCC)N(C)CCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso2,CCCC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.45519147,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,22,439.4501634,35.58,1,3,6.6361,137.8187,0.962962963,0,3,439.773,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4207,LNP_0004207,LM_2019,LM_2019_F327,A4Iso3C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCCC)N(C)CCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso3,CCCCC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.445899865,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,23,453.4658135,35.58,1,3,7.0262,142.4357,0.964285714,0,3,453.8,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4208,LNP_0004208,LM_2019,LM_2019_F328,A4Iso4C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC)N(C)CCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.082936708,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,21,455.4086926,61.88,1,5,5.009,134.9267,0.923076923,0,3,455.728,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4209,LNP_0004209,LM_2019,LM_2019_F329,A4Iso5C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.922666145,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,22,469.4243426,61.88,1,5,5.3991,139.5437,0.925925926,0,3,469.755,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4210,LNP_0004210,LM_2019,LM_2019_F330,A4Iso6C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.213950584,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,21,497.4556427,61.88,1,5,6.1777,148.7557,0.931034483,0,3,497.809,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4211,LNP_0004211,LM_2019,LM_2019_F331,A4Iso7C9,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.93177089,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,21,511.4712928,61.88,1,5,6.5662,153.3507,0.933333333,1,3,511.836,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4212,LNP_0004212,LM_2019,LM_2019_F332,A4Iso8C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.914881422,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,23,483.4399927,61.88,1,5,5.7892,144.1607,0.928571429,0,3,483.782,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4213,LNP_0004213,LM_2019,LM_2019_F333,A4Iso9C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.853793175,https://www.nature.com/articles/s41587-019-0247-3,38,1,1,22,551.4120637,69.72,1,5,6.57582,161.2755,0.774193548,0,3,551.882,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4214,LNP_0004214,LM_2019,LM_2019_F334,A4Iso10C9,CCCCCCCCC(CCCCCCCC)(C(=O)NC1CCCCC1)N(C)CCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NC1CCCCC1)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.913883199,https://www.nature.com/articles/s41587-019-0247-3,33,1,0,20,465.4658135,35.58,1,3,7.1687,144.9167,0.965517241,0,3,465.811,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4215,LNP_0004215,LM_2019,LM_2019_F335,A4Iso1C8,CCCCCCCC(CCCCCCC)(C(=O)NC(C)(C)C)N(C)CCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NC(C)(C)C)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.366971034,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,17,411.4188633,35.58,1,3,5.8543,128.5627,0.96,0,3,411.719,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4216,LNP_0004216,LM_2019,LM_2019_F336,A4Iso2C8,CCCCCCCC(CCCCCCC)(C(=O)NCCCC)N(C)CCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NCCCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso2,CCCC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.282921388,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,20,411.4188633,35.58,1,3,5.8559,128.5847,0.96,0,3,411.719,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4217,LNP_0004217,LM_2019,LM_2019_F337,A4Iso3C8,CCCCCCCC(CCCCCCC)(C(=O)NCCCCC)N(C)CCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NCCCCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso3,CCCCC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.891984578,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,21,425.4345134,35.58,1,3,6.246,133.2017,0.961538462,0,3,425.746,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4218,LNP_0004218,LM_2019,LM_2019_F338,A4Iso4C8,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC)N(C)CCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.493271838,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,19,427.3773924,61.88,1,5,4.2288,125.6927,0.916666667,0,3,427.674,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4219,LNP_0004219,LM_2019,LM_2019_F339,A4Iso5C8,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.368036144,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,20,441.3930425,61.88,1,5,4.6189,130.3097,0.92,0,3,441.701,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4220,LNP_0004220,LM_2019,LM_2019_F340,A4Iso6C8,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.851788386,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,19,469.4243426,61.88,1,5,5.3975,139.5217,0.925925926,0,3,469.755,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4221,LNP_0004221,LM_2019,LM_2019_F341,A4Iso7C8,CCCCCCCC(CCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.963011182,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,19,483.4399927,61.88,1,5,5.786,144.1167,0.928571429,1,3,483.782,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4222,LNP_0004222,LM_2019,LM_2019_F342,A4Iso8C8,CCCCCCCC(CCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.659146178,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,21,455.4086926,61.88,1,5,5.009,134.9267,0.923076923,0,3,455.728,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4223,LNP_0004223,LM_2019,LM_2019_F343,A4Iso9C8,CCCCCCCC(CCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.526960902,https://www.nature.com/articles/s41587-019-0247-3,36,1,1,20,523.3807636,69.72,1,5,5.79562,152.0415,0.75862069,0,3,523.828,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4224,LNP_0004224,LM_2019,LM_2019_F344,A4Iso10C8,CCCCCCCC(CCCCCCC)(C(=O)NC1CCCCC1)N(C)CCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NC1CCCCC1)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.41916679,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,18,437.4345134,35.58,1,3,6.3885,135.6827,0.962962963,0,3,437.757,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4225,LNP_0004225,LM_2019,LM_2019_F345,A4Iso1C7,CCCCCCC(CCCCCC)(C(=O)NC(C)(C)C)N(C)CCN(C)C,CCCCCCC(CCCCCC)(C(=O)NC(C)(C)C)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.766143819,https://www.nature.com/articles/s41587-019-0247-3,27,0,0,15,383.3875632,35.58,1,3,5.0741,119.3287,0.956521739,0,3,383.665,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4226,LNP_0004226,LM_2019,LM_2019_F346,A4Iso2C7,CCCCCCC(CCCCCC)(C(=O)NCCCC)N(C)CCN(C)C,CCCCCCC(CCCCCC)(C(=O)NCCCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso2,CCCC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.134718721,https://www.nature.com/articles/s41587-019-0247-3,27,0,0,18,383.3875632,35.58,1,3,5.0757,119.3507,0.956521739,0,3,383.665,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4227,LNP_0004227,LM_2019,LM_2019_F347,A4Iso3C7,CCCCCCC(CCCCCC)(C(=O)NCCCCC)N(C)CCN(C)C,CCCCCCC(CCCCCC)(C(=O)NCCCCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso3,CCCCC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.803141663,https://www.nature.com/articles/s41587-019-0247-3,28,0,0,19,397.4032133,35.58,1,3,5.4658,123.9677,0.958333333,0,3,397.692,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4228,LNP_0004228,LM_2019,LM_2019_F348,A4Iso4C7,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC)N(C)CCN(C)C,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.207649427,https://www.nature.com/articles/s41587-019-0247-3,28,0,0,17,399.3460923,61.88,1,5,3.4486,116.4587,0.909090909,0,3,399.62,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4229,LNP_0004229,LM_2019,LM_2019_F349,A4Iso5C7,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OCC)N(C)CCN(C)C,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.536331628,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,18,413.3617424,61.88,1,5,3.8387,121.0757,0.913043478,0,3,413.647,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4230,LNP_0004230,LM_2019,LM_2019_F350,A4Iso6C7,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCN(C)C,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.702422795,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,17,441.3930425,61.88,1,5,4.6173,130.2877,0.92,0,3,441.701,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4231,LNP_0004231,LM_2019,LM_2019_F351,A4Iso7C7,CCCCCCC(CCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCN(C)C,CCCCCCC(CCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.260382009,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,17,455.4086926,61.88,1,5,5.0058,134.8827,0.923076923,1,3,455.728,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4232,LNP_0004232,LM_2019,LM_2019_F352,A4Iso8C7,CCCCCCC(CCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCN(C)C,CCCCCCC(CCCCCC)(C(=O)NCCC(=O)OCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.328650048,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,19,427.3773924,61.88,1,5,4.2288,125.6927,0.916666667,0,3,427.674,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4233,LNP_0004233,LM_2019,LM_2019_F353,A4Iso9C7,CCCCCCC(CCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCN(C)C,CCCCCCC(CCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.071447856,https://www.nature.com/articles/s41587-019-0247-3,34,1,1,18,495.3494634,69.72,1,5,5.01542,142.8075,0.740740741,0,3,495.774,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4234,LNP_0004234,LM_2019,LM_2019_F354,A4Iso10C7,CCCCCCC(CCCCCC)(C(=O)NC1CCCCC1)N(C)CCN(C)C,CCCCCCC(CCCCCC)(C(=O)NC1CCCCC1)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.499175874,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,16,409.4032133,35.58,1,3,5.6083,126.4487,0.96,0,3,409.703,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4235,LNP_0004235,LM_2019,LM_2019_F355,A4Iso1CC7,CN(C)CCN(C)C1(C(=O)NC(C)(C)C)CCCCCCCCCCCCCC1,C[N+](C)(CCN(C)C1(C(=O)NC(C)(C)C)CCCCCCCCCCCCCC1)[H],A4,CNCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.614645479,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,5,409.4032133,35.58,1,3,5.6083,126.4487,0.96,0,3,409.703,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4236,LNP_0004236,LM_2019,LM_2019_F356,A4Iso2CC7,CCCCNC(=O)C1(N(C)CCN(C)C)CCCCCCCCCCCCCC1,CCCCNC(=O)C1(N(C)CC[N+](C)(C)[H])CCCCCCCCCCCCCC1,A4,CNCCN(C)C,Iso2,CCCC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.35642113,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,8,409.4032133,35.58,1,3,5.6099,126.4707,0.96,0,3,409.703,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4237,LNP_0004237,LM_2019,LM_2019_F357,A4Iso3CC7,CCCCCNC(=O)C1(N(C)CCN(C)C)CCCCCCCCCCCCCC1,CCCCCNC(=O)C1(N(C)CC[N+](C)(C)[H])CCCCCCCCCCCCCC1,A4,CNCCN(C)C,Iso3,CCCCC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.126012265,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,9,423.4188633,35.58,1,3,6.0,131.0877,0.961538462,0,3,423.73,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4238,LNP_0004238,LM_2019,LM_2019_F358,A4Iso4CC7,COC(=O)CNC(=O)C1(N(C)CCN(C)C)CCCCCCCCCCCCCC1,COC(=O)CNC(=O)C1(N(C)CC[N+](C)(C)[H])CCCCCCCCCCCCCC1,A4,CNCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.301625642,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,7,425.3617424,61.88,1,5,3.9828,123.5787,0.916666667,0,3,425.658,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4239,LNP_0004239,LM_2019,LM_2019_F359,A4Iso5CC7,CCOC(=O)CNC(=O)C1(N(C)CCN(C)C)CCCCCCCCCCCCCC1,CCOC(=O)CNC(=O)C1(N(C)CC[N+](C)(C)[H])CCCCCCCCCCCCCC1,A4,CNCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.115819109,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,8,439.3773924,61.88,1,5,4.3729,128.1957,0.92,0,3,439.685,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4240,LNP_0004240,LM_2019,LM_2019_F360,A4Iso6CC7,CN(C)CCN(C)C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCCCCC1,C[N+](C)(CCN(C)C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCCCCC1)[H],A4,CNCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.023194189,https://www.nature.com/articles/s41587-019-0247-3,33,1,0,7,467.4086926,61.88,1,5,5.1515,137.4077,0.925925926,0,3,467.739,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4241,LNP_0004241,LM_2019,LM_2019_F361,A4Iso7CC7,CC(NC(=O)C1(N(C)CCN(C)C)CCCCCCCCCCCCCC1)C(=O)OC(C)(C)C,CC(NC(=O)C1(N(C)CC[N+](C)(C)[H])CCCCCCCCCCCCCC1)C(=O)OC(C)(C)C,A4,CNCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.163429922,https://www.nature.com/articles/s41587-019-0247-3,34,1,0,7,481.4243426,61.88,1,5,5.54,142.0027,0.928571429,1,3,481.766,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4242,LNP_0004242,LM_2019,LM_2019_F362,A4Iso8CC7,CCOC(=O)CCNC(=O)C1(N(C)CCN(C)C)CCCCCCCCCCCCCC1,CCOC(=O)CCNC(=O)C1(N(C)CC[N+](C)(C)[H])CCCCCCCCCCCCCC1,A4,CNCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.972260384,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,9,453.3930425,61.88,1,5,4.763,132.8127,0.923076923,0,3,453.712,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4243,LNP_0004243,LM_2019,LM_2019_F363,A4Iso9CC7,Cc1ccc(S(=O)(=O)CNC(=O)C2(N(C)CCN(C)C)CCCCCCCCCCCCCC2)cc1,Cc1ccc(S(=O)(=O)CNC(=O)C2(N(C)CC[N+](C)(C)[H])CCCCCCCCCCCCCC2)cc1,A4,CNCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.283933579,https://www.nature.com/articles/s41587-019-0247-3,36,2,1,8,521.3651135,69.72,1,5,5.54962,149.9275,0.75862069,0,3,521.812,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4244,LNP_0004244,LM_2019,LM_2019_F364,A4Iso10CC7,CN(C)CCN(C)C1(C(=O)NC2CCCCC2)CCCCCCCCCCCCCC1,C[N+](C)(CCN(C)C1(C(=O)NC2CCCCC2)CCCCCCCCCCCCCC1)[H],A4,CNCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.295703614,https://www.nature.com/articles/s41587-019-0247-3,31,2,0,6,435.4188633,35.58,1,3,6.1425,133.5687,0.962962963,0,3,435.741,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4245,LNP_0004245,LM_2019,LM_2019_F365,A4Iso1CC6,CN(C)CCN(C)C1(C(=O)NC(C)(C)C)CCCCCCCCCCC1,C[N+](C)(CCN(C)C1(C(=O)NC(C)(C)C)CCCCCCCCCCC1)[H],A4,CNCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.322337694,https://www.nature.com/articles/s41587-019-0247-3,26,1,0,5,367.3562631,35.58,1,3,4.438,112.5977,0.954545455,0,3,367.622,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4246,LNP_0004246,LM_2019,LM_2019_F366,A4Iso2CC6,CCCCNC(=O)C1(N(C)CCN(C)C)CCCCCCCCCCC1,CCCCNC(=O)C1(N(C)CC[N+](C)(C)[H])CCCCCCCCCCC1,A4,CNCCN(C)C,Iso2,CCCC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.44972736,https://www.nature.com/articles/s41587-019-0247-3,26,1,0,8,367.3562631,35.58,1,3,4.4396,112.6197,0.954545455,0,3,367.622,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4247,LNP_0004247,LM_2019,LM_2019_F367,A4Iso3CC6,CCCCCNC(=O)C1(N(C)CCN(C)C)CCCCCCCCCCC1,CCCCCNC(=O)C1(N(C)CC[N+](C)(C)[H])CCCCCCCCCCC1,A4,CNCCN(C)C,Iso3,CCCCC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.086655752,https://www.nature.com/articles/s41587-019-0247-3,27,1,0,9,381.3719131,35.58,1,3,4.8297,117.2367,0.956521739,0,3,381.649,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4248,LNP_0004248,LM_2019,LM_2019_F368,A4Iso4CC6,COC(=O)CNC(=O)C1(N(C)CCN(C)C)CCCCCCCCCCC1,COC(=O)CNC(=O)C1(N(C)CC[N+](C)(C)[H])CCCCCCCCCCC1,A4,CNCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.930553936,https://www.nature.com/articles/s41587-019-0247-3,27,1,0,7,383.3147922,61.88,1,5,2.8125,109.7277,0.904761905,0,3,383.577,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4249,LNP_0004249,LM_2019,LM_2019_F369,A4Iso5CC6,CCOC(=O)CNC(=O)C1(N(C)CCN(C)C)CCCCCCCCCCC1,CCOC(=O)CNC(=O)C1(N(C)CC[N+](C)(C)[H])CCCCCCCCCCC1,A4,CNCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.612690365,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,8,397.3304422,61.88,1,5,3.2026,114.3447,0.909090909,0,3,397.604,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4250,LNP_0004250,LM_2019,LM_2019_F370,A4Iso6CC6,CN(C)CCN(C)C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCC1,C[N+](C)(CCN(C)C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCC1)[H],A4,CNCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.164207053,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,7,425.3617424,61.88,1,5,3.9812,123.5567,0.916666667,0,3,425.658,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4251,LNP_0004251,LM_2019,LM_2019_F371,A4Iso7CC6,CC(NC(=O)C1(N(C)CCN(C)C)CCCCCCCCCCC1)C(=O)OC(C)(C)C,CC(NC(=O)C1(N(C)CC[N+](C)(C)[H])CCCCCCCCCCC1)C(=O)OC(C)(C)C,A4,CNCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.516901442,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,7,439.3773924,61.88,1,5,4.3697,128.1517,0.92,1,3,439.685,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4252,LNP_0004252,LM_2019,LM_2019_F372,A4Iso8CC6,CCOC(=O)CCNC(=O)C1(N(C)CCN(C)C)CCCCCCCCCCC1,CCOC(=O)CCNC(=O)C1(N(C)CC[N+](C)(C)[H])CCCCCCCCCCC1,A4,CNCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.382272356,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,9,411.3460923,61.88,1,5,3.5927,118.9617,0.913043478,0,3,411.631,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4253,LNP_0004253,LM_2019,LM_2019_F373,A4Iso9CC6,Cc1ccc(S(=O)(=O)CNC(=O)C2(N(C)CCN(C)C)CCCCCCCCCCC2)cc1,Cc1ccc(S(=O)(=O)CNC(=O)C2(N(C)CC[N+](C)(C)[H])CCCCCCCCCCC2)cc1,A4,CNCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.271260835,https://www.nature.com/articles/s41587-019-0247-3,33,2,1,8,479.3181633,69.72,1,5,4.37932,136.0765,0.730769231,0,3,479.731,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4254,LNP_0004254,LM_2019,LM_2019_F374,A4Iso10CC6,CN(C)CCN(C)C1(C(=O)NC2CCCCC2)CCCCCCCCCCC1,C[N+](C)(CCN(C)C1(C(=O)NC2CCCCC2)CCCCCCCCCCC1)[H],A4,CNCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.847947964,https://www.nature.com/articles/s41587-019-0247-3,28,2,0,6,393.3719131,35.58,1,3,4.9722,119.7177,0.958333333,0,3,393.66,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4255,LNP_0004255,LM_2019,LM_2019_F375,A4Iso1C6,CCCCCC(CCCCC)(C(=O)NC(C)(C)C)N(C)CCN(C)C,CCCCCC(CCCCC)(C(=O)NC(C)(C)C)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.44778619,https://www.nature.com/articles/s41587-019-0247-3,25,0,0,13,355.3562631,35.58,1,3,4.2939,110.0947,0.952380952,0,3,355.611,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4256,LNP_0004256,LM_2019,LM_2019_F376,A4Iso2C6,CCCCCC(CCCCC)(C(=O)NCCCC)N(C)CCN(C)C,CCCCCC(CCCCC)(C(=O)NCCCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso2,CCCC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.31492886,https://www.nature.com/articles/s41587-019-0247-3,25,0,0,16,355.3562631,35.58,1,3,4.2955,110.1167,0.952380952,0,3,355.611,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4257,LNP_0004257,LM_2019,LM_2019_F377,A4Iso3C6,CCCCCNC(=O)C(CCCCC)(CCCCC)N(C)CCN(C)C,CCCCCNC(=O)C(CCCCC)(CCCCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso3,CCCCC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.717961464,https://www.nature.com/articles/s41587-019-0247-3,26,0,0,17,369.3719131,35.58,1,3,4.6856,114.7337,0.954545455,0,3,369.638,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4258,LNP_0004258,LM_2019,LM_2019_F378,A4Iso4C6,CCCCCC(CCCCC)(C(=O)NCC(=O)OC)N(C)CCN(C)C,CCCCCC(CCCCC)(C(=O)NCC(=O)OC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.340644878,https://www.nature.com/articles/s41587-019-0247-3,26,0,0,15,371.3147922,61.88,1,5,2.6684,107.2247,0.9,0,3,371.566,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4259,LNP_0004259,LM_2019,LM_2019_F379,A4Iso5C6,CCCCCC(CCCCC)(C(=O)NCC(=O)OCC)N(C)CCN(C)C,CCCCCC(CCCCC)(C(=O)NCC(=O)OCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.660204688,https://www.nature.com/articles/s41587-019-0247-3,27,0,0,16,385.3304422,61.88,1,5,3.0585,111.8417,0.904761905,0,3,385.593,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4260,LNP_0004260,LM_2019,LM_2019_F380,A4Iso6C6,CCCCCC(CCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCN(C)C,CCCCCC(CCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.123373143,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,15,413.3617424,61.88,1,5,3.8371,121.0537,0.913043478,0,3,413.647,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4261,LNP_0004261,LM_2019,LM_2019_F381,A4Iso7C6,CCCCCC(CCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCN(C)C,CCCCCC(CCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.109896215,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,15,427.3773924,61.88,1,5,4.2256,125.6487,0.916666667,1,3,427.674,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4262,LNP_0004262,LM_2019,LM_2019_F382,A4Iso8C6,CCCCCC(CCCCC)(C(=O)NCCC(=O)OCC)N(C)CCN(C)C,CCCCCC(CCCCC)(C(=O)NCCC(=O)OCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.126012265,https://www.nature.com/articles/s41587-019-0247-3,28,0,0,17,399.3460923,61.88,1,5,3.4486,116.4587,0.909090909,0,3,399.62,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4263,LNP_0004263,LM_2019,LM_2019_F383,A4Iso9C6,CCCCCC(CCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCN(C)C,CCCCCC(CCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.840294202,https://www.nature.com/articles/s41587-019-0247-3,32,1,1,16,467.3181633,69.72,1,5,4.23522,133.5735,0.72,0,3,467.72,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4264,LNP_0004264,LM_2019,LM_2019_F384,A4Iso10C6,CCCCCC(CCCCC)(C(=O)NC1CCCCC1)N(C)CCN(C)C,CCCCCC(CCCCC)(C(=O)NC1CCCCC1)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.234053249,https://www.nature.com/articles/s41587-019-0247-3,27,1,0,14,381.3719131,35.58,1,3,4.8281,117.2147,0.956521739,0,3,381.649,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4265,LNP_0004265,LM_2019,LM_2019_F385,A5Iso12DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCN(C)C)C(=O)NC(C)(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCC[N+](C)(C)[H])C(=O)NC(C)(C)C,A5,CN(C)CCN,Iso1,CC(C)(C)[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.350930059,https://www.nature.com/articles/s41587-019-0247-3,48,0,0,35,673.6849144,44.37,2,3,12.8661,216.0874,0.886363636,0,3,674.2,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4266,LNP_0004266,LM_2019,LM_2019_F386,A5Iso22DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCN(C)C)C(=O)NCCCC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCC[N+](C)(C)[H])C(=O)NCCCC,A5,CN(C)CCN,Iso2,CCCC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.096573828,https://www.nature.com/articles/s41587-019-0247-3,48,0,0,38,673.6849144,44.37,2,3,12.8677,216.1094,0.886363636,0,3,674.2,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4267,LNP_0004267,LM_2019,LM_2019_F387,A5Iso32DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCN(C)C)C(=O)NCCCCC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCC[N+](C)(C)[H])C(=O)NCCCCC,A5,CN(C)CCN,Iso3,CCCCC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.579763304,https://www.nature.com/articles/s41587-019-0247-3,49,0,0,39,687.7005645,44.37,2,3,13.2578,220.7264,0.888888889,0,3,688.227,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4268,LNP_0004268,LM_2019,LM_2019_F388,A5Iso42DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OC)N1CCN(C)C,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OC)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso4,[C-]#[N+]CC(=O)OC,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,3.534575768,https://www.nature.com/articles/s41587-019-0247-3,48,1,0,34,671.6328788,45.14,0,5,12.2473,211.191,0.860465116,1,3,672.14,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4269,LNP_0004269,LM_2019,LM_2019_F389,A5Iso72DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCN(C)C,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.397957151,https://www.nature.com/articles/s41587-019-0247-3,52,1,0,34,727.6954791,45.14,0,5,13.8061,229.637,0.872340426,1,3,728.248,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4270,LNP_0004270,LM_2019,LM_2019_F390,A5Iso82DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(CC(=O)OCC)N1CCN(C)C,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(CC(=O)OCC)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso8,CCOC(=O)CC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.257284697,https://www.nature.com/articles/s41587-019-0247-3,50,1,0,36,699.664179,45.14,0,5,13.0275,220.425,0.866666667,1,3,700.194,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4271,LNP_0004271,LM_2019,LM_2019_F391,A5Iso102DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCN(C)C)C(=O)NC1CCCCC1,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCC[N+](C)(C)[H])C(=O)NC1CCCCC1,A5,CN(C)CCN,Iso10,[C-]#[N+]C1CCCCC1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.167624149,https://www.nature.com/articles/s41587-019-0247-3,50,1,0,36,699.7005645,44.37,2,3,13.4003,223.2074,0.891304348,0,3,700.238,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4272,LNP_0004272,LM_2019,LM_2019_F392,A5Iso1C11,CCCCCCCCCCC(CCCCCCCCCC)(NCCN(C)C)C(=O)NC(C)(C)C,CCCCCCCCCCC(CCCCCCCCCC)(NCC[N+](C)(C)[H])C(=O)NC(C)(C)C,A5,CN(C)CCN,Iso1,CC(C)(C)[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.094582169,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,23,481.4971136,44.37,2,3,7.8527,151.6374,0.966666667,0,3,481.854,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4273,LNP_0004273,LM_2019,LM_2019_F393,A5Iso2C11,CCCCCCCCCCC(CCCCCCCCCC)(NCCN(C)C)C(=O)NCCCC,CCCCCCCCCCC(CCCCCCCCCC)(NCC[N+](C)(C)[H])C(=O)NCCCC,A5,CN(C)CCN,Iso2,CCCC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.54169841,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,26,481.4971136,44.37,2,3,7.8543,151.6594,0.966666667,0,3,481.854,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4274,LNP_0004274,LM_2019,LM_2019_F394,A5Iso3C11,CCCCCCCCCCC(CCCCCCCCCC)(NCCN(C)C)C(=O)NCCCCC,CCCCCCCCCCC(CCCCCCCCCC)(NCC[N+](C)(C)[H])C(=O)NCCCCC,A5,CN(C)CCN,Iso3,CCCCC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.468669568,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,27,495.5127637,44.37,2,3,8.2444,156.2764,0.967741935,0,3,495.881,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4275,LNP_0004275,LM_2019,LM_2019_F395,A5Iso4C11,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C(=O)OC)N1CCN(C)C,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C(=O)OC)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso4,[C-]#[N+]CC(=O)OC,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.23971148,https://www.nature.com/articles/s41587-019-0247-3,34,1,0,22,479.4450781,45.14,0,5,7.2339,146.741,0.931034483,1,3,479.794,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4276,LNP_0004276,LM_2019,LM_2019_F396,A5Iso5C11,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C(=O)OCC)N1CCN(C)C,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C(=O)OCC)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso5,CCOC(=O)C[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,2.266314079,https://www.nature.com/articles/s41587-019-0247-3,35,1,0,23,493.4607281,45.14,0,5,7.624,151.358,0.933333333,1,3,493.821,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4277,LNP_0004277,LM_2019,LM_2019_F397,A5Iso6C11,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCN(C)C,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.241034901,https://www.nature.com/articles/s41587-019-0247-3,37,1,0,22,521.4920283,45.14,0,5,8.4026,160.57,0.9375,1,3,521.875,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4278,LNP_0004278,LM_2019,LM_2019_F398,A5Iso7C11,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCN(C)C,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.202230986,https://www.nature.com/articles/s41587-019-0247-3,38,1,0,22,535.5076783,45.14,0,5,8.7927,165.187,0.939393939,1,3,535.902,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4279,LNP_0004279,LM_2019,LM_2019_F399,A5Iso8C11,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(CC(=O)OCC)N1CCN(C)C,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(CC(=O)OCC)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso8,CCOC(=O)CC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.766036523,https://www.nature.com/articles/s41587-019-0247-3,36,1,0,24,507.4763782,45.14,0,5,8.0141,155.975,0.935483871,1,3,507.848,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4280,LNP_0004280,LM_2019,LM_2019_F400,A5Iso9C11,CCCCCCCCCCC(CCCCCCCCCC)(NCCN(C)C)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCCCCCC(CCCCCCCCCC)(NCC[N+](C)(C)[H])C(=O)NCS(=O)(=O)c1ccc(C)cc1,A5,CN(C)CCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.115271007,https://www.nature.com/articles/s41587-019-0247-3,41,1,1,26,593.4590139,78.51,2,5,7.79402,175.1162,0.794117647,0,3,593.963,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4281,LNP_0004281,LM_2019,LM_2019_F401,A5Iso10C11,CCCCCCCCCCC(CCCCCCCCCC)(NCCN(C)C)C(=O)NC1CCCCC1,CCCCCCCCCCC(CCCCCCCCCC)(NCC[N+](C)(C)[H])C(=O)NC1CCCCC1,A5,CN(C)CCN,Iso10,[C-]#[N+]C1CCCCC1,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.746583525,https://www.nature.com/articles/s41587-019-0247-3,36,1,0,24,507.5127637,44.37,2,3,8.3869,158.7574,0.96875,0,3,507.892,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4282,LNP_0004282,LM_2019,LM_2019_F402,A5Iso1C10,CCCCCCCCCC(CCCCCCCCC)(NCCN(C)C)C(=O)NC(C)(C)C,CCCCCCCCCC(CCCCCCCCC)(NCC[N+](C)(C)[H])C(=O)NC(C)(C)C,A5,CN(C)CCN,Iso1,CC(C)(C)[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.156425526,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,21,453.4658135,44.37,2,3,7.0725,142.4034,0.964285714,0,3,453.8,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4283,LNP_0004283,LM_2019,LM_2019_F403,A5Iso2C10,CCCCCCCCCC(CCCCCCCCC)(NCCN(C)C)C(=O)NCCCC,CCCCCCCCCC(CCCCCCCCC)(NCC[N+](C)(C)[H])C(=O)NCCCC,A5,CN(C)CCN,Iso2,CCCC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.133027729,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,24,453.4658135,44.37,2,3,7.0741,142.4254,0.964285714,0,3,453.8,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4284,LNP_0004284,LM_2019,LM_2019_F404,A5Iso3C10,CCCCCCCCCC(CCCCCCCCC)(NCCN(C)C)C(=O)NCCCCC,CCCCCCCCCC(CCCCCCCCC)(NCC[N+](C)(C)[H])C(=O)NCCCCC,A5,CN(C)CCN,Iso3,CCCCC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.759187094,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,25,467.4814636,44.37,2,3,7.4642,147.0424,0.965517241,0,3,467.827,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4285,LNP_0004285,LM_2019,LM_2019_F405,A5Iso4C10,CCCCCCCCCC1(CCCCCCCCC)C=NC(C(=O)OC)N1CCN(C)C,CCCCCCCCCC1(CCCCCCCCC)C=NC(C(=O)OC)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso4,[C-]#[N+]CC(=O)OC,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.882976993,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,20,451.4137779,45.14,0,5,6.4537,137.507,0.925925926,1,3,451.74,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4286,LNP_0004286,LM_2019,LM_2019_F406,A5Iso5C10,CCCCCCCCCC1(CCCCCCCCC)C=NC(C(=O)OCC)N1CCN(C)C,CCCCCCCCCC1(CCCCCCCCC)C=NC(C(=O)OCC)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso5,CCOC(=O)C[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,3.828025825,https://www.nature.com/articles/s41587-019-0247-3,33,1,0,21,465.429428,45.14,0,5,6.8438,142.124,0.928571429,1,3,465.767,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4287,LNP_0004287,LM_2019,LM_2019_F407,A5Iso6C10,CCCCCCCCCC1(CCCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCN(C)C,CCCCCCCCCC1(CCCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,2.364753202,https://www.nature.com/articles/s41587-019-0247-3,35,1,0,20,493.4607281,45.14,0,5,7.6224,151.336,0.933333333,1,3,493.821,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4288,LNP_0004288,LM_2019,LM_2019_F408,A5Iso7C10,CCCCCCCCCC1(CCCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCN(C)C,CCCCCCCCCC1(CCCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.137212192,https://www.nature.com/articles/s41587-019-0247-3,36,1,0,20,507.4763782,45.14,0,5,8.0125,155.953,0.935483871,1,3,507.848,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4289,LNP_0004289,LM_2019,LM_2019_F409,A5Iso8C10,CCCCCCCCCC1(CCCCCCCCC)C=NC(CC(=O)OCC)N1CCN(C)C,CCCCCCCCCC1(CCCCCCCCC)C=NC(CC(=O)OCC)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso8,CCOC(=O)CC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.745605005,https://www.nature.com/articles/s41587-019-0247-3,34,1,0,22,479.4450781,45.14,0,5,7.2339,146.741,0.931034483,1,3,479.794,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4290,LNP_0004290,LM_2019,LM_2019_F410,A5Iso9C10,CCCCCCCCCC(CCCCCCCCC)(NCCN(C)C)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCCCCC(CCCCCCCCC)(NCC[N+](C)(C)[H])C(=O)NCS(=O)(=O)c1ccc(C)cc1,A5,CN(C)CCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.170469634,https://www.nature.com/articles/s41587-019-0247-3,39,1,1,24,565.4277137,78.51,2,5,7.01382,165.8822,0.78125,0,3,565.909,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4291,LNP_0004291,LM_2019,LM_2019_F411,A5Iso10C10,CCCCCCCCCC(CCCCCCCCC)(NCCN(C)C)C(=O)NC1CCCCC1,CCCCCCCCCC(CCCCCCCCC)(NCC[N+](C)(C)[H])C(=O)NC1CCCCC1,A5,CN(C)CCN,Iso10,[C-]#[N+]C1CCCCC1,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.516729016,https://www.nature.com/articles/s41587-019-0247-3,34,1,0,22,479.4814636,44.37,2,3,7.6067,149.5234,0.966666667,0,3,479.838,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4292,LNP_0004292,LM_2019,LM_2019_F412,A5Iso1C9,CCCCCCCCC(CCCCCCCC)(NCCN(C)C)C(=O)NC(C)(C)C,CCCCCCCCC(CCCCCCCC)(NCC[N+](C)(C)[H])C(=O)NC(C)(C)C,A5,CN(C)CCN,Iso1,CC(C)(C)[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.066068325,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,19,425.4345134,44.37,2,3,6.2923,133.1694,0.961538462,0,3,425.746,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4293,LNP_0004293,LM_2019,LM_2019_F413,A5Iso2C9,CCCCCCCCC(CCCCCCCC)(NCCN(C)C)C(=O)NCCCC,CCCCCCCCC(CCCCCCCC)(NCC[N+](C)(C)[H])C(=O)NCCCC,A5,CN(C)CCN,Iso2,CCCC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.57466219,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,22,425.4345134,44.37,2,3,6.2939,133.1914,0.961538462,0,3,425.746,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4294,LNP_0004294,LM_2019,LM_2019_F414,A5Iso3C9,CCCCCCCCC(CCCCCCCC)(NCCN(C)C)C(=O)NCCCCC,CCCCCCCCC(CCCCCCCC)(NCC[N+](C)(C)[H])C(=O)NCCCCC,A5,CN(C)CCN,Iso3,CCCCC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.176464277,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,23,439.4501634,44.37,2,3,6.684,137.8084,0.962962963,0,3,439.773,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4295,LNP_0004295,LM_2019,LM_2019_F415,A5Iso4C9,CCCCCCCCC1(CCCCCCCC)C=NC(C(=O)OC)N1CCN(C)C,CCCCCCCCC1(CCCCCCCC)C=NC(C(=O)OC)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso4,[C-]#[N+]CC(=O)OC,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,2.535266072,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,18,423.3824778,45.14,0,5,5.6735,128.273,0.92,1,3,423.686,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4296,LNP_0004296,LM_2019,LM_2019_F416,A5Iso5C9,CCCCCCCCC1(CCCCCCCC)C=NC(C(=O)OCC)N1CCN(C)C,CCCCCCCCC1(CCCCCCCC)C=NC(C(=O)OCC)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso5,CCOC(=O)C[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.123631891,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,19,437.3981279,45.14,0,5,6.0636,132.89,0.923076923,1,3,437.713,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4297,LNP_0004297,LM_2019,LM_2019_F417,A5Iso6C9,CCCCCCCCC1(CCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCN(C)C,CCCCCCCCC1(CCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.800207723,https://www.nature.com/articles/s41587-019-0247-3,33,1,0,18,465.429428,45.14,0,5,6.8422,142.102,0.928571429,1,3,465.767,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4298,LNP_0004298,LM_2019,LM_2019_F418,A5Iso7C9,CCCCCCCCC1(CCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCN(C)C,CCCCCCCCC1(CCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.591068339,https://www.nature.com/articles/s41587-019-0247-3,34,1,0,18,479.4450781,45.14,0,5,7.2323,146.719,0.931034483,1,3,479.794,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4299,LNP_0004299,LM_2019,LM_2019_F419,A5Iso8C9,CCCCCCCCC1(CCCCCCCC)C=NC(CC(=O)OCC)N1CCN(C)C,CCCCCCCCC1(CCCCCCCC)C=NC(CC(=O)OCC)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso8,CCOC(=O)CC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.510354591,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,20,451.4137779,45.14,0,5,6.4537,137.507,0.925925926,1,3,451.74,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4300,LNP_0004300,LM_2019,LM_2019_F420,A5Iso9C9,CCCCCCCCC(CCCCCCCC)(NCCN(C)C)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCCCC(CCCCCCCC)(NCC[N+](C)(C)[H])C(=O)NCS(=O)(=O)c1ccc(C)cc1,A5,CN(C)CCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.183480728,https://www.nature.com/articles/s41587-019-0247-3,37,1,1,22,537.3964136,78.51,2,5,6.23362,156.6482,0.766666667,0,3,537.855,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4301,LNP_0004301,LM_2019,LM_2019_F421,A5Iso10C9,CCCCCCCCC(CCCCCCCC)(NCCN(C)C)C(=O)NC1CCCCC1,CCCCCCCCC(CCCCCCCC)(NCC[N+](C)(C)[H])C(=O)NC1CCCCC1,A5,CN(C)CCN,Iso10,[C-]#[N+]C1CCCCC1,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.106340674,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,20,451.4501634,44.37,2,3,6.8265,140.2894,0.964285714,0,3,451.784,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4302,LNP_0004302,LM_2019,LM_2019_F422,A5Iso1C8,CCCCCCCC(CCCCCCC)(NCCN(C)C)C(=O)NC(C)(C)C,CCCCCCCC(CCCCCCC)(NCC[N+](C)(C)[H])C(=O)NC(C)(C)C,A5,CN(C)CCN,Iso1,CC(C)(C)[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.248160589,https://www.nature.com/articles/s41587-019-0247-3,28,0,0,17,397.4032133,44.37,2,3,5.5121,123.9354,0.958333333,0,3,397.692,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4303,LNP_0004303,LM_2019,LM_2019_F423,A5Iso2C8,CCCCCCCC(CCCCCCC)(NCCN(C)C)C(=O)NCCCC,CCCCCCCC(CCCCCCC)(NCC[N+](C)(C)[H])C(=O)NCCCC,A5,CN(C)CCN,Iso2,CCCC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.482203096,https://www.nature.com/articles/s41587-019-0247-3,28,0,0,20,397.4032133,44.37,2,3,5.5137,123.9574,0.958333333,0,3,397.692,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4304,LNP_0004304,LM_2019,LM_2019_F424,A5Iso3C8,CCCCCCCC(CCCCCCC)(NCCN(C)C)C(=O)NCCCCC,CCCCCCCC(CCCCCCC)(NCC[N+](C)(C)[H])C(=O)NCCCCC,A5,CN(C)CCN,Iso3,CCCCC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.486674999,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,21,411.4188633,44.37,2,3,5.9038,128.5744,0.96,0,3,411.719,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4305,LNP_0004305,LM_2019,LM_2019_F425,A5Iso4C8,CCCCCCCC1(CCCCCCC)C=NC(C(=O)OC)N1CCN(C)C,CCCCCCCC1(CCCCCCC)C=NC(C(=O)OC)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso4,[C-]#[N+]CC(=O)OC,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.27647522,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,16,395.3511777,45.14,0,5,4.8933,119.039,0.913043478,1,3,395.632,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4306,LNP_0004306,LM_2019,LM_2019_F426,A5Iso5C8,CCCCCCCC1(CCCCCCC)C=NC(C(=O)OCC)N1CCN(C)C,CCCCCCCC1(CCCCCCC)C=NC(C(=O)OCC)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso5,CCOC(=O)C[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.006189362,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,17,409.3668277,45.14,0,5,5.2834,123.656,0.916666667,1,3,409.659,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4307,LNP_0004307,LM_2019,LM_2019_F427,A5Iso6C8,CCCCCCCC1(CCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCN(C)C,CCCCCCCC1(CCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.779278535,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,16,437.3981279,45.14,0,5,6.062,132.868,0.923076923,1,3,437.713,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4308,LNP_0004308,LM_2019,LM_2019_F428,A5Iso7C8,CCCCCCCC1(CCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCN(C)C,CCCCCCCC1(CCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.174975547,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,16,451.4137779,45.14,0,5,6.4521,137.485,0.925925926,1,3,451.74,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4309,LNP_0004309,LM_2019,LM_2019_F429,A5Iso8C8,CCCCCCCC1(CCCCCCC)C=NC(CC(=O)OCC)N1CCN(C)C,CCCCCCCC1(CCCCCCC)C=NC(CC(=O)OCC)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso8,CCOC(=O)CC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.757411939,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,18,423.3824778,45.14,0,5,5.6735,128.273,0.92,1,3,423.686,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4310,LNP_0004310,LM_2019,LM_2019_F430,A5Iso9C8,CCCCCCCC(CCCCCCC)(NCCN(C)C)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCCC(CCCCCCC)(NCC[N+](C)(C)[H])C(=O)NCS(=O)(=O)c1ccc(C)cc1,A5,CN(C)CCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.40098683,https://www.nature.com/articles/s41587-019-0247-3,35,1,1,20,509.3651135,78.51,2,5,5.45342,147.4142,0.75,0,3,509.801,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4311,LNP_0004311,LM_2019,LM_2019_F431,A5Iso10C8,CCCCCCCC(CCCCCCC)(NCCN(C)C)C(=O)NC1CCCCC1,CCCCCCCC(CCCCCCC)(NCC[N+](C)(C)[H])C(=O)NC1CCCCC1,A5,CN(C)CCN,Iso10,[C-]#[N+]C1CCCCC1,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.092969411,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,18,423.4188633,44.37,2,3,6.0463,131.0554,0.961538462,0,3,423.73,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4312,LNP_0004312,LM_2019,LM_2019_F432,A5Iso1C7,CCCCCCC(CCCCCC)(NCCN(C)C)C(=O)NC(C)(C)C,CCCCCCC(CCCCCC)(NCC[N+](C)(C)[H])C(=O)NC(C)(C)C,A5,CN(C)CCN,Iso1,CC(C)(C)[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.455833283,https://www.nature.com/articles/s41587-019-0247-3,26,0,0,15,369.3719131,44.37,2,3,4.7319,114.7014,0.954545455,0,3,369.638,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4313,LNP_0004313,LM_2019,LM_2019_F433,A5Iso2C7,CCCCCCC(CCCCCC)(NCCN(C)C)C(=O)NCCCC,CCCCCCC(CCCCCC)(NCC[N+](C)(C)[H])C(=O)NCCCC,A5,CN(C)CCN,Iso2,CCCC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.565941572,https://www.nature.com/articles/s41587-019-0247-3,26,0,0,18,369.3719131,44.37,2,3,4.7335,114.7234,0.954545455,0,3,369.638,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4314,LNP_0004314,LM_2019,LM_2019_F434,A5Iso3C7,CCCCCCC(CCCCCC)(NCCN(C)C)C(=O)NCCCCC,CCCCCCC(CCCCCC)(NCC[N+](C)(C)[H])C(=O)NCCCCC,A5,CN(C)CCN,Iso3,CCCCC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.956921487,https://www.nature.com/articles/s41587-019-0247-3,27,0,0,19,383.3875632,44.37,2,3,5.1236,119.3404,0.956521739,0,3,383.665,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4315,LNP_0004315,LM_2019,LM_2019_F435,A5Iso4C7,CCCCCCC1(CCCCCC)C=NC(C(=O)OC)N1CCN(C)C,CCCCCCC1(CCCCCC)C=NC(C(=O)OC)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso4,[C-]#[N+]CC(=O)OC,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.508579364,https://www.nature.com/articles/s41587-019-0247-3,26,1,0,14,367.3198776,45.14,0,5,4.1131,109.805,0.904761905,1,3,367.578,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4316,LNP_0004316,LM_2019,LM_2019_F436,A5Iso5C7,CCCCCCC1(CCCCCC)C=NC(C(=O)OCC)N1CCN(C)C,CCCCCCC1(CCCCCC)C=NC(C(=O)OCC)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso5,CCOC(=O)C[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.140321625,https://www.nature.com/articles/s41587-019-0247-3,27,1,0,15,381.3355276,45.14,0,5,4.5032,114.422,0.909090909,1,3,381.605,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4317,LNP_0004317,LM_2019,LM_2019_F437,A5Iso6C7,CCCCCCC1(CCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCN(C)C,CCCCCCC1(CCCCCC)C=NC(C(=O)OC(C)(C)C)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.59514628,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,14,409.3668277,45.14,0,5,5.2818,123.634,0.916666667,1,3,409.659,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4318,LNP_0004318,LM_2019,LM_2019_F438,A5Iso7C7,CCCCCCC1(CCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCN(C)C,CCCCCCC1(CCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.257546994,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,14,423.3824778,45.14,0,5,5.6719,128.251,0.92,1,3,423.686,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4319,LNP_0004319,LM_2019,LM_2019_F439,A5Iso8C7,CCCCCCC1(CCCCCC)C=NC(CC(=O)OCC)N1CCN(C)C,CCCCCCC1(CCCCCC)C=NC(CC(=O)OCC)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso8,CCOC(=O)CC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.567412789,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,16,395.3511777,45.14,0,5,4.8933,119.039,0.913043478,1,3,395.632,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4320,LNP_0004320,LM_2019,LM_2019_F440,A5Iso9C7,CCCCCCC(CCCCCC)(NCCN(C)C)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCC(CCCCCC)(NCC[N+](C)(C)[H])C(=O)NCS(=O)(=O)c1ccc(C)cc1,A5,CN(C)CCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.241034901,https://www.nature.com/articles/s41587-019-0247-3,33,1,1,18,481.3338134,78.51,2,5,4.67322,138.1802,0.730769231,0,3,481.747,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4321,LNP_0004321,LM_2019,LM_2019_F441,A5Iso10C7,CCCCCCC(CCCCCC)(NCCN(C)C)C(=O)NC1CCCCC1,CCCCCCC(CCCCCC)(NCC[N+](C)(C)[H])C(=O)NC1CCCCC1,A5,CN(C)CCN,Iso10,[C-]#[N+]C1CCCCC1,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.043748237,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,16,395.3875632,44.37,2,3,5.2661,121.8214,0.958333333,0,3,395.676,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4322,LNP_0004322,LM_2019,LM_2019_F442,A5Iso1CC7,CN(C)CCNC1(C(=O)NC(C)(C)C)CCCCCCCCCCCCCC1,C[N+](C)(CCNC1(C(=O)NC(C)(C)C)CCCCCCCCCCCCCC1)[H],A5,CN(C)CCN,Iso1,CC(C)(C)[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.32621754,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,5,395.3875632,44.37,2,3,5.2661,121.8214,0.958333333,0,3,395.676,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4323,LNP_0004323,LM_2019,LM_2019_F443,A5Iso2CC7,CCCCNC(=O)C1(NCCN(C)C)CCCCCCCCCCCCCC1,CCCCNC(=O)C1(NCC[N+](C)(C)[H])CCCCCCCCCCCCCC1,A5,CN(C)CCN,Iso2,CCCC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.263264262,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,8,395.3875632,44.37,2,3,5.2677,121.8434,0.958333333,0,3,395.676,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4324,LNP_0004324,LM_2019,LM_2019_F444,A5Iso3CC7,CCCCCNC(=O)C1(NCCN(C)C)CCCCCCCCCCCCCC1,CCCCCNC(=O)C1(NCC[N+](C)(C)[H])CCCCCCCCCCCCCC1,A5,CN(C)CCN,Iso3,CCCCC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.476628474,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,9,409.4032133,44.37,2,3,5.6578,126.4604,0.96,0,3,409.703,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4325,LNP_0004325,LM_2019,LM_2019_F445,A5Iso4CC7,COC(=O)C1N=CC2(CCCCCCCCCCCCCC2)N1CCN(C)C,COC(=O)C1N=CC2(CCCCCCCCCCCCCC2)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso4,[C-]#[N+]CC(=O)OC,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.157544505,https://www.nature.com/articles/s41587-019-0247-3,28,2,0,4,393.3355276,45.14,0,5,4.6473,116.925,0.913043478,1,3,393.616,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4326,LNP_0004326,LM_2019,LM_2019_F446,A5Iso5CC7,CCOC(=O)C1N=CC2(CCCCCCCCCCCCCC2)N1CCN(C)C,CCOC(=O)C1N=CC2(CCCCCCCCCCCCCC2)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso5,CCOC(=O)C[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.935573358,https://www.nature.com/articles/s41587-019-0247-3,29,2,0,5,407.3511777,45.14,0,5,5.0374,121.542,0.916666667,1,3,407.643,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4327,LNP_0004327,LM_2019,LM_2019_F447,A5Iso6CC7,CN(C)CCN1C(C(=O)OC(C)(C)C)N=CC12CCCCCCCCCCCCCC2,C[N+](C)(CCN1C(C(=O)OC(C)(C)C)N=CC12CCCCCCCCCCCCCC2)[H],A5,CN(C)CCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.139253422,https://www.nature.com/articles/s41587-019-0247-3,31,2,0,4,435.3824778,45.14,0,5,5.816,130.754,0.923076923,1,3,435.697,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4328,LNP_0004328,LM_2019,LM_2019_F448,A5Iso7CC7,CN(C)CCN1C2(C=NC1(C)C(=O)OC(C)(C)C)CCCCCCCCCCCCCC2,C[N+](C)(CCN1C2(C=NC1(C)C(=O)OC(C)(C)C)CCCCCCCCCCCCCC2)[H],A5,CN(C)CCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.13587796,https://www.nature.com/articles/s41587-019-0247-3,32,2,0,4,449.3981279,45.14,0,5,6.2061,135.371,0.925925926,1,3,449.724,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4329,LNP_0004329,LM_2019,LM_2019_F449,A5Iso8CC7,CCOC(=O)CC1N=CC2(CCCCCCCCCCCCCC2)N1CCN(C)C,CCOC(=O)CC1N=CC2(CCCCCCCCCCCCCC2)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso8,CCOC(=O)CC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.567971451,https://www.nature.com/articles/s41587-019-0247-3,30,2,0,6,421.3668277,45.14,0,5,5.4275,126.159,0.92,1,3,421.67,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4330,LNP_0004330,LM_2019,LM_2019_F450,A5Iso9CC7,Cc1ccc(S(=O)(=O)CNC(=O)C2(NCCN(C)C)CCCCCCCCCCCCCC2)cc1,Cc1ccc(S(=O)(=O)CNC(=O)C2(NCC[N+](C)(C)[H])CCCCCCCCCCCCCC2)cc1,A5,CN(C)CCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.359322258,https://www.nature.com/articles/s41587-019-0247-3,35,2,1,8,507.3494634,78.51,2,5,5.20742,145.3002,0.75,0,3,507.785,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4331,LNP_0004331,LM_2019,LM_2019_F451,A5Iso10CC7,CN(C)CCNC1(C(=O)NC2CCCCC2)CCCCCCCCCCCCCC1,C[N+](C)(CCNC1(C(=O)NC2CCCCC2)CCCCCCCCCCCCCC1)[H],A5,CN(C)CCN,Iso10,[C-]#[N+]C1CCCCC1,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.67687818,https://www.nature.com/articles/s41587-019-0247-3,30,2,0,6,421.4032133,44.37,2,3,5.8003,128.9414,0.961538462,0,3,421.714,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4332,LNP_0004332,LM_2019,LM_2019_F452,A5Iso1CC6,CN(C)CCNC1(C(=O)NC(C)(C)C)CCCCCCCCCCC1,C[N+](C)(CCNC1(C(=O)NC(C)(C)C)CCCCCCCCCCC1)[H],A5,CN(C)CCN,Iso1,CC(C)(C)[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.955740858,https://www.nature.com/articles/s41587-019-0247-3,25,1,0,5,353.340613,44.37,2,3,4.0958,107.9704,0.952380952,0,3,353.595,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4333,LNP_0004333,LM_2019,LM_2019_F453,A5Iso2CC6,CCCCNC(=O)C1(NCCN(C)C)CCCCCCCCCCC1,CCCCNC(=O)C1(NCC[N+](C)(C)[H])CCCCCCCCCCC1,A5,CN(C)CCN,Iso2,CCCC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.985999076,https://www.nature.com/articles/s41587-019-0247-3,25,1,0,8,353.340613,44.37,2,3,4.0974,107.9924,0.952380952,0,3,353.595,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4334,LNP_0004334,LM_2019,LM_2019_F454,A5Iso3CC6,CCCCCNC(=O)C1(NCCN(C)C)CCCCCCCCCCC1,CCCCCNC(=O)C1(NCC[N+](C)(C)[H])CCCCCCCCCCC1,A5,CN(C)CCN,Iso3,CCCCC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.716040916,https://www.nature.com/articles/s41587-019-0247-3,26,1,0,9,367.3562631,44.37,2,3,4.4875,112.6094,0.954545455,0,3,367.622,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4335,LNP_0004335,LM_2019,LM_2019_F455,A5Iso4CC6,COC(=O)C1N=CC2(CCCCCCCCCCC2)N1CCN(C)C,COC(=O)C1N=CC2(CCCCCCCCCCC2)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso4,[C-]#[N+]CC(=O)OC,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.021038971,https://www.nature.com/articles/s41587-019-0247-3,25,2,0,4,351.2885774,45.14,0,5,3.477,103.074,0.9,1,3,351.535,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4336,LNP_0004336,LM_2019,LM_2019_F456,A5Iso5CC6,CCOC(=O)C1N=CC2(CCCCCCCCCCC2)N1CCN(C)C,CCOC(=O)C1N=CC2(CCCCCCCCCCC2)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso5,CCOC(=O)C[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.448828895,https://www.nature.com/articles/s41587-019-0247-3,26,2,0,5,365.3042275,45.14,0,5,3.8671,107.691,0.904761905,1,3,365.562,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4337,LNP_0004337,LM_2019,LM_2019_F457,A5Iso6CC6,CN(C)CCN1C(C(=O)OC(C)(C)C)N=CC12CCCCCCCCCCC2,C[N+](C)(CCN1C(C(=O)OC(C)(C)C)N=CC12CCCCCCCCCCC2)[H],A5,CN(C)CCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.663799753,https://www.nature.com/articles/s41587-019-0247-3,28,2,0,4,393.3355276,45.14,0,5,4.6457,116.903,0.913043478,1,3,393.616,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4338,LNP_0004338,LM_2019,LM_2019_F458,A5Iso7CC6,CN(C)CCN1C2(C=NC1(C)C(=O)OC(C)(C)C)CCCCCCCCCCC2,C[N+](C)(CCN1C2(C=NC1(C)C(=O)OC(C)(C)C)CCCCCCCCCCC2)[H],A5,CN(C)CCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.897083734,https://www.nature.com/articles/s41587-019-0247-3,29,2,0,4,407.3511777,45.14,0,5,5.0358,121.52,0.916666667,1,3,407.643,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4339,LNP_0004339,LM_2019,LM_2019_F459,A5Iso8CC6,CCOC(=O)CC1N=CC2(CCCCCCCCCCC2)N1CCN(C)C,CCOC(=O)CC1N=CC2(CCCCCCCCCCC2)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso8,CCOC(=O)CC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.445274296,https://www.nature.com/articles/s41587-019-0247-3,27,2,0,6,379.3198776,45.14,0,5,4.2572,112.308,0.909090909,1,3,379.589,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4340,LNP_0004340,LM_2019,LM_2019_F460,A5Iso9CC6,Cc1ccc(S(=O)(=O)CNC(=O)C2(NCCN(C)C)CCCCCCCCCCC2)cc1,Cc1ccc(S(=O)(=O)CNC(=O)C2(NCC[N+](C)(C)[H])CCCCCCCCCCC2)cc1,A5,CN(C)CCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.908248111,https://www.nature.com/articles/s41587-019-0247-3,32,2,1,8,465.3025132,78.51,2,5,4.03712,131.4492,0.72,0,3,465.704,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4341,LNP_0004341,LM_2019,LM_2019_F461,A5Iso10CC6,CN(C)CCNC1(C(=O)NC2CCCCC2)CCCCCCCCCCC1,C[N+](C)(CCNC1(C(=O)NC2CCCCC2)CCCCCCCCCCC1)[H],A5,CN(C)CCN,Iso10,[C-]#[N+]C1CCCCC1,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.370444388,https://www.nature.com/articles/s41587-019-0247-3,27,2,0,6,379.3562631,44.37,2,3,4.63,115.0904,0.956521739,0,3,379.633,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4342,LNP_0004342,LM_2019,LM_2019_F462,A5Iso1C6,CCCCCC(CCCCC)(NCCN(C)C)C(=O)NC(C)(C)C,CCCCCC(CCCCC)(NCC[N+](C)(C)[H])C(=O)NC(C)(C)C,A5,CN(C)CCN,Iso1,CC(C)(C)[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.805364945,https://www.nature.com/articles/s41587-019-0247-3,24,0,0,13,341.340613,44.37,2,3,3.9517,105.4674,0.95,0,3,341.584,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4343,LNP_0004343,LM_2019,LM_2019_F463,A5Iso2C6,CCCCCC(CCCCC)(NCCN(C)C)C(=O)NCCCC,CCCCCC(CCCCC)(NCC[N+](C)(C)[H])C(=O)NCCCC,A5,CN(C)CCN,Iso2,CCCC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.326328065,https://www.nature.com/articles/s41587-019-0247-3,24,0,0,16,341.340613,44.37,2,3,3.9533,105.4894,0.95,0,3,341.584,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4344,LNP_0004344,LM_2019,LM_2019_F464,A5Iso3C6,CCCCCNC(=O)C(CCCCC)(CCCCC)NCCN(C)C,CCCCCNC(=O)C(CCCCC)(CCCCC)NCC[N+](C)(C)[H],A5,CN(C)CCN,Iso3,CCCCC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.818967773,https://www.nature.com/articles/s41587-019-0247-3,25,0,0,17,355.3562631,44.37,2,3,4.3434,110.1064,0.952380952,0,3,355.611,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4345,LNP_0004345,LM_2019,LM_2019_F465,A5Iso4C6,CCCCCC1(CCCCC)C=NC(C(=O)OC)N1CCN(C)C,CCCCCC1(CCCCC)C=NC(C(=O)OC)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso4,[C-]#[N+]CC(=O)OC,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.314278598,https://www.nature.com/articles/s41587-019-0247-3,24,1,0,12,339.2885774,45.14,0,5,3.3329,100.571,0.894736842,1,3,339.524,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4346,LNP_0004346,LM_2019,LM_2019_F466,A5Iso5C6,CCCCCC1(CCCCC)C=NC(C(=O)OCC)N1CCN(C)C,CCCCCC1(CCCCC)C=NC(C(=O)OCC)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso5,CCOC(=O)C[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.343670306,https://www.nature.com/articles/s41587-019-0247-3,25,1,0,13,353.3042275,45.14,0,5,3.723,105.188,0.9,1,3,353.551,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4347,LNP_0004347,LM_2019,LM_2019_F467,A5Iso6C6,CCCCCC1(CCCCC)C=NC(C(=O)OC(C)(C)C)N1CCN(C)C,CCCCCC1(CCCCC)C=NC(C(=O)OC(C)(C)C)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.054811211,https://www.nature.com/articles/s41587-019-0247-3,27,1,0,12,381.3355276,45.14,0,5,4.5016,114.4,0.909090909,1,3,381.605,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4348,LNP_0004348,LM_2019,LM_2019_F468,A5Iso7C6,CCCCCC1(CCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCN(C)C,CCCCCC1(CCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.19572424,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,12,395.3511777,45.14,0,5,4.8917,119.017,0.913043478,1,3,395.632,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4349,LNP_0004349,LM_2019,LM_2019_F469,A5Iso8C6,CCCCCC1(CCCCC)C=NC(CC(=O)OCC)N1CCN(C)C,CCCCCC1(CCCCC)C=NC(CC(=O)OCC)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso8,CCOC(=O)CC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.476628474,https://www.nature.com/articles/s41587-019-0247-3,26,1,0,14,367.3198776,45.14,0,5,4.1131,109.805,0.904761905,1,3,367.578,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4350,LNP_0004350,LM_2019,LM_2019_F470,A5Iso9C6,CCCCCC(CCCCC)(NCCN(C)C)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCC(CCCCC)(NCC[N+](C)(C)[H])C(=O)NCS(=O)(=O)c1ccc(C)cc1,A5,CN(C)CCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.101921168,https://www.nature.com/articles/s41587-019-0247-3,31,1,1,16,453.3025132,78.51,2,5,3.89302,128.9462,0.708333333,0,3,453.693,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4351,LNP_0004351,LM_2019,LM_2019_F471,A5Iso10C6,CCCCCC(CCCCC)(NCCN(C)C)C(=O)NC1CCCCC1,CCCCCC(CCCCC)(NCC[N+](C)(C)[H])C(=O)NC1CCCCC1,A5,CN(C)CCN,Iso10,[C-]#[N+]C1CCCCC1,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.016674799,https://www.nature.com/articles/s41587-019-0247-3,26,1,0,14,367.3562631,44.37,2,3,4.4859,112.5874,0.954545455,0,3,367.622,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4352,LNP_0004352,LM_2019,LM_2019_F472,A6Iso12DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)(C)C)N(C)CCCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)(C)C)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.262857268,https://www.nature.com/articles/s41587-019-0247-3,50,0,0,36,701.7162145,35.58,1,3,13.5984,225.3317,0.891304348,0,3,702.254,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4353,LNP_0004353,LM_2019,LM_2019_F473,A6Iso22DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCC)N(C)CCCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso2,CCCC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.57787549,https://www.nature.com/articles/s41587-019-0247-3,50,0,0,39,701.7162145,35.58,1,3,13.6,225.3537,0.891304348,0,3,702.254,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4354,LNP_0004354,LM_2019,LM_2019_F474,A6Iso32DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCCC)N(C)CCCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso3,CCCCC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.314015385,https://www.nature.com/articles/s41587-019-0247-3,51,0,0,40,715.7318646,35.58,1,3,13.9901,229.9707,0.893617021,0,3,716.281,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4355,LNP_0004355,LM_2019,LM_2019_F475,A6Iso42DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC)N(C)CCCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.288124033,https://www.nature.com/articles/s41587-019-0247-3,51,0,0,38,717.6747436,61.88,1,5,11.9729,222.4617,0.866666667,0,3,718.209,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4356,LNP_0004356,LM_2019,LM_2019_F476,A6Iso72DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.676388436,https://www.nature.com/articles/s41587-019-0247-3,55,0,0,38,773.7373439,61.88,1,5,13.5301,240.8857,0.87755102,1,3,774.317,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4357,LNP_0004357,LM_2019,LM_2019_F477,A6Iso82DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.310087692,https://www.nature.com/articles/s41587-019-0247-3,53,0,0,40,745.7060438,61.88,1,5,12.7531,231.6957,0.872340426,0,3,746.263,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4358,LNP_0004358,LM_2019,LM_2019_F478,A6Iso102DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC1CCCCC1)N(C)CCCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC1CCCCC1)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.261166332,https://www.nature.com/articles/s41587-019-0247-3,52,1,0,37,727.7318646,35.58,1,3,14.1326,232.4517,0.895833333,0,3,728.292,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4359,LNP_0004359,LM_2019,LM_2019_F479,A6Iso1C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)(C)C)N(C)CCCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)(C)C)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.936835299,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,24,509.5284138,35.58,1,3,8.585,160.8817,0.96875,0,3,509.908,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4360,LNP_0004360,LM_2019,LM_2019_F480,A6Iso2C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCC)N(C)CCCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso2,CCCC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.992825236,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,27,509.5284138,35.58,1,3,8.5866,160.9037,0.96875,0,3,509.908,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4361,LNP_0004361,LM_2019,LM_2019_F481,A6Iso3C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCCC)N(C)CCCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso3,CCCCC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.937357794,https://www.nature.com/articles/s41587-019-0247-3,37,0,0,28,523.5440638,35.58,1,3,8.9767,165.5207,0.96969697,0,3,523.935,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4362,LNP_0004362,LM_2019,LM_2019_F482,A6Iso4C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC)N(C)CCCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.768401526,https://www.nature.com/articles/s41587-019-0247-3,37,0,0,26,525.4869429,61.88,1,5,6.9595,158.0117,0.935483871,0,3,525.863,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4363,LNP_0004363,LM_2019,LM_2019_F483,A6Iso5C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.188648825,https://www.nature.com/articles/s41587-019-0247-3,38,0,0,27,539.5025929,61.88,1,5,7.3496,162.6287,0.9375,0,3,539.89,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4364,LNP_0004364,LM_2019,LM_2019_F484,A6Iso6C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.190210113,https://www.nature.com/articles/s41587-019-0247-3,40,0,0,26,567.5338931,61.88,1,5,8.1282,171.8407,0.941176471,0,3,567.944,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4365,LNP_0004365,LM_2019,LM_2019_F485,A6Iso7C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.54998389,https://www.nature.com/articles/s41587-019-0247-3,41,0,0,26,581.5495431,61.88,1,5,8.5167,176.4357,0.942857143,1,3,581.971,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4366,LNP_0004366,LM_2019,LM_2019_F486,A6Iso8C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.417555306,https://www.nature.com/articles/s41587-019-0247-3,39,0,0,28,553.518243,61.88,1,5,7.7397,167.2457,0.939393939,0,3,553.917,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4367,LNP_0004367,LM_2019,LM_2019_F487,A6Iso9C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.168496476,https://www.nature.com/articles/s41587-019-0247-3,43,1,1,27,621.490314,69.72,1,5,8.52632,184.3605,0.805555556,0,3,622.017,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4368,LNP_0004368,LM_2019,LM_2019_F488,A6Iso10C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC1CCCCC1)N(C)CCCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC1CCCCC1)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.01449484,https://www.nature.com/articles/s41587-019-0247-3,38,1,0,25,535.5440638,35.58,1,3,9.1192,168.0017,0.970588235,0,3,535.946,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4369,LNP_0004369,LM_2019,LM_2019_F489,A6Iso1C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)(C)C)N(C)CCCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)(C)C)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.194966351,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,22,481.4971136,35.58,1,3,7.8048,151.6477,0.966666667,0,3,481.854,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4370,LNP_0004370,LM_2019,LM_2019_F490,A6Iso2C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCC)N(C)CCCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso2,CCCC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.445303762,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,25,481.4971136,35.58,1,3,7.8064,151.6697,0.966666667,0,3,481.854,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4371,LNP_0004371,LM_2019,LM_2019_F491,A6Iso3C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCCC)N(C)CCCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso3,CCCCC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.437260894,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,26,495.5127637,35.58,1,3,8.1965,156.2867,0.967741935,0,3,495.881,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4372,LNP_0004372,LM_2019,LM_2019_F492,A6Iso4C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC)N(C)CCCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.276539102,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,24,497.4556427,61.88,1,5,6.1793,148.7777,0.931034483,0,3,497.809,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4373,LNP_0004373,LM_2019,LM_2019_F493,A6Iso5C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.340457486,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,25,511.4712928,61.88,1,5,6.5694,153.3947,0.933333333,0,3,511.836,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4374,LNP_0004374,LM_2019,LM_2019_F494,A6Iso6C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.482622197,https://www.nature.com/articles/s41587-019-0247-3,38,0,0,24,539.5025929,61.88,1,5,7.348,162.6067,0.9375,0,3,539.89,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4375,LNP_0004375,LM_2019,LM_2019_F495,A6Iso7C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.364149069,https://www.nature.com/articles/s41587-019-0247-3,39,0,0,24,553.518243,61.88,1,5,7.7365,167.2017,0.939393939,1,3,553.917,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4376,LNP_0004376,LM_2019,LM_2019_F496,A6Iso8C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.254929373,https://www.nature.com/articles/s41587-019-0247-3,37,0,0,26,525.4869429,61.88,1,5,6.9595,158.0117,0.935483871,0,3,525.863,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4377,LNP_0004377,LM_2019,LM_2019_F497,A6Iso9C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.401139102,https://www.nature.com/articles/s41587-019-0247-3,41,1,1,25,593.4590139,69.72,1,5,7.74612,175.1265,0.794117647,0,3,593.963,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4378,LNP_0004378,LM_2019,LM_2019_F498,A6Iso10C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC1CCCCC1)N(C)CCCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC1CCCCC1)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.490377127,https://www.nature.com/articles/s41587-019-0247-3,36,1,0,23,507.5127637,35.58,1,3,8.339,158.7677,0.96875,0,3,507.892,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4379,LNP_0004379,LM_2019,LM_2019_F499,A6Iso1C9,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)(C)C)N(C)CCCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)(C)C)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.049840093,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,20,453.4658135,35.58,1,3,7.0246,142.4137,0.964285714,0,3,453.8,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4380,LNP_0004380,LM_2019,LM_2019_F500,A6Iso2C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCC)N(C)CCCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso2,CCCC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.013923865,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,23,453.4658135,35.58,1,3,7.0262,142.4357,0.964285714,0,3,453.8,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4381,LNP_0004381,LM_2019,LM_2019_F501,A6Iso3C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCCC)N(C)CCCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso3,CCCCC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.624490127,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,24,467.4814636,35.58,1,3,7.4163,147.0527,0.965517241,0,3,467.827,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4382,LNP_0004382,LM_2019,LM_2019_F502,A6Iso4C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC)N(C)CCCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.769541543,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,22,469.4243426,61.88,1,5,5.3991,139.5437,0.925925926,0,3,469.755,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4383,LNP_0004383,LM_2019,LM_2019_F503,A6Iso5C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.916788915,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,23,483.4399927,61.88,1,5,5.7892,144.1607,0.928571429,0,3,483.782,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4384,LNP_0004384,LM_2019,LM_2019_F504,A6Iso6C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.337065678,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,22,511.4712928,61.88,1,5,6.5678,153.3727,0.933333333,0,3,511.836,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4385,LNP_0004385,LM_2019,LM_2019_F505,A6Iso7C9,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.223593548,https://www.nature.com/articles/s41587-019-0247-3,37,0,0,22,525.4869429,61.88,1,5,6.9563,157.9677,0.935483871,1,3,525.863,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4386,LNP_0004386,LM_2019,LM_2019_F506,A6Iso8C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.067695697,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,24,497.4556427,61.88,1,5,6.1793,148.7777,0.931034483,0,3,497.809,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4387,LNP_0004387,LM_2019,LM_2019_F507,A6Iso9C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.591070208,https://www.nature.com/articles/s41587-019-0247-3,39,1,1,23,565.4277137,69.72,1,5,6.96592,165.8925,0.78125,0,3,565.909,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4388,LNP_0004388,LM_2019,LM_2019_F508,A6Iso10C9,CCCCCCCCC(CCCCCCCC)(C(=O)NC1CCCCC1)N(C)CCCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NC1CCCCC1)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.298093657,https://www.nature.com/articles/s41587-019-0247-3,34,1,0,21,479.4814636,35.58,1,3,7.5588,149.5337,0.966666667,0,3,479.838,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4389,LNP_0004389,LM_2019,LM_2019_F509,A6Iso1C8,CCCCCCCC(CCCCCCC)(C(=O)NC(C)(C)C)N(C)CCCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NC(C)(C)C)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.269804481,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,18,425.4345134,35.58,1,3,6.2444,133.1797,0.961538462,0,3,425.746,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4390,LNP_0004390,LM_2019,LM_2019_F510,A6Iso2C8,CCCCCCCC(CCCCCCC)(C(=O)NCCCC)N(C)CCCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NCCCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso2,CCCC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.094329186,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,21,425.4345134,35.58,1,3,6.246,133.2017,0.961538462,0,3,425.746,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4391,LNP_0004391,LM_2019,LM_2019_F511,A6Iso3C8,CCCCCCCC(CCCCCCC)(C(=O)NCCCCC)N(C)CCCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NCCCCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso3,CCCCC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.228284328,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,22,439.4501634,35.58,1,3,6.6361,137.8187,0.962962963,0,3,439.773,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4392,LNP_0004392,LM_2019,LM_2019_F512,A6Iso4C8,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC)N(C)CCCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.03628483,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,20,441.3930425,61.88,1,5,4.6189,130.3097,0.92,0,3,441.701,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4393,LNP_0004393,LM_2019,LM_2019_F513,A6Iso5C8,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.006166672,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,21,455.4086926,61.88,1,5,5.009,134.9267,0.923076923,0,3,455.728,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4394,LNP_0004394,LM_2019,LM_2019_F514,A6Iso6C8,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.212984792,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,20,483.4399927,61.88,1,5,5.7876,144.1387,0.928571429,0,3,483.782,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4395,LNP_0004395,LM_2019,LM_2019_F515,A6Iso7C8,CCCCCCCC(CCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.947832192,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,20,497.4556427,61.88,1,5,6.1761,148.7337,0.931034483,1,3,497.809,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4396,LNP_0004396,LM_2019,LM_2019_F516,A6Iso8C8,CCCCCCCC(CCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.761705207,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,22,469.4243426,61.88,1,5,5.3991,139.5437,0.925925926,0,3,469.755,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4397,LNP_0004397,LM_2019,LM_2019_F517,A6Iso9C8,CCCCCCCC(CCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.652524555,https://www.nature.com/articles/s41587-019-0247-3,37,1,1,21,537.3964136,69.72,1,5,6.18572,156.6585,0.766666667,0,3,537.855,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4398,LNP_0004398,LM_2019,LM_2019_F518,A6Iso10C8,CCCCCCCC(CCCCCCC)(C(=O)NC1CCCCC1)N(C)CCCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NC1CCCCC1)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.159769462,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,19,451.4501634,35.58,1,3,6.7786,140.2997,0.964285714,0,3,451.784,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4399,LNP_0004399,LM_2019,LM_2019_F519,A6Iso1C7,CCCCCCC(CCCCCC)(C(=O)NC(C)(C)C)N(C)CCCN(C)C,CCCCCCC(CCCCCC)(C(=O)NC(C)(C)C)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.343711669,https://www.nature.com/articles/s41587-019-0247-3,28,0,0,16,397.4032133,35.58,1,3,5.4642,123.9457,0.958333333,0,3,397.692,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4400,LNP_0004400,LM_2019,LM_2019_F520,A6Iso2C7,CCCCCCC(CCCCCC)(C(=O)NCCCC)N(C)CCCN(C)C,CCCCCCC(CCCCCC)(C(=O)NCCCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso2,CCCC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.302103038,https://www.nature.com/articles/s41587-019-0247-3,28,0,0,19,397.4032133,35.58,1,3,5.4658,123.9677,0.958333333,0,3,397.692,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4401,LNP_0004401,LM_2019,LM_2019_F521,A6Iso3C7,CCCCCCC(CCCCCC)(C(=O)NCCCCC)N(C)CCCN(C)C,CCCCCCC(CCCCCC)(C(=O)NCCCCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso3,CCCCC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.223618774,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,20,411.4188633,35.58,1,3,5.8559,128.5847,0.96,0,3,411.719,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4402,LNP_0004402,LM_2019,LM_2019_F522,A6Iso4C7,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC)N(C)CCCN(C)C,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.340877182,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,18,413.3617424,61.88,1,5,3.8387,121.0757,0.913043478,0,3,413.647,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4403,LNP_0004403,LM_2019,LM_2019_F523,A6Iso5C7,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OCC)N(C)CCCN(C)C,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.57720624,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,19,427.3773924,61.88,1,5,4.2288,125.6927,0.916666667,0,3,427.674,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4404,LNP_0004404,LM_2019,LM_2019_F524,A6Iso6C7,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCCN(C)C,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.850750815,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,18,455.4086926,61.88,1,5,5.0074,134.9047,0.923076923,0,3,455.728,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4405,LNP_0004405,LM_2019,LM_2019_F525,A6Iso7C7,CCCCCCC(CCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCCN(C)C,CCCCCCC(CCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.168251554,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,18,469.4243426,61.88,1,5,5.3959,139.4997,0.925925926,1,3,469.755,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4406,LNP_0004406,LM_2019,LM_2019_F526,A6Iso8C7,CCCCCCC(CCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCCN(C)C,CCCCCCC(CCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.536291288,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,20,441.3930425,61.88,1,5,4.6189,130.3097,0.92,0,3,441.701,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4407,LNP_0004407,LM_2019,LM_2019_F527,A6Iso9C7,CCCCCCC(CCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCCN(C)C,CCCCCCC(CCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.190210113,https://www.nature.com/articles/s41587-019-0247-3,35,1,1,19,509.3651135,69.72,1,5,5.40552,147.4245,0.75,0,3,509.801,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4408,LNP_0004408,LM_2019,LM_2019_F528,A6Iso10C7,CCCCCCC(CCCCCC)(C(=O)NC1CCCCC1)N(C)CCCN(C)C,CCCCCCC(CCCCCC)(C(=O)NC1CCCCC1)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.624227607,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,17,423.4188633,35.58,1,3,5.9984,131.0657,0.961538462,0,3,423.73,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4409,LNP_0004409,LM_2019,LM_2019_F529,A6Iso1CC7,CN(C)CCCN(C)C1(C(=O)NC(C)(C)C)CCCCCCCCCCCCCC1,C[N+](C)(CCCN(C)C1(C(=O)NC(C)(C)C)CCCCCCCCCCCCCC1)[H],A6,CNCCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.325128049,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,6,423.4188633,35.58,1,3,5.9984,131.0657,0.961538462,0,3,423.73,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4410,LNP_0004410,LM_2019,LM_2019_F530,A6Iso2CC7,CCCCNC(=O)C1(N(C)CCCN(C)C)CCCCCCCCCCCCCC1,CCCCNC(=O)C1(N(C)CCC[N+](C)(C)[H])CCCCCCCCCCCCCC1,A6,CNCCCN(C)C,Iso2,CCCC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.256345884,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,9,423.4188633,35.58,1,3,6.0,131.0877,0.961538462,0,3,423.73,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4411,LNP_0004411,LM_2019,LM_2019_F531,A6Iso3CC7,CCCCCNC(=O)C1(N(C)CCCN(C)C)CCCCCCCCCCCCCC1,CCCCCNC(=O)C1(N(C)CCC[N+](C)(C)[H])CCCCCCCCCCCCCC1,A6,CNCCCN(C)C,Iso3,CCCCC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.043366083,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,10,437.4345134,35.58,1,3,6.3901,135.7047,0.962962963,0,3,437.757,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4412,LNP_0004412,LM_2019,LM_2019_F532,A6Iso4CC7,COC(=O)CNC(=O)C1(N(C)CCCN(C)C)CCCCCCCCCCCCCC1,COC(=O)CNC(=O)C1(N(C)CCC[N+](C)(C)[H])CCCCCCCCCCCCCC1,A6,CNCCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.207126909,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,8,439.3773924,61.88,1,5,4.3729,128.1957,0.92,0,3,439.685,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4413,LNP_0004413,LM_2019,LM_2019_F533,A6Iso5CC7,CCOC(=O)CNC(=O)C1(N(C)CCCN(C)C)CCCCCCCCCCCCCC1,CCOC(=O)CNC(=O)C1(N(C)CCC[N+](C)(C)[H])CCCCCCCCCCCCCC1,A6,CNCCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.520575356,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,9,453.3930425,61.88,1,5,4.763,132.8127,0.923076923,0,3,453.712,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4414,LNP_0004414,LM_2019,LM_2019_F534,A6Iso6CC7,CN(C)CCCN(C)C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCCCCC1,C[N+](C)(CCCN(C)C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCCCCC1)[H],A6,CNCCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.464251354,https://www.nature.com/articles/s41587-019-0247-3,34,1,0,8,481.4243426,61.88,1,5,5.5416,142.0247,0.928571429,0,3,481.766,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4415,LNP_0004415,LM_2019,LM_2019_F535,A6Iso7CC7,CC(NC(=O)C1(N(C)CCCN(C)C)CCCCCCCCCCCCCC1)C(=O)OC(C)(C)C,CC(NC(=O)C1(N(C)CCC[N+](C)(C)[H])CCCCCCCCCCCCCC1)C(=O)OC(C)(C)C,A6,CNCCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.388948185,https://www.nature.com/articles/s41587-019-0247-3,35,1,0,8,495.4399927,61.88,1,5,5.9301,146.6197,0.931034483,1,3,495.793,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4416,LNP_0004416,LM_2019,LM_2019_F536,A6Iso8CC7,CCOC(=O)CCNC(=O)C1(N(C)CCCN(C)C)CCCCCCCCCCCCCC1,CCOC(=O)CCNC(=O)C1(N(C)CCC[N+](C)(C)[H])CCCCCCCCCCCCCC1,A6,CNCCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.268905872,https://www.nature.com/articles/s41587-019-0247-3,33,1,0,10,467.4086926,61.88,1,5,5.1531,137.4297,0.925925926,0,3,467.739,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4417,LNP_0004417,LM_2019,LM_2019_F537,A6Iso9CC7,Cc1ccc(S(=O)(=O)CNC(=O)C2(N(C)CCCN(C)C)CCCCCCCCCCCCCC2)cc1,Cc1ccc(S(=O)(=O)CNC(=O)C2(N(C)CCC[N+](C)(C)[H])CCCCCCCCCCCCCC2)cc1,A6,CNCCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.900358938,https://www.nature.com/articles/s41587-019-0247-3,37,2,1,9,535.3807636,69.72,1,5,5.93972,154.5445,0.766666667,0,3,535.839,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4418,LNP_0004418,LM_2019,LM_2019_F538,A6Iso10CC7,CN(C)CCCN(C)C1(C(=O)NC2CCCCC2)CCCCCCCCCCCCCC1,C[N+](C)(CCCN(C)C1(C(=O)NC2CCCCC2)CCCCCCCCCCCCCC1)[H],A6,CNCCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.384950424,https://www.nature.com/articles/s41587-019-0247-3,32,2,0,7,449.4345134,35.58,1,3,6.5326,138.1857,0.964285714,0,3,449.768,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4419,LNP_0004419,LM_2019,LM_2019_F539,A6Iso1CC6,CN(C)CCCN(C)C1(C(=O)NC(C)(C)C)CCCCCCCCCCC1,C[N+](C)(CCCN(C)C1(C(=O)NC(C)(C)C)CCCCCCCCCCC1)[H],A6,CNCCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.969080872,https://www.nature.com/articles/s41587-019-0247-3,27,1,0,6,381.3719131,35.58,1,3,4.8281,117.2147,0.956521739,0,3,381.649,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4420,LNP_0004420,LM_2019,LM_2019_F540,A6Iso2CC6,CCCCNC(=O)C1(N(C)CCCN(C)C)CCCCCCCCCCC1,CCCCNC(=O)C1(N(C)CCC[N+](C)(C)[H])CCCCCCCCCCC1,A6,CNCCCN(C)C,Iso2,CCCC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.581980944,https://www.nature.com/articles/s41587-019-0247-3,27,1,0,9,381.3719131,35.58,1,3,4.8297,117.2367,0.956521739,0,3,381.649,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4421,LNP_0004421,LM_2019,LM_2019_F541,A6Iso3CC6,CCCCCNC(=O)C1(N(C)CCCN(C)C)CCCCCCCCCCC1,CCCCCNC(=O)C1(N(C)CCC[N+](C)(C)[H])CCCCCCCCCCC1,A6,CNCCCN(C)C,Iso3,CCCCC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.168193345,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,10,395.3875632,35.58,1,3,5.2198,121.8537,0.958333333,0,3,395.676,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4422,LNP_0004422,LM_2019,LM_2019_F542,A6Iso4CC6,COC(=O)CNC(=O)C1(N(C)CCCN(C)C)CCCCCCCCCCC1,COC(=O)CNC(=O)C1(N(C)CCC[N+](C)(C)[H])CCCCCCCCCCC1,A6,CNCCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.308061911,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,8,397.3304422,61.88,1,5,3.2026,114.3447,0.909090909,0,3,397.604,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4423,LNP_0004423,LM_2019,LM_2019_F543,A6Iso5CC6,CCOC(=O)CNC(=O)C1(N(C)CCCN(C)C)CCCCCCCCCCC1,CCOC(=O)CNC(=O)C1(N(C)CCC[N+](C)(C)[H])CCCCCCCCCCC1,A6,CNCCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.14929032,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,9,411.3460923,61.88,1,5,3.5927,118.9617,0.913043478,0,3,411.631,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4424,LNP_0004424,LM_2019,LM_2019_F544,A6Iso6CC6,CN(C)CCCN(C)C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCC1,C[N+](C)(CCCN(C)C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCC1)[H],A6,CNCCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.440275494,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,8,439.3773924,61.88,1,5,4.3713,128.1737,0.92,0,3,439.685,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4425,LNP_0004425,LM_2019,LM_2019_F545,A6Iso7CC6,CC(NC(=O)C1(N(C)CCCN(C)C)CCCCCCCCCCC1)C(=O)OC(C)(C)C,CC(NC(=O)C1(N(C)CCC[N+](C)(C)[H])CCCCCCCCCCC1)C(=O)OC(C)(C)C,A6,CNCCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.599357826,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,8,453.3930425,61.88,1,5,4.7598,132.7687,0.923076923,1,3,453.712,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4426,LNP_0004426,LM_2019,LM_2019_F546,A6Iso8CC6,CCOC(=O)CCNC(=O)C1(N(C)CCCN(C)C)CCCCCCCCCCC1,CCOC(=O)CCNC(=O)C1(N(C)CCC[N+](C)(C)[H])CCCCCCCCCCC1,A6,CNCCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.006699648,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,10,425.3617424,61.88,1,5,3.9828,123.5787,0.916666667,0,3,425.658,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4427,LNP_0004427,LM_2019,LM_2019_F547,A6Iso9CC6,Cc1ccc(S(=O)(=O)CNC(=O)C2(N(C)CCCN(C)C)CCCCCCCCCCC2)cc1,Cc1ccc(S(=O)(=O)CNC(=O)C2(N(C)CCC[N+](C)(C)[H])CCCCCCCCCCC2)cc1,A6,CNCCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.421177643,https://www.nature.com/articles/s41587-019-0247-3,34,2,1,9,493.3338134,69.72,1,5,4.76942,140.6935,0.740740741,0,3,493.758,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4428,LNP_0004428,LM_2019,LM_2019_F548,A6Iso10CC6,CN(C)CCCN(C)C1(C(=O)NC2CCCCC2)CCCCCCCCCCC1,C[N+](C)(CCCN(C)C1(C(=O)NC2CCCCC2)CCCCCCCCCCC1)[H],A6,CNCCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.262586267,https://www.nature.com/articles/s41587-019-0247-3,29,2,0,7,407.3875632,35.58,1,3,5.3623,124.3347,0.96,0,3,407.687,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4429,LNP_0004429,LM_2019,LM_2019_F549,A6Iso1C6,CCCCCC(CCCCC)(C(=O)NC(C)(C)C)N(C)CCCN(C)C,CCCCCC(CCCCC)(C(=O)NC(C)(C)C)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.76609277,https://www.nature.com/articles/s41587-019-0247-3,26,0,0,14,369.3719131,35.58,1,3,4.684,114.7117,0.954545455,0,3,369.638,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4430,LNP_0004430,LM_2019,LM_2019_F550,A6Iso2C6,CCCCCC(CCCCC)(C(=O)NCCCC)N(C)CCCN(C)C,CCCCCC(CCCCC)(C(=O)NCCCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso2,CCCC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.331469745,https://www.nature.com/articles/s41587-019-0247-3,26,0,0,17,369.3719131,35.58,1,3,4.6856,114.7337,0.954545455,0,3,369.638,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4431,LNP_0004431,LM_2019,LM_2019_F551,A6Iso3C6,CCCCCNC(=O)C(CCCCC)(CCCCC)N(C)CCCN(C)C,CCCCCNC(=O)C(CCCCC)(CCCCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso3,CCCCC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.168058694,https://www.nature.com/articles/s41587-019-0247-3,27,0,0,18,383.3875632,35.58,1,3,5.0757,119.3507,0.956521739,0,3,383.665,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4432,LNP_0004432,LM_2019,LM_2019_F552,A6Iso4C6,CCCCCC(CCCCC)(C(=O)NCC(=O)OC)N(C)CCCN(C)C,CCCCCC(CCCCC)(C(=O)NCC(=O)OC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.299942439,https://www.nature.com/articles/s41587-019-0247-3,27,0,0,16,385.3304422,61.88,1,5,3.0585,111.8417,0.904761905,0,3,385.593,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4433,LNP_0004433,LM_2019,LM_2019_F553,A6Iso5C6,CCCCCC(CCCCC)(C(=O)NCC(=O)OCC)N(C)CCCN(C)C,CCCCCC(CCCCC)(C(=O)NCC(=O)OCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.147439636,https://www.nature.com/articles/s41587-019-0247-3,28,0,0,17,399.3460923,61.88,1,5,3.4486,116.4587,0.909090909,0,3,399.62,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4434,LNP_0004434,LM_2019,LM_2019_F554,A6Iso6C6,CCCCCC(CCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCCN(C)C,CCCCCC(CCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.206752374,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,16,427.3773924,61.88,1,5,4.2272,125.6707,0.916666667,0,3,427.674,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4435,LNP_0004435,LM_2019,LM_2019_F555,A6Iso7C6,CCCCCC(CCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCCN(C)C,CCCCCC(CCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.107914013,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,16,441.3930425,61.88,1,5,4.6157,130.2657,0.92,1,3,441.701,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4436,LNP_0004436,LM_2019,LM_2019_F556,A6Iso8C6,CCCCCC(CCCCC)(C(=O)NCCC(=O)OCC)N(C)CCCN(C)C,CCCCCC(CCCCC)(C(=O)NCCC(=O)OCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.043366083,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,18,413.3617424,61.88,1,5,3.8387,121.0757,0.913043478,0,3,413.647,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4437,LNP_0004437,LM_2019,LM_2019_F557,A6Iso9C6,CCCCCC(CCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCCN(C)C,CCCCCC(CCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.71529631,https://www.nature.com/articles/s41587-019-0247-3,33,1,1,17,481.3338134,69.72,1,5,4.62532,138.1905,0.730769231,0,3,481.747,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4438,LNP_0004438,LM_2019,LM_2019_F558,A6Iso10C6,CCCCCC(CCCCC)(C(=O)NC1CCCCC1)N(C)CCCN(C)C,CCCCCC(CCCCC)(C(=O)NC1CCCCC1)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.175671755,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,15,395.3875632,35.58,1,3,5.2182,121.8317,0.958333333,0,3,395.676,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4439,LNP_0004439,LM_2019,LM_2019_F559,A7Iso12DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)(C)C)N(CC)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)(C)C)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.100672478,https://www.nature.com/articles/s41587-019-0247-3,50,0,0,36,701.7162145,35.58,1,3,13.5984,225.3317,0.891304348,0,3,702.254,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4440,LNP_0004440,LM_2019,LM_2019_F560,A7Iso22DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCC)N(CC)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso2,CCCC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.408201571,https://www.nature.com/articles/s41587-019-0247-3,50,0,0,39,701.7162145,35.58,1,3,13.6,225.3537,0.891304348,0,3,702.254,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4441,LNP_0004441,LM_2019,LM_2019_F561,A7Iso32DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCCC)N(CC)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso3,CCCCC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.245770964,https://www.nature.com/articles/s41587-019-0247-3,51,0,0,40,715.7318646,35.58,1,3,13.9901,229.9707,0.893617021,0,3,716.281,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4442,LNP_0004442,LM_2019,LM_2019_F562,A7Iso42DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC)N(CC)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.432460724,https://www.nature.com/articles/s41587-019-0247-3,51,0,0,38,717.6747436,61.88,1,5,11.9729,222.4617,0.866666667,0,3,718.209,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4443,LNP_0004443,LM_2019,LM_2019_F563,A7Iso72DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.050284641,https://www.nature.com/articles/s41587-019-0247-3,55,0,0,38,773.7373439,61.88,1,5,13.5301,240.8857,0.87755102,1,3,774.317,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4444,LNP_0004444,LM_2019,LM_2019_F564,A7Iso82DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCC(=O)OCC)N(CC)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCC(=O)OCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.325141729,https://www.nature.com/articles/s41587-019-0247-3,53,0,0,40,745.7060438,61.88,1,5,12.7531,231.6957,0.872340426,0,3,746.263,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4445,LNP_0004445,LM_2019,LM_2019_F565,A7Iso102DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC1CCCCC1)N(CC)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC1CCCCC1)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.221839559,https://www.nature.com/articles/s41587-019-0247-3,52,1,0,37,727.7318646,35.58,1,3,14.1326,232.4517,0.895833333,0,3,728.292,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4446,LNP_0004446,LM_2019,LM_2019_F566,A7Iso1C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)(C)C)N(CC)CCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)(C)C)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.089453694,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,24,509.5284138,35.58,1,3,8.585,160.8817,0.96875,0,3,509.908,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4447,LNP_0004447,LM_2019,LM_2019_F567,A7Iso2C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCC)N(CC)CCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso2,CCCC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.142335107,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,27,509.5284138,35.58,1,3,8.5866,160.9037,0.96875,0,3,509.908,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4448,LNP_0004448,LM_2019,LM_2019_F568,A7Iso3C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCCC)N(CC)CCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso3,CCCCC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.808701144,https://www.nature.com/articles/s41587-019-0247-3,37,0,0,28,523.5440638,35.58,1,3,8.9767,165.5207,0.96969697,0,3,523.935,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4449,LNP_0004449,LM_2019,LM_2019_F569,A7Iso4C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC)N(CC)CCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.67357079,https://www.nature.com/articles/s41587-019-0247-3,37,0,0,26,525.4869429,61.88,1,5,6.9595,158.0117,0.935483871,0,3,525.863,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4450,LNP_0004450,LM_2019,LM_2019_F570,A7Iso5C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.347514734,https://www.nature.com/articles/s41587-019-0247-3,38,0,0,27,539.5025929,61.88,1,5,7.3496,162.6287,0.9375,0,3,539.89,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4451,LNP_0004451,LM_2019,LM_2019_F571,A7Iso6C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.116472758,https://www.nature.com/articles/s41587-019-0247-3,40,0,0,26,567.5338931,61.88,1,5,8.1282,171.8407,0.941176471,0,3,567.944,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4452,LNP_0004452,LM_2019,LM_2019_F572,A7Iso7C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.945498812,https://www.nature.com/articles/s41587-019-0247-3,41,0,0,26,581.5495431,61.88,1,5,8.5167,176.4357,0.942857143,1,3,581.971,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4453,LNP_0004453,LM_2019,LM_2019_F573,A7Iso8C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCC(=O)OCC)N(CC)CCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCC(=O)OCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.15416524,https://www.nature.com/articles/s41587-019-0247-3,39,0,0,28,553.518243,61.88,1,5,7.7397,167.2457,0.939393939,0,3,553.917,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4454,LNP_0004454,LM_2019,LM_2019_F574,A7Iso9C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.135277283,https://www.nature.com/articles/s41587-019-0247-3,43,1,1,27,621.490314,69.72,1,5,8.52632,184.3605,0.805555556,0,3,622.017,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4455,LNP_0004455,LM_2019,LM_2019_F575,A7Iso10C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC1CCCCC1)N(CC)CCN(C)C,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC1CCCCC1)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.3662203,https://www.nature.com/articles/s41587-019-0247-3,38,1,0,25,535.5440638,35.58,1,3,9.1192,168.0017,0.970588235,0,3,535.946,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4456,LNP_0004456,LM_2019,LM_2019_F576,A7Iso1C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)(C)C)N(CC)CCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)(C)C)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.313174403,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,22,481.4971136,35.58,1,3,7.8048,151.6477,0.966666667,0,3,481.854,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4457,LNP_0004457,LM_2019,LM_2019_F577,A7Iso2C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCC)N(CC)CCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso2,CCCC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.512136596,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,25,481.4971136,35.58,1,3,7.8064,151.6697,0.966666667,0,3,481.854,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4458,LNP_0004458,LM_2019,LM_2019_F578,A7Iso3C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCCC)N(CC)CCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso3,CCCCC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.743557233,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,26,495.5127637,35.58,1,3,8.1965,156.2867,0.967741935,0,3,495.881,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4459,LNP_0004459,LM_2019,LM_2019_F579,A7Iso4C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC)N(CC)CCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.241447897,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,24,497.4556427,61.88,1,5,6.1793,148.7777,0.931034483,0,3,497.809,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4460,LNP_0004460,LM_2019,LM_2019_F580,A7Iso5C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.143829737,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,25,511.4712928,61.88,1,5,6.5694,153.3947,0.933333333,0,3,511.836,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4461,LNP_0004461,LM_2019,LM_2019_F581,A7Iso6C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.245329435,https://www.nature.com/articles/s41587-019-0247-3,38,0,0,24,539.5025929,61.88,1,5,7.348,162.6067,0.9375,0,3,539.89,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4462,LNP_0004462,LM_2019,LM_2019_F582,A7Iso7C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.09146715,https://www.nature.com/articles/s41587-019-0247-3,39,0,0,24,553.518243,61.88,1,5,7.7365,167.2017,0.939393939,1,3,553.917,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4463,LNP_0004463,LM_2019,LM_2019_F583,A7Iso8C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCC(=O)OCC)N(CC)CCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCC(=O)OCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.662656454,https://www.nature.com/articles/s41587-019-0247-3,37,0,0,26,525.4869429,61.88,1,5,6.9595,158.0117,0.935483871,0,3,525.863,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4464,LNP_0004464,LM_2019,LM_2019_F584,A7Iso9C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.198550945,https://www.nature.com/articles/s41587-019-0247-3,41,1,1,25,593.4590139,69.72,1,5,7.74612,175.1265,0.794117647,0,3,593.963,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4465,LNP_0004465,LM_2019,LM_2019_F585,A7Iso10C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC1CCCCC1)N(CC)CCN(C)C,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC1CCCCC1)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.174975739,https://www.nature.com/articles/s41587-019-0247-3,36,1,0,23,507.5127637,35.58,1,3,8.339,158.7677,0.96875,0,3,507.892,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4466,LNP_0004466,LM_2019,LM_2019_F586,A7Iso1C9,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)(C)C)N(CC)CCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)(C)C)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.228383862,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,20,453.4658135,35.58,1,3,7.0246,142.4137,0.964285714,0,3,453.8,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4467,LNP_0004467,LM_2019,LM_2019_F587,A7Iso2C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCC)N(CC)CCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso2,CCCC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.136060454,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,23,453.4658135,35.58,1,3,7.0262,142.4357,0.964285714,0,3,453.8,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4468,LNP_0004468,LM_2019,LM_2019_F588,A7Iso3C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCCC)N(CC)CCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso3,CCCCC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.866047191,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,24,467.4814636,35.58,1,3,7.4163,147.0527,0.965517241,0,3,467.827,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4469,LNP_0004469,LM_2019,LM_2019_F589,A7Iso4C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC)N(CC)CCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.985687941,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,22,469.4243426,61.88,1,5,5.3991,139.5437,0.925925926,0,3,469.755,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4470,LNP_0004470,LM_2019,LM_2019_F590,A7Iso5C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.226824966,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,23,483.4399927,61.88,1,5,5.7892,144.1607,0.928571429,0,3,483.782,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4471,LNP_0004471,LM_2019,LM_2019_F591,A7Iso6C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.011072481,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,22,511.4712928,61.88,1,5,6.5678,153.3727,0.933333333,0,3,511.836,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4472,LNP_0004472,LM_2019,LM_2019_F592,A7Iso7C9,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.787258848,https://www.nature.com/articles/s41587-019-0247-3,37,0,0,22,525.4869429,61.88,1,5,6.9563,157.9677,0.935483871,1,3,525.863,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4473,LNP_0004473,LM_2019,LM_2019_F593,A7Iso8C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCCC(=O)OCC)N(CC)CCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NCCC(=O)OCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.261381046,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,24,497.4556427,61.88,1,5,6.1793,148.7777,0.931034483,0,3,497.809,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4474,LNP_0004474,LM_2019,LM_2019_F594,A7Iso9C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.014377136,https://www.nature.com/articles/s41587-019-0247-3,39,1,1,23,565.4277137,69.72,1,5,6.96592,165.8925,0.78125,0,3,565.909,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4475,LNP_0004475,LM_2019,LM_2019_F595,A7Iso10C9,CCCCCCCCC(CCCCCCCC)(C(=O)NC1CCCCC1)N(CC)CCN(C)C,CCCCCCCCC(CCCCCCCC)(C(=O)NC1CCCCC1)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.272401536,https://www.nature.com/articles/s41587-019-0247-3,34,1,0,21,479.4814636,35.58,1,3,7.5588,149.5337,0.966666667,0,3,479.838,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4476,LNP_0004476,LM_2019,LM_2019_F596,A7Iso1C8,CCCCCCCC(CCCCCCC)(C(=O)NC(C)(C)C)N(CC)CCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NC(C)(C)C)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.449110504,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,18,425.4345134,35.58,1,3,6.2444,133.1797,0.961538462,0,3,425.746,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4477,LNP_0004477,LM_2019,LM_2019_F597,A7Iso2C8,CCCCCCCC(CCCCCCC)(C(=O)NCCCC)N(CC)CCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NCCCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso2,CCCC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.037577429,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,21,425.4345134,35.58,1,3,6.246,133.2017,0.961538462,0,3,425.746,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4478,LNP_0004478,LM_2019,LM_2019_F598,A7Iso3C8,CCCCCCCC(CCCCCCC)(C(=O)NCCCCC)N(CC)CCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NCCCCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso3,CCCCC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.558235919,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,22,439.4501634,35.58,1,3,6.6361,137.8187,0.962962963,0,3,439.773,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4479,LNP_0004479,LM_2019,LM_2019_F599,A7Iso4C8,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC)N(CC)CCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.303373325,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,20,441.3930425,61.88,1,5,4.6189,130.3097,0.92,0,3,441.701,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4480,LNP_0004480,LM_2019,LM_2019_F600,A7Iso5C8,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.964336434,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,21,455.4086926,61.88,1,5,5.009,134.9267,0.923076923,0,3,455.728,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4481,LNP_0004481,LM_2019,LM_2019_F601,A7Iso6C8,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.561095785,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,20,483.4399927,61.88,1,5,5.7876,144.1387,0.928571429,0,3,483.782,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4482,LNP_0004482,LM_2019,LM_2019_F602,A7Iso7C8,CCCCCCCC(CCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.119719448,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,20,497.4556427,61.88,1,5,6.1761,148.7337,0.931034483,1,3,497.809,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4483,LNP_0004483,LM_2019,LM_2019_F603,A7Iso8C8,CCCCCCCC(CCCCCCC)(C(=O)NCCC(=O)OCC)N(CC)CCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NCCC(=O)OCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.655738103,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,22,469.4243426,61.88,1,5,5.3991,139.5437,0.925925926,0,3,469.755,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4484,LNP_0004484,LM_2019,LM_2019_F604,A7Iso9C8,CCCCCCCC(CCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.602186448,https://www.nature.com/articles/s41587-019-0247-3,37,1,1,21,537.3964136,69.72,1,5,6.18572,156.6585,0.766666667,0,3,537.855,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4485,LNP_0004485,LM_2019,LM_2019_F605,A7Iso10C8,CCCCCCCC(CCCCCCC)(C(=O)NC1CCCCC1)N(CC)CCN(C)C,CCCCCCCC(CCCCCCC)(C(=O)NC1CCCCC1)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.730753976,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,19,451.4501634,35.58,1,3,6.7786,140.2997,0.964285714,0,3,451.784,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4486,LNP_0004486,LM_2019,LM_2019_F606,A7Iso1C7,CCCCCCC(CCCCCC)(C(=O)NC(C)(C)C)N(CC)CCN(C)C,CCCCCCC(CCCCCC)(C(=O)NC(C)(C)C)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.386265759,https://www.nature.com/articles/s41587-019-0247-3,28,0,0,16,397.4032133,35.58,1,3,5.4642,123.9457,0.958333333,0,3,397.692,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4487,LNP_0004487,LM_2019,LM_2019_F607,A7Iso2C7,CCCCCCC(CCCCCC)(C(=O)NCCCC)N(CC)CCN(C)C,CCCCCCC(CCCCCC)(C(=O)NCCCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso2,CCCC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.708909652,https://www.nature.com/articles/s41587-019-0247-3,28,0,0,19,397.4032133,35.58,1,3,5.4658,123.9677,0.958333333,0,3,397.692,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4488,LNP_0004488,LM_2019,LM_2019_F608,A7Iso3C7,CCCCCCC(CCCCCC)(C(=O)NCCCCC)N(CC)CCN(C)C,CCCCCCC(CCCCCC)(C(=O)NCCCCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso3,CCCCC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.195975002,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,20,411.4188633,35.58,1,3,5.8559,128.5847,0.96,0,3,411.719,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4489,LNP_0004489,LM_2019,LM_2019_F609,A7Iso4C7,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC)N(CC)CCN(C)C,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.188472438,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,18,413.3617424,61.88,1,5,3.8387,121.0757,0.913043478,0,3,413.647,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4490,LNP_0004490,LM_2019,LM_2019_F610,A7Iso5C7,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OCC)N(CC)CCN(C)C,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.168773826,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,19,427.3773924,61.88,1,5,4.2288,125.6927,0.916666667,0,3,427.674,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4491,LNP_0004491,LM_2019,LM_2019_F611,A7Iso6C7,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CCN(C)C,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.196905762,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,18,455.4086926,61.88,1,5,5.0074,134.9047,0.923076923,0,3,455.728,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4492,LNP_0004492,LM_2019,LM_2019_F612,A7Iso7C7,CCCCCCC(CCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CCN(C)C,CCCCCCC(CCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.095448418,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,18,469.4243426,61.88,1,5,5.3959,139.4997,0.925925926,1,3,469.755,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4493,LNP_0004493,LM_2019,LM_2019_F613,A7Iso8C7,CCCCCCC(CCCCCC)(C(=O)NCCC(=O)OCC)N(CC)CCN(C)C,CCCCCCC(CCCCCC)(C(=O)NCCC(=O)OCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.739040689,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,20,441.3930425,61.88,1,5,4.6189,130.3097,0.92,0,3,441.701,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4494,LNP_0004494,LM_2019,LM_2019_F614,A7Iso9C7,CCCCCCC(CCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CCN(C)C,CCCCCCC(CCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.116472758,https://www.nature.com/articles/s41587-019-0247-3,35,1,1,19,509.3651135,69.72,1,5,5.40552,147.4245,0.75,0,3,509.801,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4495,LNP_0004495,LM_2019,LM_2019_F615,A7Iso10C7,CCCCCCC(CCCCCC)(C(=O)NC1CCCCC1)N(CC)CCN(C)C,CCCCCCC(CCCCCC)(C(=O)NC1CCCCC1)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.504607492,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,17,423.4188633,35.58,1,3,5.9984,131.0657,0.961538462,0,3,423.73,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4496,LNP_0004496,LM_2019,LM_2019_F616,A7Iso1CC7,CCN(CCN(C)C)C1(C(=O)NC(C)(C)C)CCCCCCCCCCCCCC1,CCN(CC[N+](C)(C)[H])C1(C(=O)NC(C)(C)C)CCCCCCCCCCCCCC1,A7,CCNCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.310900614,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,6,423.4188633,35.58,1,3,5.9984,131.0657,0.961538462,0,3,423.73,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4497,LNP_0004497,LM_2019,LM_2019_F617,A7Iso2CC7,CCCCNC(=O)C1(N(CC)CCN(C)C)CCCCCCCCCCCCCC1,CCCCNC(=O)C1(N(CC)CC[N+](C)(C)[H])CCCCCCCCCCCCCC1,A7,CCNCCN(C)C,Iso2,CCCC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.079486337,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,9,423.4188633,35.58,1,3,6.0,131.0877,0.961538462,0,3,423.73,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4498,LNP_0004498,LM_2019,LM_2019_F618,A7Iso3CC7,CCCCCNC(=O)C1(N(CC)CCN(C)C)CCCCCCCCCCCCCC1,CCCCCNC(=O)C1(N(CC)CC[N+](C)(C)[H])CCCCCCCCCCCCCC1,A7,CCNCCN(C)C,Iso3,CCCCC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.397113902,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,10,437.4345134,35.58,1,3,6.3901,135.7047,0.962962963,0,3,437.757,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4499,LNP_0004499,LM_2019,LM_2019_F619,A7Iso4CC7,CCN(CCN(C)C)C1(C(=O)NCC(=O)OC)CCCCCCCCCCCCCC1,CCN(CC[N+](C)(C)[H])C1(C(=O)NCC(=O)OC)CCCCCCCCCCCCCC1,A7,CCNCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.635252154,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,8,439.3773924,61.88,1,5,4.3729,128.1957,0.92,0,3,439.685,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4500,LNP_0004500,LM_2019,LM_2019_F620,A7Iso5CC7,CCOC(=O)CNC(=O)C1(N(CC)CCN(C)C)CCCCCCCCCCCCCC1,CCOC(=O)CNC(=O)C1(N(CC)CC[N+](C)(C)[H])CCCCCCCCCCCCCC1,A7,CCNCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.031156035,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,9,453.3930425,61.88,1,5,4.763,132.8127,0.923076923,0,3,453.712,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4501,LNP_0004501,LM_2019,LM_2019_F621,A7Iso6CC7,CCN(CCN(C)C)C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCCCCC1,CCN(CC[N+](C)(C)[H])C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCCCCC1,A7,CCNCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.813636288,https://www.nature.com/articles/s41587-019-0247-3,34,1,0,8,481.4243426,61.88,1,5,5.5416,142.0247,0.928571429,0,3,481.766,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4502,LNP_0004502,LM_2019,LM_2019_F622,A7Iso7CC7,CCN(CCN(C)C)C1(C(=O)NC(C)C(=O)OC(C)(C)C)CCCCCCCCCCCCCC1,CCN(CC[N+](C)(C)[H])C1(C(=O)NC(C)C(=O)OC(C)(C)C)CCCCCCCCCCCCCC1,A7,CCNCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.277922459,https://www.nature.com/articles/s41587-019-0247-3,35,1,0,8,495.4399927,61.88,1,5,5.9301,146.6197,0.931034483,1,3,495.793,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4503,LNP_0004503,LM_2019,LM_2019_F623,A7Iso8CC7,CCOC(=O)CCNC(=O)C1(N(CC)CCN(C)C)CCCCCCCCCCCCCC1,CCOC(=O)CCNC(=O)C1(N(CC)CC[N+](C)(C)[H])CCCCCCCCCCCCCC1,A7,CCNCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.663321408,https://www.nature.com/articles/s41587-019-0247-3,33,1,0,10,467.4086926,61.88,1,5,5.1531,137.4297,0.925925926,0,3,467.739,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4504,LNP_0004504,LM_2019,LM_2019_F624,A7Iso9CC7,CCN(CCN(C)C)C1(C(=O)NCS(=O)(=O)c2ccc(C)cc2)CCCCCCCCCCCCCC1,CCN(CC[N+](C)(C)[H])C1(C(=O)NCS(=O)(=O)c2ccc(C)cc2)CCCCCCCCCCCCCC1,A7,CCNCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.481894896,https://www.nature.com/articles/s41587-019-0247-3,37,2,1,9,535.3807636,69.72,1,5,5.93972,154.5445,0.766666667,0,3,535.839,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4505,LNP_0004505,LM_2019,LM_2019_F625,A7Iso10CC7,CCN(CCN(C)C)C1(C(=O)NC2CCCCC2)CCCCCCCCCCCCCC1,CCN(CC[N+](C)(C)[H])C1(C(=O)NC2CCCCC2)CCCCCCCCCCCCCC1,A7,CCNCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.468062612,https://www.nature.com/articles/s41587-019-0247-3,32,2,0,7,449.4345134,35.58,1,3,6.5326,138.1857,0.964285714,0,3,449.768,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4506,LNP_0004506,LM_2019,LM_2019_F626,A7Iso1CC6,CCN(CCN(C)C)C1(C(=O)NC(C)(C)C)CCCCCCCCCCC1,CCN(CC[N+](C)(C)[H])C1(C(=O)NC(C)(C)C)CCCCCCCCCCC1,A7,CCNCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.370047298,https://www.nature.com/articles/s41587-019-0247-3,27,1,0,6,381.3719131,35.58,1,3,4.8281,117.2147,0.956521739,0,3,381.649,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4507,LNP_0004507,LM_2019,LM_2019_F627,A7Iso2CC6,CCCCNC(=O)C1(N(CC)CCN(C)C)CCCCCCCCCCC1,CCCCNC(=O)C1(N(CC)CC[N+](C)(C)[H])CCCCCCCCCCC1,A7,CCNCCN(C)C,Iso2,CCCC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.294045632,https://www.nature.com/articles/s41587-019-0247-3,27,1,0,9,381.3719131,35.58,1,3,4.8297,117.2367,0.956521739,0,3,381.649,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4508,LNP_0004508,LM_2019,LM_2019_F628,A7Iso3CC6,CCCCCNC(=O)C1(N(CC)CCN(C)C)CCCCCCCCCCC1,CCCCCNC(=O)C1(N(CC)CC[N+](C)(C)[H])CCCCCCCCCCC1,A7,CCNCCN(C)C,Iso3,CCCCC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.738486506,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,10,395.3875632,35.58,1,3,5.2198,121.8537,0.958333333,0,3,395.676,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4509,LNP_0004509,LM_2019,LM_2019_F629,A7Iso4CC6,CCN(CCN(C)C)C1(C(=O)NCC(=O)OC)CCCCCCCCCCC1,CCN(CC[N+](C)(C)[H])C1(C(=O)NCC(=O)OC)CCCCCCCCCCC1,A7,CCNCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.913151788,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,8,397.3304422,61.88,1,5,3.2026,114.3447,0.909090909,0,3,397.604,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4510,LNP_0004510,LM_2019,LM_2019_F630,A7Iso5CC6,CCOC(=O)CNC(=O)C1(N(CC)CCN(C)C)CCCCCCCCCCC1,CCOC(=O)CNC(=O)C1(N(CC)CC[N+](C)(C)[H])CCCCCCCCCCC1,A7,CCNCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.01579461,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,9,411.3460923,61.88,1,5,3.5927,118.9617,0.913043478,0,3,411.631,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4511,LNP_0004511,LM_2019,LM_2019_F631,A7Iso6CC6,CCN(CCN(C)C)C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCC1,CCN(CC[N+](C)(C)[H])C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCC1,A7,CCNCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.809818174,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,8,439.3773924,61.88,1,5,4.3713,128.1737,0.92,0,3,439.685,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4512,LNP_0004512,LM_2019,LM_2019_F632,A7Iso7CC6,CCN(CCN(C)C)C1(C(=O)NC(C)C(=O)OC(C)(C)C)CCCCCCCCCCC1,CCN(CC[N+](C)(C)[H])C1(C(=O)NC(C)C(=O)OC(C)(C)C)CCCCCCCCCCC1,A7,CCNCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.880418705,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,8,453.3930425,61.88,1,5,4.7598,132.7687,0.923076923,1,3,453.712,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4513,LNP_0004513,LM_2019,LM_2019_F633,A7Iso8CC6,CCOC(=O)CCNC(=O)C1(N(CC)CCN(C)C)CCCCCCCCCCC1,CCOC(=O)CCNC(=O)C1(N(CC)CC[N+](C)(C)[H])CCCCCCCCCCC1,A7,CCNCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.640482538,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,10,425.3617424,61.88,1,5,3.9828,123.5787,0.916666667,0,3,425.658,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4514,LNP_0004514,LM_2019,LM_2019_F634,A7Iso9CC6,CCN(CCN(C)C)C1(C(=O)NCS(=O)(=O)c2ccc(C)cc2)CCCCCCCCCCC1,CCN(CC[N+](C)(C)[H])C1(C(=O)NCS(=O)(=O)c2ccc(C)cc2)CCCCCCCCCCC1,A7,CCNCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.516915849,https://www.nature.com/articles/s41587-019-0247-3,34,2,1,9,493.3338134,69.72,1,5,4.76942,140.6935,0.740740741,0,3,493.758,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4515,LNP_0004515,LM_2019,LM_2019_F635,A7Iso10CC6,CCN(CCN(C)C)C1(C(=O)NC2CCCCC2)CCCCCCCCCCC1,CCN(CC[N+](C)(C)[H])C1(C(=O)NC2CCCCC2)CCCCCCCCCCC1,A7,CCNCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.175671755,https://www.nature.com/articles/s41587-019-0247-3,29,2,0,7,407.3875632,35.58,1,3,5.3623,124.3347,0.96,0,3,407.687,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4516,LNP_0004516,LM_2019,LM_2019_F636,A7Iso1C6,CCCCCC(CCCCC)(C(=O)NC(C)(C)C)N(CC)CCN(C)C,CCCCCC(CCCCC)(C(=O)NC(C)(C)C)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso1,CC(C)(C)[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.640068462,https://www.nature.com/articles/s41587-019-0247-3,26,0,0,14,369.3719131,35.58,1,3,4.684,114.7117,0.954545455,0,3,369.638,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4517,LNP_0004517,LM_2019,LM_2019_F637,A7Iso2C6,CCCCCC(CCCCC)(C(=O)NCCCC)N(CC)CCN(C)C,CCCCCC(CCCCC)(C(=O)NCCCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso2,CCCC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.333760129,https://www.nature.com/articles/s41587-019-0247-3,26,0,0,17,369.3719131,35.58,1,3,4.6856,114.7337,0.954545455,0,3,369.638,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4518,LNP_0004518,LM_2019,LM_2019_F638,A7Iso3C6,CCCCCNC(=O)C(CCCCC)(CCCCC)N(CC)CCN(C)C,CCCCCNC(=O)C(CCCCC)(CCCCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso3,CCCCC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.185317275,https://www.nature.com/articles/s41587-019-0247-3,27,0,0,18,383.3875632,35.58,1,3,5.0757,119.3507,0.956521739,0,3,383.665,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4519,LNP_0004519,LM_2019,LM_2019_F639,A7Iso4C6,CCCCCC(CCCCC)(C(=O)NCC(=O)OC)N(CC)CCN(C)C,CCCCCC(CCCCC)(C(=O)NCC(=O)OC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso4,[C-]#[N+]CC(=O)OC,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.821777074,https://www.nature.com/articles/s41587-019-0247-3,27,0,0,16,385.3304422,61.88,1,5,3.0585,111.8417,0.904761905,0,3,385.593,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4520,LNP_0004520,LM_2019,LM_2019_F640,A7Iso5C6,CCCCCC(CCCCC)(C(=O)NCC(=O)OCC)N(CC)CCN(C)C,CCCCCC(CCCCC)(C(=O)NCC(=O)OCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.034496614,https://www.nature.com/articles/s41587-019-0247-3,28,0,0,17,399.3460923,61.88,1,5,3.4486,116.4587,0.909090909,0,3,399.62,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4521,LNP_0004521,LM_2019,LM_2019_F641,A7Iso6C6,CCCCCC(CCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CCN(C)C,CCCCCC(CCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.992287662,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,16,427.3773924,61.88,1,5,4.2272,125.6707,0.916666667,0,3,427.674,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4522,LNP_0004522,LM_2019,LM_2019_F642,A7Iso7C6,CCCCCC(CCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CCN(C)C,CCCCCC(CCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.014008316,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,16,441.3930425,61.88,1,5,4.6157,130.2657,0.92,1,3,441.701,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4523,LNP_0004523,LM_2019,LM_2019_F643,A7Iso8C6,CCCCCC(CCCCC)(C(=O)NCCC(=O)OCC)N(CC)CCN(C)C,CCCCCC(CCCCC)(C(=O)NCCC(=O)OCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso8,CCOC(=O)CC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.397113902,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,18,413.3617424,61.88,1,5,3.8387,121.0757,0.913043478,0,3,413.647,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4524,LNP_0004524,LM_2019,LM_2019_F644,A7Iso9C6,CCCCCC(CCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CCN(C)C,CCCCCC(CCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.501231077,https://www.nature.com/articles/s41587-019-0247-3,33,1,1,17,481.3338134,69.72,1,5,4.62532,138.1905,0.730769231,0,3,481.747,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4525,LNP_0004525,LM_2019,LM_2019_F645,A7Iso10C6,CCCCCC(CCCCC)(C(=O)NC1CCCCC1)N(CC)CCN(C)C,CCCCCC(CCCCC)(C(=O)NC1CCCCC1)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso10,[C-]#[N+]C1CCCCC1,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.262586267,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,15,395.3875632,35.58,1,3,5.2182,121.8317,0.958333333,0,3,395.676,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4526,LNP_0004526,LM_2019,LM_2019_F646,A8Iso12DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)(C)C)N1CCN(C)CC1,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)(C)C)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso1,CC(C)(C)[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.486354271,https://www.nature.com/articles/s41587-019-0247-3,49,1,0,32,685.6849144,35.58,1,3,12.9623,218.6007,0.888888889,0,3,686.211,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4527,LNP_0004527,LM_2019,LM_2019_F647,A8Iso22DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCC)N1CCN(C)CC1,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso2,CCCC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.357038835,https://www.nature.com/articles/s41587-019-0247-3,49,1,0,35,685.6849144,35.58,1,3,12.9639,218.6227,0.888888889,0,3,686.211,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4528,LNP_0004528,LM_2019,LM_2019_F648,A8Iso32DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCCC)N1CCN(C)CC1,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso3,CCCCC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.050999683,https://www.nature.com/articles/s41587-019-0247-3,50,1,0,36,699.7005645,35.58,1,3,13.354,223.2397,0.891304348,0,3,700.238,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4529,LNP_0004529,LM_2019,LM_2019_F649,A8Iso42DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC)N1CCN(C)CC1,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso4,[C-]#[N+]CC(=O)OC,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.599299041,https://www.nature.com/articles/s41587-019-0247-3,50,1,0,34,701.6434435,61.88,1,5,11.3368,215.7307,0.863636364,0,3,702.166,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4530,LNP_0004530,LM_2019,LM_2019_F650,A8Iso72DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N1CCN(C)CC1,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.358198446,https://www.nature.com/articles/s41587-019-0247-3,54,1,0,34,757.7060438,61.88,1,5,12.894,234.1547,0.875,1,3,758.274,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4531,LNP_0004531,LM_2019,LM_2019_F651,A8Iso82DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCC(=O)OCC)N1CCN(C)CC1,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCC(=O)OCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso8,CCOC(=O)CC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.01400658,https://www.nature.com/articles/s41587-019-0247-3,52,1,0,36,729.6747436,61.88,1,5,12.117,224.9647,0.869565217,0,3,730.22,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4532,LNP_0004532,LM_2019,LM_2019_F652,A8Iso102DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC1CCCCC1)N1CCN(C)CC1,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC1CCCCC1)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso10,[C-]#[N+]C1CCCCC1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.708595685,https://www.nature.com/articles/s41587-019-0247-3,51,2,0,33,711.7005645,35.58,1,3,13.4965,225.7207,0.893617021,0,3,712.249,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4533,LNP_0004533,LM_2019,LM_2019_F653,A8Iso1C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)(C)C)N1CCN(C)CC1,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)(C)C)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso1,CC(C)(C)[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.574677101,https://www.nature.com/articles/s41587-019-0247-3,35,1,0,20,493.4971136,35.58,1,3,7.9489,154.1507,0.967741935,0,3,493.865,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4534,LNP_0004534,LM_2019,LM_2019_F654,A8Iso2C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCC)N1CCN(C)CC1,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso2,CCCC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.971795343,https://www.nature.com/articles/s41587-019-0247-3,35,1,0,23,493.4971136,35.58,1,3,7.9505,154.1727,0.967741935,0,3,493.865,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4535,LNP_0004535,LM_2019,LM_2019_F655,A8Iso3C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCCC)N1CCN(C)CC1,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso3,CCCCC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.155526867,https://www.nature.com/articles/s41587-019-0247-3,36,1,0,24,507.5127637,35.58,1,3,8.3406,158.7897,0.96875,0,3,507.892,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4536,LNP_0004536,LM_2019,LM_2019_F656,A8Iso4C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC)N1CCN(C)CC1,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso4,[C-]#[N+]CC(=O)OC,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.496436115,https://www.nature.com/articles/s41587-019-0247-3,36,1,0,22,509.4556427,61.88,1,5,6.3234,151.2807,0.933333333,0,3,509.82,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4537,LNP_0004537,LM_2019,LM_2019_F657,A8Iso5C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OCC)N1CCN(C)CC1,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso5,CCOC(=O)C[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.160997913,https://www.nature.com/articles/s41587-019-0247-3,37,1,0,23,523.4712928,61.88,1,5,6.7135,155.8977,0.935483871,0,3,523.847,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4538,LNP_0004538,LM_2019,LM_2019_F658,A8Iso6C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N1CCN(C)CC1,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.936428061,https://www.nature.com/articles/s41587-019-0247-3,39,1,0,22,551.5025929,61.88,1,5,7.4921,165.1097,0.939393939,0,3,551.901,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4539,LNP_0004539,LM_2019,LM_2019_F659,A8Iso7C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N1CCN(C)CC1,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.813966253,https://www.nature.com/articles/s41587-019-0247-3,40,1,0,22,565.518243,61.88,1,5,7.8806,169.7047,0.941176471,1,3,565.928,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4540,LNP_0004540,LM_2019,LM_2019_F660,A8Iso8C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCC(=O)OCC)N1CCN(C)CC1,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCC(=O)OCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso8,CCOC(=O)CC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.548629195,https://www.nature.com/articles/s41587-019-0247-3,38,1,0,24,537.4869429,61.88,1,5,7.1036,160.5147,0.9375,0,3,537.874,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4541,LNP_0004541,LM_2019,LM_2019_F661,A8Iso9C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N1CCN(C)CC1,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.701825512,https://www.nature.com/articles/s41587-019-0247-3,42,2,1,23,605.4590139,69.72,1,5,7.89022,177.6295,0.8,0,3,605.974,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4542,LNP_0004542,LM_2019,LM_2019_F662,A8Iso10C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC1CCCCC1)N1CCN(C)CC1,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC1CCCCC1)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso10,[C-]#[N+]C1CCCCC1,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.26758627,https://www.nature.com/articles/s41587-019-0247-3,37,2,0,21,519.5127637,35.58,1,3,8.4831,161.2707,0.96969697,0,3,519.903,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4543,LNP_0004543,LM_2019,LM_2019_F663,A8Iso1C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)(C)C)N1CCN(C)CC1,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)(C)C)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso1,CC(C)(C)[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.506242545,https://www.nature.com/articles/s41587-019-0247-3,33,1,0,18,465.4658135,35.58,1,3,7.1687,144.9167,0.965517241,0,3,465.811,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4544,LNP_0004544,LM_2019,LM_2019_F664,A8Iso2C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCC)N1CCN(C)CC1,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso2,CCCC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.145152474,https://www.nature.com/articles/s41587-019-0247-3,33,1,0,21,465.4658135,35.58,1,3,7.1703,144.9387,0.965517241,0,3,465.811,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4545,LNP_0004545,LM_2019,LM_2019_F665,A8Iso3C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCCC)N1CCN(C)CC1,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso3,CCCCC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.192033412,https://www.nature.com/articles/s41587-019-0247-3,34,1,0,22,479.4814636,35.58,1,3,7.5604,149.5557,0.966666667,0,3,479.838,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4546,LNP_0004546,LM_2019,LM_2019_F666,A8Iso4C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC)N1CCN(C)CC1,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso4,[C-]#[N+]CC(=O)OC,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.191719385,https://www.nature.com/articles/s41587-019-0247-3,34,1,0,20,481.4243426,61.88,1,5,5.5432,142.0467,0.928571429,0,3,481.766,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4547,LNP_0004547,LM_2019,LM_2019_F667,A8Iso5C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OCC)N1CCN(C)CC1,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso5,CCOC(=O)C[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,2.20544984,https://www.nature.com/articles/s41587-019-0247-3,35,1,0,21,495.4399927,61.88,1,5,5.9333,146.6637,0.931034483,0,3,495.793,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4548,LNP_0004548,LM_2019,LM_2019_F668,A8Iso6C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N1CCN(C)CC1,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.237158015,https://www.nature.com/articles/s41587-019-0247-3,37,1,0,20,523.4712928,61.88,1,5,6.7119,155.8757,0.935483871,0,3,523.847,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4549,LNP_0004549,LM_2019,LM_2019_F669,A8Iso7C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N1CCN(C)CC1,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.972897281,https://www.nature.com/articles/s41587-019-0247-3,38,1,0,20,537.4869429,61.88,1,5,7.1004,160.4707,0.9375,1,3,537.874,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4550,LNP_0004550,LM_2019,LM_2019_F670,A8Iso8C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCC(=O)OCC)N1CCN(C)CC1,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCC(=O)OCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso8,CCOC(=O)CC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.901384363,https://www.nature.com/articles/s41587-019-0247-3,36,1,0,22,509.4556427,61.88,1,5,6.3234,151.2807,0.933333333,0,3,509.82,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4551,LNP_0004551,LM_2019,LM_2019_F671,A8Iso9C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N1CCN(C)CC1,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.602074861,https://www.nature.com/articles/s41587-019-0247-3,40,2,1,21,577.4277137,69.72,1,5,7.11002,168.3955,0.787878788,0,3,577.92,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4552,LNP_0004552,LM_2019,LM_2019_F672,A8Iso10C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC1CCCCC1)N1CCN(C)CC1,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC1CCCCC1)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso10,[C-]#[N+]C1CCCCC1,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.404508216,https://www.nature.com/articles/s41587-019-0247-3,35,2,0,19,491.4814636,35.58,1,3,7.7029,152.0367,0.967741935,0,3,491.849,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4553,LNP_0004553,LM_2019,LM_2019_F673,A8Iso1C9,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)(C)C)N1CCN(C)CC1,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)(C)C)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso1,CC(C)(C)[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.017064108,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,16,437.4345134,35.58,1,3,6.3885,135.6827,0.962962963,0,3,437.757,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4554,LNP_0004554,LM_2019,LM_2019_F674,A8Iso2C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCC)N1CCN(C)CC1,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso2,CCCC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.670618848,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,19,437.4345134,35.58,1,3,6.3901,135.7047,0.962962963,0,3,437.757,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4555,LNP_0004555,LM_2019,LM_2019_F675,A8Iso3C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCCC)N1CCN(C)CC1,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso3,CCCCC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.731006783,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,20,451.4501634,35.58,1,3,6.7802,140.3217,0.964285714,0,3,451.784,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4556,LNP_0004556,LM_2019,LM_2019_F676,A8Iso4C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC)N1CCN(C)CC1,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso4,[C-]#[N+]CC(=O)OC,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.563269625,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,18,453.3930425,61.88,1,5,4.763,132.8127,0.923076923,0,3,453.712,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4557,LNP_0004557,LM_2019,LM_2019_F677,A8Iso5C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OCC)N1CCN(C)CC1,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso5,CCOC(=O)C[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.402338293,https://www.nature.com/articles/s41587-019-0247-3,33,1,0,19,467.4086926,61.88,1,5,5.1531,137.4297,0.925925926,0,3,467.739,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4558,LNP_0004558,LM_2019,LM_2019_F678,A8Iso6C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N1CCN(C)CC1,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.871769464,https://www.nature.com/articles/s41587-019-0247-3,35,1,0,18,495.4399927,61.88,1,5,5.9317,146.6417,0.931034483,0,3,495.793,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4559,LNP_0004559,LM_2019,LM_2019_F679,A8Iso7C9,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N1CCN(C)CC1,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.700802886,https://www.nature.com/articles/s41587-019-0247-3,36,1,0,18,509.4556427,61.88,1,5,6.3202,151.2367,0.933333333,1,3,509.82,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4560,LNP_0004560,LM_2019,LM_2019_F680,A8Iso8C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCCC(=O)OCC)N1CCN(C)CC1,CCCCCCCCC(CCCCCCCC)(C(=O)NCCC(=O)OCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso8,CCOC(=O)CC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.257938563,https://www.nature.com/articles/s41587-019-0247-3,34,1,0,20,481.4243426,61.88,1,5,5.5432,142.0467,0.928571429,0,3,481.766,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4561,LNP_0004561,LM_2019,LM_2019_F681,A8Iso9C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N1CCN(C)CC1,CCCCCCCCC(CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.570158606,https://www.nature.com/articles/s41587-019-0247-3,38,2,1,19,549.3964136,69.72,1,5,6.32982,159.1615,0.774193548,0,3,549.866,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4562,LNP_0004562,LM_2019,LM_2019_F682,A8Iso10C9,CCCCCCCCC(CCCCCCCC)(C(=O)NC1CCCCC1)N1CCN(C)CC1,CCCCCCCCC(CCCCCCCC)(C(=O)NC1CCCCC1)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso10,[C-]#[N+]C1CCCCC1,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.948996472,https://www.nature.com/articles/s41587-019-0247-3,33,2,0,17,463.4501634,35.58,1,3,6.9227,142.8027,0.965517241,0,3,463.795,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4563,LNP_0004563,LM_2019,LM_2019_F683,A8Iso1C8,CCCCCCCC(CCCCCCC)(C(=O)NC(C)(C)C)N1CCN(C)CC1,CCCCCCCC(CCCCCCC)(C(=O)NC(C)(C)C)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso1,CC(C)(C)[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.217519356,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,14,409.4032133,35.58,1,3,5.6083,126.4487,0.96,0,3,409.703,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4564,LNP_0004564,LM_2019,LM_2019_F684,A8Iso2C8,CCCCCCCC(CCCCCCC)(C(=O)NCCCC)N1CCN(C)CC1,CCCCCCCC(CCCCCCC)(C(=O)NCCCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso2,CCCC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.992022752,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,17,409.4032133,35.58,1,3,5.6099,126.4707,0.96,0,3,409.703,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4565,LNP_0004565,LM_2019,LM_2019_F685,A8Iso3C8,CCCCCCCC(CCCCCCC)(C(=O)NCCCCC)N1CCN(C)CC1,CCCCCCCC(CCCCCCC)(C(=O)NCCCCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso3,CCCCC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.378919555,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,18,423.4188633,35.58,1,3,6.0,131.0877,0.961538462,0,3,423.73,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4566,LNP_0004566,LM_2019,LM_2019_F686,A8Iso4C8,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC)N1CCN(C)CC1,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso4,[C-]#[N+]CC(=O)OC,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.942821486,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,16,425.3617424,61.88,1,5,3.9828,123.5787,0.916666667,0,3,425.658,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4567,LNP_0004567,LM_2019,LM_2019_F687,A8Iso5C8,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OCC)N1CCN(C)CC1,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso5,CCOC(=O)C[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.860525655,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,17,439.3773924,61.88,1,5,4.3729,128.1957,0.92,0,3,439.685,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4568,LNP_0004568,LM_2019,LM_2019_F688,A8Iso6C8,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N1CCN(C)CC1,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.091089996,https://www.nature.com/articles/s41587-019-0247-3,33,1,0,16,467.4086926,61.88,1,5,5.1515,137.4077,0.925925926,0,3,467.739,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4569,LNP_0004569,LM_2019,LM_2019_F689,A8Iso7C8,CCCCCCCC(CCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N1CCN(C)CC1,CCCCCCCC(CCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.236523543,https://www.nature.com/articles/s41587-019-0247-3,34,1,0,16,481.4243426,61.88,1,5,5.54,142.0027,0.928571429,1,3,481.766,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4570,LNP_0004570,LM_2019,LM_2019_F690,A8Iso8C8,CCCCCCCC(CCCCCCC)(C(=O)NCCC(=O)OCC)N1CCN(C)CC1,CCCCCCCC(CCCCCCC)(C(=O)NCCC(=O)OCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso8,CCOC(=O)CC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.695673562,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,18,453.3930425,61.88,1,5,4.763,132.8127,0.923076923,0,3,453.712,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4571,LNP_0004571,LM_2019,LM_2019_F691,A8Iso9C8,CCCCCCCC(CCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N1CCN(C)CC1,CCCCCCCC(CCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.139129551,https://www.nature.com/articles/s41587-019-0247-3,36,2,1,17,521.3651135,69.72,1,5,5.54962,149.9275,0.75862069,0,3,521.812,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4572,LNP_0004572,LM_2019,LM_2019_F692,A8Iso10C8,CCCCCCCC(CCCCCCC)(C(=O)NC1CCCCC1)N1CCN(C)CC1,CCCCCCCC(CCCCCCC)(C(=O)NC1CCCCC1)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso10,[C-]#[N+]C1CCCCC1,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.077404775,https://www.nature.com/articles/s41587-019-0247-3,31,2,0,15,435.4188633,35.58,1,3,6.1425,133.5687,0.962962963,0,3,435.741,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4573,LNP_0004573,LM_2019,LM_2019_F693,A8Iso1C7,CCCCCCC(CCCCCC)(C(=O)NC(C)(C)C)N1CCN(C)CC1,CCCCCCC(CCCCCC)(C(=O)NC(C)(C)C)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso1,CC(C)(C)[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.033716643,https://www.nature.com/articles/s41587-019-0247-3,27,1,0,12,381.3719131,35.58,1,3,4.8281,117.2147,0.956521739,0,3,381.649,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4574,LNP_0004574,LM_2019,LM_2019_F694,A8Iso2C7,CCCCCCC(CCCCCC)(C(=O)NCCCC)N1CCN(C)CC1,CCCCCCC(CCCCCC)(C(=O)NCCCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso2,CCCC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.631959162,https://www.nature.com/articles/s41587-019-0247-3,27,1,0,15,381.3719131,35.58,1,3,4.8297,117.2367,0.956521739,0,3,381.649,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4575,LNP_0004575,LM_2019,LM_2019_F695,A8Iso3C7,CCCCCCC(CCCCCC)(C(=O)NCCCCC)N1CCN(C)CC1,CCCCCCC(CCCCCC)(C(=O)NCCCCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso3,CCCCC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.09317935,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,16,395.3875632,35.58,1,3,5.2198,121.8537,0.958333333,0,3,395.676,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4576,LNP_0004576,LM_2019,LM_2019_F696,A8Iso4C7,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC)N1CCN(C)CC1,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso4,[C-]#[N+]CC(=O)OC,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.219571317,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,14,397.3304422,61.88,1,5,3.2026,114.3447,0.909090909,0,3,397.604,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4577,LNP_0004577,LM_2019,LM_2019_F697,A8Iso5C7,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OCC)N1CCN(C)CC1,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso5,CCOC(=O)C[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.02521598,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,15,411.3460923,61.88,1,5,3.5927,118.9617,0.913043478,0,3,411.631,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4578,LNP_0004578,LM_2019,LM_2019_F698,A8Iso6C7,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N1CCN(C)CC1,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.015826421,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,14,439.3773924,61.88,1,5,4.3713,128.1737,0.92,0,3,439.685,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4579,LNP_0004579,LM_2019,LM_2019_F699,A8Iso7C7,CCCCCCC(CCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N1CCN(C)CC1,CCCCCCC(CCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.131218881,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,14,453.3930425,61.88,1,5,4.7598,132.7687,0.923076923,1,3,453.712,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4580,LNP_0004580,LM_2019,LM_2019_F700,A8Iso8C7,CCCCCCC(CCCCCC)(C(=O)NCCC(=O)OCC)N1CCN(C)CC1,CCCCCCC(CCCCCC)(C(=O)NCCC(=O)OCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso8,CCOC(=O)CC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.439334348,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,16,425.3617424,61.88,1,5,3.9828,123.5787,0.916666667,0,3,425.658,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4581,LNP_0004581,LM_2019,LM_2019_F701,A8Iso9C7,CCCCCCC(CCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N1CCN(C)CC1,CCCCCCC(CCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.936428061,https://www.nature.com/articles/s41587-019-0247-3,34,2,1,15,493.3338134,69.72,1,5,4.76942,140.6935,0.740740741,0,3,493.758,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4582,LNP_0004582,LM_2019,LM_2019_F702,A8Iso10C7,CCCCCCC(CCCCCC)(C(=O)NC1CCCCC1)N1CCN(C)CC1,CCCCCCC(CCCCCC)(C(=O)NC1CCCCC1)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso10,[C-]#[N+]C1CCCCC1,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.476366893,https://www.nature.com/articles/s41587-019-0247-3,29,2,0,13,407.3875632,35.58,1,3,5.3623,124.3347,0.96,0,3,407.687,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4583,LNP_0004583,LM_2019,LM_2019_F703,A8Iso1CC7,CN1CCN(C2(C(=O)NC(C)(C)C)CCCCCCCCCCCCCC2)CC1,C[N+]1([H])CCN(C2(C(=O)NC(C)(C)C)CCCCCCCCCCCCCC2)CC1,A8,CN1CCNCC1,Iso1,CC(C)(C)[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.338583409,https://www.nature.com/articles/s41587-019-0247-3,29,2,0,2,407.3875632,35.58,1,3,5.3623,124.3347,0.96,0,3,407.687,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4584,LNP_0004584,LM_2019,LM_2019_F704,A8Iso2CC7,CCCCNC(=O)C1(N2CCN(C)CC2)CCCCCCCCCCCCCC1,CCCCNC(=O)C1(N2CC[N+](C)([H])CC2)CCCCCCCCCCCCCC1,A8,CN1CCNCC1,Iso2,CCCC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.310064512,https://www.nature.com/articles/s41587-019-0247-3,29,2,0,5,407.3875632,35.58,1,3,5.3639,124.3567,0.96,0,3,407.687,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4585,LNP_0004585,LM_2019,LM_2019_F705,A8Iso3CC7,CCCCCNC(=O)C1(N2CCN(C)CC2)CCCCCCCCCCCCCC1,CCCCCNC(=O)C1(N2CC[N+](C)([H])CC2)CCCCCCCCCCCCCC1,A8,CN1CCNCC1,Iso3,CCCCC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.813725969,https://www.nature.com/articles/s41587-019-0247-3,30,2,0,6,421.4032133,35.58,1,3,5.754,128.9737,0.961538462,0,3,421.714,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4586,LNP_0004586,LM_2019,LM_2019_F706,A8Iso4CC7,COC(=O)CNC(=O)C1(N2CCN(C)CC2)CCCCCCCCCCCCCC1,COC(=O)CNC(=O)C1(N2CC[N+](C)([H])CC2)CCCCCCCCCCCCCC1,A8,CN1CCNCC1,Iso4,[C-]#[N+]CC(=O)OC,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.021194524,https://www.nature.com/articles/s41587-019-0247-3,30,2,0,4,423.3460923,61.88,1,5,3.7368,121.4647,0.916666667,0,3,423.642,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4587,LNP_0004587,LM_2019,LM_2019_F707,A8Iso5CC7,CCOC(=O)CNC(=O)C1(N2CCN(C)CC2)CCCCCCCCCCCCCC1,CCOC(=O)CNC(=O)C1(N2CC[N+](C)([H])CC2)CCCCCCCCCCCCCC1,A8,CN1CCNCC1,Iso5,CCOC(=O)C[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.249378561,https://www.nature.com/articles/s41587-019-0247-3,31,2,0,5,437.3617424,61.88,1,5,4.1269,126.0817,0.92,0,3,437.669,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4588,LNP_0004588,LM_2019,LM_2019_F708,A8Iso6CC7,CN1CCN(C2(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCCCCC2)CC1,C[N+]1([H])CCN(C2(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCCCCC2)CC1,A8,CN1CCNCC1,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.624351457,https://www.nature.com/articles/s41587-019-0247-3,33,2,0,4,465.3930425,61.88,1,5,4.9055,135.2937,0.925925926,0,3,465.723,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4589,LNP_0004589,LM_2019,LM_2019_F709,A8Iso7CC7,CC(NC(=O)C1(N2CCN(C)CC2)CCCCCCCCCCCCCC1)C(=O)OC(C)(C)C,CC(NC(=O)C1(N2CC[N+](C)([H])CC2)CCCCCCCCCCCCCC1)C(=O)OC(C)(C)C,A8,CN1CCNCC1,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.293193925,https://www.nature.com/articles/s41587-019-0247-3,34,2,0,4,479.4086926,61.88,1,5,5.294,139.8887,0.928571429,1,3,479.75,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4590,LNP_0004590,LM_2019,LM_2019_F710,A8Iso8CC7,CCOC(=O)CCNC(=O)C1(N2CCN(C)CC2)CCCCCCCCCCCCCC1,CCOC(=O)CCNC(=O)C1(N2CC[N+](C)([H])CC2)CCCCCCCCCCCCCC1,A8,CN1CCNCC1,Iso8,CCOC(=O)CC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.11989157,https://www.nature.com/articles/s41587-019-0247-3,32,2,0,6,451.3773924,61.88,1,5,4.517,130.6987,0.923076923,0,3,451.696,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4591,LNP_0004591,LM_2019,LM_2019_F711,A8Iso9CC7,Cc1ccc(S(=O)(=O)CNC(=O)C2(N3CCN(C)CC3)CCCCCCCCCCCCCC2)cc1,Cc1ccc(S(=O)(=O)CNC(=O)C2(N3CC[N+](C)([H])CC3)CCCCCCCCCCCCCC2)cc1,A8,CN1CCNCC1,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.775595992,https://www.nature.com/articles/s41587-019-0247-3,36,3,1,5,519.3494634,69.72,1,5,5.30362,147.8135,0.75862069,0,3,519.796,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4592,LNP_0004592,LM_2019,LM_2019_F712,A8Iso10CC7,CN1CCN(C2(C(=O)NC3CCCCC3)CCCCCCCCCCCCCC2)CC1,C[N+]1([H])CCN(C2(C(=O)NC3CCCCC3)CCCCCCCCCCCCCC2)CC1,A8,CN1CCNCC1,Iso10,[C-]#[N+]C1CCCCC1,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.481286996,https://www.nature.com/articles/s41587-019-0247-3,31,3,0,3,433.4032133,35.58,1,3,5.8965,131.4547,0.962962963,0,3,433.725,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4593,LNP_0004593,LM_2019,LM_2019_F713,A8Iso1CC6,CN1CCN(C2(C(=O)NC(C)(C)C)CCCCCCCCCCC2)CC1,C[N+]1([H])CCN(C2(C(=O)NC(C)(C)C)CCCCCCCCCCC2)CC1,A8,CN1CCNCC1,Iso1,CC(C)(C)[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.203192678,https://www.nature.com/articles/s41587-019-0247-3,26,2,0,2,365.340613,35.58,1,3,4.192,110.4837,0.954545455,0,3,365.606,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4594,LNP_0004594,LM_2019,LM_2019_F714,A8Iso2CC6,CCCCNC(=O)C1(N2CCN(C)CC2)CCCCCCCCCCC1,CCCCNC(=O)C1(N2CC[N+](C)([H])CC2)CCCCCCCCCCC1,A8,CN1CCNCC1,Iso2,CCCC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.985480128,https://www.nature.com/articles/s41587-019-0247-3,26,2,0,5,365.340613,35.58,1,3,4.1936,110.5057,0.954545455,0,3,365.606,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4595,LNP_0004595,LM_2019,LM_2019_F715,A8Iso3CC6,CCCCCNC(=O)C1(N2CCN(C)CC2)CCCCCCCCCCC1,CCCCCNC(=O)C1(N2CC[N+](C)([H])CC2)CCCCCCCCCCC1,A8,CN1CCNCC1,Iso3,CCCCC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.382809811,https://www.nature.com/articles/s41587-019-0247-3,27,2,0,6,379.3562631,35.58,1,3,4.5837,115.1227,0.956521739,0,3,379.633,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4596,LNP_0004596,LM_2019,LM_2019_F716,A8Iso4CC6,COC(=O)CNC(=O)C1(N2CCN(C)CC2)CCCCCCCCCCC1,COC(=O)CNC(=O)C1(N2CC[N+](C)([H])CC2)CCCCCCCCCCC1,A8,CN1CCNCC1,Iso4,[C-]#[N+]CC(=O)OC,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.228482423,https://www.nature.com/articles/s41587-019-0247-3,27,2,0,4,381.2991421,61.88,1,5,2.5665,107.6137,0.904761905,0,3,381.561,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4597,LNP_0004597,LM_2019,LM_2019_F717,A8Iso5CC6,CCOC(=O)CNC(=O)C1(N2CCN(C)CC2)CCCCCCCCCCC1,CCOC(=O)CNC(=O)C1(N2CC[N+](C)([H])CC2)CCCCCCCCCCC1,A8,CN1CCNCC1,Iso5,CCOC(=O)C[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.897413756,https://www.nature.com/articles/s41587-019-0247-3,28,2,0,5,395.3147922,61.88,1,5,2.9566,112.2307,0.909090909,0,3,395.588,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4598,LNP_0004598,LM_2019,LM_2019_F718,A8Iso6CC6,CN1CCN(C2(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCC2)CC1,C[N+]1([H])CCN(C2(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCC2)CC1,A8,CN1CCNCC1,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.018553789,https://www.nature.com/articles/s41587-019-0247-3,30,2,0,4,423.3460923,61.88,1,5,3.7352,121.4427,0.916666667,0,3,423.642,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4599,LNP_0004599,LM_2019,LM_2019_F719,A8Iso7CC6,CC(NC(=O)C1(N2CCN(C)CC2)CCCCCCCCCCC1)C(=O)OC(C)(C)C,CC(NC(=O)C1(N2CC[N+](C)([H])CC2)CCCCCCCCCCC1)C(=O)OC(C)(C)C,A8,CN1CCNCC1,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.205701596,https://www.nature.com/articles/s41587-019-0247-3,31,2,0,4,437.3617424,61.88,1,5,4.1237,126.0377,0.92,1,3,437.669,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4600,LNP_0004600,LM_2019,LM_2019_F720,A8Iso8CC6,CCOC(=O)CCNC(=O)C1(N2CCN(C)CC2)CCCCCCCCCCC1,CCOC(=O)CCNC(=O)C1(N2CC[N+](C)([H])CC2)CCCCCCCCCCC1,A8,CN1CCNCC1,Iso8,CCOC(=O)CC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.536301121,https://www.nature.com/articles/s41587-019-0247-3,29,2,0,6,409.3304422,61.88,1,5,3.3467,116.8477,0.913043478,0,3,409.615,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4601,LNP_0004601,LM_2019,LM_2019_F721,A8Iso9CC6,Cc1ccc(S(=O)(=O)CNC(=O)C2(N3CCN(C)CC3)CCCCCCCCCCC2)cc1,Cc1ccc(S(=O)(=O)CNC(=O)C2(N3CC[N+](C)([H])CC3)CCCCCCCCCCC2)cc1,A8,CN1CCNCC1,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.171607545,https://www.nature.com/articles/s41587-019-0247-3,33,3,1,5,477.3025132,69.72,1,5,4.13332,133.9625,0.730769231,0,3,477.715,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4602,LNP_0004602,LM_2019,LM_2019_F722,A8Iso10CC6,CN1CCN(C2(C(=O)NC3CCCCC3)CCCCCCCCCCC2)CC1,C[N+]1([H])CCN(C2(C(=O)NC3CCCCC3)CCCCCCCCCCC2)CC1,A8,CN1CCNCC1,Iso10,[C-]#[N+]C1CCCCC1,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.016674799,https://www.nature.com/articles/s41587-019-0247-3,28,3,0,3,391.3562631,35.58,1,3,4.7262,117.6037,0.958333333,0,3,391.644,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4603,LNP_0004603,LM_2019,LM_2019_F723,A8Iso1C6,CCCCCC(CCCCC)(C(=O)NC(C)(C)C)N1CCN(C)CC1,CCCCCC(CCCCC)(C(=O)NC(C)(C)C)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso1,CC(C)(C)[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.430853359,https://www.nature.com/articles/s41587-019-0247-3,25,1,0,10,353.340613,35.58,1,3,4.0479,107.9807,0.952380952,0,3,353.595,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4604,LNP_0004604,LM_2019,LM_2019_F724,A8Iso2C6,CCCCCC(CCCCC)(C(=O)NCCCC)N1CCN(C)CC1,CCCCCC(CCCCC)(C(=O)NCCCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso2,CCCC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.920428624,https://www.nature.com/articles/s41587-019-0247-3,25,1,0,13,353.340613,35.58,1,3,4.0495,108.0027,0.952380952,0,3,353.595,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4605,LNP_0004605,LM_2019,LM_2019_F725,A8Iso3C6,CCCCCNC(=O)C(CCCCC)(CCCCC)N1CCN(C)CC1,CCCCCNC(=O)C(CCCCC)(CCCCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso3,CCCCC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.037142757,https://www.nature.com/articles/s41587-019-0247-3,26,1,0,14,367.3562631,35.58,1,3,4.4396,112.6197,0.954545455,0,3,367.622,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4606,LNP_0004606,LM_2019,LM_2019_F726,A8Iso4C6,CCCCCC(CCCCC)(C(=O)NCC(=O)OC)N1CCN(C)CC1,CCCCCC(CCCCC)(C(=O)NCC(=O)OC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso4,[C-]#[N+]CC(=O)OC,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.316009695,https://www.nature.com/articles/s41587-019-0247-3,26,1,0,12,369.2991421,61.88,1,5,2.4224,105.1107,0.9,0,3,369.55,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4607,LNP_0004607,LM_2019,LM_2019_F727,A8Iso5C6,CCCCCC(CCCCC)(C(=O)NCC(=O)OCC)N1CCN(C)CC1,CCCCCC(CCCCC)(C(=O)NCC(=O)OCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso5,CCOC(=O)C[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.205339034,https://www.nature.com/articles/s41587-019-0247-3,27,1,0,13,383.3147922,61.88,1,5,2.8125,109.7277,0.904761905,0,3,383.577,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4608,LNP_0004608,LM_2019,LM_2019_F728,A8Iso6C6,CCCCCC(CCCCC)(C(=O)NCC(=O)OC(C)(C)C)N1CCN(C)CC1,CCCCCC(CCCCC)(C(=O)NCC(=O)OC(C)(C)C)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.832320817,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,12,411.3460923,61.88,1,5,3.5911,118.9397,0.913043478,0,3,411.631,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4609,LNP_0004609,LM_2019,LM_2019_F729,A8Iso7C6,CCCCCC(CCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N1CCN(C)CC1,CCCCCC(CCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.633487008,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,12,425.3617424,61.88,1,5,3.9796,123.5347,0.916666667,1,3,425.658,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4610,LNP_0004610,LM_2019,LM_2019_F730,A8Iso8C6,CCCCCC(CCCCC)(C(=O)NCCC(=O)OCC)N1CCN(C)CC1,CCCCCC(CCCCC)(C(=O)NCCC(=O)OCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso8,CCOC(=O)CC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.813725969,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,14,397.3304422,61.88,1,5,3.2026,114.3447,0.909090909,0,3,397.604,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4611,LNP_0004611,LM_2019,LM_2019_F731,A8Iso9C6,CCCCCC(CCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N1CCN(C)CC1,CCCCCC(CCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.490824118,https://www.nature.com/articles/s41587-019-0247-3,32,2,1,13,465.3025132,69.72,1,5,3.98922,131.4595,0.72,0,3,465.704,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4612,LNP_0004612,LM_2019,LM_2019_F732,A8Iso10C6,CCCCCC(CCCCC)(C(=O)NC1CCCCC1)N1CCN(C)CC1,CCCCCC(CCCCC)(C(=O)NC1CCCCC1)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso10,[C-]#[N+]C1CCCCC1,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.370444388,https://www.nature.com/articles/s41587-019-0247-3,27,2,0,11,379.3562631,35.58,1,3,4.5821,115.1007,0.956521739,0,3,379.633,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4613,LNP_0004613,LM_2019,LM_2019_F733,A9Iso12DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)(C)C)N(C)CCN(CC)CC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)(C)C)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso1,CC(C)(C)[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.522650979,https://www.nature.com/articles/s41587-019-0247-3,51,0,0,37,715.7318646,35.58,1,3,13.9885,229.9487,0.893617021,0,3,716.281,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4614,LNP_0004614,LM_2019,LM_2019_F734,A9Iso22DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCC)N(C)CCN(CC)CC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso2,CCCC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.118293859,https://www.nature.com/articles/s41587-019-0247-3,51,0,0,40,715.7318646,35.58,1,3,13.9901,229.9707,0.893617021,0,3,716.281,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4615,LNP_0004615,LM_2019,LM_2019_F735,A9Iso32DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCCC)N(C)CCN(CC)CC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso3,CCCCC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.114782703,https://www.nature.com/articles/s41587-019-0247-3,52,0,0,41,729.7475147,35.58,1,3,14.3802,234.5877,0.895833333,0,3,730.308,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4616,LNP_0004616,LM_2019,LM_2019_F736,A9Iso42DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC)N(C)CCN(CC)CC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso4,[C-]#[N+]CC(=O)OC,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.197422989,https://www.nature.com/articles/s41587-019-0247-3,52,0,0,39,731.6903937,61.88,1,5,12.363,227.0787,0.869565217,0,3,732.236,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4617,LNP_0004617,LM_2019,LM_2019_F737,A9Iso72DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCN(CC)CC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.456819355,https://www.nature.com/articles/s41587-019-0247-3,56,0,0,39,787.752994,61.88,1,5,13.9202,245.5027,0.88,1,3,788.344,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4618,LNP_0004618,LM_2019,LM_2019_F738,A9Iso82DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCN(CC)CC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso8,CCOC(=O)CC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.04475327,https://www.nature.com/articles/s41587-019-0247-3,54,0,0,41,759.7216938,61.88,1,5,13.1432,236.3127,0.875,0,3,760.29,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4619,LNP_0004619,LM_2019,LM_2019_F739,A9Iso102DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC1CCCCC1)N(C)CCN(CC)CC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC1CCCCC1)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso10,[C-]#[N+]C1CCCCC1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.151709195,https://www.nature.com/articles/s41587-019-0247-3,53,1,0,38,741.7475147,35.58,1,3,14.5227,237.0687,0.897959184,0,3,742.319,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4620,LNP_0004620,LM_2019,LM_2019_F740,A9Iso1C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)(C)C)N(C)CCN(CC)CC,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)(C)C)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso1,CC(C)(C)[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.980335758,https://www.nature.com/articles/s41587-019-0247-3,37,0,0,25,523.5440638,35.58,1,3,8.9751,165.4987,0.96969697,0,3,523.935,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4621,LNP_0004621,LM_2019,LM_2019_F741,A9Iso2C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCC)N(C)CCN(CC)CC,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso2,CCCC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.074082052,https://www.nature.com/articles/s41587-019-0247-3,37,0,0,28,523.5440638,35.58,1,3,8.9767,165.5207,0.96969697,0,3,523.935,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4622,LNP_0004622,LM_2019,LM_2019_F742,A9Iso3C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCCC)N(C)CCN(CC)CC,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso3,CCCCC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.740559557,https://www.nature.com/articles/s41587-019-0247-3,38,0,0,29,537.5597139,35.58,1,3,9.3668,170.1377,0.970588235,0,3,537.962,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4623,LNP_0004623,LM_2019,LM_2019_F743,A9Iso4C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC)N(C)CCN(CC)CC,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso4,[C-]#[N+]CC(=O)OC,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.002664966,https://www.nature.com/articles/s41587-019-0247-3,38,0,0,27,539.5025929,61.88,1,5,7.3496,162.6287,0.9375,0,3,539.89,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4624,LNP_0004624,LM_2019,LM_2019_F744,A9Iso5C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCN(CC)CC,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso5,CCOC(=O)C[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.956184443,https://www.nature.com/articles/s41587-019-0247-3,39,0,0,28,553.518243,61.88,1,5,7.7397,167.2457,0.939393939,0,3,553.917,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4625,LNP_0004625,LM_2019,LM_2019_F745,A9Iso6C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCN(CC)CC,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.053038101,https://www.nature.com/articles/s41587-019-0247-3,41,0,0,27,581.5495431,61.88,1,5,8.5183,176.4577,0.942857143,0,3,581.971,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4626,LNP_0004626,LM_2019,LM_2019_F746,A9Iso7C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCN(CC)CC,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.487488189,https://www.nature.com/articles/s41587-019-0247-3,42,0,0,27,595.5651932,61.88,1,5,8.9068,181.0527,0.944444444,1,3,595.998,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4627,LNP_0004627,LM_2019,LM_2019_F747,A9Iso8C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCN(CC)CC,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso8,CCOC(=O)CC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.369796088,https://www.nature.com/articles/s41587-019-0247-3,40,0,0,29,567.5338931,61.88,1,5,8.1298,171.8627,0.941176471,0,3,567.944,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4628,LNP_0004628,LM_2019,LM_2019_F748,A9Iso9C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCN(CC)CC,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.650998045,https://www.nature.com/articles/s41587-019-0247-3,44,1,1,28,635.5059641,69.72,1,5,8.91642,188.9775,0.810810811,0,3,636.044,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4629,LNP_0004629,LM_2019,LM_2019_F749,A9Iso10C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC1CCCCC1)N(C)CCN(CC)CC,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC1CCCCC1)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso10,[C-]#[N+]C1CCCCC1,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.12508563,https://www.nature.com/articles/s41587-019-0247-3,39,1,0,26,549.5597139,35.58,1,3,9.5093,172.6187,0.971428571,0,3,549.973,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4630,LNP_0004630,LM_2019,LM_2019_F750,A9Iso1C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)(C)C)N(C)CCN(CC)CC,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)(C)C)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso1,CC(C)(C)[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.111720544,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,23,495.5127637,35.58,1,3,8.1949,156.2647,0.967741935,0,3,495.881,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4631,LNP_0004631,LM_2019,LM_2019_F751,A9Iso2C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCC)N(C)CCN(CC)CC,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso2,CCCC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.467451492,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,26,495.5127637,35.58,1,3,8.1965,156.2867,0.967741935,0,3,495.881,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4632,LNP_0004632,LM_2019,LM_2019_F752,A9Iso3C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCCC)N(C)CCN(CC)CC,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso3,CCCCC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.160605629,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,27,509.5284138,35.58,1,3,8.5866,160.9037,0.96875,0,3,509.908,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4633,LNP_0004633,LM_2019,LM_2019_F753,A9Iso4C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC)N(C)CCN(CC)CC,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso4,[C-]#[N+]CC(=O)OC,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.892227204,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,25,511.4712928,61.88,1,5,6.5694,153.3947,0.933333333,0,3,511.836,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4634,LNP_0004634,LM_2019,LM_2019_F754,A9Iso5C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCN(CC)CC,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso5,CCOC(=O)C[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.189069649,https://www.nature.com/articles/s41587-019-0247-3,37,0,0,26,525.4869429,61.88,1,5,6.9595,158.0117,0.935483871,0,3,525.863,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4635,LNP_0004635,LM_2019,LM_2019_F755,A9Iso6C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCN(CC)CC,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.527212466,https://www.nature.com/articles/s41587-019-0247-3,39,0,0,25,553.518243,61.88,1,5,7.7381,167.2237,0.939393939,0,3,553.917,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4636,LNP_0004636,LM_2019,LM_2019_F756,A9Iso7C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCN(CC)CC,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.946460561,https://www.nature.com/articles/s41587-019-0247-3,40,0,0,25,567.5338931,61.88,1,5,8.1266,171.8187,0.941176471,1,3,567.944,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4637,LNP_0004637,LM_2019,LM_2019_F757,A9Iso8C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCN(CC)CC,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso8,CCOC(=O)CC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.400951874,https://www.nature.com/articles/s41587-019-0247-3,38,0,0,27,539.5025929,61.88,1,5,7.3496,162.6287,0.9375,0,3,539.89,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4638,LNP_0004638,LM_2019,LM_2019_F758,A9Iso9C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCN(CC)CC,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.73796035,https://www.nature.com/articles/s41587-019-0247-3,42,1,1,26,607.4746639,69.72,1,5,8.13622,179.7435,0.8,0,3,607.99,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4639,LNP_0004639,LM_2019,LM_2019_F759,A9Iso10C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC1CCCCC1)N(C)CCN(CC)CC,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC1CCCCC1)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso10,[C-]#[N+]C1CCCCC1,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.122761445,https://www.nature.com/articles/s41587-019-0247-3,37,1,0,24,521.5284138,35.58,1,3,8.7291,163.3847,0.96969697,0,3,521.919,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4640,LNP_0004640,LM_2019,LM_2019_F760,A9Iso1C9,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)(C)C)N(C)CCN(CC)CC,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)(C)C)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso1,CC(C)(C)[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.576992587,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,21,467.4814636,35.58,1,3,7.4147,147.0307,0.965517241,0,3,467.827,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4641,LNP_0004641,LM_2019,LM_2019_F761,A9Iso2C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCC)N(C)CCN(CC)CC,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso2,CCCC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.310753039,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,24,467.4814636,35.58,1,3,7.4163,147.0527,0.965517241,0,3,467.827,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4642,LNP_0004642,LM_2019,LM_2019_F762,A9Iso3C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCCC)N(C)CCN(CC)CC,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso3,CCCCC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.224459151,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,25,481.4971136,35.58,1,3,7.8064,151.6697,0.966666667,0,3,481.854,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4643,LNP_0004643,LM_2019,LM_2019_F763,A9Iso4C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC)N(C)CCN(CC)CC,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso4,[C-]#[N+]CC(=O)OC,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.902566244,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,23,483.4399927,61.88,1,5,5.7892,144.1607,0.928571429,0,3,483.782,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4644,LNP_0004644,LM_2019,LM_2019_F764,A9Iso5C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCN(CC)CC,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso5,CCOC(=O)C[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.131031045,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,24,497.4556427,61.88,1,5,6.1793,148.7777,0.931034483,0,3,497.809,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4645,LNP_0004645,LM_2019,LM_2019_F765,A9Iso6C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCN(CC)CC,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.206820542,https://www.nature.com/articles/s41587-019-0247-3,37,0,0,23,525.4869429,61.88,1,5,6.9579,157.9897,0.935483871,0,3,525.863,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4646,LNP_0004646,LM_2019,LM_2019_F766,A9Iso7C9,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCN(CC)CC,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.480055885,https://www.nature.com/articles/s41587-019-0247-3,38,0,0,23,539.5025929,61.88,1,5,7.3464,162.5847,0.9375,1,3,539.89,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4647,LNP_0004647,LM_2019,LM_2019_F767,A9Iso8C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCN(CC)CC,CCCCCCCCC(CCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso8,CCOC(=O)CC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.184949921,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,25,511.4712928,61.88,1,5,6.5694,153.3947,0.933333333,0,3,511.836,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4648,LNP_0004648,LM_2019,LM_2019_F768,A9Iso9C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCN(CC)CC,CCCCCCCCC(CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.24716314,https://www.nature.com/articles/s41587-019-0247-3,40,1,1,24,579.4433638,69.72,1,5,7.35602,170.5095,0.787878788,0,3,579.936,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4649,LNP_0004649,LM_2019,LM_2019_F769,A9Iso10C9,CCCCCCCCC(CCCCCCCC)(C(=O)NC1CCCCC1)N(C)CCN(CC)CC,CCCCCCCCC(CCCCCCCC)(C(=O)NC1CCCCC1)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso10,[C-]#[N+]C1CCCCC1,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.790953222,https://www.nature.com/articles/s41587-019-0247-3,35,1,0,22,493.4971136,35.58,1,3,7.9489,154.1507,0.967741935,0,3,493.865,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4650,LNP_0004650,LM_2019,LM_2019_F770,A9Iso1C8,CCCCCCCC(CCCCCCC)(C(=O)NC(C)(C)C)N(C)CCN(CC)CC,CCCCCCCC(CCCCCCC)(C(=O)NC(C)(C)C)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso1,CC(C)(C)[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.519610829,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,19,439.4501634,35.58,1,3,6.6345,137.7967,0.962962963,0,3,439.773,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4651,LNP_0004651,LM_2019,LM_2019_F771,A9Iso2C8,CCCCCCCC(CCCCCCC)(C(=O)NCCCC)N(C)CCN(CC)CC,CCCCCCCC(CCCCCCC)(C(=O)NCCCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso2,CCCC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.040462929,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,22,439.4501634,35.58,1,3,6.6361,137.8187,0.962962963,0,3,439.773,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4652,LNP_0004652,LM_2019,LM_2019_F772,A9Iso3C8,CCCCCCCC(CCCCCCC)(C(=O)NCCCCC)N(C)CCN(CC)CC,CCCCCCCC(CCCCCCC)(C(=O)NCCCCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso3,CCCCC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.923860161,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,23,453.4658135,35.58,1,3,7.0262,142.4357,0.964285714,0,3,453.8,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4653,LNP_0004653,LM_2019,LM_2019_F773,A9Iso4C8,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC)N(C)CCN(CC)CC,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso4,[C-]#[N+]CC(=O)OC,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.377423289,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,21,455.4086926,61.88,1,5,5.009,134.9267,0.923076923,0,3,455.728,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4654,LNP_0004654,LM_2019,LM_2019_F774,A9Iso5C8,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCN(CC)CC,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso5,CCOC(=O)C[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.503059687,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,22,469.4243426,61.88,1,5,5.3991,139.5437,0.925925926,0,3,469.755,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4655,LNP_0004655,LM_2019,LM_2019_F775,A9Iso6C8,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCN(CC)CC,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.224927815,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,21,497.4556427,61.88,1,5,6.1777,148.7557,0.931034483,0,3,497.809,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4656,LNP_0004656,LM_2019,LM_2019_F776,A9Iso7C8,CCCCCCCC(CCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCN(CC)CC,CCCCCCCC(CCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.229370352,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,21,511.4712928,61.88,1,5,6.5662,153.3507,0.933333333,1,3,511.836,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4657,LNP_0004657,LM_2019,LM_2019_F777,A9Iso8C8,CCCCCCCC(CCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCN(CC)CC,CCCCCCCC(CCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso8,CCOC(=O)CC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.715933734,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,23,483.4399927,61.88,1,5,5.7892,144.1607,0.928571429,0,3,483.782,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4658,LNP_0004658,LM_2019,LM_2019_F778,A9Iso9C8,CCCCCCCC(CCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCN(CC)CC,CCCCCCCC(CCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.277589857,https://www.nature.com/articles/s41587-019-0247-3,38,1,1,22,551.4120637,69.72,1,5,6.57582,161.2755,0.774193548,0,3,551.882,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4659,LNP_0004659,LM_2019,LM_2019_F779,A9Iso10C8,CCCCCCCC(CCCCCCC)(C(=O)NC1CCCCC1)N(C)CCN(CC)CC,CCCCCCCC(CCCCCCC)(C(=O)NC1CCCCC1)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso10,[C-]#[N+]C1CCCCC1,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.092679135,https://www.nature.com/articles/s41587-019-0247-3,33,1,0,20,465.4658135,35.58,1,3,7.1687,144.9167,0.965517241,0,3,465.811,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4660,LNP_0004660,LM_2019,LM_2019_F780,A9Iso1C7,CCCCCCC(CCCCCC)(C(=O)NC(C)(C)C)N(C)CCN(CC)CC,CCCCCCC(CCCCCC)(C(=O)NC(C)(C)C)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso1,CC(C)(C)[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.442241465,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,17,411.4188633,35.58,1,3,5.8543,128.5627,0.96,0,3,411.719,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4661,LNP_0004661,LM_2019,LM_2019_F781,A9Iso2C7,CCCCCCC(CCCCCC)(C(=O)NCCCC)N(C)CCN(CC)CC,CCCCCCC(CCCCCC)(C(=O)NCCCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso2,CCCC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.555269739,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,20,411.4188633,35.58,1,3,5.8559,128.5847,0.96,0,3,411.719,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4662,LNP_0004662,LM_2019,LM_2019_F782,A9Iso3C7,CCCCCCC(CCCCCC)(C(=O)NCCCCC)N(C)CCN(CC)CC,CCCCCCC(CCCCCC)(C(=O)NCCCCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso3,CCCCC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.372771139,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,21,425.4345134,35.58,1,3,6.246,133.2017,0.961538462,0,3,425.746,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4663,LNP_0004663,LM_2019,LM_2019_F783,A9Iso4C7,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC)N(C)CCN(CC)CC,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso4,[C-]#[N+]CC(=O)OC,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.836492838,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,19,427.3773924,61.88,1,5,4.2288,125.6927,0.916666667,0,3,427.674,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4664,LNP_0004664,LM_2019,LM_2019_F784,A9Iso5C7,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OCC)N(C)CCN(CC)CC,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso5,CCOC(=O)C[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.295349046,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,20,441.3930425,61.88,1,5,4.6189,130.3097,0.92,0,3,441.701,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4665,LNP_0004665,LM_2019,LM_2019_F785,A9Iso6C7,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCN(CC)CC,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.088598836,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,19,469.4243426,61.88,1,5,5.3975,139.5217,0.925925926,0,3,469.755,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4666,LNP_0004666,LM_2019,LM_2019_F786,A9Iso7C7,CCCCCCC(CCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCN(CC)CC,CCCCCCC(CCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.132456615,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,19,483.4399927,61.88,1,5,5.786,144.1167,0.928571429,1,3,483.782,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4667,LNP_0004667,LM_2019,LM_2019_F787,A9Iso8C7,CCCCCCC(CCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCN(CC)CC,CCCCCCC(CCCCCC)(C(=O)NCCC(=O)OCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso8,CCOC(=O)CC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.620921491,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,21,455.4086926,61.88,1,5,5.009,134.9267,0.923076923,0,3,455.728,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4668,LNP_0004668,LM_2019,LM_2019_F788,A9Iso9C7,CCCCCCC(CCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCN(CC)CC,CCCCCCC(CCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.053038101,https://www.nature.com/articles/s41587-019-0247-3,36,1,1,20,523.3807636,69.72,1,5,5.79562,152.0415,0.75862069,0,3,523.828,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4669,LNP_0004669,LM_2019,LM_2019_F789,A9Iso10C7,CCCCCCC(CCCCCC)(C(=O)NC1CCCCC1)N(C)CCN(CC)CC,CCCCCCC(CCCCCC)(C(=O)NC1CCCCC1)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso10,[C-]#[N+]C1CCCCC1,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.093432998,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,18,437.4345134,35.58,1,3,6.3885,135.6827,0.962962963,0,3,437.757,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4670,LNP_0004670,LM_2019,LM_2019_F790,A9Iso1CC7,CCN(CC)CCN(C)C1(C(=O)NC(C)(C)C)CCCCCCCCCCCCCC1,CC[N+](CC)(CCN(C)C1(C(=O)NC(C)(C)C)CCCCCCCCCCCCCC1)[H],A9,CCN(CC)CCNC,Iso1,CC(C)(C)[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.343470865,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,7,437.4345134,35.58,1,3,6.3885,135.6827,0.962962963,0,3,437.757,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4671,LNP_0004671,LM_2019,LM_2019_F791,A9Iso2CC7,CCCCNC(=O)C1(N(C)CCN(CC)CC)CCCCCCCCCCCCCC1,CCCCNC(=O)C1(N(C)CC[N+](CC)(CC)[H])CCCCCCCCCCCCCC1,A9,CCN(CC)CCNC,Iso2,CCCC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.333434536,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,10,437.4345134,35.58,1,3,6.3901,135.7047,0.962962963,0,3,437.757,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4672,LNP_0004672,LM_2019,LM_2019_F792,A9Iso3CC7,CCCCCNC(=O)C1(N(C)CCN(CC)CC)CCCCCCCCCCCCCC1,CCCCCNC(=O)C1(N(C)CC[N+](CC)(CC)[H])CCCCCCCCCCCCCC1,A9,CCN(CC)CCNC,Iso3,CCCCC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.168321089,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,11,451.4501634,35.58,1,3,6.7802,140.3217,0.964285714,0,3,451.784,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4673,LNP_0004673,LM_2019,LM_2019_F793,A9Iso4CC7,CCN(CC)CCN(C)C1(C(=O)NCC(=O)OC)CCCCCCCCCCCCCC1,CC[N+](CC)(CCN(C)C1(C(=O)NCC(=O)OC)CCCCCCCCCCCCCC1)[H],A9,CCN(CC)CCNC,Iso4,[C-]#[N+]CC(=O)OC,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.898245987,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,9,453.3930425,61.88,1,5,4.763,132.8127,0.923076923,0,3,453.712,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4674,LNP_0004674,LM_2019,LM_2019_F794,A9Iso5CC7,CCOC(=O)CNC(=O)C1(N(C)CCN(CC)CC)CCCCCCCCCCCCCC1,CCOC(=O)CNC(=O)C1(N(C)CC[N+](CC)(CC)[H])CCCCCCCCCCCCCC1,A9,CCN(CC)CCNC,Iso5,CCOC(=O)C[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.551378294,https://www.nature.com/articles/s41587-019-0247-3,33,1,0,10,467.4086926,61.88,1,5,5.1531,137.4297,0.925925926,0,3,467.739,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4675,LNP_0004675,LM_2019,LM_2019_F795,A9Iso6CC7,CCN(CC)CCN(C)C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCCCCC1,CC[N+](CC)(CCN(C)C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCCCCC1)[H],A9,CCN(CC)CCNC,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.086878613,https://www.nature.com/articles/s41587-019-0247-3,35,1,0,9,495.4399927,61.88,1,5,5.9317,146.6417,0.931034483,0,3,495.793,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4676,LNP_0004676,LM_2019,LM_2019_F796,A9Iso7CC7,CCN(CC)CCN(C)C1(C(=O)NC(C)C(=O)OC(C)(C)C)CCCCCCCCCCCCCC1,CC[N+](CC)(CCN(C)C1(C(=O)NC(C)C(=O)OC(C)(C)C)CCCCCCCCCCCCCC1)[H],A9,CCN(CC)CCNC,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.207867356,https://www.nature.com/articles/s41587-019-0247-3,36,1,0,9,509.4556427,61.88,1,5,6.3202,151.2367,0.933333333,1,3,509.82,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4677,LNP_0004677,LM_2019,LM_2019_F797,A9Iso8CC7,CCOC(=O)CCNC(=O)C1(N(C)CCN(CC)CC)CCCCCCCCCCCCCC1,CCOC(=O)CCNC(=O)C1(N(C)CC[N+](CC)(CC)[H])CCCCCCCCCCCCCC1,A9,CCN(CC)CCNC,Iso8,CCOC(=O)CC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.551729348,https://www.nature.com/articles/s41587-019-0247-3,34,1,0,11,481.4243426,61.88,1,5,5.5432,142.0467,0.928571429,0,3,481.766,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4678,LNP_0004678,LM_2019,LM_2019_F798,A9Iso9CC7,CCN(CC)CCN(C)C1(C(=O)NCS(=O)(=O)c2ccc(C)cc2)CCCCCCCCCCCCCC1,CC[N+](CC)(CCN(C)C1(C(=O)NCS(=O)(=O)c2ccc(C)cc2)CCCCCCCCCCCCCC1)[H],A9,CCN(CC)CCNC,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.950336352,https://www.nature.com/articles/s41587-019-0247-3,38,2,1,10,549.3964136,69.72,1,5,6.32982,159.1615,0.774193548,0,3,549.866,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4679,LNP_0004679,LM_2019,LM_2019_F799,A9Iso10CC7,CCN(CC)CCN(C)C1(C(=O)NC2CCCCC2)CCCCCCCCCCCCCC1,CC[N+](CC)(CCN(C)C1(C(=O)NC2CCCCC2)CCCCCCCCCCCCCC1)[H],A9,CCN(CC)CCNC,Iso10,[C-]#[N+]C1CCCCC1,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.366991702,https://www.nature.com/articles/s41587-019-0247-3,33,2,0,8,463.4501634,35.58,1,3,6.9227,142.8027,0.965517241,0,3,463.795,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4680,LNP_0004680,LM_2019,LM_2019_F800,A9Iso1CC6,CCN(CC)CCN(C)C1(C(=O)NC(C)(C)C)CCCCCCCCCCC1,CC[N+](CC)(CCN(C)C1(C(=O)NC(C)(C)C)CCCCCCCCCCC1)[H],A9,CCN(CC)CCNC,Iso1,CC(C)(C)[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.590949564,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,7,395.3875632,35.58,1,3,5.2182,121.8317,0.958333333,0,3,395.676,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4681,LNP_0004681,LM_2019,LM_2019_F801,A9Iso2CC6,CCCCNC(=O)C1(N(C)CCN(CC)CC)CCCCCCCCCCC1,CCCCNC(=O)C1(N(C)CC[N+](CC)(CC)[H])CCCCCCCCCCC1,A9,CCN(CC)CCNC,Iso2,CCCC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.824391904,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,10,395.3875632,35.58,1,3,5.2198,121.8537,0.958333333,0,3,395.676,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4682,LNP_0004682,LM_2019,LM_2019_F802,A9Iso3CC6,CCCCCNC(=O)C1(N(C)CCN(CC)CC)CCCCCCCCCCC1,CCCCCNC(=O)C1(N(C)CC[N+](CC)(CC)[H])CCCCCCCCCCC1,A9,CCN(CC)CCNC,Iso3,CCCCC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.936448715,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,11,409.4032133,35.58,1,3,5.6099,126.4707,0.96,0,3,409.703,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4683,LNP_0004683,LM_2019,LM_2019_F803,A9Iso4CC6,CCN(CC)CCN(C)C1(C(=O)NCC(=O)OC)CCCCCCCCCCC1,CC[N+](CC)(CCN(C)C1(C(=O)NCC(=O)OC)CCCCCCCCCCC1)[H],A9,CCN(CC)CCNC,Iso4,[C-]#[N+]CC(=O)OC,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.298134503,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,9,411.3460923,61.88,1,5,3.5927,118.9617,0.913043478,0,3,411.631,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4684,LNP_0004684,LM_2019,LM_2019_F804,A9Iso5CC6,CCOC(=O)CNC(=O)C1(N(C)CCN(CC)CC)CCCCCCCCCCC1,CCOC(=O)CNC(=O)C1(N(C)CC[N+](CC)(CC)[H])CCCCCCCCCCC1,A9,CCN(CC)CCNC,Iso5,CCOC(=O)C[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.416066289,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,10,425.3617424,61.88,1,5,3.9828,123.5787,0.916666667,0,3,425.658,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4685,LNP_0004685,LM_2019,LM_2019_F805,A9Iso6CC6,CCN(CC)CCN(C)C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCC1,CC[N+](CC)(CCN(C)C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCC1)[H],A9,CCN(CC)CCNC,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.772601424,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,9,453.3930425,61.88,1,5,4.7614,132.7907,0.923076923,0,3,453.712,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4686,LNP_0004686,LM_2019,LM_2019_F806,A9Iso7CC6,CCN(CC)CCN(C)C1(C(=O)NC(C)C(=O)OC(C)(C)C)CCCCCCCCCCC1,CC[N+](CC)(CCN(C)C1(C(=O)NC(C)C(=O)OC(C)(C)C)CCCCCCCCCCC1)[H],A9,CCN(CC)CCNC,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.099465602,https://www.nature.com/articles/s41587-019-0247-3,33,1,0,9,467.4086926,61.88,1,5,5.1499,137.3857,0.925925926,1,3,467.739,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4687,LNP_0004687,LM_2019,LM_2019_F807,A9Iso8CC6,CCOC(=O)CCNC(=O)C1(N(C)CCN(CC)CC)CCCCCCCCCCC1,CCOC(=O)CCNC(=O)C1(N(C)CC[N+](CC)(CC)[H])CCCCCCCCCCC1,A9,CCN(CC)CCNC,Iso8,CCOC(=O)CC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.614900894,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,11,439.3773924,61.88,1,5,4.3729,128.1957,0.92,0,3,439.685,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4688,LNP_0004688,LM_2019,LM_2019_F808,A9Iso9CC6,CCN(CC)CCN(C)C1(C(=O)NCS(=O)(=O)c2ccc(C)cc2)CCCCCCCCCCC1,CC[N+](CC)(CCN(C)C1(C(=O)NCS(=O)(=O)c2ccc(C)cc2)CCCCCCCCCCC1)[H],A9,CCN(CC)CCNC,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.327804087,https://www.nature.com/articles/s41587-019-0247-3,35,2,1,10,507.3494634,69.72,1,5,5.15952,145.3105,0.75,0,3,507.785,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4689,LNP_0004689,LM_2019,LM_2019_F809,A9Iso10CC6,CCN(CC)CCN(C)C1(C(=O)NC2CCCCC2)CCCCCCCCCCC1,CC[N+](CC)(CCN(C)C1(C(=O)NC2CCCCC2)CCCCCCCCCCC1)[H],A9,CCN(CC)CCNC,Iso10,[C-]#[N+]C1CCCCC1,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.234053249,https://www.nature.com/articles/s41587-019-0247-3,30,2,0,8,421.4032133,35.58,1,3,5.7524,128.9517,0.961538462,0,3,421.714,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4690,LNP_0004690,LM_2019,LM_2019_F810,A9Iso1C6,CCCCCC(CCCCC)(C(=O)NC(C)(C)C)N(C)CCN(CC)CC,CCCCCC(CCCCC)(C(=O)NC(C)(C)C)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso1,CC(C)(C)[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.494540472,https://www.nature.com/articles/s41587-019-0247-3,27,0,0,15,383.3875632,35.58,1,3,5.0741,119.3287,0.956521739,0,3,383.665,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4691,LNP_0004691,LM_2019,LM_2019_F811,A9Iso2C6,CCCCCC(CCCCC)(C(=O)NCCCC)N(C)CCN(CC)CC,CCCCCC(CCCCC)(C(=O)NCCCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso2,CCCC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.889863561,https://www.nature.com/articles/s41587-019-0247-3,27,0,0,18,383.3875632,35.58,1,3,5.0757,119.3507,0.956521739,0,3,383.665,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4692,LNP_0004692,LM_2019,LM_2019_F812,A9Iso3C6,CCCCCNC(=O)C(CCCCC)(CCCCC)N(C)CCN(CC)CC,CCCCCNC(=O)C(CCCCC)(CCCCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso3,CCCCC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.453692375,https://www.nature.com/articles/s41587-019-0247-3,28,0,0,19,397.4032133,35.58,1,3,5.4658,123.9677,0.958333333,0,3,397.692,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4693,LNP_0004693,LM_2019,LM_2019_F813,A9Iso4C6,CCCCCC(CCCCC)(C(=O)NCC(=O)OC)N(C)CCN(CC)CC,CCCCCC(CCCCC)(C(=O)NCC(=O)OC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso4,[C-]#[N+]CC(=O)OC,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.021598551,https://www.nature.com/articles/s41587-019-0247-3,28,0,0,17,399.3460923,61.88,1,5,3.4486,116.4587,0.909090909,0,3,399.62,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4694,LNP_0004694,LM_2019,LM_2019_F814,A9Iso5C6,CCCCCC(CCCCC)(C(=O)NCC(=O)OCC)N(C)CCN(CC)CC,CCCCCC(CCCCC)(C(=O)NCC(=O)OCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso5,CCOC(=O)C[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.137799545,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,18,413.3617424,61.88,1,5,3.8387,121.0757,0.913043478,0,3,413.647,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4695,LNP_0004695,LM_2019,LM_2019_F815,A9Iso6C6,CCCCCC(CCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCN(CC)CC,CCCCCC(CCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.098504442,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,17,441.3930425,61.88,1,5,4.6173,130.2877,0.92,0,3,441.701,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4696,LNP_0004696,LM_2019,LM_2019_F816,A9Iso7C6,CCCCCC(CCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCN(CC)CC,CCCCCC(CCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.136180435,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,17,455.4086926,61.88,1,5,5.0058,134.8827,0.923076923,1,3,455.728,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4697,LNP_0004697,LM_2019,LM_2019_F817,A9Iso8C6,CCCCCC(CCCCC)(C(=O)NCCC(=O)OCC)N(C)CCN(CC)CC,CCCCCC(CCCCC)(C(=O)NCCC(=O)OCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso8,CCOC(=O)CC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.168321089,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,19,427.3773924,61.88,1,5,4.2288,125.6927,0.916666667,0,3,427.674,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4698,LNP_0004698,LM_2019,LM_2019_F818,A9Iso9C6,CCCCCC(CCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCN(CC)CC,CCCCCC(CCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.695128227,https://www.nature.com/articles/s41587-019-0247-3,34,1,1,18,495.3494634,69.72,1,5,5.01542,142.8075,0.740740741,0,3,495.774,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4699,LNP_0004699,LM_2019,LM_2019_F819,A9Iso10C6,CCCCCC(CCCCC)(C(=O)NC1CCCCC1)N(C)CCN(CC)CC,CCCCCC(CCCCC)(C(=O)NC1CCCCC1)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso10,[C-]#[N+]C1CCCCC1,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.847947964,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,16,409.4032133,35.58,1,3,5.6083,126.4487,0.96,0,3,409.703,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4700,LNP_0004700,LM_2019,LM_2019_F820,A10Iso12DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)(C)C)N(C)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)(C)C)[N+](C)(CCO)[H],A10,CNCCO,Iso1,CC(C)(C)[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.882946291,https://www.nature.com/articles/s41587-019-0247-3,47,0,0,34,660.6532799,52.57,2,3,12.639,209.2465,0.88372093,0,2,661.157,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4701,LNP_0004701,LM_2019,LM_2019_F821,A10Iso22DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCC)N(C)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCC)[N+](C)(CCO)[H],A10,CNCCO,Iso2,CCCC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.585363102,https://www.nature.com/articles/s41587-019-0247-3,47,0,0,37,660.6532799,52.57,2,3,12.6406,209.2685,0.88372093,0,2,661.157,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4702,LNP_0004702,LM_2019,LM_2019_F822,A10Iso32DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCCC)N(C)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCCC)[N+](C)(CCO)[H],A10,CNCCO,Iso3,CCCCC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.522009206,https://www.nature.com/articles/s41587-019-0247-3,48,0,0,38,674.66893,52.57,2,3,13.0307,213.8855,0.886363636,0,2,675.184,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4703,LNP_0004703,LM_2019,LM_2019_F823,A10Iso42DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC)N(C)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC)[N+](C)(CCO)[H],A10,CNCCO,Iso4,[C-]#[N+]CC(=O)OC,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.447481803,https://www.nature.com/articles/s41587-019-0247-3,48,0,0,36,676.611809,78.87,2,5,11.0135,206.3765,0.857142857,0,2,677.112,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4704,LNP_0004704,LM_2019,LM_2019_F824,A10Iso72DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)[N+](C)(CCO)[H],A10,CNCCO,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.420087963,https://www.nature.com/articles/s41587-019-0247-3,52,0,0,36,732.6744093,78.87,2,5,12.5707,224.8005,0.869565217,1,2,733.22,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4705,LNP_0004705,LM_2019,LM_2019_F825,A10Iso82DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCC(=O)OCC)[N+](C)(CCO)[H],A10,CNCCO,Iso8,CCOC(=O)CC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.227779753,https://www.nature.com/articles/s41587-019-0247-3,50,0,0,38,704.6431092,78.87,2,5,11.7937,215.6105,0.863636364,0,2,705.166,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4706,LNP_0004706,LM_2019,LM_2019_F826,A10Iso102DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC1CCCCC1)N(C)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC1CCCCC1)[N+](C)(CCO)[H],A10,CNCCO,Iso10,[C-]#[N+]C1CCCCC1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.173871104,https://www.nature.com/articles/s41587-019-0247-3,49,1,0,35,686.66893,52.57,2,3,13.1732,216.3665,0.888888889,0,2,687.195,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4707,LNP_0004707,LM_2019,LM_2019_F827,A10Iso1C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)(C)C)N(C)CCO,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)(C)C)[N+](C)(CCO)[H],A10,CNCCO,Iso1,CC(C)(C)[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.140263842,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,22,468.4654792,52.57,2,3,7.6256,144.7965,0.965517241,0,2,468.811,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4708,LNP_0004708,LM_2019,LM_2019_F828,A10Iso2C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCC)N(C)CCO,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCC)[N+](C)(CCO)[H],A10,CNCCO,Iso2,CCCC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.156035652,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,25,468.4654792,52.57,2,3,7.6272,144.8185,0.965517241,0,2,468.811,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4709,LNP_0004709,LM_2019,LM_2019_F829,A10Iso3C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCCC)N(C)CCO,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCCC)[N+](C)(CCO)[H],A10,CNCCO,Iso3,CCCCC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.390788172,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,26,482.4811292,52.57,2,3,8.0173,149.4355,0.966666667,0,2,482.838,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4710,LNP_0004710,LM_2019,LM_2019_F830,A10Iso4C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC)N(C)CCO,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC)[N+](C)(CCO)[H],A10,CNCCO,Iso4,[C-]#[N+]CC(=O)OC,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.276437725,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,24,484.4240083,78.87,2,5,6.0001,141.9265,0.928571429,0,2,484.766,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4711,LNP_0004711,LM_2019,LM_2019_F831,A10Iso5C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCO,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OCC)[N+](C)(CCO)[H],A10,CNCCO,Iso5,CCOC(=O)C[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.375848879,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,25,498.4396583,78.87,2,5,6.3902,146.5435,0.931034483,0,2,498.793,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4712,LNP_0004712,LM_2019,LM_2019_F832,A10Iso6C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCO,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)[N+](C)(CCO)[H],A10,CNCCO,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.925203845,https://www.nature.com/articles/s41587-019-0247-3,37,0,0,24,526.4709585,78.87,2,5,7.1688,155.7555,0.935483871,0,2,526.847,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4713,LNP_0004713,LM_2019,LM_2019_F833,A10Iso7C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCO,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)[N+](C)(CCO)[H],A10,CNCCO,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.279979518,https://www.nature.com/articles/s41587-019-0247-3,38,0,0,24,540.4866085,78.87,2,5,7.5573,160.3505,0.9375,1,2,540.874,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4714,LNP_0004714,LM_2019,LM_2019_F834,A10Iso8C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCO,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCC(=O)OCC)[N+](C)(CCO)[H],A10,CNCCO,Iso8,CCOC(=O)CC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.156788605,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,26,512.4553084,78.87,2,5,6.7803,151.1605,0.933333333,0,2,512.82,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4715,LNP_0004715,LM_2019,LM_2019_F835,A10Iso9C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCO,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)[N+](C)(CCO)[H],A10,CNCCO,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.808339111,https://www.nature.com/articles/s41587-019-0247-3,40,1,1,25,580.4273794,86.71,2,5,7.56692,168.2753,0.787878788,0,2,580.92,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4716,LNP_0004716,LM_2019,LM_2019_F836,A10Iso10C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC1CCCCC1)N(C)CCO,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC1CCCCC1)[N+](C)(CCO)[H],A10,CNCCO,Iso10,[C-]#[N+]C1CCCCC1,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.74756639,https://www.nature.com/articles/s41587-019-0247-3,35,1,0,23,494.4811292,52.57,2,3,8.1598,151.9165,0.967741935,0,2,494.849,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4717,LNP_0004717,LM_2019,LM_2019_F837,A10Iso1C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)(C)C)N(C)CCO,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)(C)C)[N+](C)(CCO)[H],A10,CNCCO,Iso1,CC(C)(C)[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.421794903,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,20,440.434179,52.57,2,3,6.8454,135.5625,0.962962963,0,2,440.757,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4718,LNP_0004718,LM_2019,LM_2019_F838,A10Iso2C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCC)N(C)CCO,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCC)[N+](C)(CCO)[H],A10,CNCCO,Iso2,CCCC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.395074661,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,23,440.434179,52.57,2,3,6.847,135.5845,0.962962963,0,2,440.757,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4719,LNP_0004719,LM_2019,LM_2019_F839,A10Iso3C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCCC)N(C)CCO,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCCC)[N+](C)(CCO)[H],A10,CNCCO,Iso3,CCCCC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.3770953,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,24,454.4498291,52.57,2,3,7.2371,140.2015,0.964285714,0,2,454.784,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4720,LNP_0004720,LM_2019,LM_2019_F840,A10Iso4C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC)N(C)CCO,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC)[N+](C)(CCO)[H],A10,CNCCO,Iso4,[C-]#[N+]CC(=O)OC,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.728879425,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,22,456.3927081,78.87,2,5,5.2199,132.6925,0.923076923,0,2,456.712,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4721,LNP_0004721,LM_2019,LM_2019_F841,A10Iso5C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCO,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OCC)[N+](C)(CCO)[H],A10,CNCCO,Iso5,CCOC(=O)C[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.063869311,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,23,470.4083582,78.87,2,5,5.61,137.3095,0.925925926,0,2,470.739,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4722,LNP_0004722,LM_2019,LM_2019_F842,A10Iso6C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCO,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)[N+](C)(CCO)[H],A10,CNCCO,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.417324835,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,22,498.4396583,78.87,2,5,6.3886,146.5215,0.931034483,0,2,498.793,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4723,LNP_0004723,LM_2019,LM_2019_F843,A10Iso7C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCO,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)[N+](C)(CCO)[H],A10,CNCCO,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.91879167,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,22,512.4553084,78.87,2,5,6.7771,151.1165,0.933333333,1,2,512.82,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4724,LNP_0004724,LM_2019,LM_2019_F844,A10Iso8C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCO,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCC(=O)OCC)[N+](C)(CCO)[H],A10,CNCCO,Iso8,CCOC(=O)CC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.255785853,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,24,484.4240083,78.87,2,5,6.0001,141.9265,0.928571429,0,2,484.766,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4725,LNP_0004725,LM_2019,LM_2019_F845,A10Iso9C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCO,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)[N+](C)(CCO)[H],A10,CNCCO,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.728448649,https://www.nature.com/articles/s41587-019-0247-3,38,1,1,23,552.3960793,86.71,2,5,6.78672,159.0413,0.774193548,0,2,552.866,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4726,LNP_0004726,LM_2019,LM_2019_F846,A10Iso10C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC1CCCCC1)N(C)CCO,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC1CCCCC1)[N+](C)(CCO)[H],A10,CNCCO,Iso10,[C-]#[N+]C1CCCCC1,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.390073021,https://www.nature.com/articles/s41587-019-0247-3,33,1,0,21,466.4498291,52.57,2,3,7.3796,142.6825,0.965517241,0,2,466.795,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4727,LNP_0004727,LM_2019,LM_2019_F847,A10Iso1C9,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)(C)C)N(C)CCO,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)(C)C)[N+](C)(CCO)[H],A10,CNCCO,Iso1,CC(C)(C)[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.511713504,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,18,412.4028789,52.57,2,3,6.0652,126.3285,0.96,0,2,412.703,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4728,LNP_0004728,LM_2019,LM_2019_F848,A10Iso2C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCC)N(C)CCO,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCC)[N+](C)(CCO)[H],A10,CNCCO,Iso2,CCCC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.293594201,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,21,412.4028789,52.57,2,3,6.0668,126.3505,0.96,0,2,412.703,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4729,LNP_0004729,LM_2019,LM_2019_F849,A10Iso3C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCCC)N(C)CCO,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCCC)[N+](C)(CCO)[H],A10,CNCCO,Iso3,CCCCC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.630381891,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,22,426.418529,52.57,2,3,6.4569,130.9675,0.961538462,0,2,426.73,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4730,LNP_0004730,LM_2019,LM_2019_F850,A10Iso4C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC)N(C)CCO,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC)[N+](C)(CCO)[H],A10,CNCCO,Iso4,[C-]#[N+]CC(=O)OC,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.583542837,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,20,428.361408,78.87,2,5,4.4397,123.4585,0.916666667,0,2,428.658,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4731,LNP_0004731,LM_2019,LM_2019_F851,A10Iso5C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCO,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OCC)[N+](C)(CCO)[H],A10,CNCCO,Iso5,CCOC(=O)C[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.860208269,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,21,442.3770581,78.87,2,5,4.8298,128.0755,0.92,0,2,442.685,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4732,LNP_0004732,LM_2019,LM_2019_F852,A10Iso6C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCO,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)[N+](C)(CCO)[H],A10,CNCCO,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.808812353,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,20,470.4083582,78.87,2,5,5.6084,137.2875,0.925925926,0,2,470.739,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4733,LNP_0004733,LM_2019,LM_2019_F853,A10Iso7C9,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCO,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)[N+](C)(CCO)[H],A10,CNCCO,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.283020901,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,20,484.4240083,78.87,2,5,5.9969,141.8825,0.928571429,1,2,484.766,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4734,LNP_0004734,LM_2019,LM_2019_F854,A10Iso8C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCO,CCCCCCCCC(CCCCCCCC)(C(=O)NCCC(=O)OCC)[N+](C)(CCO)[H],A10,CNCCO,Iso8,CCOC(=O)CC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.661153224,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,22,456.3927081,78.87,2,5,5.2199,132.6925,0.923076923,0,2,456.712,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4735,LNP_0004735,LM_2019,LM_2019_F855,A10Iso9C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCO,CCCCCCCCC(CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)[N+](C)(CCO)[H],A10,CNCCO,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.787962088,https://www.nature.com/articles/s41587-019-0247-3,36,1,1,21,524.3647791,86.71,2,5,6.00652,149.8073,0.75862069,0,2,524.812,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4736,LNP_0004736,LM_2019,LM_2019_F856,A10Iso10C9,CCCCCCCCC(CCCCCCCC)(C(=O)NC1CCCCC1)N(C)CCO,CCCCCCCCC(CCCCCCCC)(C(=O)NC1CCCCC1)[N+](C)(CCO)[H],A10,CNCCO,Iso10,[C-]#[N+]C1CCCCC1,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.596181535,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,19,438.418529,52.57,2,3,6.5994,133.4485,0.962962963,0,2,438.741,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4737,LNP_0004737,LM_2019,LM_2019_F857,A10Iso1C8,CCCCCCCC(CCCCCCC)(C(=O)NC(C)(C)C)N(C)CCO,CCCCCCCC(CCCCCCC)(C(=O)NC(C)(C)C)[N+](C)(CCO)[H],A10,CNCCO,Iso1,CC(C)(C)[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.995111756,https://www.nature.com/articles/s41587-019-0247-3,27,0,0,16,384.3715788,52.57,2,3,5.285,117.0945,0.956521739,0,2,384.649,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4738,LNP_0004738,LM_2019,LM_2019_F858,A10Iso2C8,CCCCCCCC(CCCCCCC)(C(=O)NCCCC)N(C)CCO,CCCCCCCC(CCCCCCC)(C(=O)NCCCC)[N+](C)(CCO)[H],A10,CNCCO,Iso2,CCCC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.64922225,https://www.nature.com/articles/s41587-019-0247-3,27,0,0,19,384.3715788,52.57,2,3,5.2866,117.1165,0.956521739,0,2,384.649,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4739,LNP_0004739,LM_2019,LM_2019_F859,A10Iso3C8,CCCCCCCC(CCCCCCC)(C(=O)NCCCCC)N(C)CCO,CCCCCCCC(CCCCCCC)(C(=O)NCCCCC)[N+](C)(CCO)[H],A10,CNCCO,Iso3,CCCCC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.81787266,https://www.nature.com/articles/s41587-019-0247-3,28,0,0,20,398.3872288,52.57,2,3,5.6767,121.7335,0.958333333,0,2,398.676,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4740,LNP_0004740,LM_2019,LM_2019_F860,A10Iso4C8,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC)N(C)CCO,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC)[N+](C)(CCO)[H],A10,CNCCO,Iso4,[C-]#[N+]CC(=O)OC,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.100117513,https://www.nature.com/articles/s41587-019-0247-3,28,0,0,18,400.3301079,78.87,2,5,3.6595,114.2245,0.909090909,0,2,400.604,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4741,LNP_0004741,LM_2019,LM_2019_F861,A10Iso5C8,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCO,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OCC)[N+](C)(CCO)[H],A10,CNCCO,Iso5,CCOC(=O)C[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.254128517,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,19,414.345758,78.87,2,5,4.0496,118.8415,0.913043478,0,2,414.631,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4742,LNP_0004742,LM_2019,LM_2019_F862,A10Iso6C8,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCO,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)[N+](C)(CCO)[H],A10,CNCCO,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.407026127,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,18,442.3770581,78.87,2,5,4.8282,128.0535,0.92,0,2,442.685,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4743,LNP_0004743,LM_2019,LM_2019_F863,A10Iso7C8,CCCCCCCC(CCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCO,CCCCCCCC(CCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)[N+](C)(CCO)[H],A10,CNCCO,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.22497571,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,18,456.3927081,78.87,2,5,5.2167,132.6485,0.923076923,1,2,456.712,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4744,LNP_0004744,LM_2019,LM_2019_F864,A10Iso8C8,CCCCCCCC(CCCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCO,CCCCCCCC(CCCCCCC)(C(=O)NCCC(=O)OCC)[N+](C)(CCO)[H],A10,CNCCO,Iso8,CCOC(=O)CC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.521839433,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,20,428.361408,78.87,2,5,4.4397,123.4585,0.916666667,0,2,428.658,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4745,LNP_0004745,LM_2019,LM_2019_F865,A10Iso9C8,CCCCCCCC(CCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCO,CCCCCCCC(CCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)[N+](C)(CCO)[H],A10,CNCCO,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.913083446,https://www.nature.com/articles/s41587-019-0247-3,34,1,1,19,496.333479,86.71,2,5,5.22632,140.5733,0.740740741,0,2,496.758,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4746,LNP_0004746,LM_2019,LM_2019_F866,A10Iso10C8,CCCCCCCC(CCCCCCC)(C(=O)NC1CCCCC1)N(C)CCO,CCCCCCCC(CCCCCCC)(C(=O)NC1CCCCC1)[N+](C)(CCO)[H],A10,CNCCO,Iso10,[C-]#[N+]C1CCCCC1,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.014962012,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,17,410.3872288,52.57,2,3,5.8192,124.2145,0.96,0,2,410.687,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4747,LNP_0004747,LM_2019,LM_2019_F867,A10Iso1C7,CCCCCCC(CCCCCC)(C(=O)NC(C)(C)C)N(C)CCO,CCCCCCC(CCCCCC)(C(=O)NC(C)(C)C)[N+](C)(CCO)[H],A10,CNCCO,Iso1,CC(C)(C)[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.13434746,https://www.nature.com/articles/s41587-019-0247-3,25,0,0,14,356.3402786,52.57,2,3,4.5048,107.8605,0.952380952,0,2,356.595,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4748,LNP_0004748,LM_2019,LM_2019_F868,A10Iso2C7,CCCCCCC(CCCCCC)(C(=O)NCCCC)N(C)CCO,CCCCCCC(CCCCCC)(C(=O)NCCCC)[N+](C)(CCO)[H],A10,CNCCO,Iso2,CCCC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.143554202,https://www.nature.com/articles/s41587-019-0247-3,25,0,0,17,356.3402786,52.57,2,3,4.5064,107.8825,0.952380952,0,2,356.595,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4749,LNP_0004749,LM_2019,LM_2019_F869,A10Iso3C7,CCCCCCC(CCCCCC)(C(=O)NCCCCC)N(C)CCO,CCCCCCC(CCCCCC)(C(=O)NCCCCC)[N+](C)(CCO)[H],A10,CNCCO,Iso3,CCCCC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.355354053,https://www.nature.com/articles/s41587-019-0247-3,26,0,0,18,370.3559287,52.57,2,3,4.8965,112.4995,0.954545455,0,2,370.622,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4750,LNP_0004750,LM_2019,LM_2019_F870,A10Iso4C7,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC)N(C)CCO,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC)[N+](C)(CCO)[H],A10,CNCCO,Iso4,[C-]#[N+]CC(=O)OC,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.944019823,https://www.nature.com/articles/s41587-019-0247-3,26,0,0,16,372.2988078,78.87,2,5,2.8793,104.9905,0.9,0,2,372.55,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4751,LNP_0004751,LM_2019,LM_2019_F871,A10Iso5C7,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OCC)N(C)CCO,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OCC)[N+](C)(CCO)[H],A10,CNCCO,Iso5,CCOC(=O)C[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.191285796,https://www.nature.com/articles/s41587-019-0247-3,27,0,0,17,386.3144578,78.87,2,5,3.2694,109.6075,0.904761905,0,2,386.577,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4752,LNP_0004752,LM_2019,LM_2019_F872,A10Iso6C7,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCO,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC(C)(C)C)[N+](C)(CCO)[H],A10,CNCCO,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.101029816,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,16,414.345758,78.87,2,5,4.048,118.8195,0.913043478,0,2,414.631,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4753,LNP_0004753,LM_2019,LM_2019_F873,A10Iso7C7,CCCCCCC(CCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCO,CCCCCCC(CCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)[N+](C)(CCO)[H],A10,CNCCO,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.860392087,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,16,428.361408,78.87,2,5,4.4365,123.4145,0.916666667,1,2,428.658,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4754,LNP_0004754,LM_2019,LM_2019_F874,A10Iso8C7,CCCCCCC(CCCCCC)(C(=O)NCCC(=O)OCC)N(C)CCO,CCCCCCC(CCCCCC)(C(=O)NCCC(=O)OCC)[N+](C)(CCO)[H],A10,CNCCO,Iso8,CCOC(=O)CC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.434285561,https://www.nature.com/articles/s41587-019-0247-3,28,0,0,18,400.3301079,78.87,2,5,3.6595,114.2245,0.909090909,0,2,400.604,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4755,LNP_0004755,LM_2019,LM_2019_F875,A10Iso9C7,CCCCCCC(CCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCO,CCCCCCC(CCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)[N+](C)(CCO)[H],A10,CNCCO,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.925203845,https://www.nature.com/articles/s41587-019-0247-3,32,1,1,17,468.3021789,86.71,2,5,4.44612,131.3393,0.72,0,2,468.704,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4756,LNP_0004756,LM_2019,LM_2019_F876,A10Iso10C7,CCCCCCC(CCCCCC)(C(=O)NC1CCCCC1)N(C)CCO,CCCCCCC(CCCCCC)(C(=O)NC1CCCCC1)[N+](C)(CCO)[H],A10,CNCCO,Iso10,[C-]#[N+]C1CCCCC1,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.089199012,https://www.nature.com/articles/s41587-019-0247-3,27,1,0,15,382.3559287,52.57,2,3,5.039,114.9805,0.956521739,0,2,382.633,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4757,LNP_0004757,LM_2019,LM_2019_F877,A10Iso1CC7,CN(CCO)C1(C(=O)NC(C)(C)C)CCCCCCCCCCCCCC1,C[N+](CCO)(C1(C(=O)NC(C)(C)C)CCCCCCCCCCCCCC1)[H],A10,CNCCO,Iso1,CC(C)(C)[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.351154777,https://www.nature.com/articles/s41587-019-0247-3,27,1,0,4,382.3559287,52.57,2,3,5.039,114.9805,0.956521739,0,2,382.633,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4758,LNP_0004758,LM_2019,LM_2019_F878,A10Iso2CC7,CCCCNC(=O)C1(N(C)CCO)CCCCCCCCCCCCCC1,CCCCNC(=O)C1([N+](C)(CCO)[H])CCCCCCCCCCCCCC1,A10,CNCCO,Iso2,CCCC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.326138539,https://www.nature.com/articles/s41587-019-0247-3,27,1,0,7,382.3559287,52.57,2,3,5.0406,115.0025,0.956521739,0,2,382.633,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4759,LNP_0004759,LM_2019,LM_2019_F879,A10Iso3CC7,CCCCCNC(=O)C1(N(C)CCO)CCCCCCCCCCCCCC1,CCCCCNC(=O)C1([N+](C)(CCO)[H])CCCCCCCCCCCCCC1,A10,CNCCO,Iso3,CCCCC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.073939353,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,8,396.3715788,52.57,2,3,5.4307,119.6195,0.958333333,0,2,396.66,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4760,LNP_0004760,LM_2019,LM_2019_F880,A10Iso4CC7,COC(=O)CNC(=O)C1(N(C)CCO)CCCCCCCCCCCCCC1,COC(=O)CNC(=O)C1([N+](C)(CCO)[H])CCCCCCCCCCCCCC1,A10,CNCCO,Iso4,[C-]#[N+]CC(=O)OC,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.319266009,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,6,398.3144578,78.87,2,5,3.4135,112.1105,0.909090909,0,2,398.588,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4761,LNP_0004761,LM_2019,LM_2019_F881,A10Iso5CC7,CCOC(=O)CNC(=O)C1(N(C)CCO)CCCCCCCCCCCCCC1,CCOC(=O)CNC(=O)C1([N+](C)(CCO)[H])CCCCCCCCCCCCCC1,A10,CNCCO,Iso5,CCOC(=O)C[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.427018024,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,7,412.3301079,78.87,2,5,3.8036,116.7275,0.913043478,0,2,412.615,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4762,LNP_0004762,LM_2019,LM_2019_F882,A10Iso6CC7,CN(CCO)C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCCCCC1,C[N+](CCO)(C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCCCCC1)[H],A10,CNCCO,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.137141502,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,6,440.361408,78.87,2,5,4.5822,125.9395,0.92,0,2,440.669,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4763,LNP_0004763,LM_2019,LM_2019_F883,A10Iso7CC7,CC(NC(=O)C1(N(C)CCO)CCCCCCCCCCCCCC1)C(=O)OC(C)(C)C,CC(NC(=O)C1([N+](C)(CCO)[H])CCCCCCCCCCCCCC1)C(=O)OC(C)(C)C,A10,CNCCO,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.2424281,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,6,454.3770581,78.87,2,5,4.9707,130.5345,0.923076923,1,2,454.696,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4764,LNP_0004764,LM_2019,LM_2019_F884,A10Iso8CC7,CCOC(=O)CCNC(=O)C1(N(C)CCO)CCCCCCCCCCCCCC1,CCOC(=O)CCNC(=O)C1([N+](C)(CCO)[H])CCCCCCCCCCCCCC1,A10,CNCCO,Iso8,CCOC(=O)CC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.331181305,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,8,426.345758,78.87,2,5,4.1937,121.3445,0.916666667,0,2,426.642,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4765,LNP_0004765,LM_2019,LM_2019_F885,A10Iso9CC7,Cc1ccc(S(=O)(=O)CNC(=O)C2(N(C)CCO)CCCCCCCCCCCCCC2)cc1,Cc1ccc(S(=O)(=O)CNC(=O)C2([N+](C)(CCO)[H])CCCCCCCCCCCCCC2)cc1,A10,CNCCO,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.775863048,https://www.nature.com/articles/s41587-019-0247-3,34,2,1,7,494.317829,86.71,2,5,4.98032,138.4593,0.740740741,0,2,494.742,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4766,LNP_0004766,LM_2019,LM_2019_F886,A10Iso10CC7,CN(CCO)C1(C(=O)NC2CCCCC2)CCCCCCCCCCCCCC1,C[N+](CCO)(C1(C(=O)NC2CCCCC2)CCCCCCCCCCCCCC1)[H],A10,CNCCO,Iso10,[C-]#[N+]C1CCCCC1,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.982115447,https://www.nature.com/articles/s41587-019-0247-3,29,2,0,5,408.3715788,52.57,2,3,5.5732,122.1005,0.96,0,2,408.671,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4767,LNP_0004767,LM_2019,LM_2019_F887,A10Iso1CC6,CN(CCO)C1(C(=O)NC(C)(C)C)CCCCCCCCCCC1,C[N+](CCO)(C1(C(=O)NC(C)(C)C)CCCCCCCCCCC1)[H],A10,CNCCO,Iso1,CC(C)(C)[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.266002161,https://www.nature.com/articles/s41587-019-0247-3,24,1,0,4,340.3089785,52.57,2,3,3.8687,101.1295,0.95,0,2,340.552,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4768,LNP_0004768,LM_2019,LM_2019_F888,A10Iso2CC6,CCCCNC(=O)C1(N(C)CCO)CCCCCCCCCCC1,CCCCNC(=O)C1([N+](C)(CCO)[H])CCCCCCCCCCC1,A10,CNCCO,Iso2,CCCC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.533581188,https://www.nature.com/articles/s41587-019-0247-3,24,1,0,7,340.3089785,52.57,2,3,3.8703,101.1515,0.95,0,2,340.552,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4769,LNP_0004769,LM_2019,LM_2019_F889,A10Iso3CC6,CCCCCNC(=O)C1(N(C)CCO)CCCCCCCCCCC1,CCCCCNC(=O)C1([N+](C)(CCO)[H])CCCCCCCCCCC1,A10,CNCCO,Iso3,CCCCC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.020815785,https://www.nature.com/articles/s41587-019-0247-3,25,1,0,8,354.3246286,52.57,2,3,4.2604,105.7685,0.952380952,0,2,354.579,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4770,LNP_0004770,LM_2019,LM_2019_F890,A10Iso4CC6,COC(=O)CNC(=O)C1(N(C)CCO)CCCCCCCCCCC1,COC(=O)CNC(=O)C1([N+](C)(CCO)[H])CCCCCCCCCCC1,A10,CNCCO,Iso4,[C-]#[N+]CC(=O)OC,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.314029131,https://www.nature.com/articles/s41587-019-0247-3,25,1,0,6,356.2675076,78.87,2,5,2.2432,98.2595,0.894736842,0,2,356.507,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4771,LNP_0004771,LM_2019,LM_2019_F891,A10Iso5CC6,CCOC(=O)CNC(=O)C1(N(C)CCO)CCCCCCCCCCC1,CCOC(=O)CNC(=O)C1([N+](C)(CCO)[H])CCCCCCCCCCC1,A10,CNCCO,Iso5,CCOC(=O)C[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.060904447,https://www.nature.com/articles/s41587-019-0247-3,26,1,0,7,370.2831577,78.87,2,5,2.6333,102.8765,0.9,0,2,370.534,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4772,LNP_0004772,LM_2019,LM_2019_F892,A10Iso6CC6,CN(CCO)C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCC1,C[N+](CCO)(C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCC1)[H],A10,CNCCO,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.306649082,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,6,398.3144578,78.87,2,5,3.4119,112.0885,0.909090909,0,2,398.588,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4773,LNP_0004773,LM_2019,LM_2019_F893,A10Iso7CC6,CC(NC(=O)C1(N(C)CCO)CCCCCCCCCCC1)C(=O)OC(C)(C)C,CC(NC(=O)C1([N+](C)(CCO)[H])CCCCCCCCCCC1)C(=O)OC(C)(C)C,A10,CNCCO,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.112182956,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,6,412.3301079,78.87,2,5,3.8004,116.6835,0.913043478,1,2,412.615,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4774,LNP_0004774,LM_2019,LM_2019_F894,A10Iso8CC6,CCOC(=O)CCNC(=O)C1(N(C)CCO)CCCCCCCCCCC1,CCOC(=O)CCNC(=O)C1([N+](C)(CCO)[H])CCCCCCCCCCC1,A10,CNCCO,Iso8,CCOC(=O)CC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.604721508,https://www.nature.com/articles/s41587-019-0247-3,27,1,0,8,384.2988078,78.87,2,5,3.0234,107.4935,0.904761905,0,2,384.561,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4775,LNP_0004775,LM_2019,LM_2019_F895,A10Iso9CC6,Cc1ccc(S(=O)(=O)CNC(=O)C2(N(C)CCO)CCCCCCCCCCC2)cc1,Cc1ccc(S(=O)(=O)CNC(=O)C2([N+](C)(CCO)[H])CCCCCCCCCCC2)cc1,A10,CNCCO,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.175123901,https://www.nature.com/articles/s41587-019-0247-3,31,2,1,7,452.2708788,86.71,2,5,3.81002,124.6083,0.708333333,0,2,452.661,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4776,LNP_0004776,LM_2019,LM_2019_F896,A10Iso10CC6,CN(CCO)C1(C(=O)NC2CCCCC2)CCCCCCCCCCC1,C[N+](CCO)(C1(C(=O)NC2CCCCC2)CCCCCCCCCCC1)[H],A10,CNCCO,Iso10,[C-]#[N+]C1CCCCC1,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.37785936,https://www.nature.com/articles/s41587-019-0247-3,26,2,0,5,366.3246286,52.57,2,3,4.4029,108.2495,0.954545455,0,2,366.59,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4777,LNP_0004777,LM_2019,LM_2019_F897,A10Iso1C6,CCCCCC(CCCCC)(C(=O)NC(C)(C)C)N(C)CCO,CCCCCC(CCCCC)(C(=O)NC(C)(C)C)[N+](C)(CCO)[H],A10,CNCCO,Iso1,CC(C)(C)[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.314015439,https://www.nature.com/articles/s41587-019-0247-3,23,0,0,12,328.3089785,52.57,2,3,3.7246,98.6265,0.947368421,0,2,328.541,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4778,LNP_0004778,LM_2019,LM_2019_F898,A10Iso2C6,CCCCCC(CCCCC)(C(=O)NCCCC)N(C)CCO,CCCCCC(CCCCC)(C(=O)NCCCC)[N+](C)(CCO)[H],A10,CNCCO,Iso2,CCCC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.29909099,https://www.nature.com/articles/s41587-019-0247-3,23,0,0,15,328.3089785,52.57,2,3,3.7262,98.6485,0.947368421,0,2,328.541,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4779,LNP_0004779,LM_2019,LM_2019_F899,A10Iso3C6,CCCCCNC(=O)C(CCCCC)(CCCCC)N(C)CCO,CCCCCNC(=O)C(CCCCC)(CCCCC)[N+](C)(CCO)[H],A10,CNCCO,Iso3,CCCCC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.614128456,https://www.nature.com/articles/s41587-019-0247-3,24,0,0,16,342.3246286,52.57,2,3,4.1163,103.2655,0.95,0,2,342.568,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4780,LNP_0004780,LM_2019,LM_2019_F900,A10Iso4C6,CCCCCC(CCCCC)(C(=O)NCC(=O)OC)N(C)CCO,CCCCCC(CCCCC)(C(=O)NCC(=O)OC)[N+](C)(CCO)[H],A10,CNCCO,Iso4,[C-]#[N+]CC(=O)OC,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.340659215,https://www.nature.com/articles/s41587-019-0247-3,24,0,0,14,344.2675076,78.87,2,5,2.0991,95.7565,0.888888889,0,2,344.496,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4781,LNP_0004781,LM_2019,LM_2019_F901,A10Iso5C6,CCCCCC(CCCCC)(C(=O)NCC(=O)OCC)N(C)CCO,CCCCCC(CCCCC)(C(=O)NCC(=O)OCC)[N+](C)(CCO)[H],A10,CNCCO,Iso5,CCOC(=O)C[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.499875631,https://www.nature.com/articles/s41587-019-0247-3,25,0,0,15,358.2831577,78.87,2,5,2.4892,100.3735,0.894736842,0,2,358.523,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4782,LNP_0004782,LM_2019,LM_2019_F902,A10Iso6C6,CCCCCC(CCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCO,CCCCCC(CCCCC)(C(=O)NCC(=O)OC(C)(C)C)[N+](C)(CCO)[H],A10,CNCCO,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.760563983,https://www.nature.com/articles/s41587-019-0247-3,27,0,0,14,386.3144578,78.87,2,5,3.2678,109.5855,0.904761905,0,2,386.577,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4783,LNP_0004783,LM_2019,LM_2019_F903,A10Iso7C6,CCCCCC(CCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(C)CCO,CCCCCC(CCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)[N+](C)(CCO)[H],A10,CNCCO,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.819840221,https://www.nature.com/articles/s41587-019-0247-3,28,0,0,14,400.3301079,78.87,2,5,3.6563,114.1805,0.909090909,1,2,400.604,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4784,LNP_0004784,LM_2019,LM_2019_F904,A10Iso8C6,CCCCCC(CCCCC)(C(=O)NCCC(=O)OCC)N(C)CCO,CCCCCC(CCCCC)(C(=O)NCCC(=O)OCC)[N+](C)(CCO)[H],A10,CNCCO,Iso8,CCOC(=O)CC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.073939353,https://www.nature.com/articles/s41587-019-0247-3,26,0,0,16,372.2988078,78.87,2,5,2.8793,104.9905,0.9,0,2,372.55,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4785,LNP_0004785,LM_2019,LM_2019_F905,A10Iso9C6,CCCCCC(CCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCO,CCCCCC(CCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)[N+](C)(CCO)[H],A10,CNCCO,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.695123672,https://www.nature.com/articles/s41587-019-0247-3,30,1,1,15,440.2708788,86.71,2,5,3.66592,122.1053,0.695652174,0,2,440.65,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4786,LNP_0004786,LM_2019,LM_2019_F906,A10Iso10C6,CCCCCC(CCCCC)(C(=O)NC1CCCCC1)N(C)CCO,CCCCCC(CCCCC)(C(=O)NC1CCCCC1)[N+](C)(CCO)[H],A10,CNCCO,Iso10,[C-]#[N+]C1CCCCC1,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.343813738,https://www.nature.com/articles/s41587-019-0247-3,25,1,0,13,354.3246286,52.57,2,3,4.2588,105.7465,0.952380952,0,2,354.579,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4787,LNP_0004787,LM_2019,LM_2019_F907,A11Iso12DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)(C)C)N(CC)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)(C)C)[N+](CC)(CCO)[H],A11,CCNCCO,Iso1,CC(C)(C)[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.997782234,https://www.nature.com/articles/s41587-019-0247-3,48,0,0,35,674.66893,52.57,2,3,13.0291,213.8635,0.886363636,0,2,675.184,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4788,LNP_0004788,LM_2019,LM_2019_F908,A11Iso22DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCC)N(CC)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso2,CCCC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.516999513,https://www.nature.com/articles/s41587-019-0247-3,48,0,0,38,674.66893,52.57,2,3,13.0307,213.8855,0.886363636,0,2,675.184,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4789,LNP_0004789,LM_2019,LM_2019_F909,A11Iso32DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCCC)N(CC)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCCCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso3,CCCCC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.717168807,https://www.nature.com/articles/s41587-019-0247-3,49,0,0,39,688.6845801,52.57,2,3,13.4208,218.5025,0.888888889,0,2,689.211,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4790,LNP_0004790,LM_2019,LM_2019_F910,A11Iso42DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC)N(CC)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso4,[C-]#[N+]CC(=O)OC,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.520973166,https://www.nature.com/articles/s41587-019-0247-3,49,0,0,37,690.6274591,78.87,2,5,11.4036,210.9935,0.860465116,0,2,691.139,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4791,LNP_0004791,LM_2019,LM_2019_F911,A11Iso72DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)[N+](CC)(CCO)[H],A11,CCNCCO,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.549768405,https://www.nature.com/articles/s41587-019-0247-3,53,0,0,37,746.6900594,78.87,2,5,12.9608,229.4175,0.872340426,1,2,747.247,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4792,LNP_0004792,LM_2019,LM_2019_F912,A11Iso82DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCC(=O)OCC)N(CC)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCCC(=O)OCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso8,CCOC(=O)CC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.489602897,https://www.nature.com/articles/s41587-019-0247-3,51,0,0,39,718.6587592,78.87,2,5,12.1838,220.2275,0.866666667,0,2,719.193,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4793,LNP_0004793,LM_2019,LM_2019_F913,A11Iso102DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC1CCCCC1)N(CC)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NC1CCCCC1)[N+](CC)(CCO)[H],A11,CCNCCO,Iso10,[C-]#[N+]C1CCCCC1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.978669534,https://www.nature.com/articles/s41587-019-0247-3,50,1,0,36,700.6845801,52.57,2,3,13.5633,220.9835,0.891304348,0,2,701.222,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4794,LNP_0004794,LM_2019,LM_2019_F914,A11Iso1C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)(C)C)N(CC)CCO,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)(C)C)[N+](CC)(CCO)[H],A11,CCNCCO,Iso1,CC(C)(C)[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.309214359,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,23,482.4811292,52.57,2,3,8.0157,149.4135,0.966666667,0,2,482.838,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4795,LNP_0004795,LM_2019,LM_2019_F915,A11Iso2C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCC)N(CC)CCO,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso2,CCCC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.934638234,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,26,482.4811292,52.57,2,3,8.0173,149.4355,0.966666667,0,2,482.838,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4796,LNP_0004796,LM_2019,LM_2019_F916,A11Iso3C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCCC)N(CC)CCO,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCCCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso3,CCCCC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.695695225,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,27,496.4967793,52.57,2,3,8.4074,154.0525,0.967741935,0,2,496.865,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4797,LNP_0004797,LM_2019,LM_2019_F917,A11Iso4C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC)N(CC)CCO,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso4,[C-]#[N+]CC(=O)OC,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.752655736,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,25,498.4396583,78.87,2,5,6.3902,146.5435,0.931034483,0,2,498.793,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4798,LNP_0004798,LM_2019,LM_2019_F918,A11Iso5C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CCO,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso5,CCOC(=O)C[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.188137489,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,26,512.4553084,78.87,2,5,6.7803,151.1605,0.933333333,0,2,512.82,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4799,LNP_0004799,LM_2019,LM_2019_F919,A11Iso6C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CCO,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)[N+](CC)(CCO)[H],A11,CCNCCO,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.160338675,https://www.nature.com/articles/s41587-019-0247-3,38,0,0,25,540.4866085,78.87,2,5,7.5589,160.3725,0.9375,0,2,540.874,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4800,LNP_0004800,LM_2019,LM_2019_F920,A11Iso7C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CCO,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)[N+](CC)(CCO)[H],A11,CCNCCO,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.709306252,https://www.nature.com/articles/s41587-019-0247-3,39,0,0,25,554.5022586,78.87,2,5,7.9474,164.9675,0.939393939,1,2,554.901,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4801,LNP_0004801,LM_2019,LM_2019_F921,A11Iso8C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCC(=O)OCC)N(CC)CCO,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCCC(=O)OCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso8,CCOC(=O)CC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.814951473,https://www.nature.com/articles/s41587-019-0247-3,37,0,0,27,526.4709585,78.87,2,5,7.1704,155.7775,0.935483871,0,2,526.847,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4802,LNP_0004802,LM_2019,LM_2019_F922,A11Iso9C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CCO,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)[N+](CC)(CCO)[H],A11,CCNCCO,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.576737432,https://www.nature.com/articles/s41587-019-0247-3,41,1,1,26,594.4430295,86.71,2,5,7.95702,172.8923,0.794117647,0,2,594.947,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4803,LNP_0004803,LM_2019,LM_2019_F923,A11Iso10C11,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC1CCCCC1)N(CC)CCO,CCCCCCCCCCC(CCCCCCCCCC)(C(=O)NC1CCCCC1)[N+](CC)(CCO)[H],A11,CCNCCO,Iso10,[C-]#[N+]C1CCCCC1,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.713626497,https://www.nature.com/articles/s41587-019-0247-3,36,1,0,24,508.4967793,52.57,2,3,8.5499,156.5335,0.96875,0,2,508.876,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4804,LNP_0004804,LM_2019,LM_2019_F924,A11Iso1C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)(C)C)N(CC)CCO,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)(C)C)[N+](CC)(CCO)[H],A11,CCNCCO,Iso1,CC(C)(C)[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.295520148,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,21,454.4498291,52.57,2,3,7.2355,140.1795,0.964285714,0,2,454.784,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4805,LNP_0004805,LM_2019,LM_2019_F925,A11Iso2C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCC)N(CC)CCO,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso2,CCCC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.224882956,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,24,454.4498291,52.57,2,3,7.2371,140.2015,0.964285714,0,2,454.784,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4806,LNP_0004806,LM_2019,LM_2019_F926,A11Iso3C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCCC)N(CC)CCO,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCCCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso3,CCCCC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.82324933,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,25,468.4654792,52.57,2,3,7.6272,144.8185,0.965517241,0,2,468.811,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4807,LNP_0004807,LM_2019,LM_2019_F927,A11Iso4C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC)N(CC)CCO,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso4,[C-]#[N+]CC(=O)OC,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.604378307,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,23,470.4083582,78.87,2,5,5.61,137.3095,0.925925926,0,2,470.739,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4808,LNP_0004808,LM_2019,LM_2019_F928,A11Iso5C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CCO,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso5,CCOC(=O)C[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.638401476,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,24,484.4240083,78.87,2,5,6.0001,141.9265,0.928571429,0,2,484.766,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4809,LNP_0004809,LM_2019,LM_2019_F929,A11Iso6C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CCO,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)[N+](CC)(CCO)[H],A11,CCNCCO,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.239618553,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,23,512.4553084,78.87,2,5,6.7787,151.1385,0.933333333,0,2,512.82,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4810,LNP_0004810,LM_2019,LM_2019_F930,A11Iso7C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CCO,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)[N+](CC)(CCO)[H],A11,CCNCCO,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.612402558,https://www.nature.com/articles/s41587-019-0247-3,37,0,0,23,526.4709585,78.87,2,5,7.1672,155.7335,0.935483871,1,2,526.847,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4811,LNP_0004811,LM_2019,LM_2019_F931,A11Iso8C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCC(=O)OCC)N(CC)CCO,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCCC(=O)OCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso8,CCOC(=O)CC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.691280913,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,25,498.4396583,78.87,2,5,6.3902,146.5435,0.931034483,0,2,498.793,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4812,LNP_0004812,LM_2019,LM_2019_F932,A11Iso9C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CCO,CCCCCCCCCC(CCCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)[N+](CC)(CCO)[H],A11,CCNCCO,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.873733084,https://www.nature.com/articles/s41587-019-0247-3,39,1,1,24,566.4117293,86.71,2,5,7.17682,163.6583,0.78125,0,2,566.893,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4813,LNP_0004813,LM_2019,LM_2019_F933,A11Iso10C10,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC1CCCCC1)N(CC)CCO,CCCCCCCCCC(CCCCCCCCC)(C(=O)NC1CCCCC1)[N+](CC)(CCO)[H],A11,CCNCCO,Iso10,[C-]#[N+]C1CCCCC1,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.06659807,https://www.nature.com/articles/s41587-019-0247-3,34,1,0,22,480.4654792,52.57,2,3,7.7697,147.2995,0.966666667,0,2,480.822,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4814,LNP_0004814,LM_2019,LM_2019_F934,A11Iso1C9,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)(C)C)N(CC)CCO,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)(C)C)[N+](CC)(CCO)[H],A11,CCNCCO,Iso1,CC(C)(C)[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.045743915,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,19,426.418529,52.57,2,3,6.4553,130.9455,0.961538462,0,2,426.73,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4815,LNP_0004815,LM_2019,LM_2019_F935,A11Iso2C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCC)N(CC)CCO,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso2,CCCC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.688817421,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,22,426.418529,52.57,2,3,6.4569,130.9675,0.961538462,0,2,426.73,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4816,LNP_0004816,LM_2019,LM_2019_F936,A11Iso3C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCCC)N(CC)CCO,CCCCCCCCC(CCCCCCCC)(C(=O)NCCCCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso3,CCCCC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.01903642,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,23,440.434179,52.57,2,3,6.847,135.5845,0.962962963,0,2,440.757,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4817,LNP_0004817,LM_2019,LM_2019_F937,A11Iso4C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC)N(CC)CCO,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso4,[C-]#[N+]CC(=O)OC,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.269516689,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,21,442.3770581,78.87,2,5,4.8298,128.0755,0.92,0,2,442.685,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4818,LNP_0004818,LM_2019,LM_2019_F938,A11Iso5C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CCO,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso5,CCOC(=O)C[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.166500611,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,22,456.3927081,78.87,2,5,5.2199,132.6925,0.923076923,0,2,456.712,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4819,LNP_0004819,LM_2019,LM_2019_F939,A11Iso6C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CCO,CCCCCCCCC(CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)[N+](CC)(CCO)[H],A11,CCNCCO,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.561531841,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,21,484.4240083,78.87,2,5,5.9985,141.9045,0.928571429,0,2,484.766,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4820,LNP_0004820,LM_2019,LM_2019_F940,A11Iso7C9,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CCO,CCCCCCCCC(CCCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)[N+](CC)(CCO)[H],A11,CCNCCO,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.125353308,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,21,498.4396583,78.87,2,5,6.387,146.4995,0.931034483,1,2,498.793,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4821,LNP_0004821,LM_2019,LM_2019_F941,A11Iso8C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCCC(=O)OCC)N(CC)CCO,CCCCCCCCC(CCCCCCCC)(C(=O)NCCC(=O)OCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso8,CCOC(=O)CC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.175690114,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,23,470.4083582,78.87,2,5,5.61,137.3095,0.925925926,0,2,470.739,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4822,LNP_0004822,LM_2019,LM_2019_F942,A11Iso9C9,CCCCCCCCC(CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CCO,CCCCCCCCC(CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)[N+](CC)(CCO)[H],A11,CCNCCO,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.839496926,https://www.nature.com/articles/s41587-019-0247-3,37,1,1,22,538.3804292,86.71,2,5,6.39662,154.4243,0.766666667,0,2,538.839,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4823,LNP_0004823,LM_2019,LM_2019_F943,A11Iso10C9,CCCCCCCCC(CCCCCCCC)(C(=O)NC1CCCCC1)N(CC)CCO,CCCCCCCCC(CCCCCCCC)(C(=O)NC1CCCCC1)[N+](CC)(CCO)[H],A11,CCNCCO,Iso10,[C-]#[N+]C1CCCCC1,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.774812395,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,20,452.434179,52.57,2,3,6.9895,138.0655,0.964285714,0,2,452.768,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4824,LNP_0004824,LM_2019,LM_2019_F944,A11Iso1C8,CCCCCCCC(CCCCCCC)(C(=O)NC(C)(C)C)N(CC)CCO,CCCCCCCC(CCCCCCC)(C(=O)NC(C)(C)C)[N+](CC)(CCO)[H],A11,CCNCCO,Iso1,CC(C)(C)[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.110277164,https://www.nature.com/articles/s41587-019-0247-3,28,0,0,17,398.3872288,52.57,2,3,5.6751,121.7115,0.958333333,0,2,398.676,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4825,LNP_0004825,LM_2019,LM_2019_F945,A11Iso2C8,CCCCCCCC(CCCCCCC)(C(=O)NCCCC)N(CC)CCO,CCCCCCCC(CCCCCCC)(C(=O)NCCCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso2,CCCC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.055797123,https://www.nature.com/articles/s41587-019-0247-3,28,0,0,20,398.3872288,52.57,2,3,5.6767,121.7335,0.958333333,0,2,398.676,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4826,LNP_0004826,LM_2019,LM_2019_F946,A11Iso3C8,CCCCCCCC(CCCCCCC)(C(=O)NCCCCC)N(CC)CCO,CCCCCCCC(CCCCCCC)(C(=O)NCCCCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso3,CCCCC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.774516538,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,21,412.4028789,52.57,2,3,6.0668,126.3505,0.96,0,2,412.703,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4827,LNP_0004827,LM_2019,LM_2019_F947,A11Iso4C8,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC)N(CC)CCO,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso4,[C-]#[N+]CC(=O)OC,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.16848193,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,19,414.345758,78.87,2,5,4.0496,118.8415,0.913043478,0,2,414.631,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4828,LNP_0004828,LM_2019,LM_2019_F948,A11Iso5C8,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CCO,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso5,CCOC(=O)C[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.319489716,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,20,428.361408,78.87,2,5,4.4397,123.4585,0.916666667,0,2,428.658,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4829,LNP_0004829,LM_2019,LM_2019_F949,A11Iso6C8,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CCO,CCCCCCCC(CCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)[N+](CC)(CCO)[H],A11,CCNCCO,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.098714888,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,19,456.3927081,78.87,2,5,5.2183,132.6705,0.923076923,0,2,456.712,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4830,LNP_0004830,LM_2019,LM_2019_F950,A11Iso7C8,CCCCCCCC(CCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CCO,CCCCCCCC(CCCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)[N+](CC)(CCO)[H],A11,CCNCCO,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.834314666,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,19,470.4083582,78.87,2,5,5.6068,137.2655,0.925925926,1,2,470.739,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4831,LNP_0004831,LM_2019,LM_2019_F951,A11Iso8C8,CCCCCCCC(CCCCCCC)(C(=O)NCCC(=O)OCC)N(CC)CCO,CCCCCCCC(CCCCCCC)(C(=O)NCCC(=O)OCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso8,CCOC(=O)CC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.474237393,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,21,442.3770581,78.87,2,5,4.8298,128.0755,0.92,0,2,442.685,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4832,LNP_0004832,LM_2019,LM_2019_F952,A11Iso9C8,CCCCCCCC(CCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CCO,CCCCCCCC(CCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)[N+](CC)(CCO)[H],A11,CCNCCO,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.190575398,https://www.nature.com/articles/s41587-019-0247-3,35,1,1,20,510.3491291,86.71,2,5,5.61642,145.1903,0.75,0,2,510.785,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4833,LNP_0004833,LM_2019,LM_2019_F953,A11Iso10C8,CCCCCCCC(CCCCCCC)(C(=O)NC1CCCCC1)N(CC)CCO,CCCCCCCC(CCCCCCC)(C(=O)NC1CCCCC1)[N+](CC)(CCO)[H],A11,CCNCCO,Iso10,[C-]#[N+]C1CCCCC1,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.430059577,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,18,424.4028789,52.57,2,3,6.2093,128.8315,0.961538462,0,2,424.714,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4834,LNP_0004834,LM_2019,LM_2019_F954,A11Iso1C7,CCCCCCC(CCCCCC)(C(=O)NC(C)(C)C)N(CC)CCO,CCCCCCC(CCCCCC)(C(=O)NC(C)(C)C)[N+](CC)(CCO)[H],A11,CCNCCO,Iso1,CC(C)(C)[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.145752165,https://www.nature.com/articles/s41587-019-0247-3,26,0,0,15,370.3559287,52.57,2,3,4.8949,112.4775,0.954545455,0,2,370.622,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4835,LNP_0004835,LM_2019,LM_2019_F955,A11Iso2C7,CCCCCCC(CCCCCC)(C(=O)NCCCC)N(CC)CCO,CCCCCCC(CCCCCC)(C(=O)NCCCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso2,CCCC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.93434859,https://www.nature.com/articles/s41587-019-0247-3,26,0,0,18,370.3559287,52.57,2,3,4.8965,112.4995,0.954545455,0,2,370.622,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4836,LNP_0004836,LM_2019,LM_2019_F956,A11Iso3C7,CCCCCCC(CCCCCC)(C(=O)NCCCCC)N(CC)CCO,CCCCCCC(CCCCCC)(C(=O)NCCCCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso3,CCCCC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.189573884,https://www.nature.com/articles/s41587-019-0247-3,27,0,0,19,384.3715788,52.57,2,3,5.2866,117.1165,0.956521739,0,2,384.649,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4837,LNP_0004837,LM_2019,LM_2019_F957,A11Iso4C7,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC)N(CC)CCO,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso4,[C-]#[N+]CC(=O)OC,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.862160431,https://www.nature.com/articles/s41587-019-0247-3,27,0,0,17,386.3144578,78.87,2,5,3.2694,109.6075,0.904761905,0,2,386.577,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4838,LNP_0004838,LM_2019,LM_2019_F958,A11Iso5C7,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OCC)N(CC)CCO,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso5,CCOC(=O)C[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.931586375,https://www.nature.com/articles/s41587-019-0247-3,28,0,0,18,400.3301079,78.87,2,5,3.6595,114.2245,0.909090909,0,2,400.604,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4839,LNP_0004839,LM_2019,LM_2019_F959,A11Iso6C7,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CCO,CCCCCCC(CCCCCC)(C(=O)NCC(=O)OC(C)(C)C)[N+](CC)(CCO)[H],A11,CCNCCO,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.024296634,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,17,428.361408,78.87,2,5,4.4381,123.4365,0.916666667,0,2,428.658,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4840,LNP_0004840,LM_2019,LM_2019_F960,A11Iso7C7,CCCCCCC(CCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CCO,CCCCCCC(CCCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)[N+](CC)(CCO)[H],A11,CCNCCO,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.046547395,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,17,442.3770581,78.87,2,5,4.8266,128.0315,0.92,1,2,442.685,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4841,LNP_0004841,LM_2019,LM_2019_F961,A11Iso8C7,CCCCCCC(CCCCCC)(C(=O)NCCC(=O)OCC)N(CC)CCO,CCCCCCC(CCCCCC)(C(=O)NCCC(=O)OCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso8,CCOC(=O)CC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.264813281,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,19,414.345758,78.87,2,5,4.0496,118.8415,0.913043478,0,2,414.631,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4842,LNP_0004842,LM_2019,LM_2019_F962,A11Iso9C7,CCCCCCC(CCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CCO,CCCCCCC(CCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)[N+](CC)(CCO)[H],A11,CCNCCO,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.160338675,https://www.nature.com/articles/s41587-019-0247-3,33,1,1,18,482.317829,86.71,2,5,4.83622,135.9563,0.730769231,0,2,482.731,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4843,LNP_0004843,LM_2019,LM_2019_F963,A11Iso10C7,CCCCCCC(CCCCCC)(C(=O)NC1CCCCC1)N(CC)CCO,CCCCCCC(CCCCCC)(C(=O)NC1CCCCC1)[N+](CC)(CCO)[H],A11,CCNCCO,Iso10,[C-]#[N+]C1CCCCC1,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.435712265,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,16,396.3715788,52.57,2,3,5.4291,119.5975,0.958333333,0,2,396.66,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4844,LNP_0004844,LM_2019,LM_2019_F964,A11Iso1CC7,CCN(CCO)C1(C(=O)NC(C)(C)C)CCCCCCCCCCCCCC1,CC[N+](CCO)(C1(C(=O)NC(C)(C)C)CCCCCCCCCCCCCC1)[H],A11,CCNCCO,Iso1,CC(C)(C)[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.331215738,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,5,396.3715788,52.57,2,3,5.4291,119.5975,0.958333333,0,2,396.66,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4845,LNP_0004845,LM_2019,LM_2019_F965,A11Iso2CC7,CCCCNC(=O)C1(N(CC)CCO)CCCCCCCCCCCCCC1,CCCCNC(=O)C1([N+](CC)(CCO)[H])CCCCCCCCCCCCCC1,A11,CCNCCO,Iso2,CCCC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.195902379,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,8,396.3715788,52.57,2,3,5.4307,119.6195,0.958333333,0,2,396.66,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4846,LNP_0004846,LM_2019,LM_2019_F966,A11Iso3CC7,CCCCCNC(=O)C1(N(CC)CCO)CCCCCCCCCCCCCC1,CCCCCNC(=O)C1([N+](CC)(CCO)[H])CCCCCCCCCCCCCC1,A11,CCNCCO,Iso3,CCCCC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.521357533,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,9,410.3872288,52.57,2,3,5.8208,124.2365,0.96,0,2,410.687,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4847,LNP_0004847,LM_2019,LM_2019_F967,A11Iso4CC7,CCN(CCO)C1(C(=O)NCC(=O)OC)CCCCCCCCCCCCCC1,CC[N+](CCO)(C1(C(=O)NCC(=O)OC)CCCCCCCCCCCCCC1)[H],A11,CCNCCO,Iso4,[C-]#[N+]CC(=O)OC,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.339012666,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,7,412.3301079,78.87,2,5,3.8036,116.7275,0.913043478,0,2,412.615,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4848,LNP_0004848,LM_2019,LM_2019_F968,A11Iso5CC7,CCOC(=O)CNC(=O)C1(N(CC)CCO)CCCCCCCCCCCCCC1,CCOC(=O)CNC(=O)C1([N+](CC)(CCO)[H])CCCCCCCCCCCCCC1,A11,CCNCCO,Iso5,CCOC(=O)C[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.704433762,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,8,426.345758,78.87,2,5,4.1937,121.3445,0.916666667,0,2,426.642,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4849,LNP_0004849,LM_2019,LM_2019_F969,A11Iso6CC7,CCN(CCO)C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCCCCC1,CC[N+](CCO)(C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCCCCC1)[H],A11,CCNCCO,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.11978923,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,7,454.3770581,78.87,2,5,4.9723,130.5565,0.923076923,0,2,454.696,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4850,LNP_0004850,LM_2019,LM_2019_F970,A11Iso7CC7,CCN(CCO)C1(C(=O)NC(C)C(=O)OC(C)(C)C)CCCCCCCCCCCCCC1,CC[N+](CCO)(C1(C(=O)NC(C)C(=O)OC(C)(C)C)CCCCCCCCCCCCCC1)[H],A11,CCNCCO,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.385594344,https://www.nature.com/articles/s41587-019-0247-3,33,1,0,7,468.3927081,78.87,2,5,5.3608,135.1515,0.925925926,1,2,468.723,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4851,LNP_0004851,LM_2019,LM_2019_F971,A11Iso8CC7,CCOC(=O)CCNC(=O)C1(N(CC)CCO)CCCCCCCCCCCCCC1,CCOC(=O)CCNC(=O)C1([N+](CC)(CCO)[H])CCCCCCCCCCCCCC1,A11,CCNCCO,Iso8,CCOC(=O)CC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.658224568,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,9,440.361408,78.87,2,5,4.5838,125.9615,0.92,0,2,440.669,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4852,LNP_0004852,LM_2019,LM_2019_F972,A11Iso9CC7,CCN(CCO)C1(C(=O)NCS(=O)(=O)c2ccc(C)cc2)CCCCCCCCCCCCCC1,CC[N+](CCO)(C1(C(=O)NCS(=O)(=O)c2ccc(C)cc2)CCCCCCCCCCCCCC1)[H],A11,CCNCCO,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.359322258,https://www.nature.com/articles/s41587-019-0247-3,35,2,1,8,508.333479,86.71,2,5,5.37042,143.0763,0.75,0,2,508.769,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4853,LNP_0004853,LM_2019,LM_2019_F973,A11Iso10CC7,CCN(CCO)C1(C(=O)NC2CCCCC2)CCCCCCCCCCCCCC1,CC[N+](CCO)(C1(C(=O)NC2CCCCC2)CCCCCCCCCCCCCC1)[H],A11,CCNCCO,Iso10,[C-]#[N+]C1CCCCC1,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.298857164,https://www.nature.com/articles/s41587-019-0247-3,30,2,0,6,422.3872288,52.57,2,3,5.9633,126.7175,0.961538462,0,2,422.698,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4854,LNP_0004854,LM_2019,LM_2019_F974,A11Iso1CC6,CCN(CCO)C1(C(=O)NC(C)(C)C)CCCCCCCCCCC1,CC[N+](CCO)(C1(C(=O)NC(C)(C)C)CCCCCCCCCCC1)[H],A11,CCNCCO,Iso1,CC(C)(C)[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.89644285,https://www.nature.com/articles/s41587-019-0247-3,25,1,0,5,354.3246286,52.57,2,3,4.2588,105.7465,0.952380952,0,2,354.579,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4855,LNP_0004855,LM_2019,LM_2019_F975,A11Iso2CC6,CCCCNC(=O)C1(N(CC)CCO)CCCCCCCCCCC1,CCCCNC(=O)C1([N+](CC)(CCO)[H])CCCCCCCCCCC1,A11,CCNCCO,Iso2,CCCC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.36935948,https://www.nature.com/articles/s41587-019-0247-3,25,1,0,8,354.3246286,52.57,2,3,4.2604,105.7685,0.952380952,0,2,354.579,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4856,LNP_0004856,LM_2019,LM_2019_F976,A11Iso3CC6,CCCCCNC(=O)C1(N(CC)CCO)CCCCCCCCCCC1,CCCCCNC(=O)C1([N+](CC)(CCO)[H])CCCCCCCCCCC1,A11,CCNCCO,Iso3,CCCCC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.457423034,https://www.nature.com/articles/s41587-019-0247-3,26,1,0,9,368.3402786,52.57,2,3,4.6505,110.3855,0.954545455,0,2,368.606,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4857,LNP_0004857,LM_2019,LM_2019_F977,A11Iso4CC6,CCN(CCO)C1(C(=O)NCC(=O)OC)CCCCCCCCCCC1,CC[N+](CCO)(C1(C(=O)NCC(=O)OC)CCCCCCCCCCC1)[H],A11,CCNCCO,Iso4,[C-]#[N+]CC(=O)OC,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.312232758,https://www.nature.com/articles/s41587-019-0247-3,26,1,0,7,370.2831577,78.87,2,5,2.6333,102.8765,0.9,0,2,370.534,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4858,LNP_0004858,LM_2019,LM_2019_F978,A11Iso5CC6,CCOC(=O)CNC(=O)C1(N(CC)CCO)CCCCCCCCCCC1,CCOC(=O)CNC(=O)C1([N+](CC)(CCO)[H])CCCCCCCCCCC1,A11,CCNCCO,Iso5,CCOC(=O)C[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.255144271,https://www.nature.com/articles/s41587-019-0247-3,27,1,0,8,384.2988078,78.87,2,5,3.0234,107.4935,0.904761905,0,2,384.561,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4859,LNP_0004859,LM_2019,LM_2019_F979,A11Iso6CC6,CCN(CCO)C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCC1,CC[N+](CCO)(C1(C(=O)NCC(=O)OC(C)(C)C)CCCCCCCCCCC1)[H],A11,CCNCCO,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.016609905,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,7,412.3301079,78.87,2,5,3.802,116.7055,0.913043478,0,2,412.615,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4860,LNP_0004860,LM_2019,LM_2019_F980,A11Iso7CC6,CCN(CCO)C1(C(=O)NC(C)C(=O)OC(C)(C)C)CCCCCCCCCCC1,CC[N+](CCO)(C1(C(=O)NC(C)C(=O)OC(C)(C)C)CCCCCCCCCCC1)[H],A11,CCNCCO,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.011516972,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,7,426.345758,78.87,2,5,4.1905,121.3005,0.916666667,1,2,426.642,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4861,LNP_0004861,LM_2019,LM_2019_F981,A11Iso8CC6,CCOC(=O)CCNC(=O)C1(N(CC)CCO)CCCCCCCCCCC1,CCOC(=O)CCNC(=O)C1([N+](CC)(CCO)[H])CCCCCCCCCCC1,A11,CCNCCO,Iso8,CCOC(=O)CC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.80178191,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,9,398.3144578,78.87,2,5,3.4135,112.1105,0.909090909,0,2,398.588,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4862,LNP_0004862,LM_2019,LM_2019_F982,A11Iso9CC6,CCN(CCO)C1(C(=O)NCS(=O)(=O)c2ccc(C)cc2)CCCCCCCCCCC1,CC[N+](CCO)(C1(C(=O)NCS(=O)(=O)c2ccc(C)cc2)CCCCCCCCCCC1)[H],A11,CCNCCO,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.92740589,https://www.nature.com/articles/s41587-019-0247-3,32,2,1,8,466.2865288,86.71,2,5,4.20012,129.2253,0.72,0,2,466.688,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4863,LNP_0004863,LM_2019,LM_2019_F983,A11Iso10CC6,CCN(CCO)C1(C(=O)NC2CCCCC2)CCCCCCCCCCC1,CC[N+](CCO)(C1(C(=O)NC2CCCCC2)CCCCCCCCCCC1)[H],A11,CCNCCO,Iso10,[C-]#[N+]C1CCCCC1,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.153500153,https://www.nature.com/articles/s41587-019-0247-3,27,2,0,6,380.3402786,52.57,2,3,4.793,112.8665,0.956521739,0,2,380.617,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4864,LNP_0004864,LM_2019,LM_2019_F984,A11Iso1C6,CCCCCC(CCCCC)(C(=O)NC(C)(C)C)N(CC)CCO,CCCCCC(CCCCC)(C(=O)NC(C)(C)C)[N+](CC)(CCO)[H],A11,CCNCCO,Iso1,CC(C)(C)[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.345204606,https://www.nature.com/articles/s41587-019-0247-3,24,0,0,13,342.3246286,52.57,2,3,4.1147,103.2435,0.95,0,2,342.568,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4865,LNP_0004865,LM_2019,LM_2019_F985,A11Iso2C6,CCCCCC(CCCCC)(C(=O)NCCCC)N(CC)CCO,CCCCCC(CCCCC)(C(=O)NCCCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso2,CCCC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.278944674,https://www.nature.com/articles/s41587-019-0247-3,24,0,0,16,342.3246286,52.57,2,3,4.1163,103.2655,0.95,0,2,342.568,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4866,LNP_0004866,LM_2019,LM_2019_F986,A11Iso3C6,CCCCCNC(=O)C(CCCCC)(CCCCC)N(CC)CCO,CCCCCNC(=O)C(CCCCC)(CCCCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso3,CCCCC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.39716466,https://www.nature.com/articles/s41587-019-0247-3,25,0,0,17,356.3402786,52.57,2,3,4.5064,107.8825,0.952380952,0,2,356.595,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4867,LNP_0004867,LM_2019,LM_2019_F987,A11Iso4C6,CCCCCC(CCCCC)(C(=O)NCC(=O)OC)N(CC)CCO,CCCCCC(CCCCC)(C(=O)NCC(=O)OC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso4,[C-]#[N+]CC(=O)OC,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.334482656,https://www.nature.com/articles/s41587-019-0247-3,25,0,0,15,358.2831577,78.87,2,5,2.4892,100.3735,0.894736842,0,2,358.523,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4868,LNP_0004868,LM_2019,LM_2019_F988,A11Iso5C6,CCCCCC(CCCCC)(C(=O)NCC(=O)OCC)N(CC)CCO,CCCCCC(CCCCC)(C(=O)NCC(=O)OCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso5,CCOC(=O)C[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.871999306,https://www.nature.com/articles/s41587-019-0247-3,26,0,0,16,372.2988078,78.87,2,5,2.8793,104.9905,0.9,0,2,372.55,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4869,LNP_0004869,LM_2019,LM_2019_F989,A11Iso6C6,CCCCCC(CCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CCO,CCCCCC(CCCCC)(C(=O)NCC(=O)OC(C)(C)C)[N+](CC)(CCO)[H],A11,CCNCCO,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.07567779,https://www.nature.com/articles/s41587-019-0247-3,28,0,0,15,400.3301079,78.87,2,5,3.6579,114.2025,0.909090909,0,2,400.604,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4870,LNP_0004870,LM_2019,LM_2019_F990,A11Iso7C6,CCCCCC(CCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)N(CC)CCO,CCCCCC(CCCCC)(C(=O)NC(C)C(=O)OC(C)(C)C)[N+](CC)(CCO)[H],A11,CCNCCO,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.261451655,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,15,414.345758,78.87,2,5,4.0464,118.7975,0.913043478,1,2,414.631,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4871,LNP_0004871,LM_2019,LM_2019_F991,A11Iso8C6,CCCCCC(CCCCC)(C(=O)NCCC(=O)OCC)N(CC)CCO,CCCCCC(CCCCC)(C(=O)NCCC(=O)OCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso8,CCOC(=O)CC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.521357533,https://www.nature.com/articles/s41587-019-0247-3,27,0,0,17,386.3144578,78.87,2,5,3.2694,109.6075,0.904761905,0,2,386.577,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4872,LNP_0004872,LM_2019,LM_2019_F992,A11Iso9C6,CCCCCC(CCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CCO,CCCCCC(CCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)[N+](CC)(CCO)[H],A11,CCNCCO,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.767364365,https://www.nature.com/articles/s41587-019-0247-3,31,1,1,16,454.2865288,86.71,2,5,4.05602,126.7223,0.708333333,0,2,454.677,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4873,LNP_0004873,LM_2019,LM_2019_F993,A11Iso10C6,CCCCCC(CCCCC)(C(=O)NC1CCCCC1)N(CC)CCO,CCCCCC(CCCCC)(C(=O)NC1CCCCC1)[N+](CC)(CCO)[H],A11,CCNCCO,Iso10,[C-]#[N+]C1CCCCC1,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.353633281,https://www.nature.com/articles/s41587-019-0247-3,26,1,0,14,368.3402786,52.57,2,3,4.6489,110.3635,0.954545455,0,2,368.606,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4874,LNP_0004874,LM_2019,LM_2019_F994,A12Iso12DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCCN(C)C)C(=O)NC(C)(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCC[N+](C)(C)[H])C(=O)NC(C)(C)C,A12,CN(C)CCCN,Iso1,CC(C)(C)[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,3.081675902,https://www.nature.com/articles/s41587-019-0247-3,49,0,0,36,687.7005645,44.37,2,3,13.2562,220.7044,0.888888889,0,3,688.227,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4875,LNP_0004875,LM_2019,LM_2019_F995,A12Iso22DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCCN(C)C)C(=O)NCCCC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCC[N+](C)(C)[H])C(=O)NCCCC,A12,CN(C)CCCN,Iso2,CCCC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.719197725,https://www.nature.com/articles/s41587-019-0247-3,49,0,0,39,687.7005645,44.37,2,3,13.2578,220.7264,0.888888889,0,3,688.227,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4876,LNP_0004876,LM_2019,LM_2019_F996,A12Iso32DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCCN(C)C)C(=O)NCCCCC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCC[N+](C)(C)[H])C(=O)NCCCCC,A12,CN(C)CCCN,Iso3,CCCCC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.915134376,https://www.nature.com/articles/s41587-019-0247-3,50,0,0,40,701.7162145,44.37,2,3,13.6479,225.3434,0.891304348,0,3,702.254,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4877,LNP_0004877,LM_2019,LM_2019_F997,A12Iso42DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OC)N1CCCN(C)C,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OC)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso4,[C-]#[N+]CC(=O)OC,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,3.714937716,https://www.nature.com/articles/s41587-019-0247-3,49,1,0,35,685.6485289,45.14,0,5,12.6374,215.808,0.863636364,1,3,686.167,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4878,LNP_0004878,LM_2019,LM_2019_F998,A12Iso72DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCCN(C)C,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.568376817,https://www.nature.com/articles/s41587-019-0247-3,53,1,0,35,741.7111292,45.14,0,5,14.1962,234.254,0.875,1,3,742.275,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4879,LNP_0004879,LM_2019,LM_2019_F999,A12Iso82DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(CC(=O)OCC)N1CCCN(C)C,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(CC(=O)OCC)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso8,CCOC(=O)CC[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.04641223,https://www.nature.com/articles/s41587-019-0247-3,51,1,0,37,713.679829,45.14,0,5,13.4176,225.042,0.869565217,1,3,714.221,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4880,LNP_0004880,LM_2019,LM_2019_F1000,A12Iso102DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCCN(C)C)C(=O)NC1CCCCC1,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCC[N+](C)(C)[H])C(=O)NC1CCCCC1,A12,CN(C)CCCN,Iso10,[C-]#[N+]C1CCCCC1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.59084431,https://www.nature.com/articles/s41587-019-0247-3,51,1,0,37,713.7162145,44.37,2,3,13.7904,227.8244,0.893617021,0,3,714.265,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4881,LNP_0004881,LM_2019,LM_2019_F1001,A12Iso1C11,CCCCCCCCCCC(CCCCCCCCCC)(NCCCN(C)C)C(=O)NC(C)(C)C,CCCCCCCCCCC(CCCCCCCCCC)(NCCC[N+](C)(C)[H])C(=O)NC(C)(C)C,A12,CN(C)CCCN,Iso1,CC(C)(C)[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.011462468,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,24,495.5127637,44.37,2,3,8.2428,156.2544,0.967741935,0,3,495.881,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4882,LNP_0004882,LM_2019,LM_2019_F1002,A12Iso2C11,CCCCCCCCCCC(CCCCCCCCCC)(NCCCN(C)C)C(=O)NCCCC,CCCCCCCCCCC(CCCCCCCCCC)(NCCC[N+](C)(C)[H])C(=O)NCCCC,A12,CN(C)CCCN,Iso2,CCCC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.001680553,https://www.nature.com/articles/s41587-019-0247-3,35,0,0,27,495.5127637,44.37,2,3,8.2444,156.2764,0.967741935,0,3,495.881,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4883,LNP_0004883,LM_2019,LM_2019_F1003,A12Iso3C11,CCCCCCCCCCC(CCCCCCCCCC)(NCCCN(C)C)C(=O)NCCCCC,CCCCCCCCCCC(CCCCCCCCCC)(NCCC[N+](C)(C)[H])C(=O)NCCCCC,A12,CN(C)CCCN,Iso3,CCCCC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.051541893,https://www.nature.com/articles/s41587-019-0247-3,36,0,0,28,509.5284138,44.37,2,3,8.6345,160.8934,0.96875,0,3,509.908,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4884,LNP_0004884,LM_2019,LM_2019_F1004,A12Iso4C11,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C(=O)OC)N1CCCN(C)C,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C(=O)OC)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso4,[C-]#[N+]CC(=O)OC,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.312852851,https://www.nature.com/articles/s41587-019-0247-3,35,1,0,23,493.4607281,45.14,0,5,7.624,151.358,0.933333333,1,3,493.821,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4885,LNP_0004885,LM_2019,LM_2019_F1005,A12Iso5C11,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C(=O)OCC)N1CCCN(C)C,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C(=O)OCC)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso5,CCOC(=O)C[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.253664288,https://www.nature.com/articles/s41587-019-0247-3,36,1,0,24,507.4763782,45.14,0,5,8.0141,155.975,0.935483871,1,3,507.848,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4886,LNP_0004886,LM_2019,LM_2019_F1006,A12Iso6C11,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCCN(C)C,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.252571605,https://www.nature.com/articles/s41587-019-0247-3,38,1,0,23,535.5076783,45.14,0,5,8.7927,165.187,0.939393939,1,3,535.902,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4887,LNP_0004887,LM_2019,LM_2019_F1007,A12Iso7C11,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCCN(C)C,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.070159054,https://www.nature.com/articles/s41587-019-0247-3,39,1,0,23,549.5233284,45.14,0,5,9.1828,169.804,0.941176471,1,3,549.929,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4888,LNP_0004888,LM_2019,LM_2019_F1008,A12Iso8C11,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(CC(=O)OCC)N1CCCN(C)C,CCCCCCCCCCC1(CCCCCCCCCC)C=NC(CC(=O)OCC)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso8,CCOC(=O)CC[N+]#[C-],C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.614484004,https://www.nature.com/articles/s41587-019-0247-3,37,1,0,25,521.4920283,45.14,0,5,8.4042,160.592,0.9375,1,3,521.875,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4889,LNP_0004889,LM_2019,LM_2019_F1009,A12Iso9C11,CCCCCCCCCCC(CCCCCCCCCC)(NCCCN(C)C)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCCCCCC(CCCCCCCCCC)(NCCC[N+](C)(C)[H])C(=O)NCS(=O)(=O)c1ccc(C)cc1,A12,CN(C)CCCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.320865971,https://www.nature.com/articles/s41587-019-0247-3,42,1,1,27,607.4746639,78.51,2,5,8.18412,179.7332,0.8,0,3,607.99,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4890,LNP_0004890,LM_2019,LM_2019_F1010,A12Iso10C11,CCCCCCCCCCC(CCCCCCCCCC)(NCCCN(C)C)C(=O)NC1CCCCC1,CCCCCCCCCCC(CCCCCCCCCC)(NCCC[N+](C)(C)[H])C(=O)NC1CCCCC1,A12,CN(C)CCCN,Iso10,[C-]#[N+]C1CCCCC1,C11,CCCCCCCCCCC(=O)CCCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.038626866,https://www.nature.com/articles/s41587-019-0247-3,37,1,0,25,521.5284138,44.37,2,3,8.777,163.3744,0.96969697,0,3,521.919,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4891,LNP_0004891,LM_2019,LM_2019_F1011,A12Iso1C10,CCCCCCCCCC(CCCCCCCCC)(NCCCN(C)C)C(=O)NC(C)(C)C,CCCCCCCCCC(CCCCCCCCC)(NCCC[N+](C)(C)[H])C(=O)NC(C)(C)C,A12,CN(C)CCCN,Iso1,CC(C)(C)[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.402563992,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,22,467.4814636,44.37,2,3,7.4626,147.0204,0.965517241,0,3,467.827,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4892,LNP_0004892,LM_2019,LM_2019_F1012,A12Iso2C10,CCCCCCCCCC(CCCCCCCCC)(NCCCN(C)C)C(=O)NCCCC,CCCCCCCCCC(CCCCCCCCC)(NCCC[N+](C)(C)[H])C(=O)NCCCC,A12,CN(C)CCCN,Iso2,CCCC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.529287806,https://www.nature.com/articles/s41587-019-0247-3,33,0,0,25,467.4814636,44.37,2,3,7.4642,147.0424,0.965517241,0,3,467.827,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4893,LNP_0004893,LM_2019,LM_2019_F1013,A12Iso3C10,CCCCCCCCCC(CCCCCCCCC)(NCCCN(C)C)C(=O)NCCCCC,CCCCCCCCCC(CCCCCCCCC)(NCCC[N+](C)(C)[H])C(=O)NCCCCC,A12,CN(C)CCCN,Iso3,CCCCC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.552243404,https://www.nature.com/articles/s41587-019-0247-3,34,0,0,26,481.4971136,44.37,2,3,7.8543,151.6594,0.966666667,0,3,481.854,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4894,LNP_0004894,LM_2019,LM_2019_F1014,A12Iso4C10,CCCCCCCCCC1(CCCCCCCCC)C=NC(C(=O)OC)N1CCCN(C)C,CCCCCCCCCC1(CCCCCCCCC)C=NC(C(=O)OC)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso4,[C-]#[N+]CC(=O)OC,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.688036469,https://www.nature.com/articles/s41587-019-0247-3,33,1,0,21,465.429428,45.14,0,5,6.8438,142.124,0.928571429,1,3,465.767,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4895,LNP_0004895,LM_2019,LM_2019_F1015,A12Iso5C10,CCCCCCCCCC1(CCCCCCCCC)C=NC(C(=O)OCC)N1CCCN(C)C,CCCCCCCCCC1(CCCCCCCCC)C=NC(C(=O)OCC)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso5,CCOC(=O)C[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.58131433,https://www.nature.com/articles/s41587-019-0247-3,34,1,0,22,479.4450781,45.14,0,5,7.2339,146.741,0.931034483,1,3,479.794,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4896,LNP_0004896,LM_2019,LM_2019_F1016,A12Iso6C10,CCCCCCCCCC1(CCCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCCN(C)C,CCCCCCCCCC1(CCCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.825621473,https://www.nature.com/articles/s41587-019-0247-3,36,1,0,21,507.4763782,45.14,0,5,8.0125,155.953,0.935483871,1,3,507.848,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4897,LNP_0004897,LM_2019,LM_2019_F1017,A12Iso7C10,CCCCCCCCCC1(CCCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCCN(C)C,CCCCCCCCCC1(CCCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.484313694,https://www.nature.com/articles/s41587-019-0247-3,37,1,0,21,521.4920283,45.14,0,5,8.4026,160.57,0.9375,1,3,521.875,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4898,LNP_0004898,LM_2019,LM_2019_F1018,A12Iso8C10,CCCCCCCCCC1(CCCCCCCCC)C=NC(CC(=O)OCC)N1CCCN(C)C,CCCCCCCCCC1(CCCCCCCCC)C=NC(CC(=O)OCC)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso8,CCOC(=O)CC[N+]#[C-],C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.118180704,https://www.nature.com/articles/s41587-019-0247-3,35,1,0,23,493.4607281,45.14,0,5,7.624,151.358,0.933333333,1,3,493.821,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4899,LNP_0004899,LM_2019,LM_2019_F1019,A12Iso9C10,CCCCCCCCCC(CCCCCCCCC)(NCCCN(C)C)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCCCCC(CCCCCCCCC)(NCCC[N+](C)(C)[H])C(=O)NCS(=O)(=O)c1ccc(C)cc1,A12,CN(C)CCCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.728534847,https://www.nature.com/articles/s41587-019-0247-3,40,1,1,25,579.4433638,78.51,2,5,7.40392,170.4992,0.787878788,0,3,579.936,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4900,LNP_0004900,LM_2019,LM_2019_F1020,A12Iso10C10,CCCCCCCCCC(CCCCCCCCC)(NCCCN(C)C)C(=O)NC1CCCCC1,CCCCCCCCCC(CCCCCCCCC)(NCCC[N+](C)(C)[H])C(=O)NC1CCCCC1,A12,CN(C)CCCN,Iso10,[C-]#[N+]C1CCCCC1,C10,CCCCCCCCCC(=O)CCCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.215486275,https://www.nature.com/articles/s41587-019-0247-3,35,1,0,23,493.4971136,44.37,2,3,7.9968,154.1404,0.967741935,0,3,493.865,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4901,LNP_0004901,LM_2019,LM_2019_F1021,A12Iso1C9,CCCCCCCCC(CCCCCCCC)(NCCCN(C)C)C(=O)NC(C)(C)C,CCCCCCCCC(CCCCCCCC)(NCCC[N+](C)(C)[H])C(=O)NC(C)(C)C,A12,CN(C)CCCN,Iso1,CC(C)(C)[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.280071502,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,20,439.4501634,44.37,2,3,6.6824,137.7864,0.962962963,0,3,439.773,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4902,LNP_0004902,LM_2019,LM_2019_F1022,A12Iso2C9,CCCCCCCCC(CCCCCCCC)(NCCCN(C)C)C(=O)NCCCC,CCCCCCCCC(CCCCCCCC)(NCCC[N+](C)(C)[H])C(=O)NCCCC,A12,CN(C)CCCN,Iso2,CCCC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.339594794,https://www.nature.com/articles/s41587-019-0247-3,31,0,0,23,439.4501634,44.37,2,3,6.684,137.8084,0.962962963,0,3,439.773,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4903,LNP_0004903,LM_2019,LM_2019_F1023,A12Iso3C9,CCCCCCCCC(CCCCCCCC)(NCCCN(C)C)C(=O)NCCCCC,CCCCCCCCC(CCCCCCCC)(NCCC[N+](C)(C)[H])C(=O)NCCCCC,A12,CN(C)CCCN,Iso3,CCCCC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.009040735,https://www.nature.com/articles/s41587-019-0247-3,32,0,0,24,453.4658135,44.37,2,3,7.0741,142.4254,0.964285714,0,3,453.8,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4904,LNP_0004904,LM_2019,LM_2019_F1024,A12Iso4C9,CCCCCCCCC1(CCCCCCCC)C=NC(C(=O)OC)N1CCCN(C)C,CCCCCCCCC1(CCCCCCCC)C=NC(C(=O)OC)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso4,[C-]#[N+]CC(=O)OC,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.55367417,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,19,437.3981279,45.14,0,5,6.0636,132.89,0.923076923,1,3,437.713,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4905,LNP_0004905,LM_2019,LM_2019_F1025,A12Iso5C9,CCCCCCCCC1(CCCCCCCC)C=NC(C(=O)OCC)N1CCCN(C)C,CCCCCCCCC1(CCCCCCCC)C=NC(C(=O)OCC)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso5,CCOC(=O)C[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.386889764,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,20,451.4137779,45.14,0,5,6.4537,137.507,0.925925926,1,3,451.74,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4906,LNP_0004906,LM_2019,LM_2019_F1026,A12Iso6C9,CCCCCCCCC1(CCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCCN(C)C,CCCCCCCCC1(CCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.55928092,https://www.nature.com/articles/s41587-019-0247-3,34,1,0,19,479.4450781,45.14,0,5,7.2323,146.719,0.931034483,1,3,479.794,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4907,LNP_0004907,LM_2019,LM_2019_F1027,A12Iso7C9,CCCCCCCCC1(CCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCCN(C)C,CCCCCCCCC1(CCCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.97262308,https://www.nature.com/articles/s41587-019-0247-3,35,1,0,19,493.4607281,45.14,0,5,7.6224,151.336,0.933333333,1,3,493.821,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4908,LNP_0004908,LM_2019,LM_2019_F1028,A12Iso8C9,CCCCCCCCC1(CCCCCCCC)C=NC(CC(=O)OCC)N1CCCN(C)C,CCCCCCCCC1(CCCCCCCC)C=NC(CC(=O)OCC)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso8,CCOC(=O)CC[N+]#[C-],C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.254393953,https://www.nature.com/articles/s41587-019-0247-3,33,1,0,21,465.429428,45.14,0,5,6.8438,142.124,0.928571429,1,3,465.767,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4909,LNP_0004909,LM_2019,LM_2019_F1029,A12Iso9C9,CCCCCCCCC(CCCCCCCC)(NCCCN(C)C)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCCCC(CCCCCCCC)(NCCC[N+](C)(C)[H])C(=O)NCS(=O)(=O)c1ccc(C)cc1,A12,CN(C)CCCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.463574773,https://www.nature.com/articles/s41587-019-0247-3,38,1,1,23,551.4120637,78.51,2,5,6.62372,161.2652,0.774193548,0,3,551.882,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4910,LNP_0004910,LM_2019,LM_2019_F1030,A12Iso10C9,CCCCCCCCC(CCCCCCCC)(NCCCN(C)C)C(=O)NC1CCCCC1,CCCCCCCCC(CCCCCCCC)(NCCC[N+](C)(C)[H])C(=O)NC1CCCCC1,A12,CN(C)CCCN,Iso10,[C-]#[N+]C1CCCCC1,C9,CCCCCCCCC(=O)CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.224720662,https://www.nature.com/articles/s41587-019-0247-3,33,1,0,21,465.4658135,44.37,2,3,7.2166,144.9064,0.965517241,0,3,465.811,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4911,LNP_0004911,LM_2019,LM_2019_F1031,A12Iso1C8,CCCCCCCC(CCCCCCC)(NCCCN(C)C)C(=O)NC(C)(C)C,CCCCCCCC(CCCCCCC)(NCCC[N+](C)(C)[H])C(=O)NC(C)(C)C,A12,CN(C)CCCN,Iso1,CC(C)(C)[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.617555968,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,18,411.4188633,44.37,2,3,5.9022,128.5524,0.96,0,3,411.719,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4912,LNP_0004912,LM_2019,LM_2019_F1032,A12Iso2C8,CCCCCCCC(CCCCCCC)(NCCCN(C)C)C(=O)NCCCC,CCCCCCCC(CCCCCCC)(NCCC[N+](C)(C)[H])C(=O)NCCCC,A12,CN(C)CCCN,Iso2,CCCC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.112287916,https://www.nature.com/articles/s41587-019-0247-3,29,0,0,21,411.4188633,44.37,2,3,5.9038,128.5744,0.96,0,3,411.719,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4913,LNP_0004913,LM_2019,LM_2019_F1033,A12Iso3C8,CCCCCCCC(CCCCCCC)(NCCCN(C)C)C(=O)NCCCCC,CCCCCCCC(CCCCCCC)(NCCC[N+](C)(C)[H])C(=O)NCCCCC,A12,CN(C)CCCN,Iso3,CCCCC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.088060526,https://www.nature.com/articles/s41587-019-0247-3,30,0,0,22,425.4345134,44.37,2,3,6.2939,133.1914,0.961538462,0,3,425.746,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4914,LNP_0004914,LM_2019,LM_2019_F1034,A12Iso4C8,CCCCCCCC1(CCCCCCC)C=NC(C(=O)OC)N1CCCN(C)C,CCCCCCCC1(CCCCCCC)C=NC(C(=O)OC)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso4,[C-]#[N+]CC(=O)OC,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.688785024,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,17,409.3668277,45.14,0,5,5.2834,123.656,0.916666667,1,3,409.659,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4915,LNP_0004915,LM_2019,LM_2019_F1035,A12Iso5C8,CCCCCCCC1(CCCCCCC)C=NC(C(=O)OCC)N1CCCN(C)C,CCCCCCCC1(CCCCCCC)C=NC(C(=O)OCC)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso5,CCOC(=O)C[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.184057535,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,18,423.3824778,45.14,0,5,5.6735,128.273,0.92,1,3,423.686,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4916,LNP_0004916,LM_2019,LM_2019_F1036,A12Iso6C8,CCCCCCCC1(CCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCCN(C)C,CCCCCCCC1(CCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.359322258,https://www.nature.com/articles/s41587-019-0247-3,32,1,0,17,451.4137779,45.14,0,5,6.4521,137.485,0.925925926,1,3,451.74,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4917,LNP_0004917,LM_2019,LM_2019_F1037,A12Iso7C8,CCCCCCCC1(CCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCCN(C)C,CCCCCCCC1(CCCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.070787682,https://www.nature.com/articles/s41587-019-0247-3,33,1,0,17,465.429428,45.14,0,5,6.8422,142.102,0.928571429,1,3,465.767,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4918,LNP_0004918,LM_2019,LM_2019_F1038,A12Iso8C8,CCCCCCCC1(CCCCCCC)C=NC(CC(=O)OCC)N1CCCN(C)C,CCCCCCCC1(CCCCCCC)C=NC(CC(=O)OCC)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso8,CCOC(=O)CC[N+]#[C-],C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.60579576,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,19,437.3981279,45.14,0,5,6.0636,132.89,0.923076923,1,3,437.713,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4919,LNP_0004919,LM_2019,LM_2019_F1039,A12Iso9C8,CCCCCCCC(CCCCCCC)(NCCCN(C)C)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCCC(CCCCCCC)(NCCC[N+](C)(C)[H])C(=O)NCS(=O)(=O)c1ccc(C)cc1,A12,CN(C)CCCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.296065311,https://www.nature.com/articles/s41587-019-0247-3,36,1,1,21,523.3807636,78.51,2,5,5.84352,152.0312,0.75862069,0,3,523.828,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4920,LNP_0004920,LM_2019,LM_2019_F1040,A12Iso10C8,CCCCCCCC(CCCCCCC)(NCCCN(C)C)C(=O)NC1CCCCC1,CCCCCCCC(CCCCCCC)(NCCC[N+](C)(C)[H])C(=O)NC1CCCCC1,A12,CN(C)CCCN,Iso10,[C-]#[N+]C1CCCCC1,C8,CCCCCCCC(=O)CCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.252318557,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,19,437.4345134,44.37,2,3,6.4364,135.6724,0.962962963,0,3,437.757,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4921,LNP_0004921,LM_2019,LM_2019_F1041,A12Iso1C7,CCCCCCC(CCCCCC)(NCCCN(C)C)C(=O)NC(C)(C)C,CCCCCCC(CCCCCC)(NCCC[N+](C)(C)[H])C(=O)NC(C)(C)C,A12,CN(C)CCCN,Iso1,CC(C)(C)[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.322925496,https://www.nature.com/articles/s41587-019-0247-3,27,0,0,16,383.3875632,44.37,2,3,5.122,119.3184,0.956521739,0,3,383.665,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4922,LNP_0004922,LM_2019,LM_2019_F1042,A12Iso2C7,CCCCCCC(CCCCCC)(NCCCN(C)C)C(=O)NCCCC,CCCCCCC(CCCCCC)(NCCC[N+](C)(C)[H])C(=O)NCCCC,A12,CN(C)CCCN,Iso2,CCCC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.623987047,https://www.nature.com/articles/s41587-019-0247-3,27,0,0,19,383.3875632,44.37,2,3,5.1236,119.3404,0.956521739,0,3,383.665,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4923,LNP_0004923,LM_2019,LM_2019_F1043,A12Iso3C7,CCCCCCC(CCCCCC)(NCCCN(C)C)C(=O)NCCCCC,CCCCCCC(CCCCCC)(NCCC[N+](C)(C)[H])C(=O)NCCCCC,A12,CN(C)CCCN,Iso3,CCCCC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.05256016,https://www.nature.com/articles/s41587-019-0247-3,28,0,0,20,397.4032133,44.37,2,3,5.5137,123.9574,0.958333333,0,3,397.692,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4924,LNP_0004924,LM_2019,LM_2019_F1044,A12Iso4C7,CCCCCCC1(CCCCCC)C=NC(C(=O)OC)N1CCCN(C)C,CCCCCCC1(CCCCCC)C=NC(C(=O)OC)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso4,[C-]#[N+]CC(=O)OC,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.178190487,https://www.nature.com/articles/s41587-019-0247-3,27,1,0,15,381.3355276,45.14,0,5,4.5032,114.422,0.909090909,1,3,381.605,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4925,LNP_0004925,LM_2019,LM_2019_F1045,A12Iso5C7,CCCCCCC1(CCCCCC)C=NC(C(=O)OCC)N1CCCN(C)C,CCCCCCC1(CCCCCC)C=NC(C(=O)OCC)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso5,CCOC(=O)C[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.273458907,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,16,395.3511777,45.14,0,5,4.8933,119.039,0.913043478,1,3,395.632,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4926,LNP_0004926,LM_2019,LM_2019_F1046,A12Iso6C7,CCCCCCC1(CCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCCN(C)C,CCCCCCC1(CCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.24893284,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,15,423.3824778,45.14,0,5,5.6719,128.251,0.92,1,3,423.686,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4927,LNP_0004927,LM_2019,LM_2019_F1047,A12Iso7C7,CCCCCCC1(CCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCCN(C)C,CCCCCCC1(CCCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.246232311,https://www.nature.com/articles/s41587-019-0247-3,31,1,0,15,437.3981279,45.14,0,5,6.062,132.868,0.923076923,1,3,437.713,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4928,LNP_0004928,LM_2019,LM_2019_F1048,A12Iso8C7,CCCCCCC1(CCCCCC)C=NC(CC(=O)OCC)N1CCCN(C)C,CCCCCCC1(CCCCCC)C=NC(CC(=O)OCC)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso8,CCOC(=O)CC[N+]#[C-],C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.562192689,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,17,409.3668277,45.14,0,5,5.2834,123.656,0.916666667,1,3,409.659,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4929,LNP_0004929,LM_2019,LM_2019_F1049,A12Iso9C7,CCCCCCC(CCCCCC)(NCCCN(C)C)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCC(CCCCCC)(NCCC[N+](C)(C)[H])C(=O)NCS(=O)(=O)c1ccc(C)cc1,A12,CN(C)CCCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.252571605,https://www.nature.com/articles/s41587-019-0247-3,34,1,1,19,495.3494634,78.51,2,5,5.06332,142.7972,0.740740741,0,3,495.774,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4930,LNP_0004930,LM_2019,LM_2019_F1050,A12Iso10C7,CCCCCCC(CCCCCC)(NCCCN(C)C)C(=O)NC1CCCCC1,CCCCCCC(CCCCCC)(NCCC[N+](C)(C)[H])C(=O)NC1CCCCC1,A12,CN(C)CCCN,Iso10,[C-]#[N+]C1CCCCC1,C7,CCCCCCC(=O)CCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.456262634,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,17,409.4032133,44.37,2,3,5.6562,126.4384,0.96,0,3,409.703,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4931,LNP_0004931,LM_2019,LM_2019_F1051,A12Iso1CC7,CN(C)CCCNC1(C(=O)NC(C)(C)C)CCCCCCCCCCCCCC1,C[N+](C)(CCCNC1(C(=O)NC(C)(C)C)CCCCCCCCCCCCCC1)[H],A12,CN(C)CCCN,Iso1,CC(C)(C)[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.094012078,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,6,409.4032133,44.37,2,3,5.6562,126.4384,0.96,0,3,409.703,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4932,LNP_0004932,LM_2019,LM_2019_F1052,A12Iso2CC7,CCCCNC(=O)C1(NCCCN(C)C)CCCCCCCCCCCCCC1,CCCCNC(=O)C1(NCCC[N+](C)(C)[H])CCCCCCCCCCCCCC1,A12,CN(C)CCCN,Iso2,CCCC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.278387796,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,9,409.4032133,44.37,2,3,5.6578,126.4604,0.96,0,3,409.703,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4933,LNP_0004933,LM_2019,LM_2019_F1053,A12Iso3CC7,CCCCCNC(=O)C1(NCCCN(C)C)CCCCCCCCCCCCCC1,CCCCCNC(=O)C1(NCCC[N+](C)(C)[H])CCCCCCCCCCCCCC1,A12,CN(C)CCCN,Iso3,CCCCC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.969541721,https://www.nature.com/articles/s41587-019-0247-3,30,1,0,10,423.4188633,44.37,2,3,6.0479,131.0774,0.961538462,0,3,423.73,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4934,LNP_0004934,LM_2019,LM_2019_F1054,A12Iso4CC7,COC(=O)C1N=CC2(CCCCCCCCCCCCCC2)N1CCCN(C)C,COC(=O)C1N=CC2(CCCCCCCCCCCCCC2)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso4,[C-]#[N+]CC(=O)OC,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.356697716,https://www.nature.com/articles/s41587-019-0247-3,29,2,0,5,407.3511777,45.14,0,5,5.0374,121.542,0.916666667,1,3,407.643,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4935,LNP_0004935,LM_2019,LM_2019_F1055,A12Iso5CC7,CCOC(=O)C1N=CC2(CCCCCCCCCCCCCC2)N1CCCN(C)C,CCOC(=O)C1N=CC2(CCCCCCCCCCCCCC2)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso5,CCOC(=O)C[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.213343401,https://www.nature.com/articles/s41587-019-0247-3,30,2,0,6,421.3668277,45.14,0,5,5.4275,126.159,0.92,1,3,421.67,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4936,LNP_0004936,LM_2019,LM_2019_F1056,A12Iso6CC7,CN(C)CCCN1C(C(=O)OC(C)(C)C)N=CC12CCCCCCCCCCCCCC2,C[N+](C)(CCCN1C(C(=O)OC(C)(C)C)N=CC12CCCCCCCCCCCCCC2)[H],A12,CN(C)CCCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.1991486,https://www.nature.com/articles/s41587-019-0247-3,32,2,0,5,449.3981279,45.14,0,5,6.2061,135.371,0.925925926,1,3,449.724,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4937,LNP_0004937,LM_2019,LM_2019_F1057,A12Iso7CC7,CN(C)CCCN1C2(C=NC1(C)C(=O)OC(C)(C)C)CCCCCCCCCCCCCC2,C[N+](C)(CCCN1C2(C=NC1(C)C(=O)OC(C)(C)C)CCCCCCCCCCCCCC2)[H],A12,CN(C)CCCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.359322258,https://www.nature.com/articles/s41587-019-0247-3,33,2,0,5,463.4137779,45.14,0,5,6.5962,139.988,0.928571429,1,3,463.751,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4938,LNP_0004938,LM_2019,LM_2019_F1058,A12Iso8CC7,CCOC(=O)CC1N=CC2(CCCCCCCCCCCCCC2)N1CCCN(C)C,CCOC(=O)CC1N=CC2(CCCCCCCCCCCCCC2)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso8,CCOC(=O)CC[N+]#[C-],CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.131148578,https://www.nature.com/articles/s41587-019-0247-3,31,2,0,7,435.3824778,45.14,0,5,5.8176,130.776,0.923076923,1,3,435.697,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4939,LNP_0004939,LM_2019,LM_2019_F1059,A12Iso9CC7,Cc1ccc(S(=O)(=O)CNC(=O)C2(NCCCN(C)C)CCCCCCCCCCCCCC2)cc1,Cc1ccc(S(=O)(=O)CNC(=O)C2(NCCC[N+](C)(C)[H])CCCCCCCCCCCCCC2)cc1,A12,CN(C)CCCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.638432812,https://www.nature.com/articles/s41587-019-0247-3,36,2,1,9,521.3651135,78.51,2,5,5.59752,149.9172,0.75862069,0,3,521.812,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4940,LNP_0004940,LM_2019,LM_2019_F1060,A12Iso10CC7,CN(C)CCCNC1(C(=O)NC2CCCCC2)CCCCCCCCCCCCCC1,C[N+](C)(CCCNC1(C(=O)NC2CCCCC2)CCCCCCCCCCCCCC1)[H],A12,CN(C)CCCN,Iso10,[C-]#[N+]C1CCCCC1,CC7,C1CCCCCCCC(=O)CCCCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.322860378,https://www.nature.com/articles/s41587-019-0247-3,31,2,0,7,435.4188633,44.37,2,3,6.1904,133.5584,0.962962963,0,3,435.741,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4941,LNP_0004941,LM_2019,LM_2019_F1061,A12Iso1CC6,CN(C)CCCNC1(C(=O)NC(C)(C)C)CCCCCCCCCCC1,C[N+](C)(CCCNC1(C(=O)NC(C)(C)C)CCCCCCCCCCC1)[H],A12,CN(C)CCCN,Iso1,CC(C)(C)[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.307935128,https://www.nature.com/articles/s41587-019-0247-3,26,1,0,6,367.3562631,44.37,2,3,4.4859,112.5874,0.954545455,0,3,367.622,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4942,LNP_0004942,LM_2019,LM_2019_F1062,A12Iso2CC6,CCCCNC(=O)C1(NCCCN(C)C)CCCCCCCCCCC1,CCCCNC(=O)C1(NCCC[N+](C)(C)[H])CCCCCCCCCCC1,A12,CN(C)CCCN,Iso2,CCCC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.017536137,https://www.nature.com/articles/s41587-019-0247-3,26,1,0,9,367.3562631,44.37,2,3,4.4875,112.6094,0.954545455,0,3,367.622,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4943,LNP_0004943,LM_2019,LM_2019_F1063,A12Iso3CC6,CCCCCNC(=O)C1(NCCCN(C)C)CCCCCCCCCCC1,CCCCCNC(=O)C1(NCCC[N+](C)(C)[H])CCCCCCCCCCC1,A12,CN(C)CCCN,Iso3,CCCCC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.085941398,https://www.nature.com/articles/s41587-019-0247-3,27,1,0,10,381.3719131,44.37,2,3,4.8776,117.2264,0.956521739,0,3,381.649,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4944,LNP_0004944,LM_2019,LM_2019_F1064,A12Iso4CC6,COC(=O)C1N=CC2(CCCCCCCCCCC2)N1CCCN(C)C,COC(=O)C1N=CC2(CCCCCCCCCCC2)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso4,[C-]#[N+]CC(=O)OC,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.112630704,https://www.nature.com/articles/s41587-019-0247-3,26,2,0,5,365.3042275,45.14,0,5,3.8671,107.691,0.904761905,1,3,365.562,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4945,LNP_0004945,LM_2019,LM_2019_F1065,A12Iso5CC6,CCOC(=O)C1N=CC2(CCCCCCCCCCC2)N1CCCN(C)C,CCOC(=O)C1N=CC2(CCCCCCCCCCC2)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso5,CCOC(=O)C[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.50753392,https://www.nature.com/articles/s41587-019-0247-3,27,2,0,6,379.3198776,45.14,0,5,4.2572,112.308,0.909090909,1,3,379.589,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4946,LNP_0004946,LM_2019,LM_2019_F1066,A12Iso6CC6,CN(C)CCCN1C(C(=O)OC(C)(C)C)N=CC12CCCCCCCCCCC2,C[N+](C)(CCCN1C(C(=O)OC(C)(C)C)N=CC12CCCCCCCCCCC2)[H],A12,CN(C)CCCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.376342004,https://www.nature.com/articles/s41587-019-0247-3,29,2,0,5,407.3511777,45.14,0,5,5.0358,121.52,0.916666667,1,3,407.643,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4947,LNP_0004947,LM_2019,LM_2019_F1067,A12Iso7CC6,CN(C)CCCN1C2(C=NC1(C)C(=O)OC(C)(C)C)CCCCCCCCCCC2,C[N+](C)(CCCN1C2(C=NC1(C)C(=O)OC(C)(C)C)CCCCCCCCCCC2)[H],A12,CN(C)CCCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.891305304,https://www.nature.com/articles/s41587-019-0247-3,30,2,0,5,421.3668277,45.14,0,5,5.4259,126.137,0.92,1,3,421.67,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4948,LNP_0004948,LM_2019,LM_2019_F1068,A12Iso8CC6,CCOC(=O)CC1N=CC2(CCCCCCCCCCC2)N1CCCN(C)C,CCOC(=O)CC1N=CC2(CCCCCCCCCCC2)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso8,CCOC(=O)CC[N+]#[C-],CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.843869275,https://www.nature.com/articles/s41587-019-0247-3,28,2,0,7,393.3355276,45.14,0,5,4.6473,116.925,0.913043478,1,3,393.616,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4949,LNP_0004949,LM_2019,LM_2019_F1069,A12Iso9CC6,Cc1ccc(S(=O)(=O)CNC(=O)C2(NCCCN(C)C)CCCCCCCCCCC2)cc1,Cc1ccc(S(=O)(=O)CNC(=O)C2(NCCC[N+](C)(C)[H])CCCCCCCCCCC2)cc1,A12,CN(C)CCCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.760310688,https://www.nature.com/articles/s41587-019-0247-3,33,2,1,9,479.3181633,78.51,2,5,4.42722,136.0662,0.730769231,0,3,479.731,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4950,LNP_0004950,LM_2019,LM_2019_F1070,A12Iso10CC6,CN(C)CCCNC1(C(=O)NC2CCCCC2)CCCCCCCCCCC1,C[N+](C)(CCCNC1(C(=O)NC2CCCCC2)CCCCCCCCCCC1)[H],A12,CN(C)CCCN,Iso10,[C-]#[N+]C1CCCCC1,CC6,C1CCCCCC(=O)CCCCC1,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.808318484,https://www.nature.com/articles/s41587-019-0247-3,28,2,0,7,393.3719131,44.37,2,3,5.0201,119.7074,0.958333333,0,3,393.66,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4951,LNP_0004951,LM_2019,LM_2019_F1071,A12Iso1C6,CCCCCC(CCCCC)(NCCCN(C)C)C(=O)NC(C)(C)C,CCCCCC(CCCCC)(NCCC[N+](C)(C)[H])C(=O)NC(C)(C)C,A12,CN(C)CCCN,Iso1,CC(C)(C)[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.654849373,https://www.nature.com/articles/s41587-019-0247-3,25,0,0,14,355.3562631,44.37,2,3,4.3418,110.0844,0.952380952,0,3,355.611,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4952,LNP_0004952,LM_2019,LM_2019_F1072,A12Iso2C6,CCCCCC(CCCCC)(NCCCN(C)C)C(=O)NCCCC,CCCCCC(CCCCC)(NCCC[N+](C)(C)[H])C(=O)NCCCC,A12,CN(C)CCCN,Iso2,CCCC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.334172398,https://www.nature.com/articles/s41587-019-0247-3,25,0,0,17,355.3562631,44.37,2,3,4.3434,110.1064,0.952380952,0,3,355.611,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4953,LNP_0004953,LM_2019,LM_2019_F1073,A12Iso3C6,CCCCCNC(=O)C(CCCCC)(CCCCC)NCCCN(C)C,CCCCCNC(=O)C(CCCCC)(CCCCC)NCCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso3,CCCCC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.871979493,https://www.nature.com/articles/s41587-019-0247-3,26,0,0,18,369.3719131,44.37,2,3,4.7335,114.7234,0.954545455,0,3,369.638,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4954,LNP_0004954,LM_2019,LM_2019_F1074,A12Iso4C6,CCCCCC1(CCCCC)C=NC(C(=O)OC)N1CCCN(C)C,CCCCCC1(CCCCC)C=NC(C(=O)OC)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso4,[C-]#[N+]CC(=O)OC,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.337741353,https://www.nature.com/articles/s41587-019-0247-3,25,1,0,13,353.3042275,45.14,0,5,3.723,105.188,0.9,1,3,353.551,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4955,LNP_0004955,LM_2019,LM_2019_F1075,A12Iso5C6,CCCCCC1(CCCCC)C=NC(C(=O)OCC)N1CCCN(C)C,CCCCCC1(CCCCC)C=NC(C(=O)OCC)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso5,CCOC(=O)C[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.379317739,https://www.nature.com/articles/s41587-019-0247-3,26,1,0,14,367.3198776,45.14,0,5,4.1131,109.805,0.904761905,1,3,367.578,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4956,LNP_0004956,LM_2019,LM_2019_F1076,A12Iso6C6,CCCCCC1(CCCCC)C=NC(C(=O)OC(C)(C)C)N1CCCN(C)C,CCCCCC1(CCCCC)C=NC(C(=O)OC(C)(C)C)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.582120483,https://www.nature.com/articles/s41587-019-0247-3,28,1,0,13,395.3511777,45.14,0,5,4.8917,119.017,0.913043478,1,3,395.632,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4957,LNP_0004957,LM_2019,LM_2019_F1077,A12Iso7C6,CCCCCC1(CCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCCN(C)C,CCCCCC1(CCCCC)C=NC(C)(C(=O)OC(C)(C)C)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso7,CC(C(=O)OC(C)(C)C)[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.440669686,https://www.nature.com/articles/s41587-019-0247-3,29,1,0,13,409.3668277,45.14,0,5,5.2818,123.634,0.916666667,1,3,409.659,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4958,LNP_0004958,LM_2019,LM_2019_F1078,A12Iso8C6,CCCCCC1(CCCCC)C=NC(CC(=O)OCC)N1CCCN(C)C,CCCCCC1(CCCCC)C=NC(CC(=O)OCC)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso8,CCOC(=O)CC[N+]#[C-],C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.969541721,https://www.nature.com/articles/s41587-019-0247-3,27,1,0,15,381.3355276,45.14,0,5,4.5032,114.422,0.909090909,1,3,381.605,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4959,LNP_0004959,LM_2019,LM_2019_F1079,A12Iso9C6,CCCCCC(CCCCC)(NCCCN(C)C)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCC(CCCCC)(NCCC[N+](C)(C)[H])C(=O)NCS(=O)(=O)c1ccc(C)cc1,A12,CN(C)CCCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.836072905,https://www.nature.com/articles/s41587-019-0247-3,32,1,1,17,467.3181633,78.51,2,5,4.28312,133.5632,0.72,0,3,467.72,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4960,LNP_0004960,LM_2019,LM_2019_F1080,A12Iso10C6,CCCCCC(CCCCC)(NCCCN(C)C)C(=O)NC1CCCCC1,CCCCCC(CCCCC)(NCCC[N+](C)(C)[H])C(=O)NC1CCCCC1,A12,CN(C)CCCN,Iso10,[C-]#[N+]C1CCCCC1,C6,CCCCCC(=O)CCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,HeLa,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.331645034,https://www.nature.com/articles/s41587-019-0247-3,27,1,0,15,381.3719131,44.37,2,3,4.876,117.2044,0.956521739,0,3,381.649,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4961,LNP_0004961,LM_2019,LM_2019_F1081,A12Iso52DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OCC)N1CCCN(C)C,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OCC)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.918682914,https://www.nature.com/articles/s41587-019-0247-3,50,1,0,36,699.664179,45.14,0,5,13.0275,220.425,0.866666667,1,3,700.194,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4962,LNP_0004962,LM_2019,LM_2019_F1082,A2Iso52DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OCC)N1CCCN1CCCC1,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OCC)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,2.054706751,https://www.nature.com/articles/s41587-019-0247-3,52,2,0,36,725.679829,45.14,0,5,13.5617,227.545,0.872340426,1,3,726.232,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4963,LNP_0004963,LM_2019,LM_2019_F1083,A3Iso52DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CCCNCC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.809008514,https://www.nature.com/articles/s41587-019-0247-3,53,0,0,41,745.7060438,70.67,2,5,12.801,231.6854,0.872340426,0,3,746.263,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4964,LNP_0004964,LM_2019,LM_2019_F1084,A5Iso52DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OCC)N1CCN(C)C,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OCC)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.503914438,https://www.nature.com/articles/s41587-019-0247-3,49,1,0,35,685.6485289,45.14,0,5,12.6374,215.808,0.863636364,1,3,686.167,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4965,LNP_0004965,LM_2019,LM_2019_F1085,A1Iso52DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OCC)N1CCN(CC)CC,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OCC)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.118421706,https://www.nature.com/articles/s41587-019-0247-3,51,1,0,37,713.679829,45.14,0,5,13.4176,225.042,0.869565217,1,3,714.221,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4966,LNP_0004966,LM_2019,LM_2019_F1086,A4Iso52DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.499195861,https://www.nature.com/articles/s41587-019-0247-3,51,0,0,38,717.6747436,61.88,1,5,11.9729,222.4617,0.866666667,0,3,718.209,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4967,LNP_0004967,LM_2019,LM_2019_F1087,A6Iso52DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.506299189,https://www.nature.com/articles/s41587-019-0247-3,52,0,0,39,731.6903937,61.88,1,5,12.363,227.0787,0.869565217,0,3,732.236,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4968,LNP_0004968,LM_2019,LM_2019_F1088,A8Iso52DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N1CCN(C)CC1,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.374391254,https://www.nature.com/articles/s41587-019-0247-3,51,1,0,35,715.6590936,61.88,1,5,11.7269,220.3477,0.866666667,0,3,716.193,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4969,LNP_0004969,LM_2019,LM_2019_F1089,A7Iso52DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.377769556,https://www.nature.com/articles/s41587-019-0247-3,52,0,0,39,731.6903937,61.88,1,5,12.363,227.0787,0.869565217,0,3,732.236,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4970,LNP_0004970,LM_2019,LM_2019_F1090,A11Iso52DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.862566683,https://www.nature.com/articles/s41587-019-0247-3,50,0,0,38,704.6431092,78.87,2,5,11.7937,215.6105,0.863636364,0,2,705.166,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4971,LNP_0004971,LM_2019,LM_2019_F1091,A9Iso52DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCN(CC)CC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.060099356,https://www.nature.com/articles/s41587-019-0247-3,53,0,0,40,745.7060438,61.88,1,5,12.7531,231.6957,0.872340426,0,3,746.263,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4972,LNP_0004972,LM_2019,LM_2019_F1092,A10Iso52DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)[N+](C)(CCO)[H],A10,CNCCO,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.371690943,https://www.nature.com/articles/s41587-019-0247-3,49,0,0,37,690.6274591,78.87,2,5,11.4036,210.9935,0.860465116,0,2,691.139,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4973,LNP_0004973,LM_2019,LM_2019_F1093,A3Iso62DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CCCNCC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.727589537,https://www.nature.com/articles/s41587-019-0247-3,55,0,0,40,773.7373439,70.67,2,5,13.5796,240.8974,0.87755102,0,3,774.317,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4974,LNP_0004974,LM_2019,LM_2019_F1094,A2Iso62DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCCN1CCCC1,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.709269864,https://www.nature.com/articles/s41587-019-0247-3,54,2,0,35,753.7111292,45.14,0,5,14.3403,236.757,0.87755102,1,3,754.286,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4975,LNP_0004975,LM_2019,LM_2019_F1095,A12Iso62DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCCN(C)C,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.654964124,https://www.nature.com/articles/s41587-019-0247-3,52,1,0,35,727.6954791,45.14,0,5,13.8061,229.637,0.872340426,1,3,728.248,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4976,LNP_0004976,LM_2019,LM_2019_F1096,A5Iso62DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCN(C)C,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.071909769,https://www.nature.com/articles/s41587-019-0247-3,51,1,0,34,713.679829,45.14,0,5,13.416,225.02,0.869565217,1,3,714.221,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4977,LNP_0004977,LM_2019,LM_2019_F1097,A1Iso62DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CCN(CC)CC,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OC(C)(C)C)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.6476599,https://www.nature.com/articles/s41587-019-0247-3,53,1,0,36,741.7111292,45.14,0,5,14.1962,234.254,0.875,1,3,742.275,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4978,LNP_0004978,LM_2019,LM_2019_F1098,A2Iso92DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCCN1CCCC1)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCC[N+]1([H])CCCC1)C(=O)NCS(=O)(=O)c1ccc(C)cc1,A2,C1CCN(C1)CCCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.441638521,https://www.nature.com/articles/s41587-019-0247-3,58,2,1,39,825.6781148,78.51,2,5,13.73172,251.3032,0.784313725,0,3,826.374,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4979,LNP_0004979,LM_2019,LM_2019_F1099,A1Iso92DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCN(CC)CC)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCC[N+](CC)(CC)[H])C(=O)NCS(=O)(=O)c1ccc(C)cc1,A1,CCN(CC)CCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.427984264,https://www.nature.com/articles/s41587-019-0247-3,57,1,1,40,813.6781148,78.51,2,5,13.58762,248.8002,0.78,0,3,814.363,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4980,LNP_0004980,LM_2019,LM_2019_F1100,A5Iso92DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCN(C)C)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCC[N+](C)(C)[H])C(=O)NCS(=O)(=O)c1ccc(C)cc1,A5,CN(C)CCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.14381021,https://www.nature.com/articles/s41587-019-0247-3,55,1,1,38,785.6468146,78.51,2,5,12.80742,239.5662,0.770833333,0,3,786.309,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4981,LNP_0004981,LM_2019,LM_2019_F1101,A12Iso92DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCCN(C)C)C(=O)NCS(=O)(=O)c1ccc(C)cc1,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(NCCC[N+](C)(C)[H])C(=O)NCS(=O)(=O)c1ccc(C)cc1,A12,CN(C)CCCN,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.44e-05,https://www.nature.com/articles/s41587-019-0247-3,56,1,1,39,799.6624647,78.51,2,5,13.19752,244.1832,0.775510204,0,3,800.336,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4982,LNP_0004982,LM_2019,LM_2019_F1102,A9Iso92DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCN(CC)CC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.275216759,https://www.nature.com/articles/s41587-019-0247-3,58,1,1,40,827.6937648,69.72,1,5,13.92982,253.4275,0.784313725,0,3,828.39,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4983,LNP_0004983,LM_2019,LM_2019_F1103,A8Iso92DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N1CCN(C)CC1,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.290599539,https://www.nature.com/articles/s41587-019-0247-3,56,2,1,35,797.6468146,69.72,1,5,12.90362,242.0795,0.775510204,0,3,798.32,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4984,LNP_0004984,LM_2019,LM_2019_F1104,A3Iso92DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CCCNCC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.318090404,https://www.nature.com/articles/s41587-019-0247-3,58,1,1,41,827.6937648,78.51,2,5,13.97772,253.4172,0.784313725,0,3,828.39,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4985,LNP_0004985,LM_2019,LM_2019_F1105,A6Iso92DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.488626303,https://www.nature.com/articles/s41587-019-0247-3,57,1,1,39,813.6781148,69.72,1,5,13.53972,248.8105,0.78,0,3,814.363,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4986,LNP_0004986,LM_2019,LM_2019_F1106,A7Iso92DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.580807703,https://www.nature.com/articles/s41587-019-0247-3,57,1,1,39,813.6781148,69.72,1,5,13.53972,248.8105,0.78,0,3,814.363,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4987,LNP_0004987,LM_2019,LM_2019_F1107,A4Iso92DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.595131994,https://www.nature.com/articles/s41587-019-0247-3,56,1,1,38,799.6624647,69.72,1,5,13.14962,244.1935,0.775510204,0,3,800.336,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4988,LNP_0004988,LM_2019,LM_2019_F1108,A11Iso62DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)[N+](CC)(CCO)[H],A11,CCNCCO,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.670695896,https://www.nature.com/articles/s41587-019-0247-3,52,0,0,37,732.6744093,78.87,2,5,12.5723,224.8225,0.869565217,0,2,733.22,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4989,LNP_0004989,LM_2019,LM_2019_F1109,A9Iso62DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCN(CC)CC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.696677962,https://www.nature.com/articles/s41587-019-0247-3,55,0,0,39,773.7373439,61.88,1,5,13.5317,240.9077,0.87755102,0,3,774.317,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4990,LNP_0004990,LM_2019,LM_2019_F1110,A11Iso92DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(CC)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)[N+](CC)(CCO)[H],A11,CCNCCO,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.73742046,https://www.nature.com/articles/s41587-019-0247-3,55,1,1,38,786.6308302,86.71,2,5,12.97042,237.3423,0.770833333,0,2,787.293,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4991,LNP_0004991,LM_2019,LM_2019_F1111,A6Iso62DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.743910905,https://www.nature.com/articles/s41587-019-0247-3,54,0,0,38,759.7216938,61.88,1,5,13.1416,236.2907,0.875,0,3,760.29,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4992,LNP_0004992,LM_2019,LM_2019_F1112,A4Iso62DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.745508491,https://www.nature.com/articles/s41587-019-0247-3,53,0,0,37,745.7060438,61.88,1,5,12.7515,231.6737,0.872340426,0,3,746.263,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4993,LNP_0004993,LM_2019,LM_2019_F1113,A7Iso62DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.874648985,https://www.nature.com/articles/s41587-019-0247-3,54,0,0,38,759.7216938,61.88,1,5,13.1416,236.2907,0.875,0,3,760.29,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4994,LNP_0004994,LM_2019,LM_2019_F1114,A8Iso62DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N1CCN(C)CC1,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.940096296,https://www.nature.com/articles/s41587-019-0247-3,53,1,0,34,743.6903937,61.88,1,5,12.5055,229.5597,0.872340426,0,3,744.247,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4995,LNP_0004995,LM_2019,LM_2019_F1115,A10Iso92DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)N(C)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCS(=O)(=O)c1ccc(C)cc1)[N+](C)(CCO)[H],A10,CNCCO,Iso9,[C-]#[N+]CS(=O)(=O)C1=CC=C(C)C=C1,2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.952461223,https://www.nature.com/articles/s41587-019-0247-3,54,1,1,37,772.6151802,86.71,2,5,12.58032,232.7253,0.765957447,0,2,773.266,False,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4996,LNP_0004996,LM_2019,LM_2019_F1116,A10Iso62DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)N(C)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OC(C)(C)C)[N+](C)(CCO)[H],A10,CNCCO,Iso6,CC(C)(C)OC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDC,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.030796908,https://www.nature.com/articles/s41587-019-0247-3,51,0,0,36,718.6587592,78.87,2,5,12.1822,220.2055,0.866666667,0,2,719.193,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4997,LNP_0004997,LM_2019,LM_2019_F1117,A12Iso52DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OCC)N1CCCN(C)C,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OCC)N1CCC[N+](C)(C)[H],A12,CN(C)CCCN,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDM,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.74936294,https://www.nature.com/articles/s41587-019-0247-3,50,1,0,36,699.664179,45.14,0,5,13.0275,220.425,0.866666667,1,3,700.194,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4998,LNP_0004998,LM_2019,LM_2019_F1118,A2Iso52DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OCC)N1CCCN1CCCC1,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OCC)N1CCC[N+]1([H])CCCC1,A2,C1CCN(C1)CCCN,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDM,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.576348926,https://www.nature.com/articles/s41587-019-0247-3,52,2,0,36,725.679829,45.14,0,5,13.5617,227.545,0.872340426,1,3,726.232,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,4999,LNP_0004999,LM_2019,LM_2019_F1119,A3Iso52DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CCCNCC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)[N+](CC)(CCCNCC)[H],A3,CCNCCCNCC,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDM,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,1.418449803,https://www.nature.com/articles/s41587-019-0247-3,53,0,0,41,745.7060438,70.67,2,5,12.801,231.6854,0.872340426,0,3,746.263,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,5000,LNP_0005000,LM_2019,LM_2019_F1120,A5Iso52DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OCC)N1CCN(C)C,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OCC)N1CC[N+](C)(C)[H],A5,CN(C)CCN,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDM,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.359877978,https://www.nature.com/articles/s41587-019-0247-3,49,1,0,35,685.6485289,45.14,0,5,12.6374,215.808,0.863636364,1,3,686.167,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,5001,LNP_0005001,LM_2019,LM_2019_F1121,A1Iso52DC18,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OCC)N1CCN(CC)CC,CCCCCCCC/C=C\CCCCCCCC1(CCCCCCC/C=C\CCCCCCCC)C=NC(C(=O)OCC)N1CC[N+](CC)(CC)[H],A1,CCN(CC)CCN,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDM,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,0.111974111,https://www.nature.com/articles/s41587-019-0247-3,51,1,0,37,713.679829,45.14,0,5,13.4176,225.042,0.869565217,1,3,714.221,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,5002,LNP_0005002,LM_2019,LM_2019_F1122,A4Iso52DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CC[N+](C)(C)[H],A4,CNCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDM,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.341580424,https://www.nature.com/articles/s41587-019-0247-3,51,0,0,38,717.6747436,61.88,1,5,11.9729,222.4617,0.866666667,0,3,718.209,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,5003,LNP_0005003,LM_2019,LM_2019_F1123,A6Iso52DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCC[N+](C)(C)[H],A6,CNCCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDM,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.6256674,https://www.nature.com/articles/s41587-019-0247-3,52,0,0,39,731.6903937,61.88,1,5,12.363,227.0787,0.869565217,0,3,732.236,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,5004,LNP_0005004,LM_2019,LM_2019_F1124,A8Iso52DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N1CCN(C)CC1,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N1CC[N+](C)([H])CC1,A8,CN1CCNCC1,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDM,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.646289507,https://www.nature.com/articles/s41587-019-0247-3,51,1,0,35,715.6590936,61.88,1,5,11.7269,220.3477,0.866666667,0,3,716.193,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,5005,LNP_0005005,LM_2019,LM_2019_F1125,A7Iso52DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CCN(C)C,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CC[N+](C)(C)[H],A7,CCNCCN(C)C,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDM,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.666063255,https://www.nature.com/articles/s41587-019-0247-3,52,0,0,39,731.6903937,61.88,1,5,12.363,227.0787,0.869565217,0,3,732.236,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,5006,LNP_0005006,LM_2019,LM_2019_F1126,A11Iso52DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(CC)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)[N+](CC)(CCO)[H],A11,CCNCCO,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDM,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.83653452,https://www.nature.com/articles/s41587-019-0247-3,50,0,0,38,704.6431092,78.87,2,5,11.7937,215.6105,0.863636364,0,2,705.166,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,5007,LNP_0005007,LM_2019,LM_2019_F1127,A9Iso52DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCN(CC)CC,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CC[N+](CC)(CC)[H],A9,CCN(CC)CCNC,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDM,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-0.934179412,https://www.nature.com/articles/s41587-019-0247-3,53,0,0,40,745.7060438,61.88,1,5,12.7531,231.6957,0.872340426,0,3,746.263,True,False,False
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,5008,LNP_0005008,LM_2019,LM_2019_F1128,A10Iso52DC18,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)N(C)CCO,CCCCCCCC/C=C\CCCCCCCC(CCCCCCC/C=C\CCCCCCCC)(C(=O)NCC(=O)OCC)[N+](C)(CCO)[H],A10,CNCCO,Iso5,CCOC(=O)C[N+]#[C-],2DC18,CCCCCCCC/C=C\CCCCCCCC(=O)CCCCCCC/C=C\CCCCCCCC,,,,,,,35.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,16.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,46.5,DMPE-PEG2000,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(OCCNCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)O)OC(=O)CCCCCCCCCCCCC,2.5,None,,0.0,citrate,None,handmixed,in_vitro,BMDM,in_vitro,in_vitro,mRNA,FLuc,0.1,luminescence_normalized,individual,-1.165699239,https://www.nature.com/articles/s41587-019-0247-3,49,0,0,37,690.6274591,78.87,2,5,11.4036,210.9935,0.860465116,0,2,691.139,True,False,False
